triazoles has been researched along with voriconazole in 2443 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 63 (2.58) | 18.2507 |
| 2000's | 1179 (48.26) | 29.6817 |
| 2010's | 1114 (45.60) | 24.3611 |
| 2020's | 87 (3.56) | 2.80 |
| Authors | Studies |
|---|---|
| Andriole, VT; George, D; Miniter, P | 1 |
| Barry, AL; Brown, SD | 1 |
| Hitchcock, CA; Martin, MV; Yates, J | 1 |
| Ruhnke, M; Schmidt-Westhausen, A; Trautmann, M | 1 |
| Armstrong, D; Bernard, EM; Ishimaru, T; Murphy, M | 1 |
| Johnson, EM; Radford, SA; Warnock, DW | 1 |
| Gage, R; Stopher, DA | 2 |
| Milatovic, D; Schwartz, S; Thiel, E | 1 |
| Cooper, CR; Fothergill, AW; McGinnis, MR; Pasarell, L; Rinaldi, MG; Sutton, DA | 2 |
| Belanger, P; Fratti, R; Ghannoum, M; Nast, CC; Sanati, H | 1 |
| Belanger, P; Fratti, R; Ghannoum, M; Sanati, H | 1 |
| Haberreiter, A; Paule, I; Seidl, HP; Wildfeuer, A | 1 |
| Espinel-Ingroff, A | 2 |
| Jones, RN; Marco, F; Messer, S; Pfaller, MA | 1 |
| Nguyen, MH; Yu, CY | 2 |
| Belanger, PH; Fratti, RA; Ghannoum, MA; Sanati, H | 1 |
| Brummer, E; Purimetla, N; Stevens, DA; Vora, S | 1 |
| de Sévaux, RG; Kullberg, BJ; Meis, JF; van de Nes, JA; van der Meer, JW; Verweij, PE | 1 |
| Girmenia, C; Luzi, G; Martino, P; Monaco, M | 1 |
| Kauffman, CA; Zarins, LT | 2 |
| Meis, JF; van 't Hek, LG; van Dalen, R; Verweij, PE; Weemaes, CM; Yntema, JB | 1 |
| McGinnis, MR; Pasarell, L | 1 |
| Hitchcock, CA; Koltin, Y | 1 |
| Denning, DW; Moore, CB; Oakley, KL | 1 |
| Brummer, E; Chauhan, S; Stevens, DA; Vora, S | 1 |
| Cantu, RA; Fothergill, AW; Kirkpatrick, WR; Lopez-Ribot, JL; Mcatee, RK; McCarthy, DI; Patterson, TF; Revankar, SG; Rinaldi, MG; Sanche, SE | 1 |
| Brummer, E; Kamei, K; Miyaji, M | 2 |
| Denning, DW; Donnelly, JP; Meis, JF; Mensink, M; Rijs, AJ; Verweij, PE | 1 |
| Baquero, F | 1 |
| Clancy, CJ; Nguyen, MH | 1 |
| Chandrasekar, PH; Cutright, JL; Manavathu, EK | 3 |
| Cuenca-Estrella, M; Martínez-Suárez, JV; Mellado, E; Monzón, A; Rodríguez-Tudela, JL | 1 |
| Diehl, V; Fätkenheuer, G; Hegener, P; Ruhnke, M; Troke, PF | 1 |
| Brandt, ME; Doern, GV; Hajjeh, RA; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Brandt, ME; Ghannoum, MA; Hajjeh, RA; Jessup, CJ; Mbidde, EK; Messer, SA; Pfaller, MA; Tumberland, M; Zhang, J | 1 |
| Audouin, AF; Breton, P; Germaud, P; Harousseau, JL; Milpied, N; Morin, O | 1 |
| Chandrasekar, PH; Cutright, J; Manavathu, EK | 1 |
| Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
| Abraham, OC; Chandrasekar, PH; Cutright, JL; Manavathu, EK | 1 |
| Johnson, EM; Szekely, A; Warnock, DW | 1 |
| Brinkman, K; Kremer, HP; Kullberg, BJ; Meis, JF; Verweij, PE | 1 |
| Bhat, N; Ghannoum, MA; Okogbule-Wonodi, I; Sanati, H | 1 |
| Jones, RN; Marco, F; Messer, SA; Pfaller, MA | 1 |
| Hoban, DJ; Karlowsky, JA; Zhanel, GG | 1 |
| Fothergill, AW; Revankar, SG; Rinaldi, MG; Sanche, SE; Sutton, DA | 1 |
| Cuenca-Estrella, M; Martínez-Suárez, JV; Monzón, A; Rodríguez-Tudela, JL; Ruiz-Díez, B | 1 |
| Matsushima, T; Nakajima, M; Niki, Y | 1 |
| Amalfitano, G; Concia, E; Kwon-Chung, KJ; Luzzati, R; Mondon, P; Petter, R; Polacheck, I | 1 |
| Cuenca-Estrella, M; Díaz-Guerra, TM; Mellado, E; Monzón, A; Rodríguez-Tudela, JL | 1 |
| Anaissie, EJ; Arikan, S; Lozano-Chiu, M; Paetznick, VL; Rex, JH | 1 |
| Ghannoum, M; Koul, A; Reyes, G; Vitullo, J | 1 |
| Berridge, JC; Coleman, MW; Fell, AF; Owens, PK | 1 |
| Bernal, S; Chávez, M; Gutierrez, MJ; Mazuelos, EM; Quindós, G; Valverde, A | 1 |
| Arikan, S; Lozano-Chiu, M; Nangia, S; Paetznick, V; Rex, JH | 1 |
| Del Moral, F; García, MT; Lima, JE; Llorente, MT; Mínguez, F; Prieto, J | 1 |
| Patterson, TF | 1 |
| Fothergill, AW; Modak, A; Pennick, GJ; Perea, S; Rinaldi, MG; Sheehan, DJ; Sutton, DA | 1 |
| Chiou, CC; Groll, AH; Walsh, TJ | 1 |
| Chandrasekar, PH; Cutright, J; Manavathu, E | 1 |
| Ciblak, MA; Li, RK; McGinnis, MR; Nordoff, N; Pasarell, L; Warnock, DW | 1 |
| Fothergill, AW; Rinaldi, MG; Saracli, MA; Yildiran, ST | 1 |
| Ernst, EJ; Klepser, ME; Lewis, RE; Malone, D; Pfaller, MA | 1 |
| Kappe, R | 2 |
| Arnadóttir, M; Asmundsson, P; Bödvarsson, M; Hilmarsdóttir, I; Thorsteinsson, SB | 1 |
| Cerón, A; Montoya, J; Poza, G; Redondo, C; Rodriguez-Tudela, JL; Ruiz, J; Simarro, E; Vila, N | 1 |
| Liu, XP; Sugar, AM | 2 |
| Niki, Y | 1 |
| Chandrasekar, PH; Cutright, JL; Loebenberg, D; Manavathu, EK | 1 |
| Agostini, H; Althaus, C; Jensen, HE; Reis, A; Sundmacher, R; Tintelnot, K | 1 |
| Cassone, A; Girmenia, C; Martino, P; Monaco, M; Mondello, F; Santilli, S; Tuccinardi, C | 1 |
| Abdel-Rahman, SM; Sabo, JA | 1 |
| Fothergill, AW; Kirkpatrick, WR; McAtee, RK; Patterson, TF; Rinaldi, MG | 1 |
| Bolmstrom, A; Houston, A; Jones, RN; Messer, SA; Mills, K; Pfaller, MA | 1 |
| Bretagne, S; Curfs, JH; Meis, JF; Verweij, PE; Weemaes, CM | 1 |
| McDougal, EC; Nesky, MA; Peacock, JE | 1 |
| Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O | 1 |
| Lee, JK; Noskin, GA; Obias, AA; Peters, D; Peterson, LR | 1 |
| Bouza, E; Marín, M; Martín Rabadán, P; Muñoz, P; Rodríguez-Creixéms, M; Tornero, P | 1 |
| Amariglio, N; Bielorai, B; Golan, H; Kaplinisky, C; Keller, N; Mandel, M; Neumann, Y; Paswell, J; Rechavi, G; Toren, A; Weintraub, M; Wolach, B | 1 |
| Dierich, MP; Lass-Flörl, C; Nagl, M; Speth, C; Ulmer, H; Würzner, R | 1 |
| Fothergill, AW; Perea, S; Rinaldi, MG; Sutton, DA | 1 |
| Müller, FM; Weig, M | 1 |
| Leitner, I; Ryder, NS | 1 |
| Karlsson, I; Kronvall, G | 1 |
| Kämmerer, R; Klempien, I; Kujath, P; Muhl, E | 1 |
| Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
| Abraham, OC; Chandrasekar, PH; Manavathu, EK | 1 |
| Girija, R; Hwang, YK; Joo, NH; Tan, L; Tan, P; Tee, GY | 1 |
| Carrillo, AJ; Guarro, J | 1 |
| Bacigalupo, A; Machetti, M; Mordini, N; Paola, D; Van Lint, MT; Veroni, L; Viscoli, C; Zotti, M | 1 |
| Boyle, K; Espinel-Ingroff, A; Sheehan, DJ | 1 |
| Crego, AL; Gómez, J; Lavandera, JL; Marina, ML | 1 |
| Diekema, DJ; Fluit, AC; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA; Sader, HS | 1 |
| Li, RK; McGinnis, MR; Nordoff, N; Pasarell, L; Warnock, DW | 1 |
| Aguirrebengoa, K; Ally, R; Carosi, G; Dupont, B; Hodges, M; Kreisel, W; Romero, AJ; Schürmann, D; Troke, P | 1 |
| Gigliotti, F; Wellington, M | 1 |
| Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A | 1 |
| Denning, DW; Griffiths, CE | 1 |
| Diemert, D; Kunimoto, D; Rennie, R; Sand, C | 1 |
| Cuenca-Estrella, M; Gómez-López, A; Monzón, A; Rodriguez-Tudela, JL | 1 |
| Denning, DW; Mosquera, J | 1 |
| Ernst, EJ; Klepser, ME; Roling, EE; Yodoi, K | 1 |
| Anaissie, E; Arndt, C; Donowitz, G; Finberg, R; Fioritoni, G; Garber, G; Greenberg, R; Hadley, S; Laverdière, M; Lazarus, HM; Lee, J; Pappas, P; Perfect, J; Petersen, F; Raffalli, J; Reboli, A; Reinhardt, J; Schuster, M; Stiff, P; Walsh, TJ; Wingard, J; Winston, DJ; Yanovich, S | 1 |
| Marr, KA | 1 |
| Dixon, CA; Goldberger, MJ; Powers, JH | 1 |
| Caillot, D; Denning, DW; Haas, A; Herbrecht, R; Lode, H; Milpied, N; Ribaud, P; Ruhnke, M; Thiel, E | 1 |
| Higashiyama, Y; Iwakawa, J; Kohno, S; Maesaki, S; Miyazaki, Y; Tashiro, T; Tomono, K; Yanagihara, K | 1 |
| Griffiths, PD | 1 |
| Brummer, E; Chiller, T; Farrokhshad, K; Stevens, DA | 1 |
| Hoffman, HL; Rathbun, RC | 1 |
| De Roux, A; Grassot, A; Grysczyk, H; Lode, H; Mauch, H | 1 |
| Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Blumer, JL; Lazarus, HM; Romero, A; Schlamm, H; Yanovich, S | 1 |
| Le Pogamp, P; Nilsson, LG; Romero, AJ; Wood, N | 1 |
| Drew, RH; Perfect, JR; Pound, MW | 1 |
| Colebunders, R; Ieven, M; Noë, A; Ostyn, B; Swinne, D | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Huynh, H; Messer, SA; Pfaller, MA | 1 |
| Fothergill, AW; Gonzalez, G; Perea, S; Rinaldi, MG; Sutton, DA | 1 |
| Dismukes, WE; Lee, J; Walsh, TJ | 1 |
| Driscoll, T; Dupont, B; Ghahramani, P; Groll, AH; Hodges, M; Lutsar, I; Perfect, JR; Roden, M; Walsh, TJ | 1 |
| DE Carolis, E; Loranger, L; Marcotte, H; Pelletier, R | 1 |
| Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 2 |
| Espinel-Ingroff, A; Rezusta, A | 1 |
| Johnson, JR | 1 |
| Cornely, OA; Heussel, CP; Ullmann, AJ | 1 |
| Apisarnthanarak, A; Little, JR; Tebas, P | 1 |
| Ghannoum, MA; Kuhn, DM | 1 |
| Gil-Lamaignere, C; Maloukou, A; Mosquera, J; Roilides, E; Walsh, TJ | 1 |
| Barry, A; Brown, S; Traczewski, M | 1 |
| Bernhardt, H; Bernhardt, J; Knoke, M; Zimmermann, K | 1 |
| De Vries-Hospers, HG; Meis, JF; Rijs, AJ; Te Dorsthorst, DT; Verweij, PE | 1 |
| Habel, F; Hoban, D; Laverdiere, M; Restieri, C | 1 |
| Bastide, JM; Dannaoui, E; Grillot, R; Mallie, M; Meletiadis, J; Piens, MA; Rigoni, AL; Tortorano, AM; Viviani, MA | 1 |
| Allen, MJ; Ghahramani, P; Greenhalgh, K; Kleinermans, D; Purkins, L; Wood, N | 1 |
| Coco, BJ; Kirkpatrick, WR; Patterson, TF; Perea, S | 1 |
| Chen, N; Glickman, RD; Graybill, JR; Lam, KW; Sponsel, WE; Zhou, L | 1 |
| Bennett, JE; Caillot, D; Chandrasekar, PH; de Pauw, B; Denning, DW; Durand, C; Greene, RE; Herbrecht, R; Hodges, MR; Kern, WV; Lortholary, O; Marr, KA; Oestmann, JW; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Stark, P; Sylvester, R; Thiel, E; Troke, PF; Wingard, JR | 1 |
| Fothergill, AW; Gonzalez, G; Kirkpatrick, WR; Patterson, TF; Perea, S; Rinaldi, MG | 1 |
| Gayowski, T; Singh, N; Venkataramanan, R; Zang, S | 1 |
| Greenberg, RN; Martin, CA; Roberts, S | 1 |
| Chen, E; Ostrosky-Zeichner, L; Paetznick, VL; Paphitou, NI; Rex, JH; Rodriguez, JR | 1 |
| Chryssanthou, E; Cuenca-Estrella, M | 2 |
| Garbino, J; Hirschel, B | 1 |
| Baglivo, E; Baligvo, E; Bouchuiguir-Wafa, K; Garbino, J; Lew, D; Ondrusova, A; Rohner, P | 1 |
| Darouiche, RO; Kontoyiannis, DP; Lewis, RE; Prince, RA; Raad, II | 1 |
| Brown, NE; Chow, L; Kunimoto, D | 1 |
| Brown, J; Potoski, BA | 1 |
| Fothergill, AW; Rinaldi, MG; Sutton, DA; Yildiran, ST | 1 |
| Goa, KL; Muijsers, RB; Scott, LJ | 1 |
| Bacigalupo, A; Ferrua, MT; Gallamini, A; Ghirardo, D; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Viscoli, C | 1 |
| Danielsen, R; Einarsdóttir, HM; Gottfredsson, M | 1 |
| Blot, F; Edé, C; Nitenberg, GM | 1 |
| Karthaus, M | 2 |
| Meis, JF; Meletiadis, J; Mouton, JW; Verweij, PE | 1 |
| Jones, DB; Shah, KB; Wilhelmus, KR; Wu, TG | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Diekema, DJ; Hollis, RJ; Maxwell, MJ; Messer, SA; Pfaller, MA | 1 |
| Matsunaga, T; Nagino, K; Uchida, K; Yamaguchi, H | 1 |
| Deplus, S; Dombret, H; Feuillhade, M; Fournier, S; Molina, JM; Pavageau, W; Verola, O; Zagdanski, AM | 1 |
| Falk, R; Polacheck, I; Shapiro, M; Wolf, DG | 1 |
| Johnson, LB; Kauffman, CA | 1 |
| Kottom, TJ; Limper, AH; Morales, IJ; Puri, V; Thomas, CF; Vohra, PK | 1 |
| Ullmann, AJ | 2 |
| Herbrecht, R | 2 |
| Bernal, S; Chávez M, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Ramirez, M; Serrano, Mdel C; Valverde-Conde, A | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Maxwell, MJ; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
| Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, JB; Pfaller, MA | 1 |
| Howden, BP; Mijch, AM; Schwarer, AP; Slavin, MA | 1 |
| Adderson, EE; Andreansky, M; Luján-Zilbermann, J; Rodriguez, CA; Woodard, P | 1 |
| Dierch, MP; Gunsilius, E; Kofler, G; Lass-Flörl, C; Speth, C; Würzner, R | 1 |
| Chapman, SW; Cleary, JD; Pearson, MM; Rogers, PD | 1 |
| Anghilieri, M; Cafro, AM; Carrafiello, G; Cesana, C; D'Avanzo, G; Marbello, L; Morra, E; Nosari, A | 1 |
| Burt, C; de Groot, MJ; Filler, SG; Fukuoka, T; Hitchcock, CA; Johnston, DA; Winslow, CA | 1 |
| Chan, J | 1 |
| Kamei, K | 1 |
| Lipp, HP | 2 |
| Holzgrabe, U; Schäfer-Korting, M | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA | 2 |
| Hodges, MR; Lutsar, I; Tomaszewski, K; Troke, PF; Wood, ND | 1 |
| Allen, S; Pai, MP | 1 |
| Bayer, A; Edwards, JE; Rieg, G; Spellberg, B | 1 |
| Ruhnke, M | 1 |
| Hyland, R; Jones, BC; Smith, DA | 1 |
| Chen, E; Matar, MJ; Ostrosky-Zeichner, L; Paetznick, VL; Rex, JH; Rodriguez, JR | 1 |
| de la Torre-Cisneros, J; DuPont, B; Espinel-Ingroff, A; Greenberg, RN; Johnson, E; Just-Nübling, G; Lutsar, I; Marr, KA; Perfect, JR; Schlamm, HT; Walsh, TJ | 1 |
| Mori, T | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Tendolkar, S | 3 |
| Eggink, C; Nulens, E; Rijs, AJ; Verweij, PE; Wesseling, P | 1 |
| Johnson, PD; Korman, TM; Stratov, I | 1 |
| Belmatoug, N; de Lastours, V; Dufour, V; Fantin, B; Lefort, A; Zappa, M | 1 |
| Harris, GJ; Kim, JE; Perkins, SL | 1 |
| Bocanegra, R; Gonzalez, GM; Graybill, JR; Hernandez, S; Najvar, LK | 1 |
| Hamza, SH; Mercado, PJ; Skelton, HG; Smith, KJ | 1 |
| Cole, S; Comby, P; Gibson, D; Jezequel, SG; Nedderman, AN; Roffey, SJ; Smith, DA; Walker, DK; Wood, N | 1 |
| Feldmesser, M; Pamer, EG; Van Epps, HL | 1 |
| Chehade, M; Esmail-Zaden, R; Galanopoulas, A; Lai, TF; Malhotra, R; Selva, D | 1 |
| Ellis, DH; Gosbell, IB; Kuo, RS; Perrie, RC; Toumasatos, V; Yong, J | 1 |
| Bennett, JE; Cortez, KJ; Walsh, TJ | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzón, A; Rodriguez-Tudela, JL | 2 |
| del Palacio, A; Garau, M; Pereiro, M | 1 |
| Clark, M; Pennick, GJ; Rinaldi, MG; Sutton, DA | 1 |
| Sutton, DA | 1 |
| Alvarez, ME; Fortún, J; Martín-Dávila, P; Moreno, S; Pintado, V; Sánchez, MA; Sánchez-Sousa, A | 1 |
| Choquet, S; Chosidow, O; Consigny, S; Datry, A; Dhedin, N; Leblond, V | 1 |
| Walson, PD | 1 |
| Fung, HB; Jeu, L; Lyakhovetskiy, AG; Piacenti, FJ | 1 |
| Girmenia, C; Martino, P | 1 |
| Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ | 1 |
| Biert, J; Bosma, F; de Sévaux, RG; Kullberg, BJ; Melchers, WG; van Hamersvelt, HW; Verweij, PE; Voss, A | 1 |
| Arrese, JE; Piérard, GE; Piérard-Franchimont, C; Quatresooz, P | 1 |
| Lutsar, I; Roffey, S; Troke, P | 1 |
| Almela, M; Danés, C; de la Bellacasa, JP; Espasa, M; Jiménez de Anta, MT; Jurado, A; Marco, F; Martínez, JA; Mensa, J | 1 |
| Hilhorst, MI; Kuijpers, TW; Scherpbier, HJ | 1 |
| Schäfer-Korting, M | 1 |
| Gupta, AK; Tomas, E | 1 |
| Giles, SS; Kurtzberg, J; Perfect, JR; Schell, WA; Steinbach, WJ; Trinh, JV | 1 |
| Cook, C; Fernandez, C; Fraser, R; McCully, B; Schmidt, M; Shouldice, E | 1 |
| Benito, R; Gil, J; Ramírez de Ocáriz, I; Rezusta, A; Rubio Calvo, MC | 1 |
| Alaggio, R; Cecchetto, G; Cesaro, S; Cusinato, R; Pillon, M; Rigobello, L; Strugo, L; Zanesco, L | 1 |
| Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 2 |
| Capilla, J; Guarro, J; Ortoneda, M; Pastor, FJ; Rinaldi, MG; Serena, C; Sutton, DA | 1 |
| Andes, D; Conklin, R; Marchillo, K; Stamstad, T | 1 |
| Dromer, F; Lamer, C; Le Guillou, JL; Le Jouan, M; Martinez, V; Tod, M | 1 |
| Klopfenstein, KJ; Powell, D; Rosselet, R; Termuhlen, A | 1 |
| Auner, HW; Dornbusch, HJ; Eibl, M; Linkesch, W; Sill, H; Zinke-Cerwenka, W | 1 |
| Alfandari, S; Bauters, F; Benchikh, Z; Camus, D; Catteau, B; Cordevant, C; De Botton, S; Dei-Cas, E; Delhaes, L; Durand-Joly, I; Espinel-Ingroff, A; Rodrigue, M | 1 |
| Garbino, J; Kolarova, L; Lew, D; Ondrusova, A; Rohner, P | 1 |
| Kullberg, BJ; Ostrosky-Zeichner, L; Oude Lashof, AM; Rex, JH | 1 |
| Denning, D; Guiver, M; Sambatakou, H | 1 |
| Chávez-Caballero, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Serrano-Martino, Mdel C; Valverde-Conde, A | 1 |
| Kontoyiannis, DP; Lewis, RE; Lionakis, MS; Liu, W; May, GS; Wiederhold, N | 1 |
| Chaturvedi, V; Gangwar, M; Ramani, R | 1 |
| Chávez, M; Claro, R; Espinel-Ingroff, A; Mazuelos, EM; Morilla, D; Ramírez, M; Serrano, MC; Valverde, A | 1 |
| Johnston, A | 1 |
| Eve, MD; Greenhalgh, K; Nichols, D; Oliver, SD; Purkins, L; Wood, N | 1 |
| Allen, MJ; Greenhalgh, K; Oliver, SD; Purkins, L; Wood, N | 1 |
| Greenhalgh, K; Kleinermans, D; Nichols, D; Purkins, L; Wood, N | 1 |
| Kleinermans, D; Nichols, D; Purkins, L; Wood, N | 3 |
| Ghahramani, P; Kleinermans, D; Layton, G; Nichols, D; Purkins, L; Wood, N | 1 |
| Eve, MD; Fielding, A; Ghahramani, P; Love, ER; Purkins, L; Wood, N | 1 |
| Hamlin, J; Kleinermans, D; Layton, G; Nichols, D; Purkins, L; Tan, K; Wood, N | 1 |
| Kleinermans, D; Love, ER; Purkins, L; Wood, N | 1 |
| Bernhardt, H; Bernhardt, J; Knoke, M | 2 |
| Bliss, JM; Gigliotti, F; Wellington, M | 1 |
| Jacobs, RF; Maples, HD; Saccente, SL; Stowe, CD | 1 |
| Capilla, J; Guarro, J; Ortoneda, M; Pastor, FJ; Serena, C | 1 |
| Gallamini, A; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Pugno, F; Viscoli, C | 1 |
| Sims-McCallum, RP | 1 |
| Ehlert, K; Groll, AH; Kolve, H; Paulussen, M; Vormoor, J | 1 |
| Baron, EJ; Colombo, AL; de Bedout, C; del Palacio, A; Gibbs, DL; Girmenia, C; Hazen, KC; Sanchez-Sousa, A | 1 |
| Bilger, K; D'incan, E; Damaj, G; Doglio, MF; Faucher, C; Gastaut, JA; Ivanov, V; Le Brigand, B; Vey, N | 1 |
| Martin, PL; Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ | 1 |
| Bonner, D; Fung-Tomc, J; Huczko, E; Minassian, B; Washo, T | 1 |
| Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S | 1 |
| Chow, E; Moore, T; Nielsen, K | 1 |
| Baden, LR; DelVecchio, A; Doran, M; Fishman, JA; Katz, JT; Koziol, C; Rubin, RH | 1 |
| Denning, DW; Hope, WW | 1 |
| Chi, J; Gao, H; Hariprasad, SM; Holz, ER; Kim, JE; Mieler, WF; Prince, RA | 1 |
| Baboor, M; Diaz, MC; Fica, A; Luppi, M; Olivares, R; Saez, L; Vasquez, P | 1 |
| Alangaden, GJ; Baskaran, I; Chandrasekar, PH; Manavathu, EK; Varanasi, NL | 1 |
| Maertens, JA | 1 |
| De Pauw, BE; Donnelly, JP | 1 |
| Burgos San José, A; Hernández Prats, C; Llinares Tello, F; Ordovás Baines, JP; Selva Otaolaurruchi, J | 1 |
| Capilla, J; Guarro, J; Javier Pastor, F; Ortoneda, M; Pujol, I | 1 |
| Casal, M; Charriel, G; Linares, MJ; Solís, F | 1 |
| Díaz, MA; González-Vicent, M; Lassaletta, A; Madero, L; Perez, A; Sevilla, J | 1 |
| Gao, H; Hariprasad, SM; Holz, ER; Mieler, WF; Pennesi, M; Qiao, X; Shah, K; Wu, SM | 1 |
| Caliandro, R; Girard, P; Stern, JB | 1 |
| Baden, LR; Cosimi, LA; Marty, FM | 1 |
| Gothard, P; Rogers, TR | 1 |
| Cappelli, B; Castagnola, E; Dodero, P; Faraci, M; Machetti, M; Molinari, AC; Morreale, G; Tomà, P | 1 |
| Dupont, B | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Rice, C; Tendolkar, S | 2 |
| Bastié, JN; Bretagne, S; Castaigne, S; Chehata, S; Cordonnier, C; Kuentz, M; Maury, S; Pautas, C; Ribaud, P | 1 |
| Abidi, MH; Chandrasekar, PH; Ibrahim, RB; Vishnubhotla, P | 1 |
| Contu, L; La Nasa, G; Ledda, A; Littera, R; Maccioni, A; Vacca, A | 1 |
| Mehta, J; Trifilio, S; Verma, A; Williams, S; Zembower, T | 1 |
| Aliyeva, SE; Frising, M; Kottler, UB; Schwenn, O; Ullmann, AJ | 1 |
| Schwartz, S; Thiel, E | 3 |
| Höhl, R | 1 |
| Almeida, C; Chávez, M; Claro, R; Espinel-Ingroff, A; Fernández, A; Martín-Mazuelos, E; Morilla, D; Ramírez, M; Serrano, MC; Valverde, A | 1 |
| Smilack, JD; Sohail, MR | 1 |
| Barry, A; Bille, J; Brown, S; Ellis, D; Meis, JF; Pfaller, MA; Rennie, R; Rinaldi, M; Rogers, T; Traczewski, M | 1 |
| Clement, A; De Arévalo, BF; Figueroa, MS; Fortun, J | 1 |
| García-Bustínduy, M; Guimerá-Martín-Neda, F; Montelongo, RG; Noda-Cabrera, A; Sánchez-González, R | 1 |
| Blankenship, JR; Heitman, J; Onyewu, C; Perfect, JR; Schell, WA; Steinbach, WJ | 1 |
| Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Rodriguez, JR | 1 |
| Innes, JR; Moss, PJ; Thaker, HR; Varma, D; Wedgwood, K | 1 |
| Bethell, D; Goodman, TR; Hall, G; Klein, N; Pollard, AJ | 1 |
| Kamei, K; Nishimura, K; Zeng, J; Zheng, Y | 1 |
| Rubin, ZA; Somani, J | 1 |
| Alfonso, EC; Giaconi, JA; Marangon, FB; Miller, D | 2 |
| Danaher, PJ; Walter, EA | 1 |
| Miller, J; Perlroth, MG | 1 |
| Adou-Bryn, KD; Buisson, Y; Chandenier, J; Douchet, C; Kombila, M; Richard-Lenoble, D; Sar, B; Swinne, D; Thérizol-Ferly, M | 1 |
| Ausin, I; Badia, X; Carreras, E; Herrera, L; Roset, M | 1 |
| Casadevall, A; Cleare, W; Nosanchuk, JD; van Duin, D; Zaragoza, O | 1 |
| Adamson, P; Arguedas, AG; Arrieta, AC; Blumer, J; Driscoll, T; Karlsson, MO; Lutsar, I; Milligan, P; Saez-Llorens, X; Vora, AJ; Walsh, TJ; Wood, N | 1 |
| Proia, LA; Tenorio, AR | 1 |
| Basso, C; Biffanti, R; Milanesi, O; Stellin, G; Thiene, G; Vida, V | 1 |
| Buclin, T; Liaudet, L; Marchetti, O; Padoin, C; Robatel, C; Rusca, M | 1 |
| Ikeda, Y; Kondo, K; Miyoshi, S; Nakashima, M; Sekiguchi, K; Umemura, K | 1 |
| Lohr, L | 1 |
| Alaggio, R; Calore, E; Cesaro, S; Cusinato, R; Messina, C; Pillon, M; Toffolutti, T; Zanesco, L | 1 |
| Nolard, N; Swinne, D; Van der Flaes, M; Watelle, M | 1 |
| Friedrich, W; Gahr, M; Hahn, G; Koch, A; Roesler, J; Rösen-Wolff, A | 1 |
| Mattner, F; Strueber, M; Weissbrodt, H | 1 |
| Bocanegera, R; Colombo, AL; Gonzalez, GM; Graybill, JR; Hernandez, S; McCarthy, DI; Najvar, LK | 1 |
| Chang, CS; Chang, HW; Chang, WN; Chien, CC; Huang, CR; Lee, PY; Lei, CB; Lu, CH | 1 |
| Anderson, KL; Mitra, S; Pham, TA; Salouti, R; Taylor, HR | 1 |
| Antoniades, A; Giotakis, J; Imbrios, G; Manesis, EK; Tsiodras, S; Zafiropoulou, R | 1 |
| Peetermans, WE; Van Wijngaerden, E; Vandecasteele, SJ | 1 |
| Drago, M; Morace, G; Scaltrito, MM | 1 |
| Holyoake, TL; McQuaker, IG; Osborne, WL; Parker, AN | 1 |
| Aoun, M | 1 |
| Germaud, P; Morin, O | 1 |
| Benjamin, DK; Jafri, H; Kontoyiannis, DP; Lionakis, MS; Lutsar, I; Marr, KA; Perfect, JR; Steinbach, WJ; Torres, HA; Walsh, TJ | 1 |
| Bernhardt, H; Bernhardt, J; Knoke, M; Ludwig, K | 1 |
| Cheng, HH; Lo, HJ; Yang, YL | 1 |
| Al-Fattani, MA; Douglas, LJ | 1 |
| Baldassarri, I; Barchiesi, F; Fothergill, AW; Maracci, M; Rinaldi, MG; Scalise, G; Spreghini, E | 1 |
| Balajee, SA; Englund, JA; Fredricks, DN; Imhof, A; Marr, KA | 1 |
| Bartelt, LA; de Magalhaes-Silverman, M; Diekema, DJ; Dodgson, KJ; Hoth, PL; Kilborn, SB; Pfaller, MA; Siwek, GT | 1 |
| Bouteille, B; Debette-Gratien, M; Denes, E; Gaulier, JM; Pichon, N | 1 |
| Bigley, VH; Duarte, RF; Gosling, RD; Kibbler, CC; Potter, M; Seaton, S | 1 |
| Bonatti, H; Dierich, MP; Freund, MC; Gastl, G; Gschwendtner, A; Gunsilius, E; Kropshofer, G; Lass-Flörl, C; Petzer, A | 1 |
| Castro, C; Espinel-Ingroff, A; Flores, B; Martín-Mazuelos, E; Serrano, MC | 1 |
| Blin, N; Gaillard, F; Harousseau, JL; Milpied, N; Moreau, P; Morin, O; Morineau, N | 1 |
| Bruneel, F; Chevret, S; de Broucker, T; Lellouche, F; Régnier, B; Tattevin, P; Wolff, M | 1 |
| Karlsson, MO; Milligan, PA; Thomson, AH; Wählby, U | 1 |
| Kleinpeter, MA | 1 |
| Bannwarth, B; Jarry, C; Péhourcq, F | 1 |
| Capilla, J; Guarro, J | 1 |
| Kuijper, EJ; Kullberg, BJ; van 't Wout, JW; Verweij, PE | 1 |
| Gavaldá, J; Lumbreras, C | 1 |
| del Palacio, A; Garau, M; Garcí, J; Gené, J; Molina, L; Perkins, A | 1 |
| Klastersky, J | 1 |
| Chryssanthou, E; Sjölin, J | 1 |
| Espinel-Ingroff, A; Jones, RN; Pfaller, MA | 1 |
| Azzola, A; Bubendorf, L; Eich, G; Gratwohl, A; Habicht, JM; Passweg, JR; Tamm, M | 1 |
| Alkan, Y; Burhenne, J; Haefeli, WE; Shalit, I; Stein, J; Yaniv, I | 1 |
| Boeckh, M; Carter, RA; Corey, L; Kim, HW; Marr, KA | 1 |
| Viscoli, C | 1 |
| Bonnell, M; Currier, BL; Orenstein, R; Prabhu, RM | 1 |
| Wark, P | 1 |
| Blazes, DL; Dolan, CK; Hall, MA; Norwood, CW | 1 |
| Boyd, AE; Denning, DW; Howard, SJ; Keevil, BG; Modi, S; Moore, CB | 1 |
| Drusano, GL | 2 |
| Andreadis, D; Antoniades, D; Arsenis, G; Belazi, M; Destouni, E; Eliopoulou, C; Hini, S; Koussidou-Eremondi, T; Velegraki, A | 1 |
| Jones, AL; Pai, MP | 1 |
| D'Antonio, D; Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I | 1 |
| Chiodo, F; Consales, A; Manfredi, R; Pavoni, M; Sabbatani, S | 1 |
| Fujisaki, G; Kami, M; Kishi, Y; Kobayashi, K; Mitamura, T; Murashige, N | 1 |
| Gao, H; Hariprasad, SM; Holz, ER; Mieler, WF; Pennesi, ME; Qiao, X; Shah, K; Wu, SM | 1 |
| Chadwick, EG; Guzman-Cottrill, JA; Zheng, X | 1 |
| Wingard, JR | 1 |
| Balajee, SA; Gribskov, JL; Imhof, A; Marr, KA | 1 |
| Vervaeren, J | 1 |
| Comair, Y; Kanafani, ZA; Kanj, SS | 1 |
| Benjamin, DK; Heitman, J; Miller, JL; Perfect, JR; Schell, WA; Singh, N; Steinbach, WJ | 1 |
| Cariani, L; Drago, M; Morace, G; Scaltrito, MM | 1 |
| Beltramo, D; Levin, T; Samuel, R; Suh, B | 1 |
| Denning, DW; Howard, SJ; Keevil, BG; Lockhart, S; Moore, CB; Newman, S | 1 |
| Carrilero, MJ; Granados, JM; Puerto, N | 1 |
| Burn, AK; Coco, BJ; Fothergill, AW; Kirkpatrick, WR; McCarthy, DI; Patterson, TF; Redding, SW; Rinaldi, MG | 1 |
| Huang, DB; Lahart, CJ; Wu, JJ | 1 |
| Mastromarino, A; Polizzi, A; Saccà, SC; Siniscalchi, C | 1 |
| Alexander, BD; Brennan, K; Forrest, G; Husain, S; Muñoz, P; Singh, N; Somani, J; Wagener, MM | 1 |
| Friedman, GS; Mathis, AS; Shah, NK | 1 |
| Agrawal, AK; Sherman, LK | 1 |
| Aebi, C; Aebischer, CC; Ammann, RA; Gugger, M; Jaton, K; Ritz, N; Schmid, RA | 1 |
| Bansal, M; Fealy, S; Khazzam, M | 1 |
| Casal, M; Charriel, G; Ibarra, A; Linares, MJ; Rodriguez, F; Solís, F | 1 |
| Egle, H; König, A; Kümmerer, K; Trittler, R | 1 |
| Demponeras, C; Kanta, E; Karandreas, N; Manesis, EK; Tsiodras, S; Zafiropoulou, R | 1 |
| Perfect, JR | 2 |
| Marr, K | 1 |
| Breit, SM; Grand, MG; Hariprasad, SM; Mieler, WF; Mills, MD; Shah, GK | 1 |
| Birnbaum, DE; Jagiello, M; Liebold, A; Retzl, G; Wieland, T | 1 |
| Mehta, J; Ortiz, R; Pennick, G; Pi, J; Stosor, V; Trifilio, S; Verma, A; Zembower, T | 1 |
| Clezy, K; van Hal, SJ | 1 |
| Han, XY; Hassan, SA; Matsuda, SP; May, GS; Tarrand, JJ; Wilson, WK; Xiong, Q | 1 |
| Danaher, PJ | 1 |
| Lowry, CM; Marty, FM | 1 |
| Soto, J | 1 |
| Balwierz, W | 1 |
| Azanza, JR; Campanero, MA; Quetglas, EG; Sádaba, B | 1 |
| Berry, GJ; DiGiulio, DB; Fothergill, AW; McClenny, NM; Mirels, LF; Montoya, JG; Rinaldi, MG; Schaenman, JM | 1 |
| Lien, YH; Peng, LW | 1 |
| Belohradsky, BH; Führer, M; Graubner, UB; Kammer, B; Moelter, C; Schmid, I; Schuster, F | 1 |
| Gehrig, AK; Hoppe-Tichy, T; Nguyen, H; Wenzel, S | 1 |
| García-Agudo, L; García-Martos, P; Gutiérrez-Calzada, J; Marín, P; Ruiz-Aragón, J; Saldarreaga, A | 1 |
| Chevallier, P; Dubruille, V; Guillaume, T; Harousseau, JL; Mahé, B; Méchinaud, F; Milpied, N; Moreau, P; Morin, O; Morineau, N; Vigouroux, S | 1 |
| Oren, I | 1 |
| Del Favero, A; Kibbler, C; Marciniak, A; Mauskopf, J; Morris, S; Rogers, T; Rotstein, C; Schlamm, H; Troke, P; Wenzel, R | 1 |
| Klepser, ME; Lewis, RE; Wiederhold, NP | 1 |
| Alcazar-Fuoli, L; Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL | 1 |
| Cuvelier, C; Goffin, E; Kirch, L; Pochet, JM; Tintillier, M | 1 |
| Benito, R; de Ocáriz, IR; Gil, J; Rezusta, A; Rubio, MC | 1 |
| Chen, A; Sobel, JD | 1 |
| Horstkotte, MA; Rohde, H; Sobottka, I; Steininger, C; Stellbrink, HJ; van Lunzen, J | 1 |
| Burkhardt, O; Köhnlein, T; Pletz, M; Welte, T | 1 |
| Bailly, E; Bastides, F; Ehrmann, S; Gissot, V; Legras, A; Magro, P; Mercier, E | 1 |
| Bastide, JM; Blancard, A; Bonnin, A; Bretagne, S; Cambon, M; Chandenier, J; Chauveau, V; Couprie, B; Datry, A; Feuilhade, M; Grillot, R; Guiguen, C; Lavarde, V; Letscher, V; Linas, MD; Mallié, M; Michel, A; Morin, O; Paugam, A; Piens, MA; Raberin, H; Tissot, E; Toubas, D; Wade, A | 1 |
| Dupont, B; Fain, O; Herbrecht, R; Lescure, FX; Lortholary, O; Lutsar, I; Mouas, H | 1 |
| Cudillo, L; de Fabritiis, P; Dentamaro, T; Girmenia, C; Picardi, A; Santilli, S; Tendas, A | 1 |
| Fabry, K; Nelen, G; Verheyden, F | 1 |
| Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Viudes, A | 1 |
| Yasuda, MA | 1 |
| Kontoyiannis, DP; Lionakis, MS | 1 |
| Nolard, N; Swinne, D; Watelle, M | 1 |
| Dinser, R; Grgic, A; Kim, YJ; Pfreundschuh, M; Schubert, J | 1 |
| Irving, H; Labrom, R; Nissen, M; O'Regan, P; Siebert, D; Whyte, M | 1 |
| Garbino, J; Lew, D; Rohner, P; Uckay, I; Van Delden, C | 1 |
| Chandrasekar, PH; Krishnan, S; Manavathu, EK | 1 |
| Ballesta, S; García, I; Pascual, A; Perea, EJ | 1 |
| Cesaro, S; Visintin, G | 1 |
| Aksamit, AJ; Bakleh, M; Marshall, WF; Tleyjeh, IM | 1 |
| Chaberny, IF; Fischer, S; Gastmeier, P; Gottlieb, J; Haubitz, B; Mattner, F; Mattner, L; Strueber, M; Weissbrodt, H | 1 |
| Ermert, L; Lohmeyer, J; Lommel, D; Ludwig, M; Schneider, H; Sziegoleit, A; Weidner, W | 1 |
| Hansen, R; Mendelson, D; Park, A; Racette, AJ; Roenigk, HH | 1 |
| Casal, M; Linares, MJ; Solís, F | 1 |
| Mohammedi, I; Padoin, C; Piens, MA; Robert, D | 1 |
| Gil-Lamaignere, C; Hess, R; Heyn, K; Kappe, R; Müller, FM; Salvenmoser, S | 1 |
| de Kerviler, E; Derouin, F; Feuilhade de Chavin, M; Lacroix, C; Morel, P | 1 |
| Christmann, D; Eisenmann, B; Forestier, E; Hansman, Y; Lesens, O; Martinot, M; Remy, V | 1 |
| Cuenca-Estrella, M; Elia, M; Gutierrez, F; Masia, M; Ramos, JM; Rodriguez-Tudela, JL | 1 |
| Leather, H | 1 |
| Antachopoulos, C; Bibashi, E; Dotis, J; Koliouskas, D; Papakonstantinou, E; Roilides, E; Tamiolaki, M | 1 |
| Baltch, AL; Bopp, LH; Carlyn, CJ; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
| Brown, J; Freeman, BB | 1 |
| Eggink, CA; Klont, RR; Rijs, AJ; Verweij, PE; Wesseling, P | 1 |
| Böhme, A; Haas, A; Maschmeyer, G | 1 |
| Dierich, MP; Lass-Flörl, C; Leitner, S; Rief, A; Speth, C; Würzner, R | 1 |
| Berthou, C; Eveillard, JR; Ianoto, JC; Karam, A; Le Flohic, AM; Le Roy, JP; Misery, L; Quinio, D | 1 |
| Boisseau-Garsaud, AM; Calès-Quist, D; Desbois, N; Diedhou, A; Dutriaux, C; Saint-Cyr, I | 1 |
| Steinbach, WJ | 2 |
| Ambegaonkar, AJ; Boucher, HW; Day, DL; Lewis, JS; Lubowski, TJ; Patterson, TF | 1 |
| Jacobs, RF; Maples, HD; Muldrew, KM; Stowe, CD | 1 |
| Jang, GJ; Kim, KS; Lee, WK; Shin, WS | 1 |
| Alsultan, A; Goldman, FD; Lubner, S; Williams, MS | 1 |
| Kofla, G; Ruhnke, M | 1 |
| Auvrignon, A; Boccon-Gibod, L; Landman-Parker, J; Leverger, G; Moissenet, D; Petit, A; Tabone, MD | 1 |
| Keady, S; Thacker, M | 1 |
| Corey, L; Cornely, OA; Driscoll, T; Lutsar, I; Ribaud, P; Ruhnke, M; Schuler, U; Schwartz, S; Thiel, E; Troke, P | 1 |
| Banfield, M; Burhenne, J; Haefeli, WE; Mikus, G; Rengelshausen, J; Riedel, KD; Thomsen, T; Walter-Sack, I; Weiss, J | 1 |
| Fothergill, AW; González, GM; Loebenberg, D; Rinaldi, MG; Sutton, DA | 1 |
| Horn, TD; Sharp, MT | 1 |
| McCluskey, P; Singh, RP | 1 |
| Athanassiadou, F; Kalogera, A; Kourti, M; Papageorgiou, T; Tragiannidis, A; Velegraki, A | 1 |
| Fruehwirth, F; Khoschsorur, G; Zelzer, S | 1 |
| Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Philip, A; Rex, JH; Rodriguez, J | 1 |
| Morace, G; Polonelli, L | 1 |
| Bedini, A; Cocchi, S; Codeluppi, M; Esposito, R; Guaraldi, G; Squillace, N; Venturelli, C | 1 |
| Barton, TD; McGarvey, M; Milas, B; Pochettino, A; Reboli, A; Reis, LJ; Schuster, MG; Velazquez, O | 1 |
| Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE | 1 |
| Jagirdar, J; Scott, RS; Sutton, DA | 1 |
| Cetinkaya, Z; Kiraz, N | 1 |
| Kotamarthi, V; Shankar, J; Sharma, V | 1 |
| Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM | 1 |
| Cárdenes, CD; Carrillo-Muñoz, AJ; Carrillo-Orive, B; Casals, JB; Del Valle, O; Ezkurra, PA; Quindós, G; Rodríguez, V | 1 |
| Costa-de-Oliveira, S; Mårdh, PA; Pina-Vaz, C; Ricardo, E; Rodrigues, AG | 1 |
| Bullock, PR; Chakraborty, A; Workman, MR | 1 |
| Debets-Ossenkopp, YJ; van Furth, AM; van Groeningen, I; van Well, GT; Zwaan, CM | 1 |
| MacCallum, DM; Odds, FC; Whyte, JA | 1 |
| Aguado, JM; Cisneros, JM; Díaz Pedroche, C; Lumbreras, C | 1 |
| Azar, DT; D'Amico, DJ; Durand, ML; Kieval, SJ; Kim, IK; Loewenstein, JI; Lujan, BJ; Martin, SS; Miller, FS; Miller, JW; Tobin, EH | 1 |
| Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE | 1 |
| Costa-de-Oliveira, S; Espinel-Ingroff, A; Pina-Vaz, C; Rodrigues, AG | 1 |
| Bergeron, A; Dromer, F; Ferry, C; Feuilhade, M; Gluckman, E; Hermoso, DG; Lacroix, C; Molina, JM; Pavie, J; Ribaud, P; Robin, M | 1 |
| Bagg, J; Brailsford, S; Davies, AN; Jackson, MS; Sweeney, MP | 1 |
| Alía-Aponte, C; Baró-Tomás, T; Jiménez-Cabello, T; Lázera, MS; Morera-López, Y; Torres-Rodríguez, JM | 1 |
| Allepuz-Palau, A; Alvarez-Lerma, F; Díaz-Regañón, J; García-López, F; Nicolás-Arfelis, JM; Rodríguez-Borregán, JC; Sa-Borges, M | 1 |
| Fianchi, L; Gleissner, B; Pagano, L | 1 |
| Bishara, J; Peled, N; Samra, Z; Yardeni, M | 1 |
| Kontoyiannis, DP; Lewis, RE | 2 |
| Bauer, M; Graninger, W; Joukhadar, C; Kulemann, V | 1 |
| Bonatti, H; Dierich, MP; Freund, M; Gastl, G; Griff, K; Kropshofer, G; Lass-Flörl, C; Mayr, A; Nachbaur, D; Petzer, A | 1 |
| Blair, JE; Leslie, KO; Lyons, MK | 1 |
| Niwa, T; Shiraga, T; Takagi, A | 1 |
| Schiel, X; Spöhrer, U; Vogeser, M | 1 |
| Espinel-Ingroff, A; Fothergill, A; Ghannoum, M; Manavathu, E; Ostrosky-Zeichner, L; Pfaller, M; Rinaldi, M; Schell, W; Walsh, T | 1 |
| Alexander, BD; Long, GD; Miller, JL; Perfect, JR; Schell, WA | 1 |
| Chan-Tack, KM | 1 |
| Baker, CJ; Pannaraj, PS; Walsh, TJ | 1 |
| Barak, A; Bash, E; Loewenstein, A; Neudorfer, M; Siegman-Igra, Y; Zayit-Soudry, S | 1 |
| Colombo, GL; Morlotti, L; Serra, G | 1 |
| Argaud, L; Martin, O; Mohammedi, I; Piens, MA; Robert, D; Thiebaut, A | 1 |
| Bennett, JE; Boucher, HW; Denning, DW; DePauw, B; Herbrecht, R; Lortholary, O; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Troke, P; Wingard, JR | 1 |
| Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW | 1 |
| Blijlevens, NM; Jansen, JP; Meis, JF; van't Wout, JW | 1 |
| Balfour-Lynn, I; Buchdahl, R; Bush, A; Davies, J; Edwards, S; Francis, J; Hilliard, T; Rosenthal, M | 1 |
| Ballentine, CS; Glickman, RD; Graybill, JR; Harrison, JM; Kumar, N; Kurian, P; Lloyd, WC; Melendez, R; Miller, A; Miller, MM; Najvar, LK; Paris, G; Patel, AH; Pena, MA; Sponsel, WE; Trigo, Y; Trujillo, F | 1 |
| Blatny, J; Burgetova, D; Kren, L; Mudry, P; Prochazka, J; Skotakova, J; Sterba, J; Valik, D; Ventruba, J | 1 |
| Schoeni, MH | 1 |
| Bertz, H; Finke, J; Kern, WV; Sander, A; Wagner, D | 1 |
| Bennett, MT; Sirrs, S; Smith, CA; Yeung, JK | 1 |
| Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G | 1 |
| Devouassoux, G; Freymond, N; Harf, R; Le Loch, JB; Pacheco, Y; Rakotomalala, A | 1 |
| Nagino, K; Shirasawa, H | 1 |
| Decosterd, LA; Duchosal, MA; Gambillara, E; Kovacsovics, T; Laffitte, E; Panizzon, RG; Widmer, N | 1 |
| Chamilos, G; Kontoyiannis, DP | 1 |
| Baruch, A; Dowell, JA; Foster, G; Schranz, J | 1 |
| Adams, HP; Apostolova, LG; Johnson, EK | 1 |
| Conte, JV; Dropulic, LK; Girgis, R; Mcdyer, JF; Orens, JB; Shlobin, OA; Yang, SY | 1 |
| Barfield, RC; Behm, FG; Burnette, K; Eldridge, P; Hale, GA; Handgretinger, R; Knapp, K | 1 |
| Clemons, KV; Espiritu, M; Parmar, R; Stevens, DA | 1 |
| Heyn, K; Müller, FM; Salvenmoser, S; Tredup, A | 1 |
| Baró-Tomás, T; Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM | 1 |
| Cutler, JE; Hazen, KC; Wetter, TJ | 1 |
| Barnes, R; Diekema, DJ; Gibbs, DL; Hu, B; Nagy, E; Pfaller, MA; Rinaldi, MG; Tiraboschi, N; Veselov, AV | 1 |
| Burhenne, J; Foell, JL; Reiss, T; Rengelshausen, J; Staege, MS; Stiefel, M; Wawer, A | 1 |
| Fulcher, T; Hannan, M; O'Doherty, M | 1 |
| Cohen, EJ; Hammersmith, KM; Kang, S; Ozbek, Z; Rapuano, CJ; Sivalingam, J | 1 |
| Chamilos, G; Kontoyiannis, DP; Lewis, RE | 1 |
| Chen, N; Dang, D; Glickman, R; Graybill, J; Lam, KW; Najvar, LK; Paris, G; Scribbick, F; Sponsel, W; Zhou, L | 1 |
| Al-Agha, OM; Mooty, M; Salarieh, A | 1 |
| Carpenter, J; Howell, A; Hurley, D; Midturi, J; Sierra-Hoffman, M; Winn, R | 1 |
| Curigliano, G; de Braud, F; De Pas, T; Fazio, N; Formica, V; Goldhirsch, A; Pietri, E; Spitaleri, G | 1 |
| Araujo, R; Pina-Vaz, C; Rodrigues, AG | 2 |
| Chang, SC; Chen, YC; Hsieh, SM; Lee, HT; Pan, SC | 1 |
| Kumar, R; Naithani, R | 1 |
| Denning, DW; Jain, LR | 1 |
| Brayshaw, N; Tan, K; Tomaszewski, K; Troke, P; Wood, N | 1 |
| Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Bosch, M; Cantón, E; Gobernado, M; Pemán, J; Viudes, A | 1 |
| Marik, PE; Raman, T | 1 |
| Clode, AB; Davis, JL; Gilger, BC; Michau, TM; Salmon, J | 1 |
| Kyo, T; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T | 1 |
| Alarcón L, P; Camacho A, J; Cruces R, P; Donoso F, A | 1 |
| Ellis, D; Harkness, J; Kwong, T; Marriott, D | 1 |
| Magalhaes, EP; Nehemy, MB; Torqueti-Costa, L; Vasconcelos-Santos, DV | 1 |
| Baccari, P; Fumagalli, L; Lazzarin, A; Magnani, P; Prigitano, A; Sagnelli, C | 1 |
| Aguado, JM; Del Busto, R; Fisher, RA; Forrest, G; Houston, S; Husain, S; Klintmalm, GB; Kontoyiannis, DP; Lewis, RE; Limaye, AP; Miller, R; Montoya, JG; Muñoz, P; Patton, P; Pursell, K; Rosso, F; Safdar, N; Singh, N; Wagener, MM | 1 |
| Droll, A; Krähenbühl, S; Wenk, M | 1 |
| Carde, A; Faure, P; Papy, E; Ribaud, P; Touratier, S | 1 |
| Casadevall, A; Martinez, LR | 1 |
| Delikou, S; Kitra, V; Miyakis, S; Papadakis, V; Papadatos, I; Parcharidou, A; Polychronopoulou, S; Velegraki, A | 1 |
| Carmichael, JK | 1 |
| Bal, AM | 2 |
| Andes, D; Chaturvedi, V; Diekema, DJ; Espinel-Ingroff, A; Ghannoum, MA; Johnson, EM; Odds, FC; Pfaller, MA; Rex, JH; Rinaldi, MG; Sheehan, DJ; Troke, P; Walsh, TJ; Warnock, DW | 1 |
| Appelgren, P; Farnebo, F; Hedblad, MA; Petrini, B | 1 |
| Dombrowski, F; Franke, A; Jentsch-Ullrich, K; Koenigsmann, M; Mohren, M; Schalk, E | 1 |
| Al-Attar, A; Redett, RJ; Williams, CG | 1 |
| Fernández Ballesteros, A; Flox Benítez, G; Quero Escalada, M; Rondón Fernández, P | 1 |
| Badet, M; Bayle, F; Guérin, C; Lemasson, S; Philit, F; Poupelin, JC; Richard, JC | 1 |
| de Marie, S; den Hollander, JG; Levin, MD; Lugtenburg, PJ; Rijnders, BJ; van Arkel, C | 1 |
| Herbrecht, R; Jehl, F; Levêque, D; Nivoix, Y | 1 |
| Kamani, N; Panicker, J; Walsh, T | 1 |
| Coco, BJ; Kirkpatrick, WR; Patterson, TF | 1 |
| Ambrose, PG; Andes, D; Bhavnani, SM; Knasinski, V; Safdar, N; Simmons, W; Smith, J | 1 |
| Laine, K; Leino, K; Neuvonen, PJ; Olkkola, KT; Saari, TI; Valtonen, M | 3 |
| Agostinelli, C; Arpinati, M; Baccarani, M; Bandini, G; Bonifazi, F; Giannini, B; Paolini, S; Ricci, P; Stanzani, M; Vianelli, N | 1 |
| Allamani, M; Falagas, ME; Michalopoulos, A; Vassiloyanakopoulos, A | 1 |
| Le Tulzo, Y; Tattevin, P | 1 |
| Croxo, C; Darras, A; Mulliez, P; Roy-Saint Georges, F | 1 |
| Castro-Orjales, MJ; Collell-Llach, MD; de la Torre-Fernández, MJ; Díaz-López, MD; León, C; López-Ciudad, V; Pérez de Juan-Romero, MA; Sanz-Rodríguez, C | 1 |
| Ada, E; Avkan Oğuz, V; Balci, P; Ceylan, E; Gülşen, A; Güngör, O; Kargi, A; Sanli, A; Tertemiz, KC; Uçan, ES; Uğural Sezak, N | 1 |
| Brakhage, AA; da Silva Ferreira, ME; Goldman, GH; Goldman, MH; Kim, HS; Malavazi, I; Nierman, WC; Savoldi, M | 1 |
| Cobb, S; Diekema, DJ; Hoth, P; Magalheas-Silverman, M; Pfaller, MA; Polgreen, PM; Siwek, GT | 1 |
| Hasan, Y; Stableforth, P; Wandroo, F | 1 |
| Antin, JH; Baden, LR; Campbell, BJ; Cutler, CS; Fiumara, K; Lowry, CM; Marty, FM | 1 |
| Capitano, B; Husain, S; McCurry, KR; Paterson, DL; Potoski, BA; Studer, SM; Venkataramanan, R; Zhang, S | 1 |
| Alcalá, L; Bouza, E; Guinea, J; Peláez, T | 3 |
| Crum-Cianflone, N; Dull, M; Teneza-Mora, N | 1 |
| Gribskov, JL; Kirby, KA; Marr, KA; Panackal, AA; Rinaldi, M; Staab, JF | 1 |
| Bosch, M; Cantón, E; de Llanos, R; Jarque, I; Molina, A; Pemán, J; Salavert, M | 1 |
| Denis, O; Estenne, M; Jacobs, F; Knoop, C; Nolard, N; Schrooyen, M; Symoens, F | 1 |
| Amorosa, V; Bridges, CR; Isidro, AM; Pentz, WH; Rutenberg, HL; Stopyra, GA | 1 |
| Braun-Falco, M; Ring, J | 1 |
| Jarque, I; Salavert, M | 1 |
| Bosch, M; Calabuig, E; Cantón, E; Gobernado, M; Pemán, J; Valentí, A; Viudes, A | 1 |
| Axer-Siegel, R; Bishara, J; Blau, H; Kramer, M; Kramer, MR; Weinberger, D | 1 |
| Berry, A; Cassaing, S; Hajj, LE; Khatibi, S; Linas, MD; Magnaval, JF; Marchou, B; Massip, P; Porte, L; Sans, N | 1 |
| Hynninen, VV; Laine, K; Leino, K; Lundgren, S; Neuvonen, PJ; Olkkola, KT; Rane, A; Valtonen, M; Vyyryläinen, H | 1 |
| Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F | 1 |
| Gilgado, F; Guarro, J; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL | 1 |
| Akova, M; Sahin, GO | 1 |
| Aperis, G; Mylonakis, E | 1 |
| Amrein, C; Auffret, N; Chevalier, P; Guillemain, R; Janssen, F; Le Beller, C | 1 |
| Davis, JL; Papich, MG; Salmon, JH | 1 |
| Denning, DW; Dupont, B; Lode, H; Sambatakou, H | 1 |
| Brandenburg, VM; Floege, J; Guetgemann, A; Ketteler, M; Riehl, J | 1 |
| Blijlevens, NM; Donnelly, JP; Klont, RR; van der Velden, WJ; Verweij, PE | 1 |
| Clemons, KV; Martinez, M; Parmar, R; Stevens, DA | 1 |
| Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP | 2 |
| Antony, SJ; Brumble, L; Jurczyk, P | 1 |
| Kujath, P; Scheele, J | 1 |
| Agarwal, R; Singh, N | 1 |
| Claes, K; Evenepoel, P; Kuypers, DR; Vanrenterghem, Y | 1 |
| Farina, C; Goglio, A; Gotti, E; Suter, F | 1 |
| Colson, YL; Marty, FM; Paul, S | 1 |
| Edwards, C; Garcia, RJ; Troya, P | 1 |
| Craven, DE; Gorman, SR; Magiorakos, AP; Zimmerman, SK | 1 |
| Derendorf, H; Ihle, F; Theuretzbacher, U | 1 |
| Blackwood, RA; Klein, KC | 1 |
| Ghannoum, M; Isham, N; Sheehan, D | 1 |
| Lee, GA; McDougall, R; Whitehead, K | 1 |
| Carby, M; Hall, AV; Zoumot, Z | 1 |
| Almyroudis, NG; Bhatti, Z; Segal, BH; Shaukat, A | 1 |
| Asada, N; Komatsu, M; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H | 1 |
| Chiadmi, F; Cisternino, S; Fontan, JE; Sahraoui, L; Schlatter, J; Toledano, A | 1 |
| Pemán, J; Zaragoza, R | 1 |
| Bäsecke, J; Glass, B; Perske, C; Rüchel, R | 1 |
| Arechavala, A; Bianchi, MH; López Daneri, G; Negroni, R; Robles, AM; Santiso, G | 1 |
| Björkholm, M; Cherif, H; Kalin, M | 1 |
| Eifinger, F; Frankenbusch, K; Kribs, A; Rengelshauseu, J; Roth, B | 1 |
| Buzina, W; Feierl, G; Haas, D; Holl, A; Kleinert, R; Marth, E; Reichenpfader, B; Reinthaler, FF; Roll, P | 1 |
| Burhenne, J; Ding, R; Drzewinska, M; Haefeli, WE; Mikus, G; Rengelshausen, J; Riedel, KD; Schöwel, V; Thomsen, T; Weiss, J | 1 |
| Chaturvedi, V; Cole, R; Gangwar, M; Ramani, R; Sheehan, DJ | 1 |
| Casadevall, A; Mavrogiorgos, N; Nosanchuk, JD; Zaragoza, O | 1 |
| Burhenne, J; Cornely, OA; Elter, T; Fätkenheuer, G; Gossmann, A; Kuchta, J; Riedel, KD; Schröder, U; Seifert, H; Sieniawski, M; Wickenhauser, C | 1 |
| Dikman, S; Huprikar, S; Linden, E; Murphy, B; Restrepo, D | 1 |
| Gottfredsson, M; Steingrímsdóttir, H | 1 |
| Rokicka, M | 1 |
| Selleslag, D | 1 |
| Burhenne, J; Egerer, G; Geist, MJ; Mikus, G | 1 |
| Kadota, J; Tokimatsu, I | 1 |
| Hapuarachchi, S; Jayasinghe, S; Perera, KN; Ranwala, R; Rodrigo, N; Warnakulasuriya, A | 1 |
| Bailey, TA; Di Somma, A; Silvanose, CD | 1 |
| Cepero de García, MC; Espinel-Ingroff, A; Rincón, S | 1 |
| Barcs, I; Dóczi, I; Mestyán, G; Nagy, E; Nikolova, R; Puskás, E | 1 |
| Chusid, MJ; Destino, L; Havens, PL; Helon, AL; Sutton, DA; Thometz, JG; Willoughby, RE | 1 |
| Klastersky, J; Paesmans, M | 1 |
| Lill, H; Voigt, C | 1 |
| Cornely, OA; Glöckner, A | 1 |
| Burhenne, J; von Mach, MA; Weilemann, LS | 1 |
| Bodkin, J; Bubb, WA; Coen, M; Himmelreich, U; Kuchel, PW; Power, D; Sorrell, TC | 1 |
| Aperis, G; Mylonakis, E; Spanakis, EK | 1 |
| Akiyama, H; Honma, M; Ito, T; Muramatsu, T; Negishi, K; Ohashi, K; Sakai, M; Sakamaki, H; Shitara, M; Suzuki, T; Ueki, T; Yamashita, T | 1 |
| Georgopoulos, A; Graninger, W; Kratzer, C; Schmoll, M; Tobudic, S | 1 |
| Bouges-Michel, C; Dannaoui, E; Garcia-Hermoso, D; Lortholary, O; Meneau, I; Naccache, JM; Sanglard, D; Valeyre, D | 1 |
| Manfredi, R; Sabbatani, S | 1 |
| Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
| Chang, SC; Diekema, DJ; Erzsebet, P; Gibbs, DL; Kibbler, C; Mendez, M; Newell, VA; Pfaller, MA | 1 |
| Colombo, AL; Diekema, DJ; Gibbs, DL; Kibbler, C; Newell, VA; Ng, KP; Pfaller, MA | 1 |
| Beck, R; Kaben, U; Tintelnot, K | 1 |
| Alvarez-Lerma, F; Grau, S; Marín-Casino, M; Mateu-De, AJ; Torres-Rodríguez, JM | 1 |
| Gopal, L; Sen, P; Sen, PR | 1 |
| De Stefano, V; Fianchi, L; Leone, G; Murri, R; Pagano, L; Rossi, E | 1 |
| Denning, DW; Gardiner, RE; Howard, SJ; Moore, CB; Park, S; Perlin, DS; Webster, I | 1 |
| Chambers, D; Chin, W; Gabbay, E; Murray, R; Musk, M | 1 |
| Alegre, M; Alomar, A; Dalmau, J; Gurgui, M; Pimentel, CL; Roé, E; Sanchez, F | 1 |
| Burhenne, J; Haefeli, WE; Kaufmann, C; Thiel, MA; Zinkernagel, AS | 1 |
| Crespo, M; Husain, S; Johnson, B; Kwak, EJ; McCurry, KR; Pakstis, DL; Paterson, DL; Pilewski, J; Shutt, K; Studer, S; Zaldonis, D; Zeevi, A | 1 |
| Borgia, SM; El-Helou, P; Fuller, JD; Sarabia, A | 1 |
| Demchok, JP; Meletiadis, J; O'Shaughnessy, EM; Stergiopoulou, T; Walsh, TJ | 1 |
| Denning, DW; Heep, M; Mosquera, J; Schmitt-Hoffmann, A; Sharp, A; Spickermann, J; Warn, PA | 1 |
| Donati, A; Gabbanelli, V; Nataloni, S; Pantanetti, S; Pelaia, P; Rossi, R | 1 |
| Foster, G; Labadie, R; Liu, P; Sharma, A; Somoza, E | 1 |
| Garbino, J; Roberts, C; Schnetzler, G | 1 |
| Honda, M; Ichiyasu, H; Kohrogi, H; Matsumoto, M; Okamoto, S; Okamoto, T; Sato, K; Tsumori, K; Yamamura, A | 1 |
| Bille, J; Bolay, S; Buclin, T; Calandra, T; Decosterd, LA; Majcherczyk, PA; Marchetti, O; Nieth, V; Pascual, A; Sanglard, D | 1 |
| Barrao, ME; García-Gil, FA; Jiménez, B; Larraga, J; Luque, P; Serrano, MT; Tomé-Zelaya, E | 1 |
| König, B; König, W; Krause, H; Seibold, M; Tammer, I; Tintelnot, K | 1 |
| Dierich, MP; Lass-Flörl, C; Lugger, H; Perkhofer, S | 1 |
| Alak, A; Buell, D; Holum, M; Keirns, J; Sawamoto, T; Wisemandle, W | 1 |
| Galluzzo, ML; Holland, SM; Piontelli, E; Rosenzweig, SD; Santos, PE; Shea, YR; Zelazko, ME | 1 |
| Boggild, AK; Mohan, S; Ostrowski, MA; Poutanen, SM | 1 |
| Macura, AB; Pawlik, B; Szul, A | 1 |
| Guarro, J; Marimon, R; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Patel, R; Piper, KE; Shuford, JA; Steckelberg, JM | 1 |
| Fukuoka, N; Houchi, H; Ishida, T; Kawazoe, H; Ohnishi, H; Takiguchi, Y; Tanaka, H | 1 |
| Damle, B; Dodds Ashley, ES; Fang, AF; Perfect, JR; Zaas, AK | 1 |
| Baumann, A; Caversaccio, M; Hausler, R; Zimmerli, S | 1 |
| Belousov, DIu; Veselov, AV | 1 |
| Dallot, A; Dannaoui, E; Dupont, B; Hot, A; Lortholary, O; Loulergue, P; Poirée, S | 1 |
| Borrego, L; Hernández, J; Hernández-Machín, B; Islas, D; Martín, AM; Peñate, Y | 1 |
| Ioannidis, J; Likartsis, C; Orfanou, A; Paliogianni, F; Roilides, E; Simitsopoulou, M; Walsh, TJ | 1 |
| Imhof, A; Schaer, DJ; Schanz, U; Schwarz, U | 1 |
| Kalivas, J | 1 |
| Ayres, BD; Bunya, VY; Cohen, EJ; Hammersmith, KM; Rapuano, CJ | 1 |
| Carratalà, J; Garcia-Vidal, C | 1 |
| Campbell, C; Johnson, E; Lamagni, TL; Pezzoli, L | 1 |
| Canton, E; Espinel-Ingroff, A; Gibbs, D; Wang, A | 1 |
| Costa, CR; de Araujo, CR; de Fátima Lisboa Fernandes, O; do Rosário Rodrigues Silva, M; Miranda, KC; Passos, XS | 1 |
| Alcoba-Flórez, J; Arévalo, MP; Arias, A; Moragues, MD; Pontón, J; Quindós, G; Salgado-Parreño, FJ | 1 |
| Hasegawa, Y; Hitomi, S; Imagawa, S; Ishii, Y; Kaneko, S; Kojima, H; Machino, T; Mukai, HY; Muto, H; Nagasawa, T; Okoshi, Y; Suzukawa, K | 1 |
| Corbett, JR; McKeown, PP; Tolland, JP | 1 |
| Bandrés Gimeno, R; Muñoz Martínez, MJ | 1 |
| Benjamin, DK; Cotten, CM; Perfect, JR; Schell, WA; Smith, PB; Steinbach, WJ; Walsh, TJ | 1 |
| Arena, G; Bongiorni, MG; Doria, R; Germenia, C; Giannola, G; Leonildi, A; Menichetti, F; Soldati, E; Tascini, C | 1 |
| Looke, DF; McCarthy, KL; Playford, EG; Whitby, M | 1 |
| Scott, LJ; Simpson, D | 1 |
| Del Castillo, A; Díaz, S; Domínguez-Gil, A; García Vargas, M; Martín, I; Sánchez, C | 1 |
| Barchiesi, F; Borowski, E; Milewski, S; Morschhäuser, J; Prasad, R; Wakieć, R | 1 |
| Chhun, S; Jullien, V; Lortholary, O; Pons, G; Rey, E; Tran, A | 1 |
| Bennett, CL; Blum, W; Chamilos, G; Evens, A; Kennedy, L; Kontoyiannis, DP; McKoy, JM; Mehta, J; Mullane, K; Palella, F; Parada, J; Scheetz, MH; Tallman, MS; Trifilio, SM; Yarnold, PR | 1 |
| Maesaki, S | 2 |
| Baden, LR; Katz, JT; Koplan, BA; Marty, FM; Philips, JA; Stone, RM | 1 |
| Booton, GC; Doyle, RL; Montoya, JG; Visvesvera, GS; Walia, R | 1 |
| Cheng, S; Clancy, CJ; Clapp, W; Nguyen, KT; Nguyen, MH | 1 |
| Kofteridis, D; Koutsopoulos, A; Krasagakis, K; Maraki, S; Samonis, G; Sfakianakis, A; Stefanidou, M; Tosca, A | 1 |
| Boumediene, A; Darde, ML; Denes, E; Durox, H; Gaulier, JM; Oksman, A; Saint-Marcoux, F | 1 |
| da Silva Barros, ME; de Assis Santos, D; Soares Hamdan, J | 1 |
| Araújo, CR; Costa, CR; e Souza, LK; Fernandes, Ode F; Nascimento, ES; Passos, XS; Sales, WS; Silva, Mdo R | 1 |
| Evens, A; Frankfurt, O; Golf, M; Gordon, L; Kaniecki, K; Mehta, J; Pennick, G; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J; Zook, J | 1 |
| Collins, CD; DePestel, DD; Stevenson, JG; Stuntebeck, ER | 1 |
| Avci, B; Cetinkaya, Z; Ermis, SS; Inan, UU; Kusbeci, T; Ozturk, F; Yavas, G | 1 |
| Bhat, SV; Paterson, DL; Rinaldi, MG; Veldkamp, PJ | 1 |
| Kalavsky, E; Krcmery, V; Liskova, A; Shahum, A | 1 |
| Beschorner, R; Freudenstein, D; Koerbel, A; Tatagiba, M | 1 |
| Cars, O; Johansson, A; Lignell, A; Löwdin, E; Sjölin, J | 1 |
| Lambert, JS; Poulton, MB; Scott, CJ; Taylor, CB | 1 |
| Meletiadis, J; O'Shaughnessy, EM; Peter, J; Stergiopoulou, T; Walsh, TJ | 1 |
| Sellart-Altisent, M; Torres-Rodríguez, JM | 1 |
| Bergeron, A; Cadranel, J; Camuset, J; Dauriat, G; Dombret, MC; Henno, P; Mangiapan, G; Nunes, H; Philippe, B; Rabbat, A | 1 |
| Ayadi, A; Ben Salah, S; Ben Zina, Z; Cheikrouhou, F; Colin, J; Feki, J; Makni, F; Mlik, M | 1 |
| Mylona, S; Ntai, S; Pomoni, M; Thanos, L; Tzavara, V | 1 |
| Melchers, WJ; Mellado, E; Verweij, PE | 1 |
| Dahl, P; Hu, DN; Koplin, RS; Meskin, SW; Perez, W; Ritterband, DC; Seedor, JA; Shah, MK; Yang, R | 1 |
| James, C; Moore, MH; Murphy, D | 1 |
| Benjamin, DK; Jafri, HS; Mejias, A; Patel, S; Sánchez, PJ; Santos, RP; Walsh, TJ | 1 |
| Kohl, S; Madariaga, MG | 1 |
| Coates, PT; Grove, DI; Li, JY; Yong, TY | 1 |
| Arthington-Skaggs, B; Ellis, D; Espinel-Ingroff, A; Fothergill, A; Gibbs, DL; Iqbal, N; Messer, S; Pfaller, MA; Rinaldi, M; Wang, A | 1 |
| Handa, H; Irisawa, H; Karasawa, M; Matsushima, T; Murakami, H; Nojima, Y; Saitoh, T; Shimizu, H; Tsukamoto, N; Yokohama, A | 1 |
| Imai, N; Murayama, N; Nakane, T; Shimizu, M; Yamazaki, H | 1 |
| Carrillo-Munoz, AJ; Casals, JB; Eraso, E; Quindos, G; Rementeria, A; Rodriguez Andres, C; Sanchez-Vargas, LO; Villar, M | 1 |
| Arnold, S; Chen, F; Connolly, P; Freifeld, A; Lemonte, A; Meyer, T; Ooi, W; Smedema, M; Wheat, LJ | 1 |
| Alvarado-Ramírez, E; Torres-Rodríguez, JM | 1 |
| DeRemer, D; Fain, H; Farrow, S; Jillella, AP; Ustun, C | 1 |
| Colombo, AL; Diekema, DJ; Fu, W; Gibbs, DL; Gould, IM; Meis, JF; Newell, VA; Pfaller, MA; Rodriguez-Noriega, E | 1 |
| Alvárez-Espejo, T; Cobo, M; Fernández, I; Muñez, E; Muñoz, M; Ramos, A; Toquero, J | 1 |
| Ajisawa, A; Honma, M; Imamura, A; Negishi, M; Suganuma, A; Suzuki, T; Takeshita, N; Yanagisawa, N | 1 |
| Colby, K; Jurkunas, UV; Langston, DP | 1 |
| Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
| Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C | 2 |
| Blayac, JP; Cociglio, M; Djezzar, S; Eiden, C; Hansel, S; Hillaire-Buys, D; Peyrière, H | 1 |
| Lee, YF; Shen, YC; Tsai, HY; Tsai, TC; Wang, CY; Wang, MY; Wei, LC | 1 |
| Bonatti, H; Lass-Floerl, C; Lechner, M; Lorenz, I; Piza, H; Rieder, J; Rieger, M | 1 |
| Jhanji, V; Mannan, R; Sharma, N; Titiyal, JS; Vajpayee, RB | 1 |
| Aoun, N; Baixench, MT; Bretagne, S; Dannaoui, E; Desnos-Ollivier, M; Garcia-Hermoso, D; Piketty, C; Ramires, S | 1 |
| Harada, AS; Lau, W | 1 |
| Ho, DY; Lee, JD; Montoya, JG; Rosso, F | 1 |
| Amedro, P; Blayac, JP; Cociglio, M; Eiden, C; Hillaire-Buys, D; Margueritte, G; Peyrière, H; Tichit, R | 1 |
| Alonso, N; Bajo, R; Casado, MS; de la Llana, FG; Fajardo, M; Garcia-Dominguez, M; Sanz-Rodriguez, C; Vagace, JM; Zarallo, L | 1 |
| Aller, AI; Castro, C; Claro, R; Colom, MF; Martín-Mazuelos, E; Serrano, C | 1 |
| Hay, RJ | 1 |
| Cheng, S; Clancy, CJ; Derendorf, H; Li, Y; Nguyen, MH | 1 |
| Gupta, A; Mao, Q; Unadkat, JD | 1 |
| Germaud, P; Pipet, A | 1 |
| Fincher, T; Fulcher, SF | 1 |
| Eichhorn, ME; Hartl, WH; Jauch, KW; Joka, M; Küchenhoff, H; Wolf, H | 1 |
| Araujo, BV; Conrado, DJ; Dalla Costa, T; Palma, EC | 1 |
| Arendrup, MC; Denning, DW; Diekema, DJ; Pfaller, MA; Rex, JH | 1 |
| Keynan, Y; Sprecher, H; Weber, G | 1 |
| Cárdenes, CD; Carrillo-Muñoz, AJ; del Valle, O; Estivill, D; Giusiano, G; Guardia, C; Guarro, J; Quindós, G; Rodríguez, V | 1 |
| Ament, AJ; de Groot, R; Donnelly, JP; Hübben, MW; Severens, JL; van 't Wout, J; Verweij, PE; Warris, A | 1 |
| Bocanegra, R; Graybill, JR; Kirkpatrick, WR; Najvar, LK; Patterson, TF | 1 |
| Acharya, NR; Chidambaram, JD; Fothergill, AW; Hong, KC; Lalitha, P; Lietman, TM; Maxey, KJ; McLeod, SD; Prajna, NV; Ruiz, J; Shapiro, BL; Srinivasan, M | 1 |
| Alioua, D; Anract, P; Dougados, M; Dupont, B; Guerini, H; Guignard, S; Hubert, D; Paugam, A | 1 |
| Arisaka, O; Fujisawa, M; Fukushima, K; Hagisawa, S; Kurosawa, H; Matsunaga, T; Nakajima, D; Sugita, K | 1 |
| Hosoki, T; Ikuta, K; Jimbo, J; Kohgo, Y; Nishimura, K; Sano, A; Sato, K; Shindo, M; Torimoto, Y | 1 |
| Arendrup, MC; Frimodt-Moller, N; Haedersdal, M; Kloft, C; Saunte, DM; Simmel, F; Stolle, LB; Svejgaard, EL | 1 |
| Antachopoulos, C; Meletiadis, J; Pournaras, S; Roilides, E; Stergiopoulou, T; Walsh, TJ | 1 |
| Dannaoui, E; Datry, A; Dromer, F; Hoinard, D; Lacroix, C; Lortholary, O; Paugam, A; Poirot, JL; Raoux, D | 1 |
| Ishida, H; Kanda, F; Kuga, A; Oishi, K | 1 |
| Chacko, B; David, VG; Deepti, AN; John, GT; Tamilarasi, V | 1 |
| Evens, A; Frankfurt, O; Gordon, L; Mehta, J; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J | 1 |
| Collins, CD; DePestel, DD; Erba, HP; Mackler, ER; Shehab, N; Welch, K | 1 |
| Maida, CM; Milici, ME; Oliveri, S | 1 |
| Barnes, RA; Kuriyama, T; Lewis, MA; Noake, T; Potts, AJ; White, PL; Williams, DW | 1 |
| Braverman, RM; Davis, CM; Dishop, MK; Noroski, LM; Paul, ME; Rosenblatt, HM; Sutton, DA | 1 |
| Cantón, E; Chirivella, M; Crespo, M; Frasquet, J; Gobernado, M; Ortiz, R; Osseyran, F; Pemán, J; Pérez-Bellés, C; Quesada, A | 1 |
| Eschertzhuber, S; Hoefer, D; Hoermann, C; Lass-Florl, C; Velik-Salchner, C | 1 |
| Freifeld, A; Iwen, PC; Kalil, A; Lesiak, B; Sutton, DA; Van Schooneveld, T | 1 |
| Herbrecht, R; Marciniak, A; Mauskopf, J; Roberts, CS; Schlamm, HT; Wingard, JR | 1 |
| Handke, R; Peleg, AY; Slavin, M; Szer, J; Tong, SY; Yoong, J | 1 |
| Choe, L; Guglielmo, BJ; Inciardi, J; Martin, T; Riedel, A; Yuen, C | 1 |
| Burhenne, J; Egerer, G; Geist, MJ; Mikus, G; Riedel, KD | 1 |
| Bellmann, R; Bellmann-Weiler, R; Graziadei, I; Joannidis, M; Vogel, W; Weiler, S; Zoller, H | 1 |
| Hall, GS; Jeng, BH; Meisler, DM; Schoenfield, L | 1 |
| Abgrall, S; Bouchaud, O; Bouges-Michel, C; Brauner, M; Karoubi, P; Lortholary, O; Martin, A; Martinod, E; Padoin, C; Pizzocolo, C | 1 |
| Kaye, SB; Neal, TJ; Quah, SA; Stewart, RM | 1 |
| Esmore, DS; Griffiths, AP; Levvey, BJ; Oto, T; Rowland, M; Snell, GI; Williams, TJ | 1 |
| Hamanaka, N; Hiroi, N; Homma, S; Isobe, K; Kikuchi, N; Kimura, K; Muraoka, S; Shibuya, K; Shimizu, K; Sugino, K; Takai, Y; Yamazaki, Y | 1 |
| Allison, MJ; Foster, G; Gandelman, K; Gutierrez, MJ; LaBadie, RR; Liu, P; Sharma, A | 1 |
| Drees, M; Gupta, M; Hadley, S; Wickes, BL | 1 |
| Bongiovanni, M; Chalandon, Y; Meyer, M; Pache, JC; Van Delden, C; Waldvogel, S | 1 |
| Haas, A; Maschmeyer, G | 1 |
| Calderone, R; Chauhan, N; Kruppa, M | 1 |
| Granowitz, E; Iarikov, D; Robertson, D; Skiest, D | 1 |
| Aydin, S; Ertugrul, B; Gultekin, B; Kir, E; Uyar, G | 1 |
| Bertilsson, L; Laine, K; Neuvonen, PJ; Olkkola, KT; Saari, TI | 1 |
| Bertilsson, L; Hynninen, VV; Kurkinen, K; Laine, K; Neuvonen, PJ; Olkkola, KT | 1 |
| Schlamm, HT; Supparatpinyo, K | 1 |
| Geiger, S; Herold, T; Nickenig, C; Ostermann, H; Rieger, C | 1 |
| Foo, H; Gottlieb, T | 1 |
| Dotis, J; Katragkou, A; Kotsiou, M; Roilides, E; Tamiolaki, M | 1 |
| Bailey, T; Demiraj, F; Di Somma, A; Krautwald-Junghanns, ME; Schmidt, V; Ungemach, FR | 1 |
| Park, AJ; Tu, EY | 1 |
| Fujita, M; Harada, E; Ikegame, S; Inoshima, I; Nakanishi, Y; Ouchi, H | 1 |
| Gubler, C; Imhof, A; Müllhaupt, B; Schneemann, M; Wildi, SM | 1 |
| Kauffman, CA; Malani, AN | 1 |
| Cheng, S; He, J; Huang, J; Qiu, F | 1 |
| Kontoyiannis, DP; Lewis, RE; Mulanovich, V; Raad, II | 1 |
| Ferhanoglu, B; Mert, A; Sili, U; Yilmaz, M | 1 |
| Arenz, D; Böhme, A; Buchheidt, D; Cornely, OA; Drzisga, I; Frommolt, P; Harnischmacher, U; Heussel, CP; Hummel, M; Mousset, S; Ullmann, AJ; Vehreschild, JJ; Wassmer, G | 1 |
| den Hollander, JG; Levin, MD; Rijnders, BJ; Sonneveld, P; van der Holt, B; van Schaik, RH; van Vliet, M | 1 |
| Blumenkranz, MS; Egbert, P; Jain, A; McCulley, TJ; Moshfeghi, DM | 1 |
| Fuhrmann, V; Holzinger, U; Jaeger, W; Kitzberger, R; Kneidinger, N; Miksits, M; Schenk, P; Thalhammer, F; Warszawska, J | 1 |
| Del Palacio, A; Pontón, J; Quindós, G | 1 |
| Cantón, E; Carrillo-Muñoz, AJ; Eraso, E; Pemán, J; Quindós, G | 1 |
| Alvarez Lerma, F | 1 |
| Jarque, I; Sanz, MA | 1 |
| Salavert, M; Solé, A | 1 |
| Guarro, J; Pastor, FJ | 1 |
| Denning, DW | 1 |
| Cesur, S; Kaynak, F; Ozçelik, B; Sipahi, B; Sultan, N | 1 |
| Jain, A; Sun, Y; Ta, CN | 1 |
| Calvo, C; de Andoin, NG; Guerrero, R; Landa, J; Nogues, A; Onate, E; Uriz, J | 1 |
| Guest, S; Zarkovic, A | 1 |
| Chen, SC; Sorrell, TC | 1 |
| Cetinkaya, Z; Ermis, SS; Inan, UU; Kiraz, N; Küsbeci, T; Oztürk, F; Yavas, GF | 1 |
| Diekema, DJ; Pfaller, MA; Procop, GW; Rinaldi, MG | 2 |
| Chan, KK; Cheng, H; Colitz, CM; Latimer, FG; Pennick, GJ; Reed, SM | 1 |
| Casadevall, A; Gácser, A; Martinez, LR; Nosanchuk, JD; Ntiamoah, P | 1 |
| Al-Tawfiq, JA; Amr, SS | 1 |
| Caira, M; Fianchi, L; Maviglia, R; Montini, L; Pagano, L; Posteraro, B; Voso, MT | 1 |
| Boakye-Agyeman, F; Langman, LJ | 1 |
| Gahn, B; Gramatzki, M; Repp, R; Schub, N | 1 |
| Kaya, AD; Kiraz, N | 1 |
| Chanakul, K; Clongsusuek, P; Leechawengwongs, M; Liengudom, A; Milindankura, S; Viranuvatti, K | 1 |
| Dambrin, C; Durand, D; Garrouste, C; Kamar, N; Linas, MD; Rostaing, L; Tall, P; Wéclawiak, H | 1 |
| Chang, CL; Kim, MN; Kim, SH; Lee, HS; Lee, JS; Lee, K; Lee, WG; Ryang, DW; Shin, BM; Shin, JH; Shin, MG; Suh, SP; Uh, Y | 1 |
| Hsu, S; Kwong, WT | 1 |
| Hamada, S; Iwasaki, Y; Izumi, N; Kamoshima, Y; Okugawa, S; Sawamura, Y | 1 |
| Laine, K; Neuvonen, M; Neuvonen, PJ; Olkkola, KT; Saari, TI | 1 |
| Feldberg, E; Halperin, D; Lahav, J; Warman, M | 1 |
| Espinel-Ingroff, A; Goldani, LZ; Goodrich, JM; Queiroz-Telles, F; Schlamm, HT; Shikanai-Yasuda, MA | 1 |
| Awaya, Y; Murakami, I; Nagao, Y; Okimasa, S; Shibata, S; Shigetou, E | 1 |
| Foster, G; Gutierrez, MJ; LaBadie, RR; Liu, P; Sharma, A | 1 |
| Anten, S; Heddema, ER; Visser, O; Zweegman, AS | 1 |
| Bergeron, A; de Latour, RP; Devergie, A; Ferry, C; Ghannoum, M; Gluckmana, E; Lacroix, C; Lapalu, J; Madureira, A; Ribaud, P; Robin, M; Rocha, V; Socié, G | 1 |
| Hynninen, VV; Laine, K; Leino, K; Lundgren, S; Neuvonen, PJ; Olkkola, KT; Rane, A; Valtonen, M | 1 |
| Stratakos, G; Zakynthinos, S | 1 |
| Khakoo, RA; Khan, FA; Slain, D | 1 |
| Brusca, MI; Finquelievich, JL; Gliosca, LA; Jewtuchowicz, VM; Lovannitti, CA; Mujica, MT; Rosa, AC | 1 |
| Jin, LH; Kong, QF; Kostulas, N; Li, HL; Liu, XJ; Lv, GX; Peng, HS; Sun, B; Wang, DD; Wang, GY; Wang, Q; Zhai, DX; Zhao, W | 1 |
| Dunand, J; Paugam, A | 1 |
| Alkorta, M; Eraso, E; Hernández-Almaraz, JL; Quindós, G; Sánchez-Vargas, LO; Villar-Vidal, M | 1 |
| Abrantes, R; Córdoba, S; Davel, G; Rodero, L; Vitale, RG; Vivot, W | 1 |
| Alves, SH; Argenta, JS; Cavalheiro, AS; Ferreiro, L; Pereira, DI; Santurio, JM; Spanamberg, A | 1 |
| Greene, RE; Mauskopf, J; Roberts, CS; Schlamm, HT; Zyczynski, T | 1 |
| Mian, P; Pagani, L; Spoladore, G; Vedovelli, C | 1 |
| Auler, ME; Dias, AL; Gandra, RF; Gonçalves da Silva, E; Matsumoto, FE; Melhem, MS; Paula, CR; Ruiz, LS; Szeszs, MW | 1 |
| Liu, Y; Zou, H | 1 |
| Conti, S; Drago, M; Fanti, F; Morace, G; Polonelli, L; Scaltrito, MM | 1 |
| Carrillo-Muñoz, AJ; Casals, JB; del Valle, O; Estivill, MD; Ezkurra, PA; Giusiano, G; Quindós, G; Santos, P | 1 |
| Blaich, A; Hopt, UT; Kaffarnik, M; Utzolino, S | 1 |
| Ang, BS; Lim, PL; Lye, DC; Vasoo, S; Yeo, SB | 1 |
| Andrew, S; Fitzgerald, D; Singh, MN | 1 |
| Endo, I; Matsuo, K; Morioka, D; Moroboshi, T; Sekido, H; Shimada, H; Takeda, K; Togo, S | 1 |
| Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
| Meessen, NE; Oosten, AW; Sprenger, HG; van Assen, S; van Leeuwen, JT | 1 |
| Erwin, GE; Fitzgerald, JE | 1 |
| Buadi, FK; McClune, B; Przepiorka, D | 1 |
| Bonini, A; Caira, M; Fianchi, L; Girmenia, C; Leone, G; Pagano, L; Rossi, G; Sanguinetti, M; Valentini, CG | 1 |
| Cimino, G; Gentile, G; Girmenia, C; Martino, P; Pizzarelli, G; Pozzi, E | 1 |
| Davis, JL; Dillard, SL; Flammer, K; Foster, LE; Nettifee Osborne, JA; Webb, DJ | 1 |
| Bille, J; Bolay, S; Buclin, T; Calandra, T; Marchetti, O; Pascual, A | 1 |
| Lewis, RE | 1 |
| Alffenaar, JW; Doedens, RA; Groninger, E; Kosterink, JG | 1 |
| Fujishima, T; Hashimoto, M; Honda, Y | 1 |
| Chamilos, G; Kontoyiannis, DP; Lamaris, GA; Lewis, RE | 1 |
| Clauss, H; Samuel, R | 1 |
| Hariprasad, SM; Mieler, WF; Prince, RA; Shah, GK; Van Gelder, RN; Vemulakonda, GA | 1 |
| Barnes, R; Colombo, A; Diekema, DJ; Finquelievich, J; Gibbs, DL; Newell, VA; Ng, KP; Pfaller, MA; Wadula, J | 1 |
| Fozza, C; La Nasa, G; Longinotti, M; Nieddu, R; Paglietti, B; Podda, L; Sanna, S; Vacca, A | 1 |
| Bouza, E; Guinea, J; Peláez, T; Recio, S; Torres-Narbona, M | 2 |
| Aguirrebengoa, K; Arteaga, C; Chen, SC; Ellis, D; Heath, CH; Lutsar, I; Nguyen, Q; Rovira, M; Slavin, M; Troke, P | 1 |
| Cheng, S; Clancy, CJ; Derendorf, H; Li, Y; Nguyen, MH; Schmidt, S; Zhong, L | 1 |
| Espinel-Ingroff, A; Hockey, H; Johnson, E; Troke, P | 1 |
| Arnaud, P; Desmonts, JM; Lasocki, S; Massias, L; Montravers, P; Papy, E; Quintard, H | 1 |
| Arthington-Skaggs, BA; Chaturvedi, V; Ghannoum, MA; Holliday, N; Iqbal, NJ; Killian, SB; Knapp, C; Messer, SA; Ostrosky-Zeichner, L; Pfaller, MA; Ramani, R; Rex, JH; Sein, T; Vazquez, JA; Walsh, TJ | 1 |
| Boot, B; Danho, C; Huynh, A; Mejdoubi, M | 1 |
| Jones, A; Muhtaseb, M | 1 |
| Denning, DW; Pasqualotto, AC; Shah, M; Wynn, R | 1 |
| Gil-Lamaignere, C; Maloukou, A; Roilides, E; Simitsopoulou, M; Walsh, TJ | 1 |
| Fabré, G; Maes, B; Peetermans, WE; Van Dorpe, J; Vanacker, A | 1 |
| Akhaddar, A; Albouzidi, A; Boucetta, M; Elmostarchid, B; Gazzaz, M; Lmimouni, B | 1 |
| de la Fuente-Trabado, M; Díaz, MA; González-Vicent, M; Lassaletta, A; López-Pino, MA; Romero-Tejada, JC | 1 |
| Amrein, C; Bergé, MM; Billaud, EM; Boussaud, V; Chevalier, P; Daudet, N; Guillemain, R; Le Beller, C; Lillo-Le Louet, A | 1 |
| Conlon, JD; Dauenhauer, M; Drolet, BA; Fairley, JA; Margolis, D; Talano, J; Tonkovic-Capin, V | 1 |
| Golinval, O; Louis, R | 1 |
| Arenz, D; Böhme, A; Cornely, OA; Kiehl, MG; Kochanek, M; Pankraz, K; Reichert, D; Ullmann, AJ; Vehreschild, JJ | 1 |
| Andrews, E; Crownover, P; Damle, BD; Fang, A; Foster, G; Glue, P; LaBadie, R | 1 |
| Crownover, P; Damle, B; Glue, P; LaBadie, R | 1 |
| Lu, HZ; Shen, YZ; Wang, JR | 1 |
| Kobayashi, H; Kusuhara, Y; Mitsumoto, S; Nakagawa, S; Ohta, S; Shimoeda, S; Suzuki, R; Yamato, S; Yamazaki, R | 1 |
| Hariprasad, SM; Lin, RC; Sanduja, N | 1 |
| Almeida, C; Martín-Mazuelos, E; Méndez, CC; Pemán, J; Serrano, MC; Valverde, A | 1 |
| Imhof, A; Misselwitz, B; Schneemann, M | 1 |
| Daniell, M; Davies, G; Fedinands, M; Fullinfaw, R; Kong, D; Lau, D; Leung, L | 1 |
| Ali, S; Whittle, AM | 1 |
| Bahari, IS; Deris, ZZ; Harun, A; Ravichandran, M; Roziawati, Y; Shareef, BT | 1 |
| Chandler, A; Greene, JN; Houston, SH; Silapunt, S; Sriaroon, C; Vincent, AL | 1 |
| Herbrecht, R; Ribaud, P; Schlamm, HT; Wingard, JR | 1 |
| Michael, C; Preiss, R; Teichert, J | 1 |
| Ergon, C; Metin, DY; Ozkutuk, A; Polat, SH; Yucesoy, M | 1 |
| Allepuz-Palau, A; Alvarez-Lerma, F; Angeles Leon, M; Garcia, MP; Iruretagoyena, JR; Luque-Gomez, P; Navarro, A; Sanchez-Ruiz, H | 1 |
| Dierich, MP; Jost, D; Lass-Flörl, C; Perkhofer, S | 1 |
| Bailey, T; Di Somma, A; Garcia-Martinez, C; Silvanose, C | 1 |
| Chirch, L; Fuhrer, J; Roche, P | 1 |
| Annaert, PP; Augustijns, P; Benjamin, DK; Bridges, A; Gao, Y; Thakker, DR; Yanni, SB | 1 |
| Can, MF; Cetiner, S; Gorenek, L; Ozerhan, I; Tozkoparan, E; Yagci, G | 1 |
| Chryssanthou, E; Loebig, A; Sjölin, J | 1 |
| Joshi, R; Kohli, V; Sachdev, P; Taneja, V | 1 |
| Andes, D; Smith, J | 1 |
| Arsene, S; Bastides, F; Chaumais, MC; Le Guellec, C; Morange, V; Nochez, Y; Pisella, PJ | 1 |
| Begueret, H; Beylot-Barry, M; Couprie, B; Domergue, V; Doutre, MS; Huerre, M; Orlandini, V; Tunon de Lara, M | 1 |
| Alvarado-Ramírez, E; Murciano, F; Sellart, M; Torres-Rodríguez, JM | 1 |
| Athan, E; Campbell, P; Chang, CC; Cheng, AC; Devitt, B; Hughes, AJ; Low, J; Styles, K | 1 |
| Araujo, BV; Dalla Costa, T; Haas, SE; Silva, CF | 1 |
| Datry, A; Delabesse, E; Dhédin, N; Etienne, A; Gaspar, N; Lmimouni, B; Morel, V; Vernant, JP | 1 |
| Barale, PO; Chaumeil, C; Errera, MH; Guez, A; Nourry, H; Sahel, JA; Warnet, JM; Zamfir, O | 1 |
| Baldelli, F; Costantini, V; Giovenale, P; Gurdo, G; Lapalorcia, LM; Lignani, A; Pasticci, MB; Pitzurra, L; Terenzi, A; Verzini, F | 1 |
| Cars, O; Lignell, A; Löwdin, E; Sjölin, J | 1 |
| Kasahara, K; Konishi, M; Maeda, K; Mikasa, K; Nakagawa, C; Uno, K; Yonekawa, S; Yoshimoto, E | 1 |
| Foisy, MM; Hughes, CA; Yakiwchuk, EM | 1 |
| Bourolias, CA; Karatzanis, AD; Kofteridis, DP; Mantadakis, E; Papazoglou, G; Samonis, G; Velegrakis, GA | 1 |
| Aragane, N; Fukuno, Y; Fukuoka, M; Hayashi, S; Kawaura, F; Kobayashi, H; Matsuishi, E; Sano, A; Tanaka, M | 1 |
| Alanio, A; Baruchel, A; Brethon, B; de Kerviler, E; Feuilhade de Chauvin, M; Lacroix, C; Leblanc, T; Menotti, J | 1 |
| Mercier, RC; Pai, MP; Samples, ML; Spilde, MN | 1 |
| Brunel, AS; Fraisse, T; Lechiche, C; Mauboussin, JM; Pinzani, V; Sotto, A | 1 |
| Goel, M; Prakash, G; Sharma, N; Titiyal, JS; Vajpayee, RB | 1 |
| Akşit, F; Kiraz, N; Kiremitçi, A; Oz, Y | 1 |
| Kohno, S; Kurashima, A; Maesaki, S; Niki, Y; Ogawa, K | 1 |
| Chu, CC; Hsueh, PR; Ruan, SY | 1 |
| Jiang, Y; Jin, Y; Li, P; Liu, P; Sun, P; Sun, Q; Wu, Q; Xie, W; Yang, X; Zhang, D; Zhang, Y; Zhu, S | 1 |
| Lortholary, O | 1 |
| Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Bocanegra, R; Fothergill, AW; Graybill, JR; Herrera, ML; Kinney, MC; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Vallor, AC; Wickes, BL | 1 |
| Ooi, WW; Srinivasan, J | 1 |
| Mavinkurve-Groothuis, AM; van Die, LE; van't Hek, LG; Verweij, PE; Warris, A; Zwitserloot, AM | 1 |
| Lahat, Y; Sandovsky-Losica, H; Segal, E; Shwartzman, R | 1 |
| Behrens-Baumann, W; Binder, L; Knop, C; Streit, F; Tuchen, S; Vorwerk, CK | 1 |
| Bennett, JE; Childs, R; Gea-Banacloche, J; Zonios, DI | 1 |
| Guarro, J; Mariné, M; Ruíz-Cendoya, M | 1 |
| Antoniadis, A; Braimi, M; Dermitzakis, E; Kioumi, A; Papadakis, E; Tsitouridis, I; Vyzantiadis, TA | 1 |
| Carver, PL; DePestel, DD; Surowiec, D | 1 |
| Ananda-Rajah, MR; Grigg, A; Slavin, MA | 1 |
| Ikeda, T; Ishikawa, S; Kobayashi, K; Takeyama, H; Tokuda, Y; Wakabayashi, K; Yano, S | 1 |
| Chellamma, T; Cherian, KM; Verghese, S | 1 |
| Dey, P; Gupta, A; Gupta, P; Gupta, V; Kaur, J; Sachdev, N | 1 |
| Abel, S; Allan, R; Gandelman, K; Tomaszewski, K; Webb, DJ; Wood, ND | 1 |
| Ben-Ami, R; Kontoyiannis, DP; Lamaris, GA; Lewis, RE | 1 |
| Kulpraneet, M; Panichchob, P; Prayongratana, K; Tantisiriwat, W | 1 |
| Akdogan, E; Aksoy, F; Altunayoglu, V; Aydin, K; Koksal, I; Omay, SB; Sozen, EE; Yilmaz, M | 1 |
| Fujimoto, Y; Ikawa, K; Kanbayashi, Y; Nomura, K; Taniwaki, M | 1 |
| Imataki, O; Ishida, T; Kitanaka, A; Kubota, Y; Ohnishi, H; Tanaka, T | 1 |
| Graybill, JR; Hariprasad, SM; Lin, TK; Mieler, WF; Sponsel, WE | 1 |
| Annemans, L; Derde, MP; Marbaix, S; Van Campenhout, H | 1 |
| Benesch, M; Dornbusch, HJ; Lackner, H; Schwinger, W; Sovinz, P; Strenger, V; Urban, C | 1 |
| Ioannidis, J; Kanellou, K; Likartsis, C; Paliogianni, F; Roilides, E; Simitsopoulou, M; Walsh, TJ | 1 |
| Ak, Ö; Batırel, A; Demirhan, G; Gençer, S; Özer, S | 1 |
| Ayala, J; Elizondo, M; González, GM | 1 |
| Aarnoutse, RE; Blijlevens, NM; Brüggemann, RJ; Burger, DM; Donnelly, JP; Mouton, JW; Verweij, PE; Warris, A | 1 |
| Dolande, M; Panizo, MM; Reviákina, V; Selgrad, S | 1 |
| Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A | 1 |
| Iseman, MD; Peloquin, CA; Schwiesow, JN | 1 |
| Barcia, M; De-Domingo-Barón, B; Pardo-Sánchez, F; Rodríguez-Ares, T; Romero-Jung, P; Touriño-Peralba, R | 1 |
| Aprato, A; DE Rosa, FG; Di Perri, G; Garazzino, S; Maiello, A | 1 |
| Kloft, C; Radke, J; Simmel, F; Soukup, J; Zoerner, A | 1 |
| Baert, K; Beernaert, LA; Chiers, K; De Backer, P; Marin, P; Martel, A; Pasmans, F | 1 |
| Auberger, J; Bellmann, R; Buzina, W; Clausen, J; Gastl, G; Lass-Flörl, C; Nachbaur, D | 1 |
| Bosch, M; Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Valentín, A | 1 |
| Farmen, S; Kaul, DR; Khaled, YA; Lowe, L; Visvesvara, GS; Yanik, GA | 1 |
| Mircus, G; Osherov, N; Shadkchan, Y; Shalit, I | 1 |
| Hollenbach, E | 1 |
| Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N | 1 |
| Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L | 1 |
| Alangaden, GJ; Chandrasekar, PH; Krishnan-Natesan, S; Manavathu, EK | 1 |
| Hynninen, VV; Laine, K; Neuvonen, PJ; Olkkola, KT | 1 |
| Bernhardt, H; Knoke, M | 1 |
| Espinel-Ingroff, A; Hockey, H; Johnson, E; Szekely, A; Troke, P | 1 |
| Albermann, N; Ebinger, F; Haefeli, WE; Hafner, V | 1 |
| Bouadma, L; Da Silva, D; Massias, L; Nataf, P; Papy, E; Ruiz, S; Wolff, M | 1 |
| Aronoff, DM; Malani, AN | 1 |
| Adani, GL; Baccarani, U; Baraldo, M; Cojutti, P; Franceschi, L; Furlanut, M; Londero, A; Pea, F; Tavio, M; Viale, P | 1 |
| Agee, S; Ford, JG; Greenhaw, ST | 1 |
| Alves, AF; Anjos, J; de Hoog, GS; Estevão, H; Faria, E; Gonçalves, T; Hipolito, E; Morais, PV | 1 |
| Choi, CW; Joo, SI; Kim, BS; Kim, EC; Kim, TU; Kim, YK; Lee, KM; Lee, YS; Yoo, JI; Yun, SH | 1 |
| Jones, B; Lang, S; McCulloch, E; Mowat, E; Ramage, G; Williams, C | 1 |
| Ghannoum, MA; Mukherjee, PK; Shehata, AS | 1 |
| Hagelberg, NM; Laine, K; Neuvonen, M; Neuvonen, PJ; Nieminen, TH; Olkkola, KT; Saari, TI | 2 |
| Buchta, V; Vale-Silva, LA; Vejsova, M | 1 |
| Albano, EA; Carver, AE; Porter, CC | 1 |
| Cordier, JF; Cottin, V; Cristea, D; Meyronet, D; Persat, F | 1 |
| Chandrasekar, PH; Krishnan-Natesan, S; Manavathu, EK; Revankar, SG | 1 |
| Chen, JQ; Huang, MM; Li, J; Sun, MX; Yao, MC; Ye, CT | 1 |
| Imai, K; Kobayashi, D; Kogawa, K; Nonoyama, S; Nozaki, M; Sugita, T; Tokimatsu, I; Tsuji, Y | 1 |
| Anderson, R; Steel, HC; Tintinger, GR | 1 |
| Hayabuchi, T; Konishi, T; Kurai, J; Shimizu, E | 1 |
| Brusca, MI; Iovannitti, CA; Jewtuchowicz, VM; Malzone, MC; Mujica, MT; Pola, SJ; Rosa, AC; Sordelli, N | 1 |
| Fothergill, AW; Patterson, TF; Thompson, GR; Vallor, AC; Wickes, BL; Wiederhold, NP | 1 |
| Cervera, C; Crespo, G; Marco, F; Michelena, J; Moreno, A; Navasa, M | 1 |
| Caira, M; Fianchi, L; Pagano, L | 1 |
| Brown, TA; Grooters, AM; Hosgood, GL | 1 |
| Chen, Y; Fan, L; Guo, D; Hu, DL; Lei, HP; Li, Z; Tan, ZR; Wang, D; Wang, G; Zhou, HH | 1 |
| Doorduijn, JK; el Barzouhi, A; Lugtenburg, PJ; Polinder, S; Rijnders, BJ; Slobbe, L; Steyerberg, EW | 1 |
| De Kaspar, HM; Kampik, A; Kernt, M; Neubauer, AS | 1 |
| Donders, AR; Kuijpers, J; Melchers, WJ; Mellado, E; Rijs, AJ; Samson, RA; Snelders, E; van der Lee, HA; Varga, J; Verweij, PE | 1 |
| Dupuis, A; Le Moal, G; Tournier, N; Venisse, N | 1 |
| Al-Badriyeh, D; Kong, DC; Liew, D; Stewart, K | 2 |
| Bijie, H; Diekema, DJ; Dzierzanowska, D; Gibbs, DL; Klimko, NN; Letscher-Bru, V; Lisalova, M; Muehlethaler, K; Newell, VA; Pfaller, MA; Rennison, C; Zaidi, M | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Hazar, V; Ogunc, D; Ongut, G; Ozhak-Baysan, B; Rodriguez-Tudela, JL; Tezcan, G; Yildiran, ST | 1 |
| Denning, DW; Majithiya, J; Parmar, A; Sharp, A; Warn, PA | 1 |
| da Silva, CF; Dalla Costa, T; de Araujo, BV; Haas, SE | 1 |
| Cubillos, GF; Kett, DH | 1 |
| Burhenne, J; Haefeli, WE; Hess, M; Scope, A | 1 |
| Bertilsson, L; Hynninen, VV; Korhonen, T; Kurkinen, KJ; Laine, K; Neuvonen, PJ; Olkkola, KT | 1 |
| Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Touw, DJ; Verweij, PE | 1 |
| Barbabietola, G; Barker, K; Flynn, E; Marciniak, A; Oppenheim, BA; Roberts, C | 1 |
| Hoffman, J; Howard, A; Sheth, A | 1 |
| Chang, BP; Chen, YC; Huang, FY; Lee, MD; Lin, CC; Sheu, JC; Sun, PL; Tsai, JD; Tsai, TC | 1 |
| Desta, Z; Jeong, S; Nguyen, PD | 1 |
| Aisa, Y; Ikeda, Y; Kato, J; Mori, T; Nakamura, Y; Okamoto, S; Sakurai, M | 1 |
| Bearman, G; Pakyz, A | 1 |
| Burhenne, J; Haefeli, WE; Hoffmann, MM; Mikus, G; Rengelshausen, J; Ten Hoevel, MM; Walter-Sack, I; Weiss, J | 1 |
| Okuda, A; Okuda, T; Takao, M; Takayanagi, K; Watanabe, N | 1 |
| van Rijswijk, J; van Tol, A | 1 |
| Antonius, T; Brüggemann, RJ; Burger, DM; Heijst, Av; Hoogerbrugge, PM; Warris, A | 1 |
| Baba, T; Endo, T; Hagiwara, E; Komatsu, S; Matsumoto, Y; Nishihira, R; Ogura, T; Sato, T; Sekine, A; Shinohara, T; Sogo, Y; Takahashi, H | 1 |
| Niimi, K; Niimi, M; Tanabe, K | 1 |
| Maesaki, S; Tarumoto, N | 1 |
| Fujii, Y; Inase, N; Yoshizawa, Y | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
| dos Santos Lazéra, M; Guarro, J; Pastor, FJ; Pujol, I | 1 |
| Karlsson, MO; Lutsar, I; Milligan, PA | 1 |
| Pea, F; Viale, P | 1 |
| Fujita, N; Oyake, M; Sugai, A; Umeda, M; Umeda, Y | 1 |
| Tu, EY | 1 |
| Alffenaar, JW; Daenen, SM; de Vos, T; Uges, DR | 1 |
| Bienvenu, B; Bougnoux, ME; Chandesris, MO; Herman, P; Lanternier, F; Lecuit, M; Lortholary, O; Mamzer, MF; Méchai, F; Mimoun, M; Parize, P; Poirée, S; Viard, JP | 1 |
| Kisac, P; Krcmery, V; Liskova, A | 1 |
| Fothergill, AW; Rinaldi, MG; Sutton, DA | 1 |
| Anaissie, E; Chang, C; Fishman, J; Horn, D; Marr, K; Neofytos, D; Olyaei, A; Pfaller, M; Steinbach, W; Webster, K | 1 |
| Nawrot, U; Nowicka, J; Wlodarczyk, K | 1 |
| Azuma, E; Hosoki, K; Iwamoto, S; Komada, Y; Kumamoto, T | 1 |
| Andes, D; Arnold, S; Baddour, LM; Blair, J; Freifeld, A; Lentnek, A; Proia, L; Spellberg, B; Wheat, LJ | 1 |
| Guggemos, W; Hecht, A; Rüdisser, K; Seilmaier, M | 1 |
| Kanazawa, K; Niki, Y; Takemoto, K; Ueda, Y; Yamamoto, Y; Yoshida, K | 1 |
| de Mol, P; Meis, JF | 1 |
| Fatuzzo, F; Iacobello, C; La Rosa, R; Larocca, L; Montineri, A; Nigro, L | 1 |
| Aralikatti, A; Dean, S; Mitra, A; Savant, V; Shah, S | 1 |
| Enache-Angoulvant, A; Girard, A; Hennequin, C; Poirot, JL | 1 |
| Chan, RC; Pinto, A | 1 |
| Danner, RL; Elinoff, J; Gea-Banacloche, J; Moriyama, B; Pennick, G; Rinaldi, MG; Walsh, TJ | 1 |
| Gerlach, U; Guckelberger, O; Jörres, D; Kohler, S; Neuhaus, P; Pascher, A; Pratschke, J; Sauer, IM | 1 |
| Alp, S; Arikan, S; Hascelik, G; McNicholas, P; Sancak, B | 1 |
| Allizond, V; Banche, G; Carlone, N; Cuffini, AM; Fucale, G; Malabaila, A; Mandras, N; Roana, J; Robbiano, F; Scalas, D; Tullio, V | 1 |
| Guarro, J; Mariné, M; Rodríguez, MM; Ruíz-Cendoya, M | 1 |
| Arsenis, G; Kafetzis, D; Lebessi, E; Pasparakis, D; Stripeli, F; Tsolia, M; Velegraki, A | 1 |
| Baltadakis, I; Karakasis, D; Liapis, K; Manaka, K | 1 |
| Chandy, R; Chehadeh, W; Chowdhary, A; Khan, ZU; Kowshik, T; Randhawa, HS | 1 |
| Baird, K; Cowen, EW; Gea-Banacloche, J; Mitchell, S; Patel, AR; Pavletic, SZ; Turner, ML; Wise, B | 1 |
| Alaggio, R; Alessia, B; Cesaro, S; Gamba, P; Marinello, S; Putti, MC; Rossi, L; Toffolutti, T | 1 |
| Anderson, AM; Diazgranados, CA; Gongora, MC; Hidron, AI | 1 |
| Annaert, P; Hermans, G; Meersseman, P; Meersseman, W; Spriet, I; Verbesselt, R; Willems, L | 1 |
| Adams, AI; Bergold, AM; Meneghini, LZ; Morimoto, LN | 1 |
| Sung, VW | 1 |
| Calvo, E; Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
| Mehta, J; Pennick, G; Pi, J; Scheetz, MH; Trifilio, SM; Yarnold, PR | 1 |
| Marti, J | 1 |
| Bakker-Woudenberg, IA; Mathot, RA; Rijnders, BJ; Tavakol, M; ten Kate, MT; van de Sande, WW; van Vianen, W | 1 |
| Chemaissani, A; Ernestus, K; Kamp, M; Knüttgen, D; Matten, J; Sakka, SG; Ströhlein, M; Wappler, F | 1 |
| Horn, D; Neofytos, D; Sae-Tia, S | 1 |
| Beernaert, LA; Dorrestein, GM; Haesebrouck, F; Martel, A; Pasmans, F; Van Waeyenberghe, L; Vercammen, F; Verstappen, F | 1 |
| Lee, HN; Shen, YC; Tsai, HY; Tsai, TC; Wang, CY; Wang, MY; Wei, LC | 1 |
| Baba, T; Endo, T; Enomoto, T; Hagiwara, E; Kato, T; Komatsu, S; Matsushima, A; Nishihira, R; Ogura, T; Sekine, A; Shiihara, J; Shinohara, T; Sogo, Y; Tagawa, A; Takahashi, H; Tsuchiya, N | 1 |
| Abematsu, K; Fukamizu, T; Fukunaga, N; Ikawa, K; Matsumoto, K; Morikawa, N; Nishida, K; Shimodozono, Y; Takeda, Y; Yamada, K | 1 |
| Aisa, Y; Ikeda, Y; Kato, J; Mori, T; Nakamura, Y; Okamoto, S | 1 |
| Maertens, J; Meersseman, W; Van Bleyenbergh, P | 1 |
| Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M | 1 |
| Jadoul, M; Labriola, L; Swinne, D; V, B | 1 |
| Adel, N; Harnicar, S; Jurcic, J | 1 |
| Elnazir, B; Glackin, L; Greally, P; Leen, G | 1 |
| Deng, SX; Hollander, DA; Kamal, KM | 1 |
| Matsumoto, Y; Nagai, A; Oh-I, T; Ohyama, F; Ooishi, T; Tsuboi, R | 1 |
| Bocanegra, R; Coalson, JJ; Graybill, JR; McConville, JT; Najvar, LK; Patterson, TF; Peters, JI; Tolman, JA; Wiederhold, NP; Williams, RO | 1 |
| Chen, MH; Crespo, M; Humar, A; Husain, S; Kumar, D; Manuel, O; McCurry, KR; Moussa, G; Pilewski, J; Studer, SM | 1 |
| Fanci, R | 1 |
| Bandettini, R; Calvillo, M; Castagnola, E; Conte, M; Cuzzubbo, D; Faraci, M; Lanino, E; Manzitti, C; Miano, M; Micalizzi, C; Morreale, G; Pescetto, L; Ravegnani, M; Ricagni, L; Soro, O | 1 |
| Chen, H; Fan, L; He, YJ; Lei, HP; Li, Q; Ou-yang, DS; Tan, ZR; Wang, G; Wang, LS; Zhang, W; Zhou, HH | 1 |
| Amrein, C; Batisse, A; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Dannaoui, E; Guillemain, R; Lillo-Le Louet, A; Loriot, MA; Pham, MH | 1 |
| Ayats, J; Fernández, N; Gasch, O; Santin, M | 1 |
| Avila, NA; Bacher, J; Cotton, MP; Francesconi, A; Hope, WW; Hughes, JE; Kasai, M; Meletiadis, J; Mickiene, D; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Stergiopoulou, T; Walsh, TJ | 1 |
| Bellemore, MC; Ellis, DH; Kesson, AM; O'Mara, TJ; Sorrell, TC | 1 |
| Joukhadar, C; Joukhadar, SM; Konz, KH; Kovar, F; Pöppl, W; Thallinger, C; Traunmüller, F | 1 |
| Kim, SD; Lee, JJ; Lee, SJ | 1 |
| Clancy, CJ; Derendorf, H; Li, Y; Nguyen, MH; Schmidt, S; Zhong, L | 1 |
| Aşik, G; Ayçiçek, A; Cetinkaya, Z; Kenar, F; Kiraz, N; Kiyici, H | 1 |
| Hangaishi, A; Imai, Y; Kumano, K; Kurokawa, M; Nannya, Y; Takahashi, T; Ueda, K | 1 |
| Kida, M | 1 |
| Inagaki, N; Mori, T; Yasuda, H | 1 |
| Bosselmann, S; McConville, JT; Nelson, NA; Peters, JI; Son, YJ; Tolman, JA; Wiederhold, NP; Williams, RO | 1 |
| Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S | 1 |
| Ben-Ami, R; Chamilos, G; Kontoyiannis, DP; Lamaris, GA; Lewis, RE; Samonis, G | 1 |
| Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R | 1 |
| Bourcier, T; Fabre, M; Labetoulle, M; Offret, H; Proença-Pina, J; Ssi Yan Kai, I | 1 |
| Bluemel, A; Ghebremedhin, B; Koenig, B; Koenig, W; Neumann, KH | 1 |
| Maschmeyer, G | 1 |
| Heinz, WJ; Helle, A; Kahle, K; Keller, D; Klinker, H; Langmann, P; Lenker, U; Schirmer, D | 1 |
| Carbonara, S; Ciracì, E; Cusato, M; Heichen, M; Monno, L; Regazzi, M; Stano, F; Villani, P | 1 |
| Costa-de-Oliveira, S; Pina-Vaz, C; Pinto e Silva, AT; Rodrigues, AG; Silva-Dias, A | 1 |
| Aguirre, JM; Carrillo-Muñoz, AJ; Eraso, E; Gaitán-Cepeda, LA; Quindós, G; Sánchez Vargas, LO | 1 |
| Baggen, L; Chisholm, J; Sharland, M; Thomas, L | 1 |
| De Carolis, E; Fadda, G; Fiori, B; Florio, AR; La Sorda, M; Martucci, R; Posteraro, B; Sanglard, D; Sanguinetti, M | 1 |
| Segal, BH | 1 |
| Pérez, P; Piñar, D; Quiles, JA; Reus, S | 1 |
| Schots, R; Vande Broek, I | 1 |
| Han, FC; Jureen, R; Tew, CW; Tey, BH | 1 |
| Castel, V; Gonzalez-Esteban, J; Madero, L; Sanchez de Toledo, J; Sanz-Rodriguez, C; Sevilla, J | 1 |
| Kampik, A; Kernt, M | 1 |
| Hasegawa, A; Imaji, M; Kano, R; Maruyama, H; Murakami, Y; Okabayashi, K; Osumi, T; Watanabe, T | 1 |
| Al-Badriyeh, D; Daniell, M; Davies, GE; Fullinfaw, R; Kong, DC; Leung, L; Roydhouse, T; Stewart, K | 1 |
| Al-Badriyeh, D; Davies, GE; Kong, D; Leung, L; Stewart, K | 2 |
| Ayats, J; Cabellos, C; Fernandez-Viladrich, P; Ferran, E; Font, F; Garcia-Vidal, C | 1 |
| Bhavna, B; Kumar, K; Narayan, SK; Roopeshkumar, VR; Swaminathan, RP | 1 |
| Bulut, Y; Günday, E; Güven, M; Yenişehirli, G | 1 |
| de La Blanchardière, A; de La Gastine, B; Fromager, G; Gendrot, A; Massias, L; Verdon, R | 1 |
| Ambudkar, SV; Manoharlal, R; Prasad, R; Prasad, T; Puri, N; Sharma, M; Shukla, S | 1 |
| Guarro, J; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Beck, O; Björkhem, I; Björkhem-Bergman, L; Heo, GY; Lütjohann, D; Mast, N; Nayef, R; Pikuleva, IA; Shafaati, M | 1 |
| Joshi, A; Khattry, N; Shah, MS; Singh, R; Umesh, S | 1 |
| Berger, N; Bonatti, H; Geltner, C; Grif, K; Lass-Flörl, C; Lechner, M; Margreiter, R; Stelzmueller, I | 1 |
| Almony, A; Apte, RS; Kraus, CL | 1 |
| Angerer, K; Bonatti, H; Geltner, C; Lass-Floerl, C; Lechner, M; Schmid, T; Singh, N; Singh, R; Stelzmueller, I | 1 |
| Abboud, I; Antoine, C; Benammar, M; Berge, M; Billaud, EM; Glotz, D; Lefeuvre, S | 1 |
| Kang, CI; Mandrekar, JN; Patel, R; Rouse, MS; Steckelberg, JM | 1 |
| Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL | 1 |
| Bosselmann, S; Coalson, JJ; Nelson, NA; Peters, JI; Tolman, JA; Wiederhold, NP; Williams, RO | 1 |
| Dinc, BM; Kalkanci, A; Kekilli, M; Kurt, M; Odemis, B; Oztas, E; Parlak, E; Sasmaz, N | 1 |
| Batoz, H; Breilh, D; Dromer, C; Janvier, G; Joannes-Boyau, O; Lafargue, M; Rozé, H | 1 |
| Aguado, JM; Fernández-Ruiz, M; Gutiérrez, E; López-Medrano, F | 1 |
| Li, R; Liu, W; Wan, Z; Wang, X; Yang, J | 1 |
| Clemons, KV; Kass, PH; Kline, Y; Martinez, M; Stevens, DA; Tell, LA; Woods, L | 1 |
| Aoyagi, I; Hidaka, H; Katori, Y; Kobayashi, T; Kudo, T; Nakaya, K; Oda, K; Oshima, T; Ota, J | 1 |
| Hawkins, MG; Nguyen, KQ; Taylor, IT; Tell, LA; Wiebe, VJ | 1 |
| Andrade, SE; Elizondo, M; González, GM; Portillo, OJ; Robledo, M; Rodríguez, C; Uscanga, GI | 1 |
| Canton, E; Espinel-Ingroff, A; Fothergill, AW; Peman, J; Rinaldi, MG | 1 |
| Baert, K; Beernaert, LA; Chiers, K; Haesebrouck, F; Martel, A; Pasmans, F; Van Waeyenberghe, L | 1 |
| Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S | 1 |
| Asticcioli, S; Daturi, R; Matti, C; Nucleo, E; Pagani, L; Sacco, L; Zara, F | 1 |
| Fung, CP; Lee, N; Lee, SC; Lo, HJ; See, LC | 1 |
| Hiraga, A; Kamitsukasa, I; Numata, T; Shibuya, M; Sunami, S; Uzawa, A | 1 |
| Accoceberry, I; Bernadou, JM; Breilh, D; Gordien, JB; Pigneux, A; Rouault, A; Saux, MC; Tabrizi, R; Vigouroux, S | 1 |
| Autthateinchai, R; Ikeda, R; Mekha, N; Nishikawa, A; Poonwan, N; Sawanpanyalert, P; Sugita, T | 1 |
| Eberhardt, R; Ebinger, D; Eckerle, I; Eisenbach, C; Gotthardt, D; Junghanss, T; Schnabel, PA; Stremmel, W | 1 |
| Alp, S; Arikan, S; Hasçelik, G; Sancak, B | 1 |
| Laporta, R; Lázaro, MT; Ramos, A; Sánchez-Romero, I; Ussetti, P | 1 |
| Albarrag, A; Anderson, MJ; Arendrup, MC; Cerar, D; Denning, DW; Fisher, MC; Howard, SJ; Laverdiere, M; Pasqualotto, AC; Perlin, DS | 1 |
| Aggermann, T; Binder, S; Haas, P; Hochwarter, A; Krepler, K | 1 |
| Alex, A; Harvey, S; Parsons, T; Pullen, FS; Riley, JA; Wright, P | 1 |
| Choe, DH; Kang, MS; Kim, CH; Lee, JC; Noh, GY | 1 |
| Angel, LF; Brady, R; Cadena, J; Levine, DJ; Levine, SM; Maxwell, PR; Michalek, JE; Restrepo, MI; Sanchez, JF | 1 |
| Chan, HM; Duran, SH; Ravis, WR; Walz, PH | 1 |
| Feder, RS; Gupta, G; Lyon, AT | 1 |
| Acharya, NR; Hong, K; Lee, S; Loh, AR; Mannis, M | 1 |
| Lass-Flörl, C; Perkhofer, S | 1 |
| Balajee, SA; Brandt, ME; Gade, L; McCloskey, CB | 1 |
| Chang, CM; Chang, HH; Ko, WC; Lee, HC; Lee, NY; Wu, CJ; Yang, YH | 1 |
| Al-Badriyeh, D; Davies, GE; Fullinfaw, R; Kong, DC; Leung, L; Li, J; Stewart, K | 1 |
| Denning, DW; Howard, SJ; Pasqualotto, AC | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S | 2 |
| Lapthorn, C; Pullen, F | 1 |
| Atienzar, M; Blanch, JJ; Escribano, E; Rodríguez, M | 1 |
| Delaere, L; Lagrou, K; Maertens, J; Peetermans, WE; Spriet, I; Willems, L | 1 |
| Anasetti, C; Field, T; Gergis, U; Greene, J; Huang, Y; Kharfan-Dabaja, M; Markey, K; Perkins, J; Schell, MJ; Wetzstein, G | 1 |
| Ader, F; Bienvenu, AL; Nseir, S; Rammaert, B | 1 |
| Costa, CR; de Aquino Lemos, J; de Fátima Lisboa Fernandes, O; do Rosário Rodrigues Silva, M; Hasimoto e Souza, LK; Jesuíno, RS; Passos, XS | 1 |
| Carter, JE; Culpepper, M; Goel, S; Kahn, AG | 1 |
| Akova, M; Beyazit, Y; Purnak, T; Sahin, GO; Shorbagi, A | 1 |
| Karaahmet, T; Korten, V; Odabasi, Z; Tigen, E; Tigen, K | 1 |
| Genzen, JR; Kenney, B | 1 |
| Allen, PJ; Davies, GE; Ferdinands, M; Fullinfaw, RO; Kong, DC; Lau, D; Leung, L | 1 |
| Flowers, SA; Rogers, PD; Ta, M | 1 |
| Frueh, BE; Goldblum, D; Muehlethaler, K; Theoulakis, P; Zimmerli, S | 1 |
| Hirano, T; Imai, K; Kagawa, K; Kasai, M; Kiyama, Y; Kobayashi, K; Kobayashi, N; Miyazono, T; Ogasawara, M; Tanimoto, M | 1 |
| Alffenaar, JW; Daenen, SM; Kosterink, JG; Uges, DR; van der Elst, KC | 1 |
| Cao, Y; Che, X; Ji, H; Miao, Z; Sheng, C; Wang, W; Yao, J; Zhang, W | 1 |
| Alastruey-Izquierdo, A; Castelli, MV; Cuesta, I; Mellado, E; Monzón, A; Rodríguez-Tudela, JL; Zaragoza, O | 1 |
| Kontoyiannis, DP; Lewis, RE; Pongas, GN; Samonis, G | 1 |
| Imamura, Y; Kaneko, Y; Kohno, S; Miyazaki, Y; Ohno, H | 1 |
| Abderrahim, E; Ben Abdallah, T; Ben Hamida, F; Ben Maïz, H; Bezzine, H; Hedri, H; Khaled, S; Kheder, A; Ounissi, M; Trabelsi, S | 1 |
| Bahador, A; Dehghani, M; Gholami, S; Hashemi, SB; Janghorban, P; Kakaei, F; Kazemi, K; Malek-Hosseini, SA; Nikeghbalian, S; Salahi, H; Shishegar, M | 1 |
| Banevicius, MA; Crandon, JL; Crownover, PH; Fang, AF; Knauft, RF; Kuti, JL; Nicolau, DP; Pope, JS; Russomanno, JH; Shore, E | 1 |
| Colby, KA; Mandell, KJ | 1 |
| Gu, P; Li, Y | 1 |
| George, E; Shinohara, MM | 1 |
| Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A | 1 |
| Damon, L; Guglielmo, BJ; Hwang, J; Kaplan, L; Linker, C; Martin, T; O'Malley, R; Sharma, M; Working, M | 1 |
| Ali, R; Altundal, Y; Ener, B; Hakyemez, B; Kocaeli, H; Ozçelik, T; Ozkalemkaş, F; Ozkocaman, V; Tunali, A | 1 |
| Constantinou, M; Jhanji, V; Sheorey, H; Vajpayee, RB; Yohendran, J | 1 |
| Fujii, A; Hamano, T; Itoh, H; Kuriyama, M; Matsunaga, A; Naganuma, S; Ueno, A; Yoneda, M | 1 |
| Hogan, BK; Lewis, JS; Nierenberg, NE; Patterson, TF; Thompson, GR | 1 |
| Annaert, PP; Augustijns, P; Benjamin, DK; Ibrahim, JG; Thakker, DR; Yanni, SB | 1 |
| Boikov, D; Nagappan, V; Vazquez, JA | 1 |
| Altman, R; Belperio, JA; Eshaghian, P; Gregson, A; Kubak, B; Lynch, JP; Ross, DJ; Saggar, R; Wang, T; Wang, TF; Weigt, SS | 1 |
| Marriott, D; Miyakis, S; Ray, J; van Hal, SJ | 1 |
| Aloisi, T; Aversa, F; Bonini, A; Caira, M; Candoni, A; Caramatti, C; Cattaneo, C; Chierichini, A; de Waure, C; Fadda, RM; Fanci, R; Ferrara, F; Fianchi, L; Invernizzi, R; Leone, G; Luppi, M; Martino, B; Melillo, L; Mitra, ME; Nosari, A; Offidani, M; Pagano, L; Pastore, D; Picardi, M; Potenza, L; Riva, M; Rossini, F; Specchia, G; Stanzani, M; Vacca, A | 1 |
| Azeredo, J; Henriques, M; Martins, M; Negri, M; Oliveira, R; Svidzinski, TI | 1 |
| Bueno, JG; Gallego, M; Martinez, C; Mesa, AC; Sanclemente, G; Zapata, B | 1 |
| Gómez-Bueno, M; Lázaro, MT; Pulpón, L; Ramos, A; Salas, C; Sanchez, I; Segovia, J | 1 |
| Bang, S; Edell, E; Eghrari, AO; Gottsch, JD | 1 |
| Badenoch, PR; Chang, JH; Coster, DJ; Klebe, S; Mills, RA; Sadlon, TA | 1 |
| Capote, M; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rojas, R; Sánchez-García, J; Serrano, J; Tabares, S; Torres, A | 1 |
| Olson, EL; Tonelli, AR | 1 |
| Al-Abdely, HM; Al-Tawfiq, JA | 1 |
| Böhme, A; Cornely, OA; Drzisga, I; Frommolt, P; Hallek, M; Harnischmacher, U; Mousset, S; Müller, C; Rüping, MJ; Vehreschild, JJ; Wassmer, G | 1 |
| Bertout, S; Bourgeois, N; Bousquet, PJ; Dehandschoewercker, L; Lachaud, L; Rispail, P | 1 |
| Arron, ST; Cowen, EW; Fox, LP; McShane, D; Miller, DD; Nguyen, JC; Prose, NS; Turner, ML | 1 |
| Higuchi, T; Kako, S; Kanda, Y; Kimura, S; Nakasone, H; Nishida, J; Okuda, S; Oshima, K; Sato, K; Sato, M; Tanaka, Y; Tanihara, A; Terasako, K; Yamazaki, R | 1 |
| Allenet, B; Auzéric, M; Bedouch, P; Bellemère, J; Charpiat, B; Conort, O; Juste, M; Rose, FX; Roubille, R | 1 |
| In, KH; Kang, EH; Kim, MJ; Yoon, YK | 1 |
| Akin, M; Ay, Y; Balkan, C; Karapinar, B; Kavakli, K; Yilmaz, D | 1 |
| Blanch-Iribarne, P; Garcia-Ramirez, M; Martin-Carballido, S; Martinez-Ferriz, MC; Martinez-Pajares, JD; Moreno-Perez, D | 1 |
| Grün, B; Krautter, S; Mikus, G; Riedel, KD | 1 |
| Rappersberger, K; Saxa-Enenkel, M; Stos, S; Stur-Hofmann, K | 1 |
| Beani, JC; Charles, J; Epaulard, O; Leccia, MT; Roch, N; Saint-Raymond, C; Villier, C | 1 |
| Blijlevens, NM; Brüggemann, RJ; Burger, DM; Donnelly, JP; Franke, B; Troke, PF | 1 |
| Blisard, D; Capitano, B; Han, K; Husain, S; Johnson, HJ; Kwak, EJ; Linden, PK; Marcos, A; Paterson, DL; Potoski, B; Romkes, M; Venkataramanan, R | 1 |
| Christen, S; Egger, SS; Gratwohl, A; Haschke, M; Krähenbühl, S; Leu, C; Meier, S | 1 |
| Lewis, JS; Thompson, GR | 1 |
| Jiménez Caballero, PE; Mollejo Villanueva, M | 1 |
| Hoffman, J; Jelliffe, R; Kovacs, A; Neely, M; Rushing, T | 1 |
| Alvarado, G; Blamble, D; Cortes, J; Faderl, S; Hernandez, M; Kantarjian, H; Koller, C; Mattiuzzi, GN; Pierce, S; Verstovsek, S; Xiao, L | 1 |
| Alagöz, N; Bozkurt, E; Cakir, M; Cekiç, O; Imamoğlu, S; Oksüz, L; Yilmaz, OF | 1 |
| Fukazawa, H; Imamura, Y; Kaneko, Y; Kohno, S; Miyazaki, Y; Murakami, Y; Ohno, H | 1 |
| Mehta, J; Pi, J; Scheetz, MH; Trifilio, SM | 1 |
| Meletiadis, J; Pournaras, S; Roilides, E; Walsh, TJ | 1 |
| Arendrup, MC; Krarup, E; Larsen, CG; Larsen, FG; Pedersen, M; Thybo, S | 1 |
| Ethier, MC; Maloney, AM; Mitchell, D; Sung, L; Zaoutis, T | 1 |
| Burhenne, J; Haefeli, WE; Mikus, G; Oberwittler, H; Riedel, KD; Scholz, I; Weiss, J | 1 |
| Guarro, J; Madrid, H; Pastor, J; Ruíz-Cendoya, M | 1 |
| Alvarez, M; Attal, M; Cassaing, S; Chabrol, A; Cuzin, L; Giron, J; Huguet, F; Linas, MD; Récher, C; Tetu, L; Verdeil, X | 1 |
| Kumar, P; Matsumoto, C; Pien, E; Rosen, J; Shanmugam, VK; Steen, V; Whelton, S | 1 |
| Andreolla, HF; Linden, R; Pasqualotto, AC; Xavier, MO | 1 |
| Nehls, S; Ogawa, GS; Pariseau, B; Romanelli, AM; Sutton, DA; Wickes, BL | 1 |
| Hara, Y; Mitani, A; Miyamoto, H; Ohashi, Y; Shiraishi, A; Uno, T; Yamaguchi, M | 1 |
| Barlow, G; Lillie, P; Moss, PJ; Parsonage, MJ; Stafford, ND; Thaker, H | 1 |
| Ikeda, R; Miyamoto, M; Nishikawa, A; Sugita, T; Takatori, K; Tsuboi, R | 1 |
| Buil, JA; Díaz-Cascajosa, J; Roselló, N; Sanchez, F; Vela, JI | 1 |
| Amigues, I; Barker, J; Chung, D; Cohen, N; Jakubowski, A; Papanicolaou, GA; Plescia, C; Seo, SK | 1 |
| Bakker-Woudenberg, IA; Tavakol, M; van de Sande, WW; van Vianen, W | 1 |
| Bellete, B; Flori, P; Hafid, J; Manhsung, RT; Morel, J; Raberin, H | 1 |
| Blundell, CM; Greig, JM; Oddy, MJ; Suvarna, SK | 1 |
| Cowen, EW; Fox, LP; McCalmont, TH; Miller, DD; Nguyen, JC | 1 |
| Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ | 1 |
| Cornely, OA | 1 |
| Celik, U; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Nguyen, ML; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A; Yousem, SA | 1 |
| Hsiao, CH; Lai, CH; Ma, DH; Tan, HY; Wu, PC | 1 |
| Georgiadou, E; Roilides, E; Simitsopoulou, M; Walsh, TJ | 1 |
| Klompas, M; Koo, S; Marty, FM | 1 |
| Duval, A; Hickman, G; Petit, A; Picard, C | 1 |
| Chang, SC; Chang, YL; Lin, KP; Sheng, WH; Wang, CP | 1 |
| Guarro, J; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
| Adiri, Y; Karatela, S; Lyon, GM; Sunay, S | 1 |
| Miharu, M; Osumi, T; Shima, H; Shimada, H; Takahashi, T | 1 |
| Wingard, J | 1 |
| Choi, JH; Choi, SM; Kwon, EY; Lee, DG; Park, CM; Shin, WS; Stevens, DA; Yoo, JH | 1 |
| Furuya, A; Ida, K; Kato, M; Koh, K; Okamoto, T; Takita, J | 1 |
| Diekema, DJ; Ellis, D; Fu, W; Gibbs, DL; Ling, TA; Newell, VA; Pfaller, MA; Rodloff, A; Tullio, V | 1 |
| Chew, HF; Cohen, EJ; Jungkind, DL; Mah, DY; Raber, IM; Tokarczyk, MJ; Toll, AD | 1 |
| Begué, D; Billaud, E; Boussaud, V; Caruba, T; Guillemain, R; Korb, V; Prognon, P; Sabatier, B; Thomas, A | 1 |
| Basile, V; Capone, D; Ciotola, A; D'Alessandro, V; Federico, S; Gentile, A; Nappi, R; Polichetti, G; Renda, A; Sabbatini, M; Santangelo, M; Tarantino, G | 1 |
| Borse, N; Jain, V; Natarajan, S; Shome, D | 1 |
| Baltopoulos, G; Despotelis, S; Evaggelopoulou, P; Evodia, E; Markantonis, SL; Myrianthefs, P; Panidis, D | 1 |
| Dag, I; Kasifoglu, N; Kiraz, N; Kiremitci, A; Oz, Y; Yamac, M | 1 |
| Grau, S; Rubio-Terrés, C | 1 |
| Li, H; Lu, Q; Wan, Z; Zhang, J | 1 |
| Damle, B; Luke, DR; Schlamm, HT; Tomaszewski, K | 1 |
| Basara, N; Bierbach, U; Frenzel, K; Lange, T; Mauz-Körholz, C; Michael, C; Niederwieser, D; Preiss, R | 2 |
| Bouchara, JP; Danner-Boucher, I; Despins, P; Gay-Andrieu, F; Haloun, A; Horeau-Langlard, D; Jossic, F; Le Pape, P; Miegeville, M; Morio, F; Nourry, L; Pattier, S; Talarmin, JP; Treilhaud, M | 1 |
| Beral, L; Desbois, N; Donnio, A; Guyomarch, J; Merle, H; Olive, C; Theodose, R; van Nuoï, DN | 1 |
| Besse, B; Hennequin, C; Le Pape, P; Loge, C; Morio, F | 1 |
| Buzina, W; Horré, R; Lackner, M; Tintelnot, K | 1 |
| Akashi, K; Aoki, T; Harada, N; Iwasaki, H; Kamezaki, K; Miyamoto, T; Mori, Y; Nagafuji, K; Shimono, N; Takenaka, K; Teshima, T; Yamauchi, T; Yoshimoto, G | 1 |
| Al-Badriyeh, D; Bajel, A; Downey, M; Grigg, A; Kong, DC; Liew, D; Slavin, M; Stewart, K; Thursky, K | 1 |
| Jensen, SG; Nielsen, TL | 1 |
| Chudgar, SM; Norton, BL; Person, AK; Stout, JE; Tong, BC | 1 |
| Agoglia, L; Alves, J; Araujo, A; Balbi, E; Carius, L; Covelo, M; Enne, M; Gonzalez, AC; Guedes, C; Halpern, M; Martinho, JM; Pacheco, L; Roma, J | 1 |
| Ailani, H; Cohen, EJ; Eagle, RC; Hammersmith, KM; Rapuano, CJ; Yildiz, EH | 1 |
| Barton, R; Bijie, H; Bille, J; Chang, SC; da Luz Martins, M; Diekema, DJ; Duse, A; Dzierzanowska, D; Ellis, D; Finquelievich, J; Gibbs, DL; Gould, I; Gur, D; Hoosen, A; Lee, K; Mallatova, N; Mallie, M; Newell, VA; Peng, NG; Petrikos, G; Pfaller, MA; Santiago, A; Trupl, J; VanDen Abeele, AM; Wadula, J; Zaidi, M | 1 |
| Bouchara, JP; Chabasse, D; Hitoto, H; Pihet, M; Rachieru-Sourisseau, P; Weil, B | 1 |
| Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
| King, AL; Massey, HD; Stolk, MJ | 1 |
| Applegate, J; Flammer, K; Grooters, AM; Papich, MG; Sanchez-Migallon Guzman, D; Shaw, S; Tully, TN | 1 |
| Bommer, J; Burhenne, J; Czock, D; Haefeli, WE; Hafner, V; Machleidt, C; Mikus, G; Riedel, KD; Weinreich, T | 1 |
| Arendrup, MC; Cuenca-Estrella, M; Donnelly, JP; Lass-Flörl, C; Rodríguez-Tudela, JL | 1 |
| Baert, K; Beernaert, L; de Backer, P; Haesebrouck, F; Hellebuyck, T; Martel, A; Pasmans, F; van Rooij, P; Van Waeyenberghe, L | 1 |
| Segal, BH; Sherif, R | 1 |
| Li, R; Liu, W; Qiao, J | 1 |
| Gabrielian, A; Hariprasad, SM | 1 |
| Burhenne, J; Burkhardt, O; Kielstein, JT; Thon, S; Welte, T | 1 |
| Alffenaar, JW; de Monchy, JG; Kosterink, JG; Uges, DR; van Assen, S; van der Werf, TS | 1 |
| Hariga, D; Khaled, S; Trabelsi, S | 1 |
| Chatzimoschou, A; Cotten, CJ; Diza-Mataftsi, E; Katragkou, A; Kruhlak, MJ; Paliogianni, F; Roilides, E; Simitsopoulou, M; Taparkou, A; Tsantali, C; Walsh, TJ | 1 |
| Fuqua, TH; Knoll, M; Said-Al-Naief, N; Sittitavornwong, S | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Cuesta, I; Rodriguez-Tudela, JL; Walther, G | 1 |
| Corey, M | 1 |
| Cooperstock, MS; Griffard, EA; Guajardo, JR; Scoville, CL | 1 |
| Frick, MA; Guarner, ME; Martín Nalda, A; Nadal, CF; Soler-Palacín, P | 1 |
| Lee, HN; Shen, YC; Tsai, HY; Wang, CY | 1 |
| Ito, E; Kamio, T; Kudo, K; Sasaki, S; Sato, T; Terui, K | 1 |
| Chan, HM; Duran, SH; Lin, HC; Passler, NH; Ravis, WR; Stewart, AJ; Welles, EG | 1 |
| Arteaga, MA; Gómez, Cde B; Marín, AG; Moreno, AR; Parra, HH; Restrepo, CA; Rodríguez, AZ | 1 |
| Dirr, F; Ebel, F; Echtenacher, B; Heesemann, J; Hoffmann, P; Wagener, J | 1 |
| Kato, J; Mori, T; Okamoto, S; Ono, Y; Shimizu, T; Yamane, A | 1 |
| Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA | 1 |
| Patterson, K; Strek, ME | 1 |
| Bernardin, G; Burel-Vandenbos, F; Dunais, B; Gari-Toussaint, M; Guidicelli, S; Hyvernat, H | 1 |
| Anyfantakis, V; Camus, M; Dammak, A; Delouane, H; Guillet, G; Riche, A; Roblot, F | 1 |
| Askari, SK; Beaty, SR; Burkemper, CN; Frisch, S | 1 |
| Elston, DM | 1 |
| Chen, HT; Cheng, WT; Leaw, SN; Lo, HJ; Wang, AH; Yang, YL | 1 |
| Baert, K; Beernaert, L; Chiers, K; De Backer, P; Haesebrouck, F; Hellebuyck, T; Martel, A; Pasmans, F; Van Waeyenberghe, L | 1 |
| Hoffman, SB; Smith, LN | 1 |
| Borman, AM; Houbraken, J; Rijs, AJ; Samson, RA; Verweij, PE | 1 |
| Baietto, L; D'Avolio, A; De Rosa, FG; Di Perri, G; Sciandra, M; Siccardi, M; Simiele, M; Ventimiglia, G | 1 |
| Arron, ST; Ibrahim, SF; Singer, JP | 1 |
| Joslin, CE; Shoff, ME; Tu, EY | 1 |
| Theurillat, R; Thormann, W; Zimmerli, S | 1 |
| Castanheira, M; Jones, RN; Pfaller, MA | 1 |
| Calvo, E; Guarro, J; Mayayo, E; Pastor, FJ; Rodríguez, MM; Salas, V | 1 |
| Acharya, NR; Hong, KC; Krishnan, T; Lee, SM; Lietman, TM; Mascarenhas, J; McLeod, SD; Porco, TC; Prajna, L; Prajna, NV; Reddy, PR; Srinivasan, M; Vaitilingam, CM; Zegans, ME | 1 |
| Kondori, N; Mattsby-Baltzer, I; Svensson, E | 1 |
| Kim, A; Kuti, JL; Nicolau, DP | 1 |
| Higashimoto, I; Koreeda, Y; Mataki, H; Matsuda, T; Noma, S; Taira, T | 1 |
| Azofra, MM; Carrillo, LH; Pérez, RD; Porras, MC; Somovilla, JL | 1 |
| Boel, A; Cartuyvels, R; Magerman, K; Naesens, R; Nys, S; Vijgen, S | 1 |
| Murayama, N; Nakamoto, M; Niwa, T; Shimizu, M; Yamazaki, H | 1 |
| de Hoon, J; Meersseman, P; Meersseman, W; Spriet, I; Willems, L | 1 |
| Bouza, E; Escribano, P; Gama, B; Guinea, J; Peláez, T; Recio, S | 1 |
| Inoue, T; Kakita, T; Matsuda, H; Mori, T; Nagatoya, K; Teranishi, J; Yamauchi, Y | 1 |
| Cheng, MP; Lands, LC; Ovetchkine, P; Paquette, K; Quach, C; Théoret, Y | 1 |
| Berrak, SG; Cakir, E; Cakir, FB; Canpolat, C; Dagli, E; Karakoc, F; Uyan, ZS | 1 |
| Meersseman, W | 1 |
| Bermudez, C; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A | 2 |
| Canton, E; Diekema, DJ; Espinel-Ingroff, A; Fothergill, A; Johnson, E; Pelaez, T; Pfaller, MA; Rinaldi, MG; Turnidge, J | 1 |
| Shen, YC; Tsai, HY; Tsai, TC; Wang, CY; Wei, LC | 1 |
| Chen, JM; Kuo, CH; Lin, SC; Lin, SW | 1 |
| Andreesen, R; Beier, F; Hildebrandt, GC; Holler, E; Holzmann, T; Kittan, N; Schardt, K | 1 |
| McCormack, J; Pollard, J | 1 |
| Falzone, E; Guarneri, L; Gugliara, C; Maffeo, F; Pasqua, P; Pulvirenti, F | 1 |
| Hou, Z; Li, C; Liu, G; Liu, Z; Lu, M; Sha, X; Tan, D; Xie, J; Xie, Y | 1 |
| Cisneros-Lanuza, A; Díaz-Llopis, M; Duch-Samper, A; Hurtado-Sarrió, M; Peman-Garcíia, J; Vazquez-Polo, A | 1 |
| Calvo, E; Guarro, J; Pastor, FJ; Pujol, I; Rodríguez, MM | 1 |
| Kelly, DE; Kelly, SL; Lamb, DC; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG | 1 |
| Bienvenu, AL; Biswas, P; Caillot, D; Chachaty, E; Cornet, M; Greene, J; Grenouillet, F; Herbrecht, R; Lacroix, C; Lortholary, O; Obenga, G; Raad, I; Sitbon, K; Troke, P | 1 |
| Dalpke, A; Müller, FM; Salvenmoser, S; Seidler, MJ | 1 |
| Biassoni, C; Borghi, E; Cuna, T; Iatta, R; Montagna, MT; Morace, G; Sciota, R | 1 |
| Abecasis, M; Bilger, K; Bofarull, RM; Cordonnier, C; Cornely, OA; de la Cámara, R; Einsele, H; Faucher, C; Heussel, CP; Liakopoulou, E; Ljungman, P; Maertens, J; Olavarria, E; Pigneux, A; Pineau, M; Rovira, M; Ullmann, AJ; Weisser, M | 1 |
| Aznar, J; de Toro, M; Maite, R; Torres, MJ | 1 |
| Aversa, F; Caira, M; Candoni, A; Leone, G; Luppi, M; Martino, B; Nosari, A; Offidani, M; Pagano, L; Specchia, G; Tosti, ME; Valentini, CG | 1 |
| Ceballos, P; Cociglio, M; Eiden, C; Eymard-Duvernay, S; Fegueux, N; Hillaire-Buys, D; Peyrière, H | 1 |
| Chen, L; Mulligan, ME | 1 |
| Barkmeier, A; Carvounis, PE; Kadikoy, H; Peck, B | 1 |
| Heeres, J; Lewi, P; Meerpoel, L | 1 |
| Kelly, DE; Kelly, SL; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG | 1 |
| Arrieta, AC; Driscoll, T; Groll, AH; Jafri, H; Klein, NJ; Lutsar, I; Milligan, PA; Schlamm, H; Walsh, TJ; Wood, ND | 1 |
| Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A | 1 |
| Belda, W; Careta, MF; Criado, PR; Martins, JE; Rivitti, EA; Spina, R; Valente, NY | 1 |
| Buer, J; Huelsewede, J; Rath, PM; Steinmann, J | 1 |
| Charvet, C; Mast, N; Pikuleva, IA; Stout, CD | 1 |
| Chen, XP; Ouyang, DS; Shi, HY; Tan, ZR; Wu, WH; Yan, J; Yang, GP; Zhou, G; Zhu, WH | 1 |
| Bies, R; Capitano, B; Gilbert, S; Han, K; Husain, S; McCurry, K; Paterson, DL; Potoski, BA; Venkataramanan, R | 1 |
| Chavda, M; Clawson, JS; Edwards, AJ; Pham, TN; Strohmeier, M; Vogt, FG; Watson, SA | 1 |
| Dag, I; Kiraz, N; Oz, Y | 3 |
| Belda, S; Cremades, R; Lopez, P; Rodriguez, JC; Royo, G; Ruiz-Garcia, M; Soler, L | 1 |
| Cleveland, KO; Mazumder, SA; Norwood, J | 1 |
| Kim, SY; Lee, YC; Yang, J | 1 |
| Costa, TD; Farias da Silva, C; Verlindo de Araujo, B | 1 |
| Baert, K; Debacker, P; Ducatelle, R; Garner, TW; Haesebrouck, F; Martel, A; Pasmans, F; Van Rooij, P; Van Waeyenberghe, L; Vercauteren, G; Woeltjes, T | 1 |
| Marriott, D; Miyakis, S; Ray, J; Solvag, CJ; van Hal, SJ | 1 |
| Ahmad, S; Burhamah, MHA; Khan, ZU; Mokaddas, E | 1 |
| Fisher, C; Jones, RL; Judson, IR; Ratnayake, G; Scurr, M; Thway, K | 1 |
| Bowyer, P; Bueid, A; Denning, DW; Harrison, E; Howard, SJ; Moore, CB; Richardson, MD | 1 |
| Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, N; Warrilow, AG; Weig, M | 1 |
| Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, NJ; Warrilow, AG | 1 |
| Bruggemann, RJ; Mavridou, E; Melchers, WJ; Mouton, JW; Verweij, PE | 1 |
| Magrath, GN; Mason, C; Montero, J; Pulido, JS; Wilson, J | 1 |
| Lagrou, K; Maertens, J; Meersseman, W; Saegeman, V; Spriet, I; Verbeken, E | 1 |
| Ehlert, K; Fegeler, W; Groll, AH; Kerl, K; Koch, B; Rossig, C | 1 |
| Atalay, H; Erekul, S; Nar, A; Ozbek, O; Solak, Y; Turk, S; Turkmen, K | 1 |
| Díaz-Llopis, M; Garcia-Delpech, S; Salom, D; Udaondo, P | 1 |
| Amitani, R; Izumikawa, K; Kakeya, H; Kohno, S; Kurashima, A; Miyazaki, Y; Niki, Y; Ogawa, K; Okimoto, N | 1 |
| Cai, B; Chen, H; Li, G; Li, H; Liu, W; You, C | 1 |
| Cutlan, JE; Geddes, ER; Hymes, SR; Polder, K; Torres-Cabala, CA | 1 |
| Guarro, J; Mayayo, E; Pastor, FJ; Pujol, I; Ruíz-Cendoya, M; Sutton, DA | 1 |
| Arendrup, MC; Johansen, HK; Lass-Flörl, C; Mellado, E; Mortensen, KL; Rodriguez-Tudela, JL | 1 |
| Abe, M; Fujii, S; Harada, T; Jinno, T; Kagawa, K; Matsumoto, T; Miki, H; Nakamura, S; Nakano, A; Ozaki, S; Takeuchi, K; Yata, K | 1 |
| Kim, M; Kim, MN; Lee, K; Lee, MK; Yong, D | 1 |
| Aydin, F; Bayramoglu, G; Guler, NC; Kaklikkaya, N; Tosun, I | 1 |
| Fernandes, M; Lakshmipathy, M; Shah, SG; Sharma, S | 1 |
| Bleyzac, N; Goutelle, S; Larcher, R; Mialou, V; Padoin, C | 1 |
| Anandbabu, K; Basu, G; Devasia, A; Sundaram, M; Tamilarasi, V | 1 |
| Chen, J; Chen, RZ; Huang, HQ; Lai, W; Xi, LY; Xue, RZ; Zhang, J; Zhang, XH | 1 |
| Judson, MA; Kravitz, JN; Steed, LL | 1 |
| Grundon, RA; Hardman, C; Muhlnickel, C; O'Reilly, A; Stanley, RG | 1 |
| Bello, I; Golmia, R; Hamerschlak, N; Marra, A; Osawa, A; Scheinberg, M | 1 |
| Guarro, J; Pastor, J; Ruíz-Cendoya, M | 1 |
| Bartlett, KH; Boekhout, T; Geertsen, E; Hagen, F; Illnait-Zaragozi, MT; Klaassen, CH; Meis, JF; Swinne, D | 1 |
| Bille, J; Calandra, T; Decosterd, LA; Marchetti, O; Mercier, T; Pesse, B; Rochat, B; Tissot, F; Widmer, N; Zanolari, B | 1 |
| Mulliez, P | 1 |
| Croxo, C; Mulliez, P; Saint-Georges, FR | 1 |
| Huang, Y; Li, HY; Liu, L; Wang, GY; Xia, ZF; Zhang, JR; Zhu, SH | 1 |
| Jiang, HR; Wu, XG; Xin, M; Yang, LN | 1 |
| Duan, J; Lan, X; Wang, L; Xiong, X; Zhai, S | 1 |
| Accoceberry, I; Gabriel, F; Noel, T | 1 |
| Gupta, P; Haripriya, A; Lalitha, P; Nirmal, J; Prajna, NV; Senthilkumari, S; Velpandian, T | 1 |
| Chong, PP; Jamal, F; Madhavan, P; Ng, KP | 1 |
| Cosaert, K; de Hoon, J; Meyfroidt, G; Meyts, I; Proesmans, M; Renard, M; Spriet, I; Uyttebroeck, A; Verbesselt, R; Willems, L | 1 |
| Heijink, A; Patel, R; Rouse, MS; Steckelberg, JM | 1 |
| Chang, MR; Dias, AL; Gambale, V; Paula, CR; Prates, RA; Ribeiro, MS; Ruiz, Lda S; Silva, EG | 1 |
| Esterly, JS; Fotis, M; Gorski, E; Postelnick, M; Scheetz, MH; Trifilio, S | 1 |
| Hagihara, M; Hasegawa, T; Kawasumi, N; Kimura, M; Mikamo, H; Yamagishi, Y | 1 |
| Kloft, C; Simmel, F | 1 |
| Chen, DM; Guo, LN; Liu, Y; Lü, HX; Shi, JY; Shi, Y; Wang, H; Xi, LY; Xu, YC; Zhao, WS; Zhou, X | 1 |
| Amrein, C; Beaune, PH; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Laurent-Puig, P; Le Beller, C; Lillo-Lelouet, A; Loriot, MA; Trégouet, DA | 1 |
| Auffarth, GU; Dithmar, S; Thomas, BC; Völcker, HE; Zimmermann, S | 1 |
| Höger, PH; Ott, H; Schrum, J; Vöhringer, S | 1 |
| Bulloch, MN | 1 |
| Borghi, E; Iatta, R; Manca, A; Montagna, MT; Morace, G | 1 |
| Bellmann, R; Bellmann-Weiler, R; Dunzendorfer, S; Fiegl, D; Joannidis, M; MacFarland, R; Stienecke, E; Weiler, S | 1 |
| Cecil, JA; Wenzel, RP | 1 |
| Clancy, CJ; Cline, C; Jantz, MA; Kulkarni, V; Leather, H; Nguyen, MH; Wheat, LJ; Wingard, JR | 1 |
| Fujiya, M; Hosoki, T; Ikuta, K; Kohgo, Y; Okamura, N; Sato, K; Torimoto, Y; Yamamoto, M | 1 |
| Fernandes, M; Goyal, J; Shah, SG | 1 |
| Higaki, T; Itokawa, T; Kami, M; Komatsu, T; Miura, Y; Murashige, N; Murata, K; Takei, N; Tsubokura, M | 1 |
| Balestrazzi, A; Ciompi, L; Franceschini, R; Martone, G; Moramarco, A; Pichierri, P; Tosi, GM | 1 |
| Coorevits, L; Jeurissen, A; Lagrou, K; Schuermans, C; Surmont, I; van Bergen, M; Verhaegen, J | 1 |
| Arora, R; Goyal, J; Gupta, D; Kaur, R | 1 |
| Balasingham, A; Balasingham, S; Chalkias, S; Saul, Z; Sutton, DA; Wickes, BL | 1 |
| Falcone, M; Massetti, AP; Russo, A; Venditti, M; Vullo, V | 1 |
| Brüggemann, RJ; Burger, DM; van der Linden, JW; Verweij, PE; Warris, A | 1 |
| Bierings, MB; Melchers, WJ; Thors, VS; Verweij, PE; Wolfs, TF | 1 |
| Alanio, A; Botterel, F; Bretagne, S; Cordonnier, C; Costa, JM; Farrugia, C; Foulet, F; Hicheri, Y; Liance, M; Sitterlé, E | 1 |
| Gyo, K; Hato, N; Hinohira, Y; Hyodo, J; Takahashi, H; Ugumori, T; Wakisaka, H | 1 |
| Fujishima, K; Fukae, J; Furuya, T; Hattori, N; Hirayama, T; Noda, K; Ogaki, K; Okuma, Y | 1 |
| Dolton, MJ; McLachlan, AJ | 2 |
| Al-Badriyeh, D; Heng, SC; Kong, DC; Neoh, CF; Slavin, M; Stewart, K | 1 |
| Böhme, A; Heinz, WJ; Silling, G | 1 |
| Durrani, OM; Joganathan, V; Mehta, P; Oppenheim, B | 1 |
| Chen, KJ; Hsiao, CH; Sun, CC; Tan, HY; Yeh, LK | 1 |
| Ko, KS; Lee, JY; Peck, KR; Song, JH | 1 |
| Ayub, A; Kenney, CV; McKiernan, FE | 1 |
| Charles, JF; Daikh, DI; Eberle, C; Rooney, T | 1 |
| Abbes, S; Ayadi, A; Ben Jemaa, M; Bouaziz, M; Cheikhrouhou, F; Chelly, H; Hammami, B; Khaled, S; Makni, F; Néji, S; Sellami, A; Sellami, H | 1 |
| Clemons, KV; Kline, Y; Stevens, DA; Tell, LA; Woods, L | 1 |
| Ciecko, SC; Scher, R | 1 |
| Bedouch, P; Belaiche, S; Pison, C; Quetant, S; Roustit, M; Saint-Raymond, C | 1 |
| Azevedo, AC; Bizerra, FC; Colombo, AL; da Matta, DA; de Almeida, LP; Rosas, R | 1 |
| Askari, E; Cáceres Agra, JJ; Jarque, I; Nicolás Franco, S | 1 |
| Burhenne, J; Czock, D; Haefeli, WE; Hassan, A; Mikus, G; Riedel, KD; Weiss, J | 1 |
| Boyken, L; Diekema, D; Hollis, R; Kroeger, J; Messer, S; Pfaller, M; Tendolkar, S | 1 |
| Bloomer, MM; Fintelmann, RE; Gilmer, W; Jeng, BH | 1 |
| Chiba, S; Hara, A; Homma, M; Kohda, Y; Momo, K; Okoshi, Y; Wada, T; Watanabe, M | 1 |
| Boyken, L; Diekema, DJ; Espinel-Ingroff, A; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
| Deeren, D | 1 |
| Cooper, K; Deziel, PJ; Kremers, WK; Moyer, TP; Razonable, RR; Wermers, RA; Whitford, GM | 1 |
| Chai, LY; Hsu, LY | 1 |
| Kuithan, F; Scheer, F; Wiggermann, P | 1 |
| Alvarez Tundidor, S; González Rozas, M; Pineda Alonso, M | 1 |
| Cornely, OA; Farowski, F; Hussaini, T; Rüping, MJ; Vehreschild, JJ | 1 |
| Cuenca-Estrella, M; Cuesta, I; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL; Zaragoza, O | 1 |
| Cars, O; Lignell, A; Löwdin, E; Sanglard, D; Sjölin, J | 1 |
| Andes, D; Bastulli, C; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Iqbal, N; Knapp, C; Lockhart, SR; Marchillo, K; Messer, S; Ostrosky-Zeichner, L; Paetznick, VL; Pfaller, MA; Ramani, R; Rodriguez, J; Sein, T; Walsh, TJ; Welshenbaugh, AR | 1 |
| Cordonnier, C; Cornely, OA; Einsele, H; Ljungman, P; Maertens, J; Rovira, M | 1 |
| Wilson, MA; Wise, SM | 1 |
| Boyken, LB; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
| Chang, FY; Ho, SJ; Lin, JC; Shang, ST; Wang, NC; Yang, YS | 1 |
| Giguère, P; Kravcik, S; la Porte, CJ; Toy, J | 1 |
| Bies, R; Capitano, B; Han, K; Johnson, H; Venkataramanan, R | 1 |
| De Rosa, FG; Falcone, M; Ghezzi, MC; Pasero, D; Raponi, G; Russo, A; Toma, L; Venditti, M | 1 |
| de Queiroz-Telles, F; Fraunfelder, FT; Goodrich, J; Laties, AM; Moreira, AT; Sato, MT; Tomaszewski, K | 1 |
| Jones, B; Lang, S; Lappin, DF; Majithiya, JB; McCulloch, E; Mowat, E; Rajendran, R; Ramage, G; Warn, P; Williams, C | 1 |
| Bouza, E; Escribano, P; Guinea, J; Peláez, T; Recio, S | 1 |
| Deuel, T; Folkerth, R; Jiang, JX; Kesari, S; Lechpammer, M; Marty, FM; Milner, DA; Rosow, L; Zamani, AA | 1 |
| Bigorra, L; Garduño, E; Hidalgo, R; Torres, JP | 1 |
| Pena, TA; Samavati, L; Soubani, AO | 1 |
| Gurgle, HE; Oinonen, MJ; Pakyz, AL | 1 |
| Antachopoulos, C; Chatzimoschou, A; Georgiadou, E; Katragkou, A; Roilides, E; Simitsopoulou, M; Walsh, TJ | 1 |
| Davis, JL; Goldstein, SC; Lombardi, LR; Miano, TA; Mitra, N; Morgan, SC; Vardhanabhuti, S; Vozniak, JM | 1 |
| Ananda-Rajah, MR; Cheng, A; Dooley, M; Morrissey, CO; Neville, AM; Slavin, M; Spelman, T | 1 |
| Bajwa, RP; Fung, B; Garee, A; Gross, TG; Pietryga, D; Rawlinson, NJ; Skeens, M; Soni, S; Termuhlen, AM | 1 |
| Aiba, K; Dobashi, N; Kasama, K; Katsube, A; Machishima, T; Minami, J; Nishiwaki, K; Ogasawara, Y; Saito, T; Shimada, T; Sugiyama, K; Takahara, S; Takei, Y; Usui, N; Yahagi, Y; Yamaguchi, Y; Yano, S; Yokoyama, H | 1 |
| Hao-Ran, J; Li-Na, Y; Meng, X; Xiang-Gen, W | 1 |
| Azim, S; Fadoo, Z; Manzoor, NF | 1 |
| Bourgeois, N; Crouzet, J; Lachaud, L; Picard, E; Sotto, A | 1 |
| Cohen, PR; Riahi, RR | 1 |
| Actis Dato, GM; Bardi, G; Casabona, R; Del Ponte, S; Flocco, R; Forsennati, P; Parisi, F; Punta, G; Sansone, F; Zingarelli, E | 1 |
| Ahmad, S; Chandra, J; Chowdhary, A; Kathuria, S; Khan, ZU; Khanna, G; Randhawa, HS; Roy, P; Singh, V | 1 |
| Yong, L | 1 |
| Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC | 1 |
| Flynn, HW; Liggett, PE; Scartozzi, R; Tom, D | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Xu, J; Yu, S; Zhang, D; Zhang, J; Zou, Y | 1 |
| Lodise, TP; Pai, MP | 1 |
| Huang, CY; Sun, PL; Tseng, HK | 1 |
| Durand, CM; Durand, DJ; Lee, R; Neofytos, D; Ray, SC | 1 |
| Cheng, Y; Li, WJ; Tian, Y; Wei, W; Zhang, ZJ | 1 |
| Hatta, Y; Inoue, Y; Kato, M; Miura, I; Ogawa, K; Saito, T; Shibuya, Y; Suzuki, Y; Takahashi, M; Takeuchi, J; Takimoto, M | 1 |
| Bency, R; Blyth, CC; Chapman, J; Chen, SC; Gilroy, N; Harun, A; Meyer, W; Ong, A; Shingde, M; Vicaretti, M | 1 |
| Iwata, N; Kimotsuki, T; Kinoshita, J; Ohba, M; Yasuda, M | 1 |
| Hoshika, Y; Kato, M; Katsura, Y; Kikuchi, K; Misawa, S; Nagaoka, T; Ohashi, R; Seyama, K; Sugawara, T; Takahashi, K; Takekawa, H; Togo, S; Tsuchiya, K; Yoshimi, K | 1 |
| Daneshgar, F; Khodabande, A; Siatiri, H; Siatiri, N | 1 |
| Chen, WT; Chen, YC; Hsiao, CH; Hsueh, PR; Ko, BS; Kuo, YM; Liu, JY; Yao, M | 1 |
| Agarwal, P; Sharma, N; Sinha, R; Titiyal, JS; Vajpayee, RB; Velpandian, T | 1 |
| Katragkou, A; Roilides, E | 1 |
| Askari, E; Fernandez Guerrero, ML; Gadea, I; Prieto, E; Román, A | 1 |
| Cormican, M; Hanahoe, B; Lyons, M; O'Connell, K | 1 |
| Caira, M; Fianchi, L; Pagano, L; Valentini, CG | 1 |
| Kurokawa, M; Masamoto, Y; Nannya, Y | 1 |
| Brizio, A; Cantoni, S; Lombardi, G; Morra, E; Nosari, A; Riva, M | 1 |
| Grossniklaus, HE; Hall, T; Khandelwal, SS; Stulting, RD; Woodward, MA | 1 |
| Maschmeyer, G; Sandherr, M | 1 |
| Barnes, A; Barr, FJ; Hotston-Moore, A; Malik, R; Murphy, KF; Pearson, GR | 1 |
| Funakoshi, Y; Matsuoka, H; Minami, H; Yakushijin, K | 1 |
| Booth, DR; Liddle, C; O'Connor, K; Stewart, GJ; Suan, D | 1 |
| Reisman, A; Schwartz, S; Troke, PF | 1 |
| Geller, L; Mercer, SE; Phelps, RG; Raciti, PM | 1 |
| Amorim, A; Butler, G; Guida, A; Miranda, IM; Pina-Vaz, C; Rocha, R; Rodrigues, AG; Silva, AP; Silva, R; Synnott, J | 1 |
| Kong, DC; Leung, L; Neoh, CF; Stewart, K; Vajpayee, RB | 1 |
| Nweze, EI; Ogbonnaya, UL | 1 |
| Angoulvant, A; Epaud, R; Le Pointe, HD; Levine, E; Petit, A | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Zhang, D; Zhang, J; Zou, Y | 1 |
| Clemons, KV; Schwartz, JA; Stevens, DA | 2 |
| Arendrup, MC; Fuursted, K; Gahrn-Hansen, B; Howard, SJ; Jensen, RH; Johansen, HK; Knudsen, JD; Mortensen, KL | 1 |
| He, L; Ji, WB; Liang, YR; Lu, F; Lü, SC; Luo, Y; Shi, XJ; Zhao, ZM | 1 |
| Garcia-Hermoso, D; Gay-Andrieu, F; Haloun, A; Le Pape, P; Leclair, F; Lepoivre, T; Miegeville, M; Miossec, C; Morio, F; Treilhaud, M | 1 |
| Alexander, BD; Andes, D; Arendrup, MC; Brown, SD; Chaturvedi, V; Diekema, DJ; Espinel-Ingroff, A; Fowler, CL; Ghannoum, MA; Johnson, EM; Knapp, CC; Motyl, MR; Ostrosky-Zeichner, L; Pfaller, MA; Walsh, TJ | 1 |
| Spriet, I; Wauters, J; Willems, L | 1 |
| Borman, A; Cartwright, KE; Clark, TW; Hussain, AM; Johnson, EM; Wiselka, M | 1 |
| Caggiano, G; Cuna, T; Iatta, R; Montagna, MT | 1 |
| Alvarez, MA; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rodríguez, G; Rodríguez-Villa, A; Rojas, R; Sánchez-García, J; Serrano, J; Tallón, D; Torres, A | 1 |
| Calvo, E; Guarro, J; Hernández, P; Mayayo, E; Pastor, FJ | 1 |
| Chugh, TD; Duggal, S; Jain, H; Sharma, A; Tyagi, A | 1 |
| Ilkit, M; Kiraz, N; Oz, Y; Ozdemir, HG | 1 |
| Bhagwat, K; Brooks, M; Eisen, D; Royse, A; Royse, C; Sparks, P | 1 |
| Dong, X; Min, X; Wu, X; Xie, L; Yang, L | 1 |
| Malfertheiner, MV; Schreiber, J; Waldburg, N | 1 |
| Badali, H; de Hoog, GS; Meis, JF; Sudhadham, M | 1 |
| Falade-Nwulia, O; Henning, SA; Huang, X; JJingo, C; Leung, J; Moriyama, B; Penzak, SR; Walsh, TJ; Wilson, WH | 1 |
| Delaunay, J; Fraissinet, F; Gastinne, T; Gibas, CF; Le Pape, P; Miegeville, M; Morio, F; Sigler, L | 1 |
| Aki, ŞZ; Akyürek, N; Şenol, E; Sucak, G; Tunçcan, ÖG | 1 |
| Bergstresser, P; Chan, J; Dai, W; Dharamsi, JW; Gander, R; Ricotti, C; Soliman, S | 1 |
| Chvojka, J; Karvunidis, T; Krouzecky, A; Matejovic, M; Novak, I; Radej, J; Stehlik, P; Sykora, R | 1 |
| Alves, SH; Azevedo, MI; Botton, SA; Dutra, V; Jesus, FP; Lautert, C; Machado, ML; Mahl, DL; Santurio, JM; Zanette, RA | 1 |
| Ko, WC; Lee, HC; Lo, HJ; Wu, CJ | 1 |
| Bajaj, MS; Kashyap, S; Meel, R; Pushker, N; Sen, S | 1 |
| Avery, S; Chang, CC; Grigoriadis, G; Morrissey, O; Patil, S; Spencer, A; Walker, P | 1 |
| George, J; Reboli, AC | 1 |
| Das, M; Dikshit, S; Murthy, SI; Rathi, V | 1 |
| Jang, IJ; Kim, KH; Kim, NJ; Lee, S; Oh, MD; Park, WB; Yu, KS; Yun, NR | 1 |
| Fujiwara, Y; Ota, Y; Takeuchi, M; Yoshida, C | 1 |
| Dan, M; Edelman, A; Gottesman-Yekutieli, T; Hendel, D; Shwartz, O | 1 |
| Baxter, CG; Denning, DW; Felton, TW; Marshall, A; Roberts, M | 1 |
| Hagiwara, E; Kamei, K; Ogata, R; Ogura, T; Shiihara, J; Takahashi, H | 1 |
| Brilhante, RS; Caetano, EP; Castelo-Branco, Dde S; Cordeiro, Rde A; de Lima, RA; Fechine, MA; Marques, FJ; Mesquita, JR; Monteiro, AJ; Mourão, CI; Ribeiro, JF; Rocha de Castro E Silva, K; Rocha, FA; Rocha, MF; Sidrim, JJ | 1 |
| Biancalana, FS; Lyra, L; Schreiber, AZ | 1 |
| Mikus, G; Scholz, IM; Weiss, J | 1 |
| El-Hadidy, GN; El-Milligi, MF; Ibrahim, HK; Mohamed, MI | 1 |
| Castanheira, M; Hata, K; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA | 1 |
| Chavala, SH; Ehlers, JP; Postel, EA; Woodward, JA | 1 |
| Agarwal, P; Gogia, V; Gupta, S; Satpathy, G; Shrivastava, RM; Tandon, R | 1 |
| Williams, D | 1 |
| Salameire, D | 1 |
| Blanche, S; Bougnoux, ME; Elie, C; Gerin, M; Jullien, V; Lanternier, F; Lortholary, O; Mahlaoui, N | 1 |
| de Hoog, S; Debourgogne, A; Lozniewski, A; Machouart, M | 1 |
| Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
| Bignell, EM; Cairns, T; Doyle, S; Kavanagh, K; Larsen, TO; Miggin, SM; O'Hanlon, KA; O'Keeffe, G; Schrettl, M; Stack, D | 1 |
| Osmond, GW; Puri, PK; Walters, RW | 1 |
| Miller, CJ; Seykora, JT; Shinohara, MM | 1 |
| Brown, M; O'Reilly Zwald, F | 1 |
| Kullberg, BJ; Oborska, IT; Oude Lashof, AM; Pappas, PG; Rex, JH; Rothova, A; Ruhnke, M; Schlamm, HT; Sobel, JD; Viscoli, C | 1 |
| Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, W; Smith, RP | 1 |
| Click, J; Gee, SN; Hsu, MY; Rothschild, B; Saavedra, A; Sheth, V | 1 |
| Hockey, HP; Hope, WW; Troke, PF | 1 |
| Han, SB; Hyon, JY; Shin, YJ; Wee, WR | 1 |
| Stirbu, O; Suriano, MM; Vila Arteaga, J | 1 |
| Lingegowda, PB; Tan, AL; Tan, BH; Tan, CK | 1 |
| Björkholm, M; Celsing, F; Grane, P; Kalin, M | 1 |
| Mitrokhin, SD; Sokolov, AA | 1 |
| Asslaber, M; Buzina, W; Haas, D; Heiling, B; Hoenigl, M; Koidl, C; Krause, R; Neumeister, P; Pichler, M; Rohn, A; Salzer, HJ; Valentin, T; Zollner-Schwetz, I | 1 |
| Choi, SM; Kang, MK; Kim, HJ; Kim, SH; Kwon, JC; Lee, DG; Min, WS | 1 |
| Chang, SE; Choi, JH; Kim, MS; Lee, HM; Lee, MW; Moon, KC; Sung, HS; Won, CH | 1 |
| Clifton, IJ; Conway, SP; Metcalfe, R; Peckham, DG; Phillip, M; Shaw, N; Whitaker, P | 1 |
| Banerjee, R; Dhiman, N; Henry, NK; Huskins, WC; Joshi, AY; Santillan Salas, CF; Wengenack, NL | 1 |
| Fujieda, A; Iwamoto, T; Katayama, N; Monma, F; Nakatani, K; Okuda, M | 1 |
| Doroftei, B; Mareş, M; Năstasă, V; Ramona, FM; Stefanache, A | 1 |
| Fothergill, AW; Grimsrud, C; Kim, HT; Raven, R | 1 |
| Akalin, H; Dizdar, OS; Ener, B; Ersoy, A; Koc, AO | 1 |
| Beiras-Fernandez, A; Bigdeli, AK; Kaczmarek, I; Michel, S; Nickel, T; Reichart, B; Ueberfuhr, P | 1 |
| Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Shirotori, S; Tanaka, K; Watanabe, NA; Yoshimatsu, K | 1 |
| Berbel, RF; Casella, AM; de Freitas, D; Höfling-Lima, AL | 1 |
| Choi, JH; Choi, SM; Han, S; Kim, SH; Kwon, EY; Kwon, JC; Lee, DG; Park, C; Park, SH; Yim, DS; Yoo, JH | 1 |
| Bentley, RT; Faissler, D; Sutherland-Smith, J | 1 |
| Alves, SH; Azevedo, MI; Rossato, L; Santurio, JM; Spader, TB; Tronco-Alves, GR; Venturini, TP; Weiler, CB | 1 |
| Carrillo-Muñoz, AJ; Eraso, E; Madariaga, L; Marcos-Arias, C; Quindós, G | 1 |
| Castanheira, M; Duncanson, F; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA | 1 |
| Dickmeyer, NJ; Kiel, PJ | 1 |
| Afshari, NA; Goldhagen, BE; Majka, CP; Perfect, JR; Rebong, RA; Santaella, RM; Steinbach, WJ | 1 |
| Agrawal, S; Bali, R; Bhagol, A; Sen, R; Sharma, B; Singh, V | 1 |
| Damle, B; Luke, DR; Tomaszewski, KE; Wood, ND | 1 |
| Alcazar-Fuoli, L; Cuenca-Estrella, M; Cuesta, I; Mellado, E; Rodriguez-Tudela, JL; Sanglard, D | 1 |
| Damle, B; Varma, MV; Wood, N | 1 |
| Cook, G; Glasmacher, A; Heussel, CP; Kantecki, M; Kibbler, CC; Marks, DI; Miller, PJ; Pagliuca, A; Ribaud, P; Schlamm, HT; Solano, C | 1 |
| Kamei, K; Nishimura, K; Sugaya, K; Sugiyama, Y; Suzuki, Y; Tokura, Y; Yaguchi, T | 1 |
| Aubry-Rozier, B; Boubaker, A; Dunet, V; Marchetti, O; Rossier, C; Tissot, F | 1 |
| Al-Nawas, B; Karbach, J; Walter, C | 1 |
| Baruch, A; Blumer, J; Driscoll, TA; Frangoul, H; Krance, RA; Liu, P; Murphey, DK; Nemecek, ER; Yu, LC | 1 |
| Castanheira, M; Diekema, DJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Binder, DR; Herring, IP; Sugrue, JE | 1 |
| Beguin, H; Detandt, M; Hendrickx, M | 1 |
| Katkov, AI; Katkova, VO; Nesterov, AP; Novikova, NA; Ovchinnikov, RS; Sedov, VP; Syrkin, AL; Vakhliaev, AV | 1 |
| Bassetti, M; Molinari, MP; Mussap, M; Nicco, E; Taramasso, L; Viscoli, C | 1 |
| Arda, B; Ceylan, N; Erdem, A; Işıkgöz Taşbakan, M; Metin, DY; Midilli, R; Pullukçu, H; Sipahi, OR; Taşbakan, MS; Ulusoy, S; Yamazhan, T | 1 |
| Burhenne, J; Haefeli, WE; Katzenmaier, S; Markert, C; Mikus, G; Riedel, KD | 1 |
| Haagsma, CJ; Hendrix, R; Ruinemans, GM | 1 |
| Atalay, S; Aypar, E; Çiftçi, E; Ileri, T; Ince, E; Kendirli, T; Tutar, E | 1 |
| Cafarchia, C; Figueredo, LA; Iatta, R; Montagna, MT; Otranto, D | 1 |
| Arrieta, A; Baruch, A; Blumer, J; Bradfield, SM; Driscoll, TA; Frangoul, H; Graham, ML; Krance, RA; Liu, P; Nemecek, E; Yu, LC | 1 |
| Bell, JE; Christenson, JC; Hulbert, ML; Imel, EA; Skiles, JL | 1 |
| Aoun, M; Gadisseur, A; Jacobs, F; Selleslag, D; Sonet, A | 1 |
| Acharya, NR; Gronert, K; Keenan, JD; Krishnan, T; Lietman, TM; Oldenburg, CE; Prajna, NV; Ray, KJ | 1 |
| Prasad, PA; Vaughan, AM; Zaoutis, TE | 1 |
| Hamoud, S; Hayek, T; Keidar, Z | 1 |
| de Hoog, GS; Hell, M; Lackner, M; Neureiter, J; Presterl, E; Willinger, B; Wojna, A | 1 |
| Fulco, PP; Gibson, JN | 1 |
| Chang, TC; Hsiue, HC; Hsiue, YC; Hsueh, PR; Huang, YT; Lee, PI; Wu, TH | 1 |
| Cornish, NE; Hoffman, MA; Simonsen, KA | 1 |
| Choi, SH; Hong, SB; Kim, MN; Kim, SH; Kim, YS; Koh, Y; Lee, SO; Lim, CM; Woo, JH | 1 |
| Falcone, M; Mancini, C; Morelli, A; Russo, A; Vena, A; Venditti, C; Venditti, M | 1 |
| Bays, D; Cohen, SH; Pappagianis, D; Thompson, GR | 1 |
| Bouza, E; Escribano, P; González-Rivera, M; Guinea, J; Peláez, T; Recio, S | 1 |
| Blosser, SJ; Cramer, RA | 1 |
| Cui, Y; Jin, C; Li, X; Wu, N | 1 |
| Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Iwanaga, N; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Minematsu, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
| Chu, J; Meehan, S; Patel, R; Patel, U | 1 |
| Bakhshi, S; Kabra, SK; Mandhaniya, S; Swaroop, C; Thulkar, S; Vishnubhatla, S; Xess, I | 1 |
| Blair, JE; Kim, MM; Kusne, S; Seville, MT; Vikram, HR | 1 |
| Granata, JD; Lustenberger, DP; Scharschmidt, TJ | 1 |
| Blanche, S; Chosidow, O; Epaulard, O; Leccia, MT; Lortholary, O; Mamzer-Bruneel, MF; Ravaud, P; Thiebaut, A; Villier, C | 2 |
| Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M | 1 |
| Bahlaoui, A; Bakhatar, A; Chakib, A; El Fane, M; El Filali, KM; Ouladlahsen, A; Sodqi, M | 1 |
| Ananda-Rajah, MR; Bajel, A; Cheng, A; Downey, MT; Grigg, A; Slavin, MA; Spelman, T; Thursky, KT; Vincent, J | 1 |
| Hope, WW | 1 |
| Al-Saigh, R; Meletiadis, J; Roilides, E; Velegraki, A; Walsh, TJ; Zerva, L | 1 |
| Cendejas-Bueno, E; Cuenca-Estrella, M; Cuesta, I; García Rodríguez, J; Gómez-López, A; Gutiérrez-Altés, A; Rodríguez-Tudela, JL | 1 |
| de Assis Baroni, F; Gambale, W; Paula, CR; Silva, EG | 1 |
| Schmutz, JL; Trechot, P | 1 |
| Bedini, A; Cavrini, F; Cocchi, S; Codeluppi, M; De Ruvo, N; Di Benedetto, F; Gennari, W; Gerunda, GE; Grottola, A; Guaraldi, G; Rumpianesi, F; Venturelli, C | 1 |
| Castanheira, M; Diekema, DJ; Duncanson, FP; Guarro, J; Jones, RN; Pfaller, MA | 1 |
| Hayashi, T; Hosokawa, K; Ishiyama, K; Kondo, Y; Mochizuki, K; Nakao, S; Ohata, K; Okumura, H; Sugimori, N; Takami, A; Yamazaki, H | 1 |
| Alcazar-Fuoli, L; Bignell, E; Blatzer, M; Cairns, T; Grimalt, JO; Gründlinger, M; Haas, H; Lopez, JF; Puempel, T; Yasmin, S | 1 |
| Mada, SR; Pillai, VC; Strom, S; Venkataramanan, R; Zhang, S | 1 |
| Herbrecht, R; Kemmel, V; Levêque, D; Nivoix, Y; Scholler, J | 1 |
| Godschalk, PC; Klein, SK; Malingré, MM | 1 |
| Gray, C; Labois, A; Lepretre, S | 1 |
| Rocha, L; Saleiro, S | 1 |
| Wintenberger, C | 1 |
| Kawakami, J; Mino, Y; Naito, T; Yagi, T; Yamada, T | 1 |
| Calvo, E; Guarro, J; Mayayo, E; Pastor, FJ; Salas, V | 1 |
| Lass-Flörl, C | 1 |
| Chiche, L; Dicostanzo, MP; Durand, JM; Eldin, C; Harle, JR; Ranque, S; Thomas, G | 1 |
| Gyotoku, H; Ikeda, H; Imamura, Y; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, T; Kohno, S; Miyazaki, T; Miyzaki, Y; Morinaga, Y; Nakamura, S; Nishino, T; Ohno, H; Takazono, T; Yaguchi, T; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
| Chang, YC; Dolan, MA; Garraffo, HM; Ghannoum, MA; Kwon-Chung, KJ; Sionov, E | 1 |
| Briegel, J; Chouker, A; Frey, L; Kaufmann, I; Mayr, D; Spiekermann, K; Thiel, M; van der Heide, V | 1 |
| de Heredia, CD; Figueras, C; Frick, MA; Lanaspa, M; Martín-Nalda, A; Pou, L; Roselló, E; Soler-Palacín, P | 1 |
| Koshy, R; Malhotra, P | 1 |
| Balakrishnan, P; Chong, S; Chung, SJ; Kim, DD; Shim, CK; Song, CK | 1 |
| de Hoog, GS; Mahgoub, el-S; van de Sande, WW; van Diepeningen, AD | 1 |
| Chan, C; Chen, J; Colantonio, D; Seto, W | 1 |
| Feng, AM; Wei, JY; Yu, WJ | 1 |
| Capilla, J; Gazzoni, AF; Guarro, J; Mayayo, E | 1 |
| Hamada, Y; Kuroyama, M; Seto, Y; Yago, K | 1 |
| Desta, Z; Guo, Y; Ogburn, ET; Xu, C | 1 |
| Allizond, V; Banche, G; Cuffini, AM; Fucale, G; Mandras, N; Roana, J; Scalas, D; Tullio, V | 1 |
| Bocanegra, R; Kirkpatrick, WR; Kugler, AR; Najvar, LK; Patterson, TF; Perkins, K; Pfeiffer, J; Sweeney, TD; Vallor, AC; Wiederhold, NP | 1 |
| Bouza, E; Giannella, M; Guinea, J; Klaassen, CH; Muñoz, P; Peláez, T; Valerio, M | 1 |
| Kontoyiannis, DP; Lewis, RE; Lortholary, O; Roilides, E; Spellberg, B; Walsh, TJ | 1 |
| Ibrahim, A; Kontoyiannis, DP; Lewis, RE; Lortholary, O; Lotholary, O; Petrikkos, G; Roilides, E; Roillides, E; Spellberg, B; Walsh, TJ | 1 |
| Lombardi, LR; Marr, KA; Neofytos, D; Nguyen, MH; Ostrander, D; Shields, RK; Thompson, CB; Warren, L | 1 |
| Desmet, K; Pauwels, S; Van Eldere, J; Vermeersch, P | 1 |
| Doudounakis, S; Katelari, A; Markantonis, SL; Pappa, E | 1 |
| Ahmad, Z; Chung, JH; Kadir, AA; Somchit, N; Yaacob, A; Zakaria, ZA | 1 |
| Curfs-Breuker, I; de Hoog, GS; Klaassen, CH; Lackner, M; Meis, JF; Najafzadeh, MJ; Verweij, PE | 1 |
| Campos-Herrero, MI; Horcajada, I; Medina-Rivero, F; Tandón, L | 1 |
| Benjamin, DK; Blaschke, AJ; Cohen-Wolkowiez, M; Doby, EH; Driscoll, TA; Martin, PL; Moran, C; Pavia, AT; Ward, RM | 1 |
| Hu, Y; Li, X; Liang, Y; Lu, C; Xi, L; Yang, Y; Zhang, J | 1 |
| Dukhan, A; Paderu, P; Park, S; Perlin, DS; Senter, M; Zhao, Y | 1 |
| Bu, D; Chen, W; Li, R; Liu, W; Sun, Y; Wan, Z | 1 |
| Catania, MR; De Domenico, G; Panellis, D; Pulcrano, G; Rossano, F | 1 |
| De Smet, J; Frueh, BE; Stary, J; Tappeiner, C; Thormann, W; Tschopp, M; Van Bocxlaer, J | 1 |
| Niki, Y; Ohbayashi, H; Shoji, H; Takuma, T; Yamamoto, T; Yoshida, K | 1 |
| Cheng, MF; Hsieh, LY; Liou, CH; Lo, HJ; Lu, DC; Shi, ZY; Tsai, MS; Wang, AH; Wang, LS; Wu, CJ; Yang, YL | 1 |
| Ahmad, S; Al-Ghimlas, F; Al-Mutairi, S; Chandy, R; Guarro, J; Joseph, L; Khan, Z; Sutton, DA | 1 |
| Mavridou, E; Melchers, WJ; Meletiadis, J; Mouton, JW; Verweij, PE | 1 |
| Bermudez, C; Bhama, JK; Clancy, CJ; Crespo, MM; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, JM; Shields, RK; Silveira, FP; Toyoda, Y | 1 |
| Acharya, NR; Krishnan, T; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, NV; Srinivasan, M; Vaitilingam, CM; Zegans, ME | 1 |
| Shen, YF; Sun, HL; Zhou, X | 1 |
| Cil, H; Elbey, MA; Islamoglu, Y; Onturk, E | 1 |
| Bowman, CJ; Chmielewski, G; Cross, DM; Lewis, EM; Liu, L; Modesitt, MS; Ripp, SL; Sawaryn, CM | 1 |
| Andrés, R; Elías, T; Fernandez de Orueta, L; Pintado, V | 1 |
| Couderc, L; Dominique, S; Favennec, L; Leguillon, C; Marguet, C; Masseline, B; Pramil, S; Rondeau, S | 1 |
| Beom, SH; Chin, HJ; Kim, S; Kim, YC; Lee, H; Ryu, HH; Yang, Y | 1 |
| Chishimba, L; Cooley, J; Denning, DW; Niven, RM | 1 |
| Han, SB; Hyon, JY; Shin, YJ; Wee, WR; Yang, HK | 1 |
| Auzinger, G; Borges Sá, M; Dimopoulos, G; Grigoras, I; Kantecki, M; Marček, T; Meersseman, W; Menichetti, F; Miller, PJ; Montravers, P; Pachl, J; Paiva, JA; Ruhnke, M; Sganga, G | 1 |
| Daajani, NA; Farouq, MF; Ghanem, AT; Kamal, JS; Saadah, OI | 1 |
| Cook, G; Cordonnier, C; Hicheri, Y | 1 |
| Mittal, R; Mittal, V | 1 |
| Buresova, L; Cetkovsky, P; Kocmanova, I; Kouba, M; Lengerova, M; Malaskova, L; Mayer, J; Racil, Z; Rolencova, M; Timilsina, S; Toskova, M; Weinbergerova, B; Winterova, J; Zak, P | 1 |
| Friberg, LE; Karlsson, MO; Liu, P; Ravva, P | 1 |
| Newton, EJ | 1 |
| Beinborn, NA; Lirola, HL; Williams, RO | 1 |
| Deering, KM; Dunn, JL; Field, CL; Frasca, S; Gilbert-Marcheterre, K; Meegan, J; Nyaoke, A; Risatti, G; Romano, TA; Sidor, IF; Spoon, T; Tuttle, AD | 1 |
| Kullberg, BJ; Oude Lashof, AM; Pappas, PG; Rex, JH; Ruhnke, M; Schlamm, HT; Sobel, JD; Viscoli, C | 1 |
| Blyth, CC; Cole, C; Gottardo, NG; Hansford, JR | 1 |
| Kato, J; Kikuchi, T; Kohashi, S; Mori, T; Okamoto, S; Ono, Y; Sakurai, M; Yamane, A | 1 |
| Barreiro, GC; Leite, PF; Samano, MN; Siciliano, RF; Strabelli, TM; Tuma Júnior, P; Waisberg, DR | 1 |
| Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M | 1 |
| Biswas, J; Gopal, L; Selvakumar, P; Sofia, O | 1 |
| Arron, ST; Binstock, M; Boettger, R; Boker, A; Glidden, DV; Golden, JA; Metchnikoff, C; Singer, JP | 1 |
| Campbell, WN; Fothergill, AW; Keshtkar-Jahromi, M; McTighe, AH; Segalman, KA | 1 |
| Azad, S; Boutros, PC; Chaparro, C; Hosseini-Moghaddam, SM; Husain, S; Keshavjee, S; Lazar, N; Luong, ML; Rotstein, C; Singer, LG | 1 |
| Alou, L; Cafini, F; Corcuera, MT; Gómez-Aguado, F; González, N; Guinea, J; Prieto, J; Sevillano, D | 1 |
| Eberhard, R; Fleischhauer, J; Kocher, C; Trachsler, S | 1 |
| Babor, F; Borkhardt, A; Janßen, G; Laws, HJ; Mackenzie, C; Meisel, R; Sabir, H; Schaper, J; Schuster, F; Siepermann, M; Wessalowski, R | 1 |
| Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC | 1 |
| Allbaugh, RA; Pucket, JD; Rankin, AJ | 1 |
| Aebi, C; Ammann, RA; Bernhard, S; Diepold, M; Kernland Lang, K; Leibundgut, K; Lüer, S | 1 |
| Egerer, G | 1 |
| Chakrabarti, A; Jatana, M; Rudramurthy, SM; Singh, R | 1 |
| Corso, V; Drudi, F; Fantini, M; Imola, M; Mianulli, AM; Pasini, G; Ravaioli, A; Santelmo, C; Veneroni, L | 1 |
| Carroll, KC; Illei, PB; Lederman, HM; Marr, KA; Meriden, Z; Riedel, S; Villa, K; Zhang, SX | 1 |
| Chen, SC; Lawrence, C; Lemos, BD; Marshall Lyon, G; Spratt, M; Veledar, E; Zwald, FO | 1 |
| Chakrabarty, A; Gupta, A; Gupta, N; Parchand, S; Ram, J | 1 |
| Kim, HR; Lee, MK; Yu, N | 1 |
| Beinborn, NA; Du, J; Smyth, HD; Wiederhold, NP; Williams, RO | 1 |
| Bouza, E; Bunsow, E; Cuenca-Estrella, M; Gama, B; Gijón, P; Mellado, E; Pelaez, T; Sánchez-Yebra, W; Valerio, M | 1 |
| Constantinou, M; Jhanji, V; Ramakrishnan, T; Vajpayee, RB | 1 |
| Aubin, GG; Bretagne, S; Danner-Boucher, I; Garcia-Hermoso, D; Haloun, A; Le Pape, P; Miegeville, M; Morio, F; Sacchetto, E | 1 |
| Andersen, N; Baltch, AL; Bopp, LH; Carlyn, CJ; Lawrence, D; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
| Chandrasekar, PH; Krishnan-Natesan, S; Wu, W | 1 |
| Cheng, ML; Ha, E; Leibowitz, M | 1 |
| Andes, D; Lepak, A | 1 |
| Bille, J; Bolay, S; Buclin, T; Calandra, T; Csajka, C; Marchetti, O; Pascual, A | 1 |
| Bai, C; Chen, B; Huang, HD; Huang, Y; Li, Q; Wang, Q; Wu, N; Yao, XP | 1 |
| Bader, O; Gross, U; Hull, CM; Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG; Weig, M | 2 |
| Alanio, A; Bougnoux, ME; Dannaoui, E; Ducroz, S; Lortholary, O; Planche, V | 1 |
| Baghaei, P; Droudinia, A; Javanmard, P; Mansouri, D; Marjani, M; Najafizadeh, K; Sarrafzadeh, SA; Soraghi, A; Tabarsi, P; Zandian, P | 1 |
| Chen, TC; Chen, YC; Chen, YH; Lu, PL | 1 |
| Chen, Z; Wei, J; Yang, Q | 1 |
| Mukherjee, B; Pattnaik, G; Sinha, B | 1 |
| Al-Nakeeb, Z; Arendrup, MC; Cuenca-Estrella, M; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Lass-Flörl, C; Majithiya, JB; Warn, PA | 1 |
| Kuroki, K; Murakami, T | 1 |
| Bartolesi, AM; Fanci, R; Pecile, P; Pini, G | 1 |
| Abdi, RF; Al-Tawfiq, JA; Tarazi, AE | 1 |
| Chandra, J; Ghannoum, MA; Mukherjee, PK; Pearlman, E; Sun, Y; Yu, C | 1 |
| Lacroix, C; Le Pape, P; Miegeville, M; Morio, F; Pagniez, F | 1 |
| Bua, J; Marchetti, F; Ventura, A; Zennaro, F | 1 |
| Andes, DR; Baddley, JW; Boeckh, M; Brizendine, KD; Chiller, T; Ito, JI; Kauffman, CA; Kontoyiannis, DP; Lyon, GM; Marr, KA; Oster, RA; Pappas, PG; Patterson, TF; Schuster, MG | 1 |
| Ieda, M; Kobayashi, D; Ohshima, S; Yamamoto, M | 1 |
| Gárate, C; García, P; Guzmán, AM; Labarca, J; León, P; Porte, L | 1 |
| Goel, RS; Gupta, A; Jain, A; Kataria, R; Singh, S; Sinha, VD | 1 |
| Brilhante, RS; Caetano, ÉP; Camargo, ZP; Castelo-Branco, DS; Cordeiro, RA; Fechine, MA; Lima, RA; Mesquita, JR; Monteiro, AJ; Pereira, JF; Rocha, MF; Sidrim, JJ | 1 |
| Ito, M; Kato, K; Kawashima, N; Matsumoto, K; Matsushita, N; Yoshida, N | 1 |
| Alanio, A; Bretagne, S; Brisse, S; Cabaret, O; Cordonnier, C; Costa, JM; Sitterlé, E | 1 |
| Behrens-Baumann, W; Haeberle, H; Hofmüller, W; Seibold, M; Tammer, I; Tintelnot, K; Walter, S; Wecke, T | 1 |
| Ackerman, BH; Guilday, RE; Haith, LR; Hornbeek, H; Patton, ML; Reigart, CL; Stair-Buchmann, M | 1 |
| Choi, SH; Chun, S; Kim, DY; Kim, SH; Kim, YS; Lee, JH; Lee, KH; Lee, SO; Lee, YJ; Woo, JH | 1 |
| Ganesan, P; Philip, A; Sagar, TG; Sivaprakasam, P | 1 |
| Fukushima, K; Goto, H; Miharu, M; Mori, M; Shoji, S; Yoshida, M | 1 |
| Bienvenu, AL; Borderie, V; Chaumeil, C; Cornet, M; Gaujoux, T; Goldschmidt, P; Grenouillet, F; Lortholary, O; Obenga, G; Pons, D; Ranque, S; Sitbon, K; Troke, P | 1 |
| Feng, G; Li, J; Liu, W; Pang, X; Shang, W; Sun, R; Wang, X; Wang, Y; Zhang, S; Zhang, W | 1 |
| Kikuti, K | 1 |
| Cantón, E; Martínez, JP; Pemán, J; Valentín, A | 1 |
| Acharya, NR; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, NV; Srinivasan, M; Sy, A; Toutain-Kidd, CM; Zegans, ME | 1 |
| Dag, I; Kiraz, N; Kiremitci, A; Metintas, S; Oz, Y | 1 |
| Kema, GH; Melchers, WJ; van de Sande-Bruisma, N; Verweij, PE | 1 |
| Chen, SC; Dolton, MJ; McLachlan, AJ; Ng, K; Pont, LG; Ray, JE | 1 |
| Andersen, CU; Bendstrup, E; Henning, O; Hilberg, O; Lundby, T; Mortensen, J | 1 |
| Choe, PG; Jang, IJ; Kim, KH; Kim, NH; Kim, NJ; Lee, SH; Nam, WS; Oh, MD; Park, WB; Song, KH; Yoon, SH; Yu, KS | 1 |
| Cendejas-Bueno, E; Cuenca-Estrella, M; Gómez-López, A; Rodríguez-Tudela, JL | 1 |
| Deniz, K; Karakukcu, M; Ozdemir, MA; Patiroglu, T; Tucer, B; Unal, E; Yikilmaz, A | 1 |
| Becce, F; Lecouvet, FE; Malghem, J; Omoumi, P; Vande Berg, BC | 1 |
| Bergeron, A; Bergot, E; Bourdin, A; Cadranel, J; Cottin, V; Germaud, P; Godet, C; Hennequin, C; Jeanfaivre, T; Philippe, B; Pineau, M | 1 |
| Clarke, HD; McLaren, AC; McLemore, R; Miller, RB; Pauken, C | 1 |
| Das, S; Gupta, N; Jain, S; Malik, JN | 1 |
| Goletz, G; Groll, AH; Gumbinger, HG; Kolve, H; Pieper, S; Würthwein, G | 1 |
| Andersen, CB; Carlsen, J; Iversen, M; Jensen, C; Tofte, N; Tvede, M | 1 |
| Egli, A; Fuller, J; Humar, A; Kapasi, A; Kumar, D; Lien, D; Nador, R; Weinkauf, J | 1 |
| Al-Nakeeb, Z; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Warn, PA | 1 |
| Hockey, H; Holford, N; Senn, S | 1 |
| Grimault, A; Lyoen, M; Minello, A; Rostain, F; Sgro, C | 1 |
| Feist, A; Lane, J; Lee, R; Osborne, S; Yung, G | 1 |
| Bicmen, C; Doluca, M; Gulat, S; Gunduz, AT; Tuksavul, F | 1 |
| Adachi, Y; Araki, K; Ikeda, T; Ishikawa, S; Kadowaki, T; Kimura, M; Kobayashi, K; Nagaoka, S; Wakabayashi, K; Yano, S | 1 |
| Beltran, C; Bourge, RC; Bourke, P; Castro, P; Rabagliati, R; Verdejo, H; Winter, JL | 1 |
| Clark, LP; Folio, L; Henderson, CM; Holland, SM; Kwon-Chung, KJ; Nardone, G; Peterson, SW; Riedlinger, G; Shea, Y; Sugui, JA; Zelazny, AM; Zerbe, CS | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Pastor, FJ; Rinaldi, MG; Salas, V; Sutton, DA | 1 |
| Fasler, D; Gerber, B; Guggenberger, R; Manz, MG; Nair, G; Schanz, U; Stussi, G | 1 |
| Denning, DW; Felton, S; Haylett, AK; Rhodes, LE | 1 |
| Al-Saigh, R; Elefanti, A; Meletiadis, J; Velegraki, A; Zerva, L | 1 |
| Bilbao, J; Duplisea, K; Guiot, MC; Kolyvas, G; Qvarnstrom, Y; Umar, I; Visvesvara, GS; Webster, D | 1 |
| Chen, Y; Groothuis, GM; Hadi, M; Merema, MT; Starokozhko, V | 1 |
| Debaveye, Y; Grootaert, V; Meyfroidt, G; Spriet, I; Willems, L | 1 |
| Baez, AA; Bonfietti, LX; Castro e Silva, DM; Martins, MA; Melhem, MS; Pukinskas, SR; Purisco, SU; Szeszs, MW | 1 |
| Cid Lama, A; Crespo Erchiga, V; Fernández Ballesteros, MD; Gomez-Moyano, E; Lova Navarro, M; Vera Casaño, A | 1 |
| Choi, SH; Hwang, JY; Kim, YJ; Koo, HH; Lee, SH; Lee, SY; Sung, KW; Yoo, KH | 1 |
| Bhavan, KP; Boyd, NK; Swancutt, MA; Zoellner, CL | 1 |
| Chandrasekar, PH; Cutright, JL; Krishnan Natesan, S; Wu, W | 1 |
| Huang, XE; Shen, ZS; Su, AL; Xu, YL; Zhang, XQ; Zhang, XZ | 1 |
| Cowen, EW; Elbaum, DJ | 1 |
| Acharya, NR; Keenan, JD; Krishnan, T; Lalitha, PS; Lietman, TM; Mascarenhas, J; Oldenburg, CE; Porco, TC; Prajna, VN; Srinivasan, M; Sy, A; Vaitilingam, CM | 1 |
| Koselke, E; Kraft, S; Nagel, J; Smith, J | 1 |
| Harada, H; Inoue, A; Iwata, S; Kumon, Y; Ohnishi, T; Teraoka, M; Yamashita, D | 1 |
| Hayashi, Y; Kobayashi, T; Mito, T; Ohashi, Y; Shiraishi, A; Suzuki, T; Zheng, X | 1 |
| Atkinson, G; Lee, GA; McLintock, CA | 1 |
| Baker, SD; Chaudhry, AS; Finkelstein, D; Gibson, A; Inaba, H; Li, L; Roberts, JL; Rubnitz, JE; Schuetz, EG; Zimmerman, EI | 1 |
| Arnalich-Montiel, F; Irigoyen, C; López-Vélez, R; Lorenzo-Morales, J; Morcillo-Laiz, R; Muñoz-Negrete, F; Piñero, JE; Valladares, B | 1 |
| Maack, KH; Tarp, B | 1 |
| Costa, CR; de Fátima Lisboa Fernandes, O; de Paula, JA; de Souza Lino Junior, R; do Rosário Rodrigues Silva, M; Hasimoto E Souza, LK; Vinaud, MC | 1 |
| Logan, BR; Zhang, MJ | 1 |
| Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L | 1 |
| Aller, AI; Canton, E; Castañón-Olivares, LR; Chowdhary, A; Cordoba, S; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Govender, N; Hagen, F; Illnait-Zaragozi, MT; Johnson, E; Kidd, S; Lass-Flörl, C; Lockhart, SR; Martins, MA; Meis, JF; Melhem, MS; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; Schell, WA; St-Germain, G; Trilles, L; Turnidge, J | 1 |
| Fujiuchi, S; Kato, T; Kawabata, M; Kuba, M; Kurashima, A; Ogawa, K; Saito, T; Sakatani, M; Sasaki, Y; Suzuki, K; Tada, A; Tao, Y | 1 |
| Berghs, HAM; Carvalho, LR; Kacew, S; Martins, MA; Melhem, MSC; Mendes, RP; Moris, DV; Pimenta-Rodrigues, MV; Souza, LR; Szeszs, MW | 1 |
| Su, J; Sun, W; Xu, S; Yan, D | 1 |
| Curtis, LT | 1 |
| Aomori, T; Araki, T; Fujita, Y; Hiromura, K; Nakamura, T; Nojima, Y; Okada, Y; Shimizu, R; Tomizawa, T; Yamamoto, K | 1 |
| Bos, B; Buchheidt, D; Cornely, OA; Halbsguth, TV; Hallek, M; Hamprecht, A; Kahl, P; Kutsch, N; Persigehl, T; Plum, G; Spiess, B; Steinbach, A; Stippel, D; Vehreschild, JJ; Vehreschild, MJ | 1 |
| Gamaletsou, MN; Kontos, AN; Kontoyiannis, DP; Kordossis, T; Sipsas, NV; Stefanou, I; Tsiakalos, A | 1 |
| Hashimoto, N; Hattori, Y; Kato, J; Koda, Y; Mori, T; Okamoto, S; Sadahira, K; Shimizu, T; Tsukada, Y; Yamane, A; Yokoyama, K | 1 |
| de Souza Bonfim-Mendonça, P; Fiorini, A; Godoy, JS; Nakamura, SS; Pieralisi, N; Shinobu-Mesquita, C; Svidzinski, TI; Yamada, SS | 1 |
| Hide, M; Kamegashira, A; Kan, T; Ooiwa, H; Takahagi, S; Yaguchi, T | 1 |
| Almendral, A; Arnalich, F; Arnalich-Montiel, F; Lorenzo-Morales, J; Valladares, B | 1 |
| Campo, S; De Santis, R; Lo Giudice, P; Salvatori, G | 1 |
| Strohmeier, M; Vogt, FG | 1 |
| Chakrabarti, A; Darji, P; Patel, AK; Patel, KK; Shivaprakash, MR; Singh, R | 1 |
| Chen, W; Li, L; Li, R; Liu, W; Sun, Y; Wan, Z | 1 |
| Cherian, T; Giakoustidis, A; Heaton, DN; Heneghan, M; O'Grady, J; Rela, M; Verma, A; Wendon, J; Yokoyama, S | 1 |
| Chen, SC; Chu, YZ; Fan, H; Hu, TS; Hu, ZD; Kong, F; Liao, K; Lu, J; Ni, YX; Shao, HF; Sun, ZY; Wang, H; Xiao, M; Xu, YC; Yan, Y; Zou, GL | 1 |
| Chauhan, NM; Karuppayil, SM; Raut, JS; Shinde, RB | 1 |
| Matsumoto, K | 1 |
| Auzinger, G; Bernal, W; Heneghan, MA; López, JC; Solís-Muñoz, P; Verma, A; Wendon, J; Willars, C | 1 |
| Denes, E; Dupon, M; Fiorenza, F; Megherbi, M; Saint-Marcoux, F; Weinbreck, P | 1 |
| Abu El-Naaj, I; Leiser, Y; Peled, M; Wolff, A | 1 |
| Fiehler, J; Gerloff, C; Kruetzelmann, A; Rosenkranz, M; Sobottka, I; Tolosa, E | 1 |
| Erdogan, Z; Kirbs, C; Kloft, C; Lackner, E; Simmel, F; Zeitlinger, M | 1 |
| Lu, HZ; Shen, YZ; Wang, ZY | 1 |
| Higgins, HW; Telang, GH; Vaidya, DC | 1 |
| Basse, G; Berry, A; Cassaing, S; Cointault, O; Fillaux, J; Iriart, X; Kamar, N; Lamant, L; Lavayssière, L; Lavergne, RA; Linas, MD; Magnaval, JF; Nocera, T; Paul, C; Pauwels, C; Valentin, A | 1 |
| Berzins, IK; Naples, LM; Poll, CP | 1 |
| Kauffman, CA; Pappas, PG; Patterson, TF | 1 |
| Choi, YL; Joo, H; Kang, SW; Kim, E; Kim, TH; Kim, YH; Park, SJ; Shin, JG; Son, JH; Song, IS; Yoon, YC | 1 |
| Bojtarova, E; Cetkovsky, P; Drgona, L; Foralova, R; Forsterova, K; Guman, T; Haber, J; Kandrnal, V; Kocmanova, I; Kouba, M; Mallatova, N; Masarova, L; Mayer, J; Mudry, P; Muzik, J; Racil, Z; Sejnova, D; Tothova, E; Vydra, J; Weinbergerova, B; Ziakova, B | 1 |
| Duan, J; Xiong, X; Zhai, S | 1 |
| Balfour-Lynn, IM; Bentley, S; Gupta, A | 1 |
| Chen, J; Liang, L; Liu, D | 1 |
| Bartelink, IH; Bierings, M; Boelens, JJ; de Waal, M; Egberts, TC; Jonker, M; Ververs, TT; Wolfs, T | 1 |
| Brüggemann, RJ; Melchers, WJ; Mouton, JW; Seyedmousavi, S; Verweij, PE | 2 |
| Chang, YF; Lee, FL; Lee, SM; Yang, CS | 1 |
| Brüggemann, RJ; Melchers, WJ; Mouton, JW; Rijs, AJ; Seyedmousavi, S; Verweij, PE | 1 |
| Choi, HJ; Ju, MY; Jung, SI; Kim, SH; Lee, K; Lee, WG; Park, YJ; Shin, JH | 1 |
| Alió, JL; Arnalich-Montiel, F; López-Vélez, R; Lorenzo-Morales, J; Martín-Navarro, CM; Martínez-Carretero, E; Piñero, JE; Valladares, B | 1 |
| Brokalaki, EI; Hillen, U; Sommerwerck, U; von Heinegg, EH | 1 |
| Chen, L; Li, G; Lin, D | 1 |
| Marr, KA; Shoham, S | 1 |
| Barclay, ML; Begg, EJ; Moore, GA; Zhang, M | 1 |
| Fan, YM; Huang, WM; Li, W; Yang, YP; Zhou, Y | 1 |
| Allisy, C; Bougnoux, ME; Charlier, C; Hermine, O; Lecuit, M; Lortholary, O; Roth, P; Shoai Tehrani, M; Sicre de Fontbrune, F | 1 |
| Buer, J; Dittmer, S; Hamprecht, A; Lackner, M; Rath, PM; Schemuth, H; Sedlacek, L; Steinmann, E; Steinmann, J | 1 |
| Boehme, A; Egerer, G; Greiner, J; Heinz, WJ; Lellek, H | 1 |
| Traynor, K | 1 |
| Aversa, F; Cesaro, S; de Rosa, FG; Girmenia, C; Micozzi, A; Mikulska, M; Novelli, A; Sanguinetti, M; Viscoli, C | 1 |
| Melchers, WJ; Meletiadis, J; Mouton, JW; Rijs, AJ; Seyedmousavi, S; Verweij, PE | 1 |
| Aldoghaither, RA; Baffoe-Bonnie, AW; Bansal, E; Demicco, DD; Garner, DC; Grifasi, ML; Kerkering, TM; Savaliya, VA; Schleupner, CJ; Smith, JA | 1 |
| Atalay, MA; Koç, N; Sav, H; Unal, E | 1 |
| Brilhante, RS; Caetano, EP; Camargo, ZP; Castelo Branco, DS; Cordeiro, RA; Fechine, MA; Lima, DT; Lima, RA; Marques, FJ; Mesquita, JR; Monteiro, AJ; Rocha, MF; Sidrim, JJ | 1 |
| Li, L; Ling, Z; Shao, F; Sheng, J; Wu, Z | 1 |
| Dua, V; Oberoi, J; Sachdeva, A; Yadav, SP | 1 |
| Altcheh, J; Bournissen, FG; Cutrullis, RA; Eagleson, MA; Freilij, H; Gulin, JE; Petray, PB; Postan, M | 1 |
| Autmizguine, J; Krajinovic, M; Litalien, C; Marquis, C; Ovetchkine, P; Rousseau, J; Tapiéro, B; Théorêt, Y | 1 |
| Plummer, CE; Tsujita, H | 1 |
| Bennett, JE; Myers, TG; Noble, JA; Su, Q; Suffis, SD; Tsai, HF | 1 |
| Estes, LL; Wilson, JW; Zeuli, JD | 1 |
| Abdulaziz, S; Al Jahdali, H; Baharoon, S | 1 |
| Chacko, J; Satpathy, G; Sharma, N; Sinha, R; Tandon, R; Titiyal, JS; Vajpayee, RB; Velpandian, T | 1 |
| Nishiyama, Y | 1 |
| Arabia, FA; Blair, JE; Kusne, S; Scott, RL; Steidley, DE; Vikram, HR; Webb, BJ | 1 |
| Cornely, OA; Heinz, WJ; Hertenstein, B; Horst, HA; Löffler, J; Maschmeyer, G; Requadt, C; Ruhnke, M; Wagner, T | 1 |
| Inoue, A; Kaneko, H; Kawamura, A; Matsumoto, S; Ohbuchi, M; Usui, T; Yamazoe, Y; Yoshinari, K | 1 |
| Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG | 1 |
| Cools, HJ; Fraaije, BA; Griffiths, WJ; Kelly, DE; Kelly, SL; Lucas, JA; Parker, JE; Rigdova, K; Warrilow, AG | 1 |
| Hoenigl, M; Krause, R | 1 |
| Ahmed, R; Akdal, G; Ananda, A; Chan, R; Chiu, AL; Crompton, JL; Francis, I; Ghabrial, R; Gibson, J; Goold, LA; Halmagyi, GM; Madge, SN; McCluskey, PJ; Rodriguez, M; Selva, D; Thompson, EO; Thurtell, MJ | 1 |
| Cavaleiro, I; Félix, S; Proença, L; Salema-Oom, M | 1 |
| Blondonnet, R; Cayot-Constantin, S; Constantin, JM; Guérin, R; Perbet, S | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Pastor, FJ; Salas, V; Sutton, DA | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Mayayo, E; Pastor, FJ; Rinaldi, MG; Salas, V; Sutton, DA | 1 |
| Annaert, P; Brüggemann, RJ; Lagrou, K; Meersseman, P; Spriet, I; Van Wijngaerden, E; Willems, L | 1 |
| Dadwal, SS; Davies-Vorbrodt, S; Ito, JI; Kriengkauykiat, J; Tegtmeier, BR | 1 |
| Husain, S; Luong, ML; Rotstein, C | 1 |
| Heng, SC; Kong, DC; Levvey, B; Nation, RL; Slavin, MA; Snell, GI | 1 |
| Bennett, D; Endo, J; Kleker, B; Snow, S | 1 |
| Al-Saigh, R; Elefanti, A; Krompa, K; Meletiadis, J; Mouton, JW; Verweij, PE; Zerva, L | 1 |
| Allen, PB; Baer, MR; Kleinberg, ME; Koka, R | 1 |
| Lilly, CM; Luke, DR; Mayer, T; Meisner, J; Ranauro, P; Welch, VL | 1 |
| Carter, Y; Christie, J; Rimawi, RH; Siraj, D; Ware, T | 1 |
| Fujioka, S; Hoffmann, T; Husar, S; Idlhammer, M; Kalaivanan, F; Khan, M; Lange, T; Poppenberger, B; Rozhon, W; Schwab, W; Shumilina, D | 1 |
| Yoshida, M | 1 |
| Gibas, CF; Malejczyk, K; Sigler, L; Smith, SW | 1 |
| Gärtner, P; Knoth, H; Petry, T | 1 |
| Barkai, G; Jacoby, E; Keller, N | 1 |
| Askew, DS; Bick, G; Feng, X; Krishnan, K; Powers-Fletcher, MV; Richie, DL; Woollett, LA | 1 |
| Li, R; Mu, X; Yu, J | 1 |
| Albarrag, AM; Anderson, MJ; Bowyer, P; Denning, DW; Gregson, L; Harrison, E; Howard, SJ; Leatherbarrow, H; Pasqualotto, AC | 1 |
| Borowiec-Chłopek, Z; Czepita, D; Giedrys-Kalemba, S; Karczewicz, D; Kot, J; Lachowicz, E | 1 |
| Ayed, S; Bouguila, H; Malek, I; Nacef, L | 1 |
| Shi, Y; Sun, HM; Xu, XY; Zhao, BL | 1 |
| Badali, H; Curfs-Breuker, I; de Hoog, GS; Deng, S; Liao, W; Meis, JF; Najafzadeh, MJ; Pan, B; Yang, L | 1 |
| Blijlevens, NM; Brüggemann, RJ; Donnelly, JP; Hope, WW; Jelliffe, RW; Neely, MN; Vanguilder, M | 1 |
| Del Rosario, RC; Halloush, RA; Khasawneh, FA | 1 |
| Furuya, N; Mano, Y; Morishige, H; Oguri, T | 1 |
| Stevens, DA | 1 |
| Banerjee, D; Khetan, A; Mandal, SM; Saha, S; Sengupta, J | 1 |
| Golden, JA; Kukreja, J; Leard, LE; Sayah, DM; Schwartz, BS; Singer, JP | 1 |
| Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C | 1 |
| Gude, T; Kulkarni, MM; McGwire, BS; Reddy, N | 1 |
| Abe, K; Arakawa, H; Ishida, T; Notani, H; Ookubo, Y; Suto, C | 1 |
| Aharchi, F; Hoetelmans, RM; Kakuda, TN; Nijs, S; Smedt, GD; Van Solingen-Ristea, R; Vyncke, V; Witek, J | 1 |
| Danner, RL; Figg, WD; Henning, SA; Jarosinski, PF; Moriyama, B; Penzak, SR; Walsh, TJ; Wayne, AS | 1 |
| Hu, LF; Lin, GY; Liu, YJ; Pan, XF; Shi, DW; Xu, RA; Ye, XL; Zhang, CH; Zhang, XH | 1 |
| Dinesh, K; Karim, PM; Khan, S; Pillai, GS; Vivek, V | 1 |
| Arendrup, MC; Cuenca-Estrella, M; Hope, WW; Lass-Flörl, C | 1 |
| Jones, B; Jose, A; Lappin, DF; Ramage, G; Sherry, L; Williams, C | 1 |
| Bouchara, JP; Diquet, B; Franconi, F; Godon, C; Legras, P; Lelièvre, B; Saint-André, JP | 1 |
| Arora, R; Chaudhary, SC; Kumar, V; Sawlani, KK | 1 |
| McLaren, A; McLemore, R; Pauken, C; Schmidt, K | 1 |
| Hamill, R; Kamili, Q; Lai, S; Lin, D; Musher, DM; Qurat-Ul-Ain, K | 1 |
| Chu, HY; Fredricks, DN; Jain, R; Pottinger, P; Xie, H | 1 |
| Bhatt, YM; Nair, B; Pahade, N | 1 |
| Deuse, T; Kluge, S; Loderstaedt, U; Sobottka, I; Soeffker, G; Wichmann, D | 1 |
| Barreto, JN; Beach, CL; Hogan, WJ; Litzow, MR; Merten, JA; Tosh, PK; Wilson, JW; Wolf, RC | 1 |
| Levy, ER; McCarty, JM; Shane, AL; Weintrub, PS | 1 |
| Galgiani, JN | 1 |
| Aguirre, HD; Cataño, JC | 1 |
| Hamada, Y; Hirayama, T; Ichibe, Y; Katori, Y; Kuroyama, M; Okuma, R; Takahashi, S | 1 |
| Celkan, T; Eroğlu, AG; Ozdemir, N; Tüysüz, G; Uludağ, D | 1 |
| Abdi, R; Basiri, A; Hedayati, MT; Najafi, N; Parvin, M; Shokohi, T; Taghavi, F; Yadegarinia, D | 1 |
| Al-Badriyeh, D; Bajel, A; Grigg, A; Heng, SC; Kirsa, S; Kong, DC; Nation, RL; Seymour, JF; Slavin, MA; Thursky, K | 1 |
| Aram, JA; Barbers, RG; Equils, O; Mardekian, J; McLaughlin, JM; Schlamm, HT; Somerville, KT; Welch, VL | 1 |
| Ahmad, S; Al-Wathiqi, F; Khan, Z | 1 |
| Huang, L; Miao, X; Wu, Y | 1 |
| Chen, H; Hu, J; Hu, L; Jiang, M; Li, B; Li, Y; Lou, X; Ning, H; Wang, J; Xu, C; Yu, Z | 1 |
| Agarwal, K; Chowdhary, A; Gaur, SN; Kathuria, S; Meis, JF; Randhawa, HS; Roy, P; Singh, PK | 1 |
| Charles, JI; Jeanbourquin, D; Mostofi, K | 1 |
| Campoli, C; Capone, A; Chiappetta, D; Chinello, P; Di Bella, S; Petrosillo, N | 1 |
| Kong, DC; Kotsimbos, T; Levvey, B; Morrissey, CO; Neoh, CF; Slavin, MA; Snell, GI; Stewart, K | 1 |
| Chowdhary, A; Kathuria, S; Khan, N; Kumar, DA; Meis, JF; Muralidhar, S; Prakash, A; Randhawa, HS; Sharma, C; Singh, PK; Wankhede, S | 1 |
| Barbaz, M; Bellissant, E; Lemaitre, F; Scailteux, LM; Tadié, JM; Uhel, F; Verdier, MC | 1 |
| Akture, E; Baskaya, MK; Salamat, S | 1 |
| Cuenca-Estrella, M; de Lucas, MP; Fusco-Almeida, AM; Lozano, E; Mendes-Giannini, MJ; Mesa-Arango, AC; Scorzoni, L; Zaragoza, O | 1 |
| Cano, J; Crous, PW; da Cunha, KC; Fothergill, AW; Gené, J; Guarro, J; Hoog, Sd; Madrid, H; Sutton, DA | 1 |
| Barrett, DM; Gerber, JS; Larru, B | 1 |
| Arima, N; Iida, J; Inano, S; Kimura, M | 1 |
| Bush, JW; Del Bigio, MR; Embil, JM; Krawitz, S; McDonald, PJ; Wuerz, T | 1 |
| Huitema, AD; Schellens, JH; Schouten-van Meeteren, AY; van Eijkelenburg, NK; van Hasselt, JG | 1 |
| Bellesoeur, A; Blot, F; Chalumeau-Lemoine, L | 1 |
| Chen, HT; Chu, WL; Lin, CC; Lo, HJ; Yang, YL | 1 |
| Brock, M; Galiger, C; Ibrahim-Granet, O; Jouvion, G; Parlato, M; Savers, A | 1 |
| Doisaki, S; Furukawa-Hibi, Y; Hama, A; Kato, K; Kojima, S; Kudo, K; Matsumoto, K; Muramatsu, H; Narita, A; Sakaguchi, H; Shimada, A; Takahashi, Y; Tanaka, M; Yamada, K; Yoshida, N | 1 |
| Chayakulkeeree, M; Sangsiriwut, K | 1 |
| Berry, A; Cardeau-Desangles, I; Cassaing, S; Cointault, O; Esposito, L; Fabre, A; Guitard, J; Iriart, X; Kamar, N; Valentin, A | 1 |
| Mast, N; Pikuleva, IA; Stout, CD; Zheng, W | 1 |
| Celik, IH; Demirel, G; Dilmen, U; Erdeve, O; Oguz, SS; Uras, N | 1 |
| da Trindade, MC; de Menezes, AI; de Souza, DW; Dos Santos, VM; Nascimento, AL; Oguma, PM | 1 |
| Huang, JT; Margossian, SP; Nambudiri, VE; Rork, JF | 1 |
| Arıkan Akdağlı, S; Aydeniz Ozansoy, F; Dursunoğlu, N; Ergin, C; Kutlu, M; Sarı, I; Sarıbaş, Z | 1 |
| Bonhomme, J; de la Blanchardière, A; Hamon, M; Hitier, M; Leclercq, R; Nicolle, A | 1 |
| Hatipoglu, H; Hatipoglu, N | 1 |
| Amsden, JR; Anaissie, E; Gubbins, PO; McConnell, S | 1 |
| Coste, A; Eddouzi, J; Ischer, F; Kelly, S; Manai, M; Parker, JE; Sanglard, D; Vale-Silva, LA | 1 |
| Duettmann, W; Fruhwald, S; Hoenigl, M; Krause, R; Prueller, F; Raggam, RB; Seeber, K; Troppan, K; Valentin, T; Wagner, J; Wölfler, A; Zollner-Schwetz, I | 1 |
| Hubschman, JP; Reed, DC; Shah, KH | 1 |
| Cendejas-Bueno, E; Cuenca-Estrella, M; Gomez-Lopez, A | 1 |
| Frechen, S; Fuhr, U; Junge, L; Neuvonen, PJ; Olkkola, KT; Rokitta, D; Saari, TI; Suleiman, AA | 1 |
| El-Sherief, A; Gordon, S; Olbrych, T; Tedja, R | 1 |
| Azzam, R; Katirji, B; Serra, A; Shaikh, AG | 1 |
| Arends, JP; Camps, SM; Debets-Ossenkopp, YJ; Haas, PJ; Kampinga, GA; Karawajczyk, A; Kuijper, EJ; Melchers, WJ; Rijnders, BJ; van der Linden, JW; van Tiel, FH; Varga, J; Verweij, PE; Zoll, J | 1 |
| Bowyer, P; Denning, DW | 1 |
| Chang, CL; Jang, HC; Jang, MJ; Kim, MN; Kim, SH; Lee, HS; Lee, K; Lee, MK; Lee, WG; Ryang, DW; Shin, JH; Shin, MG; Song, ES; Suh, SP | 1 |
| Bader, O; Buchheidt, D; Christner, M; Groß, U; Held, J; Kuhns, M; Lugert, R; Peter, S; Reichard, U; Schumacher, U; Tintelnot, K; Weig, M | 1 |
| Hamada, Y; Igarashi, M; Kasahara, K; Kimura, M; Kimura, T; Kobayashi, M; Matsumoto, K; Mikamo, H; Mochizuki, T; Nishi, Y; Ohmagari, N; Okada, K; Seki, M; Takahashi, Y; Takakura, S; Takesue, Y; Tanigawara, Y; Tokimatsu, I | 1 |
| Co, VM; Hsueh, PR; Mootsikapun, P; Ong, ML; Rajadhyaksha, V; Talwar, D | 1 |
| Arnalich-Montiel, F; López-Arencibia, A; Lorenzo-Morales, J; Martín-Navarro, CM; Piñero, JE; Valladares, B | 1 |
| Acharya, NR; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; O'Brien, KS; Porco, TC; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Srinivasan, M; Sun, CQ | 1 |
| Acharya, NR; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, L; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Srinivasan, M; Zegans, ME | 1 |
| Abreu, P; Colombo, AL; Magana, M; Nucci, M; Petti, M; Sanchez, SP; Schlamm, HT | 1 |
| Chowdhary, A; Espinel-Ingroff, A; Gonzalez, GM; Lass-Flörl, C; Martin-Mazuelos, E; Meis, J; Peláez, T; Pfaller, MA; Turnidge, J | 1 |
| Chaudry, MN; Park, BJ; Schaefer, MK; Smith, RM; Tipple, M | 1 |
| Krishnan, T; Rishi, P | 1 |
| Gao, X; Ji, X; Marks, DI; Schlamm, HT; Stephens, JM; Tarallo, M | 1 |
| Goto, T; Hashinaga, K; Hiramatsu, K; Itoh, H; Kadota, J; Kawasaki, K; Sato, Y; Suzuki, Y; Tokimatsu, I | 1 |
| Kashyap, H; Malhotra, S; Pawar, P; Sindhu, R | 1 |
| Azari, AA; Ghoghawala, SY; Kanavi, MR; Lee, V; Nehls, S; Potter, HD | 1 |
| Burhenne, J; Egerer, G; Geist, MJ; Mikus, G; Riedel, KD; Weiss, J | 1 |
| Bobek-Billewicz, B; Foroncewicz, B; Jarząb, B; Krawczyk, M; Mucha, K; Orłowski, T; Pączek, L; Raczyńska, J; Religioni, J | 1 |
| Arakawa, S; Fujisawa, M; Osawa, K; Shigemura, K; Yoshida, H | 1 |
| Ballot, DE; Bosman, N; Cooper, PA; Nana, T; Ramdin, T | 1 |
| Benjamin, DK; Ericson, J; Manzoni, P | 1 |
| Hino, M; Iino, M; Kanamaru, A; Koh, H; Masaoka, T; Ohta, K; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A; Urase, F; Usui, N; Yamaguchi, M; Yamanouchi, J; Yoshida, M | 1 |
| Behera, A; Bhansali, A; Chakrabarti, A; De, D; Dutta, P; Premkumar, A; Rudramurthy, SM; Shah, VN | 1 |
| Heng, SC; Keating, D; Kong, DC; Levvey, B; Morrissey, O; Nation, RL; Slavin, MA; Snell, GI; Westall, GP; Whitford, H; Williams, TJ | 1 |
| Bhaskaran, A; Hosseini-Moghaddam, SM; Husain, S; Rotstein, C | 1 |
| Johnston, RB; Shenefelt, PD; Thareja, S | 1 |
| Elefanti, A; Meletiadis, J; Mouton, JW; Tsakris, A; Verweij, PE; Zerva, L | 1 |
| Biswas, C; Chen, SC; Djordjevic, JT; Jolliffe, KA; Sorrell, TC; Zuo, X | 1 |
| Burgos Teruel, A; Domínguez-Márquez, V; Martinez-Macias, O; Navalpotro Rodríguez, D | 1 |
| Arikan-Akdagli, S; Canton, E; Hazirolan, G; Sahin, S | 1 |
| Capilla, J; Fernández-Silva, F; Guarro, J; Mayayo, E | 1 |
| Geffroy, L; Gras-Le Guen, C; Launay, E; Lortholary, O; Moreau, A; Thomas, C | 1 |
| Lamichchane, AK; Natesan, SK; Swaminathan, S; Wu, W | 1 |
| Cicora, F; Mos, F; Paz, M; Roberti, J | 1 |
| Gnanalingham, K; Nadig, A; Pal, P; Singh, N; Subudhi, CP | 1 |
| Sebestyén, Z; Szabó, B; Szepesi, K | 1 |
| Furustrand Tafin, U; Meis, JF; Trampuz, A | 1 |
| Andrews, E; Bolo, NR; Cayetano, K; Churchill, JH; Damle, BD; Glue, P; Henry, ME; Lauriat, TL; Rana, NS; Renshaw, PF; Villafuerte, RA; Zuo, CS | 1 |
| Baden, LR; Bolaños-Meade, J; Brown, JM; Chirila, C; Gersten, ID; Graham, J; Horowitz, MH; Kurtzberg, J; Leather, H; Marr, KA; Mauskopf, J; Maziarz, RT; Walsh, TJ; Wingard, JR | 1 |
| Calzada, JI; Diaz, RI; Randolph, JC; Sigler, EJ | 1 |
| Blitz, A; Burger, P; Gallia, G; Ishii, M; Leyngold, I; Olivi, A; Subramanian, PS | 1 |
| Arnalich-Montiel, F; Jaumandreu, L; Leal, M; Lorenzo-Morales, J; Valladares, B | 1 |
| Graovac, A; Ibric, S; Kyriakos, K; Miletic, T | 1 |
| Aline-Fardin, A; Buot, G; Dannaoui, E; Degulys, A; Guitard, J; Hennequin, C; Lapusan, S; Marie, JP; Rio, B | 1 |
| Borkar, V; Joshi, M; Kalamkar, V; Kanyalkar, M; Srivastava, S | 1 |
| Doyle, S; Jöchl, C; Kavanagh, K; O'Keeffe, G | 1 |
| Boral, OB; Cağatay, P; Keçeli, SA; Sonmez, N; Tamer, GS; Willke, A | 1 |
| Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C | 1 |
| Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Johnson, A; McEntee, L; Moore, CB; Richardson, M | 1 |
| Boongird, A; Chongtrakool, P; Jirasiritham, S; Larbcharoensub, N; Sumethkul, V; Watcharananan, SP; Wirojtananugoon, C | 1 |
| Brüggemann, RJ; Mouton, JW; Seyedmousavi, S; Verweij, PE | 1 |
| Chen, SC; Meyer, W; Middleton, PG | 1 |
| Abdel Aziz, S; Kowalski, RP; Nau, AC; Raju, LV; Romanowski, EG; Shanks, RM | 1 |
| Berger, JR; Lahoti, S | 1 |
| Cai, J; Chen, S; Cheng, X; Dong, H; Dong, W; Dong, Y; Sun, J; Wang, T; Wang, X; Xing, J; Yao, H | 1 |
| Pea, F | 2 |
| Capilla, J; Fernández-Silva, F; Guarro, J; Hernández, P; Mayayo, E; Sutton, DA | 1 |
| Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA | 1 |
| Furutachi, M; Kumagai, N; Shibasaki, M; Tamura, K | 1 |
| Dupont, L; Lagrou, K; Maertens, J; Meersseman, P; Saegeman, V; Vermeulen, E | 1 |
| Dony, A; Ducastelle, S; Ferry, T; Perpoint, T | 1 |
| Chen, H; Chen, M; Liao, W; Pan, W; Zhou, J | 1 |
| Leroux, S; Ullmann, AJ | 1 |
| Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF | 1 |
| Adamski, Z; Gil, L; Komarnicki, M; Kubisiak-Michalska, A; Kubisiak-Rzepczyk, H; Mol, A; Reich, A; Zawirska, A | 1 |
| Fernandez Miralbell, A; Garcia Mellado, V; Martin Castro, A; Martinez Peinado, C; Nogueras Morillas, P; Soto Diaz, A; Tercedor Sanchez, J; Valenzuela Salas, I | 1 |
| Al Asmi, MM; Al-Hussaini, AA; Alshahrani, DA; Faqeehi, HY | 1 |
| Chen, J; Huang, J; Li, L; Yang, Q | 1 |
| Dominelli, GS; Shaipanich, T | 1 |
| Mikamo, H; Nishiyama, Y; Ohki, E; Satoh, K; Terada, M; Uchida, K; Yamagishi, Y; Yamaguchi, H | 1 |
| Hirose, Y; Kokuzawa, S; Mochizuki, K; Suemori, S; Yaguchi, T | 1 |
| Benatti, C; Cavallini, GM; Ducange, P; Volante, V | 1 |
| Dorsey, SA; Fothergill, AW; Furmaga, W; Lewis, JS; Patterson, TF; Pennick, GJ; Sutton, DA; Wiederhold, NP | 1 |
| Goletz, G; Groll, AH; Jürgens, H; Kolve, H; Pieper, S; Yunus, S | 1 |
| Açıkgöz, ZC; Cağıl, N; Can, ME; Celikbilek, N; Dereli Can, G; Kalkan Akçay, E | 1 |
| Atalay, MA; Copur Çiçek, A; Kasap Tekinşen, FF; Kaynar, L; Koç, AN; Sav, H | 1 |
| Endo, S; Fujimura, I; Kamei, K; Kato, K; Miyamoto, S; Murata, O; Nagashima, H; Nakadate, T; Nakajima, Y; Nakamura, Y; Ogino, Y; Saito, H; Sasaki, N; Shibuya, K; Suzuki, N; Terayama, Y; Utsumi, Y; Yamauchi, K; Yarita, K | 1 |
| Capilla, J; Fernández-Silva, F; Guarro, J; Mayayo, E; Sutton, D | 1 |
| Clements, RM; Estrada, L; Jon, CK; Mosquera, RA | 1 |
| Balci, I; Eksi, F; Gayyurhan, ED | 1 |
| Chang, K; Chang, TC; Chen, CY; Chen, YH; Lai, CC; Lee, KM; Lin, CY; Lin, WR; Lu, PL | 1 |
| Fox, DA; Gladue, HS | 1 |
| Cabello-Vílchez, AM; López-Arencibia, A; Lorenzo-Morales, J; Martín-Navarro, CM; Piñero, JE; Reyes-Batlle, M; Sifaoui, I; Valladares, B | 1 |
| Dasararaju, R; Many, WJ; Samant, JS | 1 |
| Gomes, MZ; Jiang, Y; Kontoyiannis, DP; Lewis, RE; Mulanovich, VE | 2 |
| Al-Badriyeh, D; Dinleyici, EC; Kara, A; Kong, DC; Senol, E; Turner, SJ | 1 |
| Dorazilova, Z; Maly, J; Netuka, I; Pirk, J; Szarszoi, O | 1 |
| Kamei, K; Watanabe, A | 1 |
| Akata, K; Aoki, T; Fujii, M; Hisaoka, M; Ishimoto, H; Kawanami, T; Kinoshita, S; Korogi, Y; Mukae, H; Yatera, K | 1 |
| Chen, F; Shi, Y; Su, X; Sun, WK; Xu, XY; Zhang, M | 1 |
| Blot, SI; Charles, PE; Dimopoulos, G; Martin, C; Meersseman, W; Pérez, M; Rao, R; Rello, J; Spapen, H; Spapen, J; Taccone, FS; Vogelaers, D | 1 |
| Gamaletsou, MN; Walsh, TJ | 1 |
| Badoual, C; Devars Du Mayne, M; El Naderi, S; Rodriguez, C | 1 |
| Cuenca-Estrella, M; Escribano, P; Guinea, J; Martín-Mazuelos, E; Pemán, J; Sánchez-Reus, F; Zaragoza, Ó | 1 |
| Bašková, L; Buchta, V; Feuermannová, A; Kubátová, A; Kutová, R; Váša, M; Vejsová, M | 1 |
| Elenitsas, R; Massey, PR; Rosenbach, M; Wanat, KA | 1 |
| Almeida Júnior, JN; Benard, G; Campos, SV; Del Negro, GM; Figueiredo, DS; Guitard, J; Hennequin, C; Motta, AL; Rossi, F; Song, AT; Strabelli, TM | 1 |
| Bennett, JE; Childs, R; Murayama, N; Natarajan, V; Palmore, T; Skinner, J; Yamazaki, H; Zonios, D | 1 |
| Barbosa, NS; Wetter, DA | 1 |
| Chang, CY; Chen, KH; Hou, JY; Huang, TH; Liang, DC; Liu, HC; Yeh, TC | 1 |
| Bonfietti, LX; Bustamante, B; Canton, E; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Gonzalez, GM; Guarro, J; Lass-Flörl, C; Lockhart, SR; Martin-Mazuelos, E; Meis, JF; Melhem, MS; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; St-Germain, G; Szeszs, MW; Turnidge, J | 1 |
| Bucknor, MD; Gross, AJ; Link, TM | 1 |
| Kim, DY; Lee, YJ; Park, HJ | 1 |
| Ascioglu, S; Chan, KA | 1 |
| Kunicka-Styczyńska, A; Maroszyńska, I; Maroszyńska, M; Rajkowska, K | 1 |
| Acharya, NR; Cevallos, V; Geetha, M; Karpagam, R; Lalitha, P; Lietman, TM; McLeod, SD; O'Brien, KS; Prajna, NV; Sun, CQ | 1 |
| Acar, N; Bretillon, L; Bron, AM; Creuzot-Garcher, CP; Fourgeux, C; Martine, L | 1 |
| Ahmad, S; Alkharashi, M; Jun, AS | 1 |
| Halderman, A; Shrestha, R; Sindwani, R | 1 |
| Luliński, P; Maciejewska, D; Sobiech, M; Żołek, T | 1 |
| Mitra, AK; Pal, D; Patel, M; Paturi, DK; Vadlapatla, RK | 1 |
| Brownell, I; Cowen, EW; De Ravin, SS; Lee, CC; Malech, HL; Turegano, MM | 1 |
| Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Chai, LY; Earnest, A; Herbrecht, R; Johnson, EM; Kullberg, BJ; Netea, MG; Schlamm, HT; Teerenstra, S; Troke, PF; Vonk, AG | 1 |
| Balasubramanian, S; Dhanakodi, N; Shashidhar, N; Tripathy, SK; Venkataramaiah, S | 1 |
| Cogley, KM; Gehris, RP; Goyal, RK; Howrie, D; Venkataramanan, R; Windreich, RM | 1 |
| Aslan, SO; Dizbay, M; Fidan, I; Kalkanci, A; Ogan, MC; Sahin, N; Yesilyurt, E | 1 |
| Jackson, TL; Rodrigues, IA | 1 |
| Procter, DG; Schmitt, TL | 1 |
| Bandeira, TJPG; Brilhante, RSN; Cordeiro, RA; Macedo, RB; Marques, FJF; Moreira, JLB; Rocha, MFG; Sidrim, JJC; Teixeira, CEC | 1 |
| Chan, T; Ding, WY; McWilliams, R; Yadavilli, RK | 1 |
| Cevallos, V; Hoover, C; Jeng, BH; Keenan, JD; Layer, N; Maxwell, AJ | 1 |
| Duarte, M; Foppa, M; Goldani, L; Jeffman, M; Rohde, LE; Sprinz, E; Torres, FS | 1 |
| Aguiar, A; Faria, M; Fernandes, C; Lago, M; Natário, A; Pinto, E | 1 |
| Kauffman, CA; Kerr, L; Malani, AN; Obear, J; Singal, B | 1 |
| Benedetti, E; Choudhury, N; Garcia-Roca, R; Jeon, H; Khan, AB; Oberholzer, J; Tzvetanov, I | 1 |
| Fung, HC; Peksa, GD; Schultz, K | 1 |
| Cooke, RP; Denning, DW; Ellenbogen, JR; Javadpour, M; Lesser, T; Skinner, DW; Waqar, M | 1 |
| Capilla, J; Fothergill, AW; Guarro, J; Mayayo, E; Paredes, K; Sutton, DA | 1 |
| Azie, NE; Franks, B; Freifeld, AG; Horn, DL; Kauffman, CA; Schuster, MG | 1 |
| Chowdhary, A; Hagen, F; Meis, JF; Sharma, C | 1 |
| Borghi, E; Falleni, M; Jones, B; Lappin, DF; Nile, CJ; Perdoni, F; Rajendran, R; Ramage, G; Sherry, L; Smith, K; Tosi, D; Williams, C | 1 |
| Alfonso, EC; Iovieno, A; Ledee, DR; Miller, D | 1 |
| Capilla, J; Fothergill, AW; Guarro, J; Pastor, FJ; Sanchis, M; Sutton, DA | 1 |
| Alp Meşe, E; Atalay, MA; Koç, AN; Koyuncu, S; Kurtsoy, A; Ulu Kiliç, A | 1 |
| Aquino, VR; Bergamasco, MD; Castro, PT; Colombo, AL; Gonçalves, SS; Negri, CE; Xafranski, H | 1 |
| Akshita, K; Datry, A; Fekkar, A; Lescar, J; Mazier, D; Meyer, I; Palous, M; Srinivasaraghavan, K; Verma, C | 1 |
| Kikuchi, T; Kikuchi, Y; Miki, H; Nishimaki, K; Saito, W; Sasamori, K; Shishikura, Y | 1 |
| Boekhout, T; Doroftei, B; Flonta, MM; Kolecka, A; Lupse, M; Man, A; Marangoci, N; Mares, M; Marincu, I; Minea, B; Moraru, RF; Nastasa, V; Pinteala, M; Toma, F | 1 |
| Amazzough, K; Arvieux, C; Barete, S; Bougnoux, ME; Crabol, Y; Lanternier, F; Lecuit, M; Lortholary, O; Maunoury, C; Pineau, S; Poiree, S; Zeller, V | 1 |
| Alfaya Muñoz, L; Avendaño Cantos, EM; Celis Sánchez, J; Mesa Varona, D; Romero Moraleda, L | 1 |
| Cassumbhoy, M; Chau, MM; Cooper, CM; Kong, DC; Marriott, DJ; Roberts, JA; Trubiano, JA; Urbancic, K; van Hal, SJ; Wilkes, J; Worth, LJ | 1 |
| Bosschaerts, T; Boulet, G; Cos, P; Fortin, A; Maes, L; Paulussen, C | 1 |
| Kohn, R; Kotton, CN; Markmann, JF; Patel, MS; Vagefi, PA; Wright, AJ | 1 |
| Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Conant, MM; Proia, LA; Sha, BE | 1 |
| Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R | 1 |
| Marr, K; Ostrander, D; Shoham, S | 1 |
| Goeman, E; Kidd, SE; Meis, JF; Slavin, MA; Verweij, PE | 1 |
| Chang, SC; Ko, BS; Lee, SH; Sun, HY | 1 |
| Chang, YC; Eckhaus, MA; Fedorova, N; Figat, A; Joardar, V; Kwon-Chung, KJ; Losada, L; Mounaud, S; Nierman, WC; Pakala, S; Pakala, SB; Sugui, JA; Venepally, P | 1 |
| Carver, PL; Pettit, NN | 1 |
| Kelly, DE; Kelly, SL; Lamb, DC; Nes, WD; Parker, JE; Rolley, NJ; Smith, SN; Warrilow, AG | 1 |
| Ağca, H; Ak, S; Akalın, H; Cilo, BD; Ener, B; Özmerdiven, GE; Tunca, B | 1 |
| Bulanda, M; Jagielski, T; Skóra, M | 1 |
| Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF | 1 |
| Bernal-Martínez, L; Cendejas, E; Forastiero, A; Gomez-Lopez, A; Mellado, E | 1 |
| Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF | 1 |
| Bailly, S; Cornet, M; Gautier-Veyret, E; Maubon, D; Pelloux, H; Stanke-Labesque, F; Thiébaut-Bertrand, A; Tonini, J; Wambergue, C | 1 |
| Barrs, VR; Beatty, JA; Kidd, SE; Martin, P; Talbot, JJ | 1 |
| Albert, ND; Bellanger, AP; Kontoyiannis, DP; Lewis, RE; Walsh, TJ | 1 |
| Maertens, J; Miceli, MH | 1 |
| Gregg, KS; Kauffman, CA | 1 |
| Patterson, TF; Wiederhold, NP | 1 |
| Thompson, GR; Twarog, M | 1 |
| Chowdhary, A; Hagen, F; Kathuria, S; Meis, JF; Singh, PK | 1 |
| Capilla, J; Fothergill, AW; Guarro, J; Sanchis, M; Sutton, DA; Wiederhold, N | 1 |
| Coste, AT; Sanglard, D | 1 |
| Aftab, M; Almanfi, A; El-Sayed Ahmed, MM; Frazier, OH; Mallidi, HR; Singh, SK | 1 |
| Chai, LY; Khoo, AL; Lim, BP; Ong, B; Tan, BH; Tan, G; Tee, C; Teng, M; Zhao, YJ | 1 |
| Dehghan, P; Hashemi, SJ; Melchers, WJ; Mohammadi, F; Rafati, H; Rezaie, S; Seyedmousavi, S; Tamadon, Y; Tolooe, A; van der Lee, HA; Verweij, PE; Zoll, J | 1 |
| Arendrup, MC; Cuenca-Estrella, M; Jensen, RH | 1 |
| Cogliati, M; De Lorenzis, G; Esposto, MC; Lazzarini, C; Prigitano, A; Tortorano, AM | 1 |
| Manavathu, EK; Vazquez, JA | 1 |
| Fosso, MY; Garneau-Tsodikova, S; Shrestha, SK | 1 |
| Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S | 1 |
| Badali, H; Dolatabadi, S; Fakhim, H; Mirhendi, H; Nabili, M; Poorzad, N; Vaezi, A; Zarei, F | 1 |
| Molinelli, AR; Rose, CH | 1 |
| Aoun, M; Baddley, JW; Bow, EJ; Cornely, OA; Giladi, M; Heinz, WJ; Herbrecht, R; Hope, W; Karthaus, M; Kontoyiannis, DP; Lee, DG; Lee, M; Lortholary, O; Maertens, JA; Maher, RM; Marr, KA; Morrison, VA; Neofytos, D; Oren, I; Patterson, TF; Raad, II; Rahav, G; Schmitt-Hoffmann, AH; Selleslag, D; Shoham, S; Thompson, GR; Ullmann, AJ; Zeiher, B | 1 |
| Slavin, MA; Thursky, KA | 1 |
| Capilla, J; Guarro, J; Mayayo, E; Paredes, K | 1 |
| Alencar, LP; Bandeira, SP; Bandeira, TJ; Brandine, GS; Brilhante, RS; Castelo-Branco, DS; Cordeiro, RA; Guedes, GM; Melo, LM; Moreira, JL; Paiva, MA; Pereira-Neto, WA; Ponte, YB; Rocha, MF; Sales, JA; Sidrim, JJ | 1 |
| Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W | 1 |
| Aala, F; Amirizad, K; Aslani, N; Badali, H; Hashemi, SJ; Khodavaisy, S; Nazeri, M; Nouripour-Sisakht, S; Rezaie, S; Sorkherizi, MS | 1 |
| Azie, N; Franks, B; Goff, D; Horn, D; Khandelwal, N; Shi, F; Shorr, AF; Spalding, J | 1 |
| Ding, X; Gao, L; Liu, Z; Sun, Y; Wu, Q; Zeng, T | 1 |
| Lanternier, FL; Lortholary, O; Pilmis, B | 1 |
| Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ | 1 |
| Andes, D; Azie, N; Franks, B; Harrington, R; Kelley, C; Khandelwal, N; Kristy, R; Lee, E; Spalding, J; Tan, RD; Wu, EQ; Yang, H | 1 |
| Jacobsen, AA; Papo, YB; Sarro, R; Strasswimmer, J; Weisse, K | 1 |
| Alem, N; Karabıçak, N | 1 |
| Eljaaly, K; Nix, DE | 1 |
| Chakrabarti, A; Ghosh, A; Honnavar, P; Pamidi, U; Rastogi, V; Rudramurthy, SM | 1 |
| Augustynowicz-Kopeć, E; Garczewska, B; Jarzynka, S; Kuś, J; Skorupa, W | 1 |
| Arslan, U; Dagi, HT; Findik, D; Senkeles, C | 1 |
| Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK | 1 |
| Chung, SJ; Hwang, WY; Tan, AL; Tan, BH; Tan, TT; Thien, SY | 1 |
| Alffenaar, JC; Ter Avest, M; Touw, DJ; Veringa, A | 1 |
| Backman, JT; Fihlman, M; Hagelberg, NM; Hemmilä, T; Kuusniemi, K; Laine, K; Laitila, J; Neuvonen, PJ; Olkkola, KT; Saari, TI | 1 |
| Barrueta, JA; Bow, EJ; Charbonneau, C; Cordonnier, C; Cornely, OA; Cragin, L; De Salas-Cansado, M; Garcia-Vidal, C; Jarque, I; Marks, DI; Pagliuca, A; Peral, C; Shaul, AJ; Slavin, M; Solano, C; Sorensen, S; Vanness, DJ | 1 |
| Bader, O; Buname, G; Groß, U; Mshana, SE; Mushi, MF | 1 |
| Akiti, T; Barreiros, G; Nouér, SA; Nucci, M; Trope, BM; Varon, AG | 1 |
| Bouza, E; Escribano, P; Guinea, J; Montilla, P; Muñoz, P; Padilla, B | 1 |
| Al-Hatmi, AM; de Hoog, GS; Meis, JF; Meletiadis, J; Normand, AC; Piarroux, R; Ranque, S | 1 |
| Basu, SS; Jarolim, P; Mason, DS; Petrides, A | 1 |
| Ahmed, SA; Behrens-Baumann, W; de Hoog, GS; Harak, H; Hofmüller, W; Seibold, M; Tammer, I; van Diepeningen, AD | 1 |
| Azie, N; Harrington, R; Lee, E; Messali, A; Spalding, J; Wei, J; Wu, EQ; Yang, H | 1 |
| Guo, H; Jiang, L; Li, DM; Li, SX; Song, YJ; Zhang, H; Zhao, YJ; Zhu, KJ | 1 |
| Annaert, P; Bouwsma, H; Hilbrands, L; Kuypers, DRJ; Spriet, I; Swen, JJ; Vanaudenaerde, B; Vanhove, T; Verleden, G; Vos, R | 1 |
| Alkhazraji, S; Baldin, C; Gebremariam, T; Ibrahim, AS; Kovanda, L; Wiederhold, NP | 1 |
| Behr, J; Ceelen, F; Ihle, F; Kneidinger, N; Matthes, S; Neurohr, C; Schramm, R; Stelzer, D; Vogeser, M; Weber, A; Winter, H; Zimmermann, G; Zoller, M | 1 |
| Bateman, AC; Clarridge, J; Garvin, K; Greenbaum, A; Grim, J; Liu, AW | 1 |
| Chen, F; Feng, CL; He, Q; Shi, Y; Su, X; Zhang, M | 1 |
| Crusz, SA; Denning, D; Mitchell, S; Simmonds, L; White, B | 1 |
| Birch, M; Law, D; Wiederhold, NP | 1 |
| Liu, Q; Marks, DI; Slavin, M | 1 |
| Hope, WW; Stott, KE | 1 |
| Bassetti, M; Bouza, E | 1 |
| Denis, J; Herbrecht, R; Ledoux, MP; Toussaint, E | 1 |
| Arthur, I; Baird, R; Bak, N; Blyth, C; Botes, J; Chapman, B; Chen, S; Cheong, E; Cooley, L; George, CR; Goeman, E; Hajkowicz, K; Halliday, C; Heath, CH; Hofmeyr, A; Kalukottege, P; Keighley, C; Kennedy, K; Kesson, A; Kidd, S; Korman, TM; Leung, M; Liu, E; Macesic, N; Marriott, D; McMullan, B; Morrissey, CO; Pendle, S; Robson, J; Slavin, M; Sorrell, TC; Underwood, N; van Hal, S; Weeks, K | 1 |
| Ivulich, S; Jeong, W; Kong, DCM; Levvey, BJ; Morrissey, CO; Neoh, CF; Slavin, MA; Snell, GI; Westall, GP | 1 |
| Albert, ND; Heo, ST; Jiang, Y; Jiménez-Ortigosa, C; Kontoyiannis, DP; Lewis, RE; Meis, JF; Mikos, AG; Perlin, DS; Tarrand, J; Tatara, AM; Tverdek, F; Verweij, PE | 1 |
| D'Inzeo, T; De Carolis, E; Mello, E; Posteraro, B; Sanguinetti, M; Torelli, R; Vella, A; Verweij, PE | 1 |
| Agurto, C; Bustamante, B; Diaz, A; Hidalgo, J; Huaroto, L; Illescas, R; Ramirez, R; Rodriguez, L | 1 |
| Hanretty, AM; Langelier, C; Trang, TP; Yang, K | 1 |
| Birch, M; Buil, JB; Law, D; Meis, JF; Melchers, WJG; Rijs, AJMM; Verweij, PE | 1 |
| Assaf, A; Chaftari, AM; Hachem, R; Jiang, Y; Numan, Y; Raad, II; Shah, P | 1 |
| Ashu, EE; Korfanty, GA; Xu, J | 1 |
| Blaich, C; Gehlen, D; Liss, B; Müller, C; Prozeller, D; Streichert, T; Wiesen, MHJ | 1 |
| Bader, O; Baretton, G; Buchheidt, D; Geibel, S; Groß, U; Jacobs, E; Ostrosky-Zeichner, L; Rößler, S; Sommer, U; Spiess, B; Stölzel, F | 1 |
| Hassan, FAM; Tartor, YH | 1 |
| Gao, L; Lu, Q; Sun, Y; Tian, D; Xiang, S | 1 |
| Badali, H; Chowdhary, A; Dannaoui, E; Fakhim, H; Meis, JF; Prakash, A; Vaezi, A | 1 |
| Harris, C; Morales, MK; Shoham, S | 1 |
| Bertaccini, P; Castagnetti, F; Cavo, M; Faccioli, L; Lewis, RE; Paolucci, M; Primavera, L; Rizzello, I; Spinardi, L; Stanzani, M; Toschi, PG | 1 |
| Fish, DN; Jaeger, J; Kiser, TH; MacLaren, R; Mueller, SW; Schoeppler, KE; Yi, WM | 1 |
| Gao, L; He, C; Li, M; Sun, Y; Zeng, T | 1 |
| Box, H; Colombo, AL; Hope, WW; Johnson, A; Kolamunnage-Dona, R; Livermore, J; McEntee, L; Negri, CE; Ramos-Martín, V; Schwartz, JA; Whalley, S | 1 |
| Byun, SA; Choi, MJ; Jung, JS; Kim, SH; Park, YJ; Shin, JH; Shin, MG; Suh, SP; Won, EJ | 1 |
| Brüggemann, RJM; Buil, JB; Meis, JF; Melchers, WJG; Mouton, JW; Verweij, PE; Wasmann, RE; Zoll, J | 1 |
| Benamu, E; Fernandez-Pol, S; Ho, DY; Liu, AY; Xie, L; Yu, AT | 1 |
| Hoenigl, M; Krause, R; Neumeister, P; Prattes, J; Wölfler, A | 1 |
| Foolad, F; Kontoyiannis, DP | 1 |
| Badali, H; Badiee, P; Boekhout, T; Diba, K; Hossaini Nasab, A; Jafarian, H; Mirhendi, H; Moghadam, AG; Mohammadi, R; Najafzadeh, MJ; Shamsizadeh, A; Soltani, J | 1 |
| Cornely, OA; Croos-Dabrera, R; Engelhardt, M; Hope, W; Kontoyiannis, DP; Lademacher, C; Lortholary, O; Mullane, K; Patterson, TF; Selleslag, D | 1 |
| Basak, GW; Brillowska-Dąbrowska, A; Kurzyk, E; Mroczyńska, M; Nawrot, U; Sulik-Tyszka, B; Wróblewska, M; Włodarczyk, K | 1 |
| Alakel, N; Behre, G; Buchheidt, D; Christopeit, M; Cornely, OA; Hasenkamp, J; Kiehl, M; Koldehoff, M; Krause, SW; Lehners, N; Löhnert, AY; Maschmeyer, G; Mayer, K; Mellinghoff, SC; Ostermann, H; Panse, J; Penack, O; Ruhnke, M; Teschner, D; Ullmann, AJ; von Lilienfeld-Toal, M; Wolf, HH | 1 |
| Bouchand, F; Bougnoux, ME; Coignard, H; Davido, B; Demay, O; Dinh, A; Duran, C; Gaudot, F; Nich, C; Rottman, M; Rouzaud, C | 1 |
| Birkenbach, M; Faizer, R; Green, JS; Ustun, C; Wasko, JA | 1 |
| Ahangarkani, F; Aslani, N; Badali, H; Boekhout, T; Hagen, F; Kolecka, A; Meis, JF; Meyabadi, MF; Shokohi, T | 1 |
| Bader, O; Becker, K; Groß, U; Idelevich, EA | 1 |
| Bailleux, C; Gari-Toussaint, M; Gastaud, L; Hasseine, L; Martiano, D; Simon, L | 1 |
| Greene, M; Harris, B; Kuriakose, K; Nesbitt, WJ | 1 |
| Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A | 1 |
| Butterton, JR; Cho, CR; de Haes, JIU; Drexel, M; Hulskotte, EGJ; Hussaini, A; Iwamoto, M; Jordan, HR; Kantesaria, BS; Liu, F; Macha, S; Marshall, WL; McCrea, JB; Menzel, K; Tsai, C; van Schanke, A | 1 |
| Bartoszewicz, M; Król, J; Nawrot, U | 1 |
| Alcazar-Fuoli, L; Cuesta, I; Garcia-Rubio, R; Mellado, E; Monteiro, MC; Monzon, S; Pelaez, T | 1 |
| Qiao, M; Qiu, HY; Sun, AN; Tang, L; Tang, XW; Wu, DP; Yang, XF; Zhang, L | 1 |
| Andes, D; Desai, A; Kitt, T; Kovanda, L; Walsh, TJ; Zhao, M | 1 |
| Alcazar-Fuoli, L; Bernal-Martínez, L; Gomez-Lopez, A | 1 |
| Lang, R; Minion, J; Skinner, S; Wong, A | 1 |
| Landsberg, D; Leung, M; Poinen, K; Wright, AJ | 1 |
| Bollmann, T; Ewert, R; Nowak, S; Rathmann, E; Ribback, S; Rosenstengel, C; Schroeder, HWS | 1 |
| Escrig, C; Herbrecht, R; Kuessner, D; Pooley, N; Posthumus, J | 1 |
| Bartizal, K; Daruwala, P; Locke, JB; Wiederhold, NP | 1 |
| Aoun, M; Cornely, OA; Engelhardt, M; Giladi, M; Heinz, WJ; Herbrecht, R; Kaufhold, A; Kovanda, L; Maertens, J; Rahav, G; Saulay, M; Selleslag, D; Ullmann, AJ | 1 |
| Dowis, J; French, D; Smith, A | 1 |
| Keniya, MV; Monk, BC; Ruma, YN; Tyndall, JDA | 1 |
| Fleming, ME; Gordon, WT; Jessie, EM; Khan, M; Malone, DL; Murray, CK; Potter, BK; Rodriguez, CJ; Shackelford, SA; Tribble, DR | 1 |
| Folić, M; Janković, SM; Jović, Z; Kostić, M; Milovanović, D; Milovanović, J; Ružić Zečević, D; Stefanović, S | 1 |
| French, B; Mandell, K; Martinez, R | 1 |
| Ahuja, T; Cirrone, F; Papadopoulos, J; Phillips, K; Siegfried, J | 1 |
| Shen, L; Tu, F; Wang, J; Wang, R; Xia, G; Xu, J; Ye, C; Yi, Y; Yu, C; Zheng, Z | 1 |
| Andes, DR; Ghannoum, MA; Hope, WW; Jones, ME; Kovanda, LL; Lademacher, C; Lu, Q; Mukherjee, PK; Santerre Henriksen, A | 1 |
| Lehrnbecher, T; Schmidt, S; Schubert, R; Tramsen, L | 1 |
| Girmenia, C; Goffredo, BM; Marchesi, F; Mengarelli, A; Menna, P; Minotti, G; Romano, A; Salvatorelli, E | 1 |
| Bandettini, R; Cavanna, C; Esposto, MC; Grancini, A; Lallitto, F; Lo Cascio, G; Mularoni, A; Ossi, C; Prigitano, A; Tejada, M; Tortorano, AM | 1 |
| Bongomin, F; Felton, T; Maguire, N; Moore, CB; Rautemaa-Richardson, R | 1 |
| Capellier, G; Clairet, AL; Lagoutte-Renosi, J; Millon, L; Navellou, JC; Piton, G; Rougny, AC; Winiszewski, H | 1 |
| Chen, L; Li, M; Li, N; Qi, F; Wang, N; Zhu, L | 1 |
| Bagshaw, E; Floros, L; Kuessner, D; Posthumus, J; Sjölin, J | 1 |
| Flowers, SA; Kelly, DE; Kelly, SL; Nishimoto, AT; Parker, JE; Price, CL; Rogers, PD; Warrilow, AG | 1 |
| Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
| Al-Hatmi, AM; Arastehfar, A; Bakhtiari, M; Boekhout, T; Daneshnia, F; Fang, W; Groenewald, M; Hagen, F; Liao, W; Pan, W; Sadati, SK; Sharifi-Mehr, H; Zomorodian, K | 1 |
| Daly, RC; Kennedy, CC; Pennington, KM; Peters, S; Razonable, RR; Scott, JP; Wylam, M | 1 |
| Evans, SL; Fish, DN; Kiser, TH; MacLaren, R; Mueller, SW; Van Matre, ET | 1 |
| Alflen, A; Aranda Lopez, P; Beckert, H; Radsak, MP; Ries, F; Schild, H; Teschner, D; Theobald, M | 1 |
| Chen, M; Chen, R; Chen, Y; Hu, G; Huang, C; Sun, W; Wang, Z; Zhang, X | 1 |
| Belga, S; Cervera, C; Hussain, MW; Kabbani, D; MacDonald, C; Roelofs, K | 1 |
| Floros, L; Georgallis, M; Pagliuca, A; Rita Capparella, M; Sung, AH; Taie, AA; Weidlich, D | 1 |
| Colley, T; Daly, L; Ito, K; Kimura, G; Kizawa, Y; Nakaoki, T; Nishimoto, Y; Rapeport, G; Sehra, G; Strong, P | 1 |
| Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Rolley, NJ; Warrilow, AGS | 1 |
| Andes, DR; Bayless, M; Lepak, AJ; McCreary, EK; Schulz, LT; Van, AP; Wiebe, DA | 1 |
| Corcoran, TE; Ensor, CR; Hussain, S; Iasella, CJ; McDyer, JF; Moore, CA; Morrell, MR; Nero, JA; Nguyen, MH; Thanukrishnan, H; Venkataramanan, R | 1 |
| Braga, SS | 1 |
| Li, R; Sun, L; Wan, Z; Yu, J | 1 |
| Arbona-Haddad, E; Bold, TD; Chen, K; Cheng, MP; Cummins, KC; Hammond, SP; Koo, S; Kusztos, AE; Liakos, A; Marty, FM; Orejas, JL; Pandit, A; Solomon, IH | 1 |
| Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
| Bigot, J; Botterel, F; Bougnoux, ME; Dannaoui, E; Dellière, S; Fekkar, A; Guitard, J; Hennequin, C; Senghor, Y; Verdurme, L | 1 |
| Moncada, D; Ramírez, I | 1 |
| Elgierari, ETM; Kirkpatrick, LM; Manicke, NE; Ren, GJ; Shi, RZ; Skaggs, CL; Sturmer, LR | 1 |
| Dobiáš, R; Hošková, L; Hubka, V; Jaworská, P; Kautznerová, D; Kubánek, M; Lysková, P; Mrázek, J; Němcová, D; Skružná, M; Sumerauerová, P; Vrbská, J; Žáčková, P | 1 |
| Erbaş, G; Kalkanci, A; Köktürk, N; Özkurt, ZN; Pepeler, MS; Tunçcan, ÖG; Yegin, ZA; Yildirim, Z; Yildiz, Ş | 1 |
| Kauffman, CA; Schwartz, IS | 1 |
| Li, H; Tu, B; Yin, G | 1 |
| Abou El-Alamin, MM; Aboul-Enein, HY; Atia, MA; Sultan, MA | 1 |
| Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA | 1 |
| Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M | 1 |
| Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS | 1 |
| Böll, B; Böttiger, BW; Cornely, OA; Dusse, F; Eichenauer, DA; Fuchs, F; Hallek, M; Jung, N; Klein, F; Kochanek, M; Koehler, P; Persigehl, T; Rybniker, J; Shimabukuro-Vornhagen, A | 1 |
| Assaf, A; Chopin, MC; Dozier, A; Faure, E; Faure, K; Goeminne, C; Leroy, J; Loridant, S; Panaget, S; Sermet, K; Vuotto, F | 1 |
| Arron, ST; Brownell, I; Cahoon, EK; Cowen, EW; D'Arcy, ME; Engels, EA; Hess, GP; Israni, AK; Pfeiffer, RM; Rivera, DR; Triplette, MA; Yanik, EL | 1 |
| Clancy, CJ; Clarke, L; Falcione, BA; Kwak, EJ; Marini, RV; McCreary, EK; Morrell, M; Nguyen, MH; Rivosecchi, RM; Sacha, L; Samanta, P; Sanchez, PG; Shields, RK; Silveira, FP; Viehman, A | 1 |
| Kaye, K; Majdick, K; Shorman, MA | 1 |
| Arendrup, MC; Guinea, J; Hare, RK; Jørgensen, KM; Meletiadis, J | 1 |
| Arendrup, MC; Friberg, N; Guinea, J; Kahlmeter, G; Mares, M; Meletiadis, J | 1 |
| Dong, J; Li, D; Li, X; Liu, W; Mei, H; Song, N; Zheng, H | 1 |
| Usayaporn, S; Vanichanan, J; Weeraphon, B | 1 |
| Azanza, JR; Grau, S; López-Gómez, V; López-Ibáñez de Aldecoa, A; Peral, C; Rebollo, P; Vázquez, L | 1 |
| Brito Devoto, T; Carmona, M; Cuestas, ML; Formento, N; Gordó, M; Hermida-Alava, K; Luque, A; Sautua, F; Scandiani, M | 1 |
| Chen, B; Wan, Y; Wang, J; Xu, JY; Zhou, M; Zhou, RF | 1 |
| Corallo, CE; Ivulich, SP; Kotecha, DS; Morrissey, O | 1 |
| Cheng, G; Huang, L; Li, T; Luo, X; Xue, X; Zhang, Y | 1 |
| Gharaghani, M; Taghipour, S; Zarei Mahmoudabadi, A | 1 |
| Clerkin, P; Kuzmic, B; Laningham, F; McCarty, J; Naeem, F | 1 |
| Bassetti, M; Böll, B; Brüggemann, R; Chakrabarti, A; Chen, SCA; Colombo, AL; Cornely, OA; Gangneux, JP; Hoenigl, M; Klimko, N; Koehler, P; Lass-Flörl, C; Meis, JF; Oladele, RO; Ostrosky-Zeichner, L; Patterson, TF; Perfect, JR; Persigehl, T; Verweij, PE; Vinh, DC; White, PL; Zhu, LP | 1 |
| Agarwal, R; Chakrabarti, A; Choudhary, H; Ghosh, A; Kaur, H; Rudramurthy, SM; Singh, R; Singh, S | 1 |
| Ben-Ami, R; Diego Vélez, J; Grandhi, A; Haider, S; Han, S; Karthaus, M; Klimko, N; Koh, LP; Lee, DG; Maertens, JA; Motyl, MR; Ponce-de-León, A; Raad, I; Rahav, G; Ramírez Sánchez, IC; Sonet, A; Waskin, H; Zhou, J | 1 |
| Castanheira, M; Collingsworth, TD; Davis, AP; Deshpande, LM; Pfaller, MA | 1 |
| Akbari, F; Deng, S; Houbraken, J; Najafzadeh, MJ; Naseri, A; Wang, X; Xu, X; Zhang, H; Zhao, R | 1 |
| Aguirre, MA; Basquiera, AL; Buttazzoni, M; Degrave, AM; Diehl, M; Fernández Ávila, DC; Pereira, T; Scolnik, M | 1 |
| Azmanis, P; Naidoo, V; Pappalardo, L; Sara, ZAJ; Silvanose, C | 1 |
| Mammen, MD; Rupa, V; Sahni, RD; Varghese, GM | 1 |
| Brüggemann, RJ; Bury, D; Muilwijk, EW; Tissing, WJE; Wolfs, TFW | 1 |
| Bogler, Y; Lee, YJ; Neofytos, D; Papanicolaou, GA; Perales, MA; Seo, SK; Shaffer, B; Stern, A; Su, Y | 1 |
| Eadie, K; Fahal, AH; Nyuykonge, B; van Amelsvoort, L; van de Sande, W; Verbon, A | 1 |
| Castanheira, M; Deshpande, LM; Messer, SA; Pfaller, MA; Rhomberg, PR; Utt, EA | 1 |
| Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA; Rhomberg, PR | 1 |
| Bafghi, MH; Darroudi, M; Nazari, R; Zargar, M; Zarrinfar, H | 1 |
| Dumoulin, A; Van Hoecke, F; Vangheluwe, T; Vogelaers, D | 1 |
| Beauchemin, C; Claveau, D; Dufresne, SF; Guinan, K; Rotstein, C | 1 |
| Athayde-Filho, PF; Barbosa-Filho, JM; Castro, RD; Cordeiro, LV; Ferreira, ES; Lima, EO; Scotti, L; Silva, DF; Souza, HDS | 1 |
| Debaveye, Y; Lagrou, K; Spriet, I; Van Daele, R; Vandenbriele, C; Vos, R; Wauters, J | 1 |
| Couraud, S; Dannaoui, E; Déméautis, T; Devouassoux, G; Dupont, D; Durieu, I; Garnier, H; Kramer, R; Lina, B; Menotti, J; Persat, F; Rabodonirina, M; Reix, P; Sénéchal, A; Simon, L; Wallon, M | 1 |
| Hochstetler, LJ; Jones, SL; McKinzie, BP; Musick, KL; Norris, AM; Williams, FN | 1 |
| Carlesse, F; Colombo, AL; Kontoyiannis, DP; Nobrega de Almeida, J; Rossato, L | 1 |
| Bernards, S; de Boer, MGJ; Hendriks, BJC; Jolink, H; Koopmans, JG; van de Peppel, RJ; van der Beek, MT; van Grootveld, R; van Paassen, J; von dem Borne, PA | 1 |
| Chen, L; Chen, W; Li, L | 1 |
| Buil, JB; den Dekker, BM; Festen, B; Heusinkveld, M; Melchers, M; Mooren, ERM; Schellaars, R; van Binsbergen, AL; van Bree, SHW; van Zanten, ARH; Verweij, PE | 1 |
| Gao, L; Sun, Y; Tan, L; Yang, J; Yao, Z; Zeng, T | 1 |
| Atas, U; Aydin Ersoy, M; Iltar, U; Salim, O; Turkoglu, EB; Yucel, OK | 1 |
| Bae, NY; Byun, JM; Choe, PG; Kang, CK; Kim, MS; Kim, NJ; Park, KJ; Yoon, SS | 1 |
| Ito, H; Ogawa, R | 1 |
| DiNardo, CD; DiPippo, AJ; Jiang, Y; Kadia, T; Kontoyiannis, DP; Maiti, A; Montalban-Bravo, G; Rausch, CR; Ravandi, F | 1 |
| Belotti, T; Campoli, C; Cojutti, PG; Gatti, M; Masetti, R; Pea, F; Pession, A; Viale, P | 1 |
| Chen, W; Goldman, GH; Li, R; Li, Y; Liang, T; Liu, W; Osherov, N; Verweij, PE; Wan, Z; Wang, Q; Zheng, B | 1 |
| Chen, SC; Greenwood, M; Hill, JA; Joshi, A; Kong, DCM; Krantz, EM; Lindsay, J; Liu, C; Morris, J; Pergam, SA; Slavin, M; Sweet, A; Tverdek, F; Yeh, R | 1 |
| Ito, K | 1 |
| Abou Kandil, A; Handelman, M; Morogovsky, A; Osherov, N; Shadkchan, Y | 1 |
| Chaphekar, N; Cheng, Y; Huang, H; Huang, W; Liu, M; Wu, X; Zheng, Y | 1 |
| Dong, Y; Liu, Z; Wang, Y; Wang, YF; Xie, J; Yang, Q; Zhang, K | 1 |
| Aram, JA; Cao, G; Cornely, OA; Desai, A; Fayyad, R; Guo, X; Hamed, K; Wu, D; Zhang, J; Zhang, Y | 1 |
| Hakki, M; Lewis, JS; Thompson, GR; Wiederhold, NP | 1 |
| Buchweitz, JP; Johnson, SD; Lehner, AF | 1 |
| Cai, Y; Chen, A; He, J; Ju, C; Li, S; Lian, Q; Wei, L; Xie, H; Zhao, B; Zhou, S | 1 |
| Cheng, H; Gao, SY; Hu, W; Jiang, QL; Li, WJ; Lu, Y; Wang, XX; Wu, DF; Yang, K | 1 |
| Akashi, K; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, Y; Kimura, SI; Kishida, M; Kohno, S; Matsuda, M; Miyazaki, T; Miyazaki, Y; Mukae, H; Niki, Y; Ogawa, K; Okada, F; Suzuki, J; Takazono, T; Taniguchi, S; Tateda, K; Yoshida, M | 1 |
| Abastabar, M; Aghili, SR; Akhtari, J; Al Hatmi, AMS; Al-Harrasi, A; Badali, H; Haghani, I; Hajheydari, Z; Hedayati, MT; Javidnia, J; Kermani, F; Khojasteh, S; Moazeni, M; Shokohi, T; Yahyazadeh, Z | 1 |
| Colombo, AL; Dieleman, C; Francisco, EC; Hagen, F | 1 |
| Chen, P; Chen, Y; Feng, Z; Gao, F; Jin, Y; Lin, W; Lu, C; Shang, Z; Wang, F; Yang, J | 1 |
| Aram, JA; Engelhardt, M; Hamed, K; Huang, JJ; Kovanda, LL; Yan, J | 1 |
| Meng, XX; Su, CZ; Su, F; Zhang, JL | 1 |
| Bellomo, R; Costa-Pinto, R; Finlay, L; Klink, S; Perera, P; Rotherham, H; Trubiano, J; Urbancic, K; Vaz, K | 1 |
| Asai, N; Hagihara, M; Hirai, J; Iwamoto, T; Kato, H; Mikamo, H; Mori, N; Umemura, T; Yamagishi, Y | 1 |
| Andes, DR; Cattaneo, D; Christian, R; Davis, MR; Johnson, MD; Lewis, RE; McCreary, EK; Narayanan, N; Watt, KM; Wiederhold, NP | 1 |
| Kakizaki, MIT; Melhem, MSC | 1 |
| Brito Devoto, T; Cuestas, ML; Finquelievich, JL; García-Effrón, G; Hermida-Alva, K; Posse, G | 1 |
| Bamba, S; Denis, O; Lagrou, K; Montesinos, I; Nakanabo Diallo, S; Resendiz-Sharpe, A; Rodriguez-Villalobos, H; Rouamba, T; Yerbanga, IW | 1 |
| Grandhi, A; Haider, S; Han, S; Klimko, N; Lee, DG; Maertens, JA; Ponce-de-León, A; Rahav, G; Ramirez-Sanchez, IC; Waskin, H; Winchell, GA; Wrishko, R | 1 |
| Cha, JH; Cho, Y; Choi, H; Kim, J; Kim, KJ; Lee, CK; Nam, M; Nam, MH; Yim, J; Yun, SG | 1 |
| Chu, J; Tu, S; Wang, N; Xie, Z; Yang, L; Zhang, K | 1 |
| Bazydlo, L; Girton, M; Tomsig, J | 1 |
272 review(s) available for triazoles and voriconazole
| Article | Year |
|---|---|
The search for new triazole antifungal agents.
Topics: Antifungal Agents; Drugs, Investigational; Humans; Pyrimidines; Triazoles; Voriconazole | 1997 |
[Present problems and future trend of antifungals for deep seated mycosis. Azole antifungal agents].
Topics: Animals; Antifungal Agents; Azoles; Dosage Forms; Drug Interactions; Drug Resistance, Microbial; Fungi; Humans; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
Role of newer azoles in surgical patients.
Topics: Antifungal Agents; Azoles; Candidiasis; Cross Infection; Dose-Response Relationship, Drug; Drug Design; Fluconazole; Humans; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole | 1999 |
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.
Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neoplasms; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2000 |
Antifungal activity of the new azole UK-109, 496 (voriconazole).
Topics: Animals; Antifungal Agents; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1999 |
Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis.
Topics: Antifungal Agents; Brain Abscess; Central Nervous System; Drainage; Humans; Male; Middle Aged; Mycoses; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole | 2000 |
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole | 2001 |
Update on antifungal agents.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Enzyme Inhibitors; Glucosyltransferases; Humans; Membrane Proteins; Mycoses; Pyrimidines; Schizosaccharomyces pombe Proteins; Treatment Outcome; Triazoles; Voriconazole | 2001 |
Review of the safety and efficacy of voriconazole.
Topics: Animals; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2002 |
Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumonia.
Topics: Antifungal Agents; Aspergillus; Humans; Lung Diseases, Fungal; Pneumonia; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole -- better chances for patients with invasive mycoses.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Interactions; Drug Resistance, Fungal; Drug Tolerance; Humans; Mycoses; Pyrimidines; Safety; Triazoles; Voriconazole | 2002 |
Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Endophthalmitis; Female; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole: in the treatment of invasive aspergillosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Humans; Injections, Intravenous; Pyrimidines; Triazoles; Voriconazole | 2002 |
Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
Topics: Antifungal Agents; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Risk Factors; Triazoles; Trichosporon; Voriconazole | 2002 |
Voriconazole: a new triazole antifungal agent.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Dermatitis; Drug Interactions; Exanthema; Humans; Liver; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
Pharmacological aspects of the new triazole voriconazole.
Topics: Antifungal Agents; Contraindications; Drug Interactions; Humans; Kidney Diseases; Liver Diseases; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole: a new triazole antifungal agent.
Topics: Antifungal Agents; Drug Administration Schedule; Drug Interactions; Formularies as Topic; Humans; Length of Stay; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2003 |
[Present status and future prospects of azole antifungal agents in Japan].
Topics: Antifungal Agents; Azoles; Cyclodextrins; Drug Design; Fluconazole; Forecasting; Itraconazole; Japan; Miconazole; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
[Clinical development of antimycotics. Medical challenges].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Excipients; Fungi; Humans; Itraconazole; Lipopeptides; Liposomes; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Voriconazole | 2003 |
[A silver lining on the horizon: new antimycotics].
Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[Voriconazole - applications and perspectives].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Pyrimidines; Triazoles; Voriconazole | 2002 |
[Aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Biomarkers; Diagnosis, Differential; Echinocandins; Glucans; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Serologic Tests; Triazoles; Voriconazole | 2003 |
Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Follow-Up Studies; Humans; Immunocompetence; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pyrimidines; Risk Assessment; Severity of Illness Index; Spondylitis; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Laboratory evaluation of new antifungal agents against rare and refractory mycoses.
Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Voriconazole.
Topics: Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Candidiasis; Child; Child, Preschool; Female; Fungi; Half-Life; Humans; Intestinal Absorption; Male; Microbial Sensitivity Tests; Pyrimidines; Randomized Controlled Trials as Topic; Scedosporium; Tissue Distribution; Triazoles; Voriconazole; Yeasts | 2003 |
New antifungal drugs and new clinical trials: interpreting results may be difficult.
Topics: Animals; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Data Interpretation, Statistical; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide.
Topics: Administration, Topical; Anti-Bacterial Agents; Antifungal Agents; Biguanides; Caspofungin; Child, Preschool; Disinfectants; Echinocandins; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Mucormycosis; Osteomyelitis; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2003 |
[Drug of the month. Voriconazole (Vfend)].
Topics: Antifungal Agents; Drug Interactions; Humans; Molecular Structure; Pyrimidines; Triazoles; Voriconazole | 2003 |
[New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].
Topics: Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Fungi; Glucosyltransferases; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
New antifungal agents.
Topics: Administration, Oral; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Drug Approval; Echinocandins; Humans; Lipopeptides; Macrolides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2003 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.
Topics: Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Humans; Immunocompromised Host; Lipopeptides; Male; Mitosporic Fungi; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2004 |
History of the development of azole derivatives.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.
Topics: Antifungal Agents; Drug Interactions; Humans; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole for serious fungal infections.
Topics: Antifungal Agents; Aspergillus; Candida; Controlled Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2004 |
[New antifungal agents: voriconazole and caspofungin].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[Experience with voriconazole in invasive aspergillosis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biological Availability; Humans; Immunocompromised Host; Pyrimidines; Triazoles; Voriconazole | 2003 |
CNS-aspergillosis: are there new treatment options?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[New therapeutical options for pulmonary fungal infections in non-neutropenic ICU-patients].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Fungi; Humans; Intensive Care Units; Lipopeptides; Lung Diseases, Fungal; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2003 |
Aspergillus fumigatus septic arthritis complicating intra-articular corticosteroid injection.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Debridement; Diagnosis, Differential; Humans; Injections, Intra-Articular; Magnetic Resonance Imaging; Male; Pain; Pyrimidines; Shoulder Injuries; Shoulder Joint; Triamcinolone Acetonide; Triazoles; Voriconazole | 2004 |
New options for the treatment of invasive fungal infections.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
[Meta-analysis on safety and efficacy of liposomal amphotericin B in the empirical treatment of febrile neutropenia].
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fever; Humans; Liposomes; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2004 |
Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient.
Topics: Absidia; Antibiotic Prophylaxis; Antifungal Agents; Bronchi; Fatal Outcome; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mucormycosis; Pyrimidines; Triazoles; Voriconazole | 2004 |
[Voriconazole: a new weapon against invasive fungal infections].
Topics: Antifungal Agents; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Safety; Tissue Distribution; Triazoles; Voriconazole | 2004 |
[New antifungal agents and bronchopulmonary mycoses].
Topics: Antifungal Agents; Caspofungin; Drug Costs; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Successful treatment of Candida infections in peritoneal dialysis patients: case reports and review of the literature.
Topics: Aged; Antifungal Agents; Candidiasis; Catheters, Indwelling; Cefazolin; Female; Humans; Middle Aged; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2004 |
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole | 2004 |
[Invasive aspergillosis: clinical manifestations and treatment].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Dermatomycoses; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Immunologic Factors; Itraconazole; Lipopeptides; Neuroaspergillosis; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Respiratory Tract Infections; Triazoles; Voriconazole | 2003 |
Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Azoles; Evidence-Based Medicine; Forecasting; Humans; Itraconazole; Ketoconazole; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole: therapeutic review of a new azole antifungal.
Topics: Animals; Antifungal Agents; Azoles; Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Endocarditis; Female; Follow-Up Studies; Fungemia; Fusarium; Humans; Immunocompromised Host; Infant; Leukemia, Myeloid, Acute; Liposomes; Opportunistic Infections; Pyrimidines; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review.
Topics: Adult; Antifungal Agents; Empyema, Subdural; Female; Humans; Mycoses; Osteomyelitis; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole | 2004 |
Aspergillus mediastinitis following orthotopic heart transplantation: case report and review of the literature.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Administration Schedule; Heart Transplantation; Humans; Male; Mediastinitis; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2004 |
Use of newer antifungal therapies in clinical practice: what do the data tell us?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Combination antifungal therapy: where are we now, and where are we going?
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Antifungal resistance: the clinical front.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Health Status; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome; Triazoles; United States; Voriconazole | 2004 |
Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy.
Topics: Administration, Oral; Antifungal Agents; Arm; Female; Hand; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Emerging azole antifungals.
Topics: Animals; Antifungal Agents; Azoles; Drugs, Investigational; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2005 |
Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole.
Topics: Adult; Aged; Antifungal Agents; Child; Female; Fluconazole; Humans; Infant; Male; Middle Aged; Pyrimidines; Saccharomyces; Sepsis; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Pharmacological management of paracoccidioidomycosis.
Topics: Amphotericin B; Central Nervous System Fungal Infections; Drug Resistance; Fluconazole; Follow-Up Studies; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Paracoccidioidomycosis; Pyrimidines; Sulfonamides; Triazoles; Voriconazole | 2005 |
Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature.
Topics: Antifungal Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fusarium; Humans; Kidney Transplantation; Middle Aged; Mycoses; Organ Transplantation; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2005 |
Systemic aspergillosis with predominant genitourinary manifestations in an immunocompetent man: what we can learn from a disastrous follow-up.
Topics: Abscess; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Kidney Diseases; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Peptides, Cyclic; Prostatic Diseases; Pyrimidines; Retroperitoneal Space; Triazoles; Voriconazole | 2005 |
A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Female; Heart Transplantation; Humans; Lipopeptides; Mediastinitis; Middle Aged; Peptides, Cyclic; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole | 2005 |
[Update on therapy of invasive mycoses in hematology and oncology].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2005 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Chronic granulomatous disease presenting with disseminated intracranial aspergillosis.
Topics: Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Child; Diagnosis, Differential; Granulomatous Disease, Chronic; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole | 2006 |
Voriconazole: review of a broad spectrum triazole antifungal agent.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2005 |
Pseudoporphyria induced by voriconazole.
Topics: Antifungal Agents; Humans; Male; Middle Aged; Porphyrias; Pyrimidines; Triazoles; Voriconazole | 2005 |
Scedosporium apiospermum brain abscess treated with surgery and voriconazole. Case report.
Topics: Antifungal Agents; Brain Abscess; Drainage; Humans; Immunocompetence; Infant; Magnetic Resonance Imaging; Male; Mycetoma; Near Drowning; Neurosurgical Procedures; Pyrimidines; Quadriplegia; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Chemoprevention; Drug Resistance, Fungal; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Peptides, Cyclic; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2005 |
Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Cross Infection; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Echinocandins; Food-Drug Interactions; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Liver; Mycoses; Peptides, Cyclic; Polypharmacy; Pyrimidines; Reverse Transcriptase Inhibitors; Triazoles; Voriconazole | 2005 |
[Drug-drug interaction of antifungal drugs].
Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microsomes, Liver; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Voriconazole-medicalneeds, evidence, potential for the future].
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Biological Availability; Candida; Candidiasis; Guinea Pigs; Humans; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2005 |
Voriconazole versus amphotericin B in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Fungal infections in bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Administration Schedule; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Postoperative Complications; Premedication; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Invasive Acremonium strictum infection in a bone marrow transplant recipient.
Topics: Acremonium; Antifungal Agents; Bone Marrow Transplantation; Child; Female; Humans; Male; Mycoses; Opportunistic Infections; Osteomyelitis; Pyrimidines; Tibia; Triazoles; Urine; Voriconazole | 2006 |
Zygomycoses in patients with acute leukaemia.
Topics: Amphotericin B; Antifungal Agents; Female; Humans; Immunocompromised Host; Leukemia; Male; Middle Aged; Neutropenia; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2006 |
Clinical pharmacokinetics of voriconazole.
Topics: Absorption; Antifungal Agents; Drug Interactions; Humans; Metabolic Clearance Rate; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2006 |
Fungal prosthetic mitral valve endocarditis caused by Scopulariopsis species: case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Arterial Occlusive Diseases; Cardiac Surgical Procedures; Device Removal; Endarterectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Leg; Mitosporic Fungi; Mitral Valve; Mycoses; Prosthesis-Related Infections; Pyrimidines; Reoperation; Triazoles; Voriconazole | 2006 |
[In vitro activity of voriconazole against yeast and algae isolates according to new resistance pattern cut-off points].
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Resistance; Drug Resistance, Fungal; Fungi; Microbial Sensitivity Tests; Prototheca; Pyrimidines; Rhodotorula; Saccharomyces cerevisiae; Saccharomycetales; Species Specificity; Triazoles; Trichosporon; Voriconazole | 2006 |
Treatment of invasive infections due to rare or emerging yeasts and moulds.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Mucormycosis; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Thiazoles; Triazoles; Voriconazole | 2006 |
Invasive aspergillosis with central nervous system dissemination in a presumably immunocompetent, non-neutropenic patient: case report and review.
Topics: Antifungal Agents; Aspergillosis; Brain Diseases; Humans; Immunocompetence; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2006 |
Pharmacokinetic/pharmacodynamic profile of voriconazole.
Topics: Animals; Antifungal Agents; Biotransformation; Drug Interactions; Fungi; Half-Life; Humans; Mycoses; Protein Binding; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2006 |
Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Therapy, Combination; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2006 |
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Lethal brain abscess due to the fungus Scedosporium apiospermum (teleomorph Pseudallescheria boydii) after a near-drowning incident: case report and review of the literature.
Topics: Accidents, Traffic; Adolescent; Adult; Antifungal Agents; Brain Abscess; Child; Child, Preschool; Fatal Outcome; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mycetoma; Near Drowning; Pseudallescheria; Pyrimidines; Scedosporium; Telencephalon; Triazoles; Voriconazole | 2006 |
[Efficacies and clinical roles of new antifungal agents].
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fever; Hematologic Neoplasms; Humans; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
[Zygomycosis after hematogeneic stem cell transplantation--a current problem?].
Topics: Aspergillosis; Cancer Care Facilities; Cross Infection; Cross-Sectional Studies; Germany; Hematopoietic Stem Cell Transplantation; Humans; Long-Term Care; Opportunistic Infections; Pyrimidines; Risk Factors; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis | 2006 |
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Successful treatment of disseminated scedosporium infection in 2 lung transplant recipients: review of the literature and recommendations for management.
Topics: Antifungal Agents; Blindness; Diagnosis, Differential; Drug Administration Schedule; Endophthalmitis; Humans; Kidney Pelvis; Lung Transplantation; Male; Middle Aged; Mycetoma; Polymerase Chain Reaction; Postoperative Complications; Pyrimidines; Recurrence; Retreatment; Scedosporium; Therapeutic Irrigation; Triazoles; Urine; Vision, Monocular; Voriconazole | 2006 |
Disseminated phaeohyphomycosis due to Ochroconis gallopavum in the setting of advanced HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Ascomycota; Biopsy; Fatal Outcome; Histocytochemistry; Humans; Male; Marijuana Abuse; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Voriconazole safety: short review of clinical data].
Topics: Antifungal Agents; Drug Interactions; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Voriconazole : a review of its use in the management of invasive fungal infections.
Topics: Adolescent; Adult; Antifungal Agents; Child; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
[The future of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2007 |
Aspergillus infection of implantable cardioverter-defibrillators and pacemakers: case report and literature review.
Topics: Aged; Antifungal Agents; Aspergillus flavus; Defibrillators, Implantable; Female; Humans; Mycoses; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole | 2007 |
[Voriconazole as an effective therapy against pulmonary aspergillosis in a man with immunodeficiency virus-infection: a case report].
Topics: Antifungal Agents; Aspergillosis; HIV Infections; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2007 |
Use of voriconazole in the treatment of fungal keratitis.
Topics: Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
Treating disseminated fusariosis: amphotericin B, voriconazole or both?
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fever; Fusarium; Humans; Immunocompromised Host; Liposomes; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Fusarium infections of the skin.
Topics: Antifungal Agents; Dermatomycoses; Fusarium; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2007 |
[Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review].
Topics: Amaurosis Fugax; Aneurysm, Infected; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Biomarkers; Caspofungin; Combined Modality Therapy; Echinocandins; Endocarditis; False Negative Reactions; Fatal Outcome; Fungemia; Galactose; Heart Valve Prosthesis Implantation; Humans; Infarction; Kidney; Lipopeptides; Male; Mannans; Mesenteric Arteries; Mesenteric Vascular Occlusion; Middle Aged; Mitral Valve; Peptides, Cyclic; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Renal Artery; Triazoles; Voriconazole | 2007 |
Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature.
Topics: Antifungal Agents; Humans; International Cooperation; Liver Transplantation; Male; Middle Aged; Mycoses; Paecilomyces; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole | 2008 |
Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fever; Humans; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2007 |
Scedosporium apiospermum infection after near-drowning.
Topics: Adolescent; Adult; Antifungal Agents; Brain Abscess; Child; Child, Preschool; Fatal Outcome; Female; Humans; Lung Abscess; Lung Diseases; Male; Meningitis, Fungal; Microbial Sensitivity Tests; Near Drowning; Pyrimidines; Radiography; Rare Diseases; Scedosporium; Triazoles; Voriconazole | 2007 |
Changing epidemiology of rare mould infections: implications for therapy.
Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fusarium; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Zygomycosis | 2007 |
[In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].
Topics: Antifungal Agents; Aspergillus; Biofilms; Candida; Cryptococcus; Drug Resistance, Fungal; Drug Synergism; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2007 |
[Role of voriconazole in critically ill patients with invasive mycoses].
Topics: Antifungal Agents; Comorbidity; Critical Care; Fungemia; Humans; Intensive Care Units; Kidney; Multicenter Studies as Topic; Mycoses; Prospective Studies; Pyrimidines; Spain; Triazoles; Voriconazole | 2007 |
[Current indications for voriconazole in onco-hematological patients].
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Drug Resistance, Fungal; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Salvage Therapy; Spain; Triazoles; Voriconazole; Zygomycosis | 2007 |
[Voriconazole for the therapy of mycoses in recipients of solid organ transplants].
Topics: Antibiotic Prophylaxis; Antifungal Agents; Drug Interactions; Humans; Immunosuppressive Agents; Lung Diseases, Fungal; Lung Transplantation; Mycoses; Organ Transplantation; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole | 2007 |
[The role of voriconazole in the treatment of emerging mycoses].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2007 |
Antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2007 |
[New development in the treatment of deep-seated mycoses].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Candida endophthalmitis: focus on current and future antifungal treatment options.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Echinocandins; Endophthalmitis; Fluconazole; Flucytosine; Humans; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
Efficacy of voriconazole for Scedosporium apiospermum skull base osteomyelitis: case report and literature review.
Topics: Antifungal Agents; Humans; Male; Middle Aged; Osteomyelitis; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2008 |
Bilateral renal aspergillosis in a patient with AIDS: a case report and review of reported cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Aspergillus fumigatus; HIV Infections; Humans; Kidney Diseases; Male; Pyrimidines; Radiography; Tomography Scanners, X-Ray Computed; Triazoles; Voriconazole | 2008 |
Invasive pulmonary aspergillosis after liver transplantation: rapid and complete response to combined and sequential antifungal therapy.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Immunosuppression Therapy; Lipopeptides; Liver Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography, Thoracic; Tomography, Emission-Computed; Triazoles; Voriconazole | 2008 |
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Complexity of interactions between voriconazole and antiretroviral agents.
Topics: Anti-Retroviral Agents; Drug Interactions; Humans; Pyrimidines; Triazoles; Voriconazole | 2008 |
Antifungal agents--clinical pharmacokinetics and drug interactions.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Echinocandins; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Acute monoblastic leukemia with t(10;11)(p12;q23) presenting with pulmonary involvement: a case report and literature review.
Topics: Adult; Antibiotics, Antineoplastic; Antifungal Agents; Antimetabolites, Antineoplastic; Aspergillosis, Allergic Bronchopulmonary; Bronchoalveolar Lavage; Caspofungin; Cytarabine; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Monocytic, Acute; Lipopeptides; Lung Neoplasms; Male; Pyrimidines; Thailand; Triazoles; Voriconazole | 2008 |
Voriconazole in the treatment of fungal eye infections: a review of current literature.
Topics: Animals; Antifungal Agents; Eye Infections, Fungal; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Therapeutic drug monitoring of voriconazole.
Topics: Aging; Antifungal Agents; Drug Interactions; Drug Monitoring; Female; Genotype; Humans; Liver Failure; Male; Pyrimidines; Renal Insufficiency; Sex Characteristics; Triazoles; Voriconazole | 2008 |
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Intensive Care Units; Itraconazole; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2008 |
Treatment of invasive candidal infections: systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Anidulafungin in the treatment of patients with invasive candidiasis.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Echinocandins; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole | 2008 |
Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Humans; Liver Function Tests; Pyrimidines; Treatment Outcome; Triazoles; Vision Disorders; Voriconazole | 2008 |
[What's new in the molecular basis of antifungal drug resistance in pathogenic yeasts].
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Fluconazole; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Mutation; Pyrimidines; Saccharomyces cerevisiae Proteins; Sterols; Trans-Activators; Triazoles; Voriconazole | 2008 |
[Oral antifungal agents].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Clinical efficacies of antifungal injections].
Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2008 |
Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review.
Topics: Antifungal Agents; Aspergillosis; Humans; Male; Middle Aged; Otitis Externa; Pyrimidines; Radiography; Temporal Bone; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Cerebral aspergillosis: tissue penetration is the key.
Topics: Animals; Antifungal Agents; Fluconazole; Humans; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
New therapies for fungal pneumonia.
Topics: Amphotericin B; Antifungal Agents; Fungi; Galactose; Humans; Mannans; Mycoses; Pneumonia; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Triazoles; Voriconazole | 2009 |
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections.
Topics: Antifungal Agents; Chemoprevention; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Neutropenia; Patient Isolation; Pyrimidines; Triazoles; Voriconazole | 2009 |
Diagnosis and treatment of aspergillosis in children.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Echinocandins; Fungal Vaccines; Genomics; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2009 |
Aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Debridement; Echinocandins; Humans; Immunity, Cellular; Immunity, Innate; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2009 |
Fungal postoperative spondylodiscitis due to Scedosporium prolificans.
Topics: Anti-Bacterial Agents; Antifungal Agents; Arthrodesis; Debridement; Discitis; Female; Humans; Intervertebral Disc Displacement; Magnetic Resonance Imaging; Middle Aged; Mycoses; Orthopedic Procedures; Postoperative Complications; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2009 |
Invasive Aspergillus fumigatus infection after Plasmodium falciparum malaria in an immuno-competent host: case report and review of literature.
Topics: Antifungal Agents; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Malaria, Falciparum; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2009 |
Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.
Topics: Anidulafungin; Animals; Antifungal Agents; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Synergism; Echinocandins; Humans; Molecular Structure; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.
Topics: Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
The role of voriconazole in the treatment of central nervous system blastomycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Child; Child, Preschool; Humans; Infant; Magnetic Resonance Imaging; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2009 |
In vitro activity of antifungals against Zygomycetes.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Humans; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?
Topics: Antifungal Agents; Chemoprevention; Drug Resistance, Fungal; Humans; Immunocompromised Host; Mucorales; Mucormycosis; Pyrimidines; Transplantation; Triazoles; Voriconazole | 2009 |
Unilateral ureteral obstruction caused by Aspergillus, subgenus Nidulantes in a patient on steroid therapy: a case report and review of the literature.
Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Aspergillus nidulans; Bezoars; Female; Humans; Immunocompromised Host; Middle Aged; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Triazoles; Ureteral Obstruction; Voriconazole | 2010 |
Pharmacology and clinical use of voriconazole.
Topics: Animals; Antifungal Agents; Drug Interactions; Drug Monitoring; Drug Resistance, Fungal; Fungi; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole therapeutic drug monitoring: focus on safety.
Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Clinical Laboratory Techniques; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Humans; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole | 2010 |
Fonsecaea monophora cerebral phaeohyphomycosis: case report of successful surgical excision and voriconazole treatment and review.
Topics: Antifungal Agents; Ascomycota; beta-Glucans; Central Nervous System Fungal Infections; Female; Frontal Lobe; Histocytochemistry; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Magnetic Resonance Imaging; Microscopy; Middle Aged; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Pharmacoeconomics of voriconazole.
Topics: Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Evidence-Based Medicine; Humans; Models, Economic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD).
Topics: Animals; Antifungal Agents; beta-Cyclodextrins; Dogs; Excipients; Humans; Pyrimidines; Rats; Triazoles; Voriconazole | 2010 |
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.
Topics: Amino Acid Substitution; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Pyrimidines; Sequence Analysis, DNA; Sterol 14-Demethylase; Triazoles; Voriconazole | 2010 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Aspergillus; DNA, Fungal; Female; Fungemia; Humans; Immunocompromised Host; Incidence; Male; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Risk Assessment; Severity of Illness Index; Survival Rate; Triazoles; Voriconazole | 2010 |
First case of Trichoderma longibrachiatum infection in a renal transplant recipient in Tunisia and review of the literature.
Topics: Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Trichoderma; Tunisia; Voriconazole | 2010 |
Primary invasive oral aspergillosis: an updated literature review.
Topics: Acyclovir; Aged; Amphotericin B; Antifungal Agents; Antiviral Agents; Aspergillosis; Fatal Outcome; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Mouth Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole | 2010 |
Modern antifungal therapy for neutropenic fever.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fever; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Liposomes; Liver Diseases; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2006 |
Traditional and emerging antifungal therapies.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2010 |
Allergic bronchopulmonary aspergillosis.
Topics: Antibodies, Monoclonal; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Disease Susceptibility; Glucocorticoids; Humans; Immunoglobulin E; Lymphocyte Activation; Pyrimidines; Respiratory Function Tests; T-Lymphocytes, Helper-Inducer; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Medication-induced periostitis in lung transplant patients: periostitis deformans revisited.
Topics: Aged; Antibiotic Prophylaxis; Antifungal Agents; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Periostitis; Pyrimidines; Radiography; Triazoles; Voriconazole | 2011 |
Conazoles.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole | 2010 |
Aspergillus fumigatus joint infection: a review.
Topics: Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Caspofungin; Combined Modality Therapy; Drainage; Echinocandins; Female; Humans; Immunocompromised Host; Lipopeptides; Middle Aged; Pyrimidines; Sacroiliac Joint; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Severe phototoxicity associated with long-term voriconazole treatment.
Topics: Antifungal Agents; Child; Dermatitis, Photoallergic; Diagnosis, Differential; Drug Eruptions; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
Topics: Antifungal Agents; Drug Resistance, Fungal; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature.
Topics: Aged; Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Female; Geotrichosis; Geotrichum; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2011 |
Invasive aspergillosis in patients with liver disease.
Topics: Aged; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Liver Diseases; Lung; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2011 |
Pharmacoeconomics of voriconazole in the management of invasive fungal infections.
Topics: Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Recent advances in invasive pulmonary aspergillosis.
Topics: Antifungal Agents; Biomarkers; Galactose; Humans; Invasive Pulmonary Aspergillosis; Lectins, C-Type; Mannans; Membrane Proteins; Nerve Tissue Proteins; Polymorphism, Genetic; Pyrimidines; Toll-Like Receptor 4; Triazoles; Voriconazole | 2011 |
Therapeutic drug monitoring of voriconazole and posaconazole.
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Humans; Pyrimidines; Triazoles; Voriconazole | 2011 |
The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review.
Topics: Aged; Antifungal Agents; Diabetes Mellitus, Type 2; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Risk Factors; Saccharomycetales; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Risk Factors; Sarcoidosis, Pulmonary; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients : a case report and literature review.
Topics: Adult; Alemtuzumab; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antineoplastic Agents; Combined Modality Therapy; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fever; Fusariosis; Fusarium; Granulocytes; Humans; Immunocompromised Host; Leukocyte Transfusion; Lymphoma, T-Cell, Cutaneous; Male; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole | 2011 |
Best practice in treating infants and children with proven, probable or suspected invasive fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Child; Echinocandins; Fever of Unknown Origin; Humans; Infant; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity.
Topics: Adult; Amphotericin B; Antifungal Agents; Communicable Diseases, Emerging; Embolectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Humans; Immunocompromised Host; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Scedosporium; Thrombosis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2011 |
Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature.
Topics: Antifungal Agents; Drug Interactions; Humans; Invasive Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2011 |
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Therapy, Combination; Echinocandins; Evidence-Based Medicine; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2011 |
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria.
Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Rhodotorula fungemia: two cases and a brief review.
Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Female; Fungemia; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Pyrimidines; Rhodotorula; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries | 2011 |
Anidulafungin: when and how? The clinician's view.
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Pharmacogenomics of the triazole antifungal agent voriconazole.
Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Drug Interactions; Humans; Pharmacogenetics; Pyrimidines; Triazoles; Voriconazole | 2011 |
Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients.
Topics: Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Education, Medical, Continuing; Female; Humans; Immunocompromised Host; Incidence; Male; Melanoma; Organ Transplantation; Prognosis; Pyrimidines; Risk Assessment; Sarcoma, Kaposi; Sirolimus; Skin Neoplasms; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients.
Topics: Adult; Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Monitoring; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Phototoxicity and photocarcinogenesis associated with voriconazole.
Topics: Antifungal Agents; Biotransformation; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cocarcinogenesis; Comorbidity; Dermatitis, Phototoxic; Drug Interactions; Humans; Immunocompromised Host; Melanoma; Mycoses; Neoplasms, Radiation-Induced; Photochemistry; Postoperative Complications; Pyrimidines; Retinoids; Retrospective Studies; Skin Neoplasms; Sunlight; Transplantation; Triazoles; Voriconazole | 2011 |
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Triazole antifungal agents in invasive fungal infections: a comparative review.
Topics: Antifungal Agents; Fluconazole; Fungi; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Scedosporium apiospermum catheter-related soft-tissue infection: a case report and review of the literature.
Topics: Aged; Catheter-Related Infections; DNA, Fungal; Genes, Fungal; Humans; Male; Mycoses; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Scedosporium; Sequence Analysis, DNA; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Treatment of primary aspergilloma of the central nervous system in a diabetic immunocompetent patient with surgical resection and voriconazole: a case report and review of the literature.
Topics: Aged; Antifungal Agents; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Immunocompetence; Neuroaspergillosis; Neurosurgical Procedures; Pyrimidines; Temporal Lobe; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Therapeutic drug monitoring of voriconazole in children.
Topics: Antifungal Agents; Child; Drug Monitoring; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis.
Topics: Age Factors; Antifungal Agents; Drug Monitoring; Female; Humans; Liver Diseases; Male; Mycoses; Odds Ratio; Pyrimidines; Triazoles; Voriconazole | 2012 |
Endophthalmitis caused by Phialophora verrucosa: a case report and literature review of Phialophora ocular infections.
Topics: Aged; Amphotericin B; Antifungal Agents; Caspofungin; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Glaucoma; Humans; Hypertension; Intravitreal Injections; Lipopeptides; Male; Phialophora; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2012 |
Antifungal prophylaxis in haematology patients: the role of voriconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Clinical Trials as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Pyrimidines; Triazoles; Voriconazole | 2012 |
Unusual case of cutaneous and synovial Paecilomyces lilacinus infection of hand successfully treated with voriconazole and review of published literature.
Topics: Adult; Aged; Antifungal Agents; Bursa, Synovial; Dermatomycoses; Female; Hand; Histocytochemistry; Humans; Male; Microscopy; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Synovitis; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Ochroconis gallopava infection in a patient with chronic granulomatous disease: case report and review of the literature.
Topics: Antifungal Agents; Ascomycota; Granulomatous Disease, Chronic; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Azole resistance in Aspergillus fumigatus in the Netherlands--increase due to environmental fungicides?].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Environmental Microbiology; Fungicides, Industrial; Humans; Itraconazole; Microbial Sensitivity Tests; Netherlands; Pyrimidines; Triazoles; Voriconazole | 2012 |
Exophiala dermatitidis endocarditis on native aortic valve in a postrenal transplant patient and review of literature on E. dermatitidis infections.
Topics: Antifungal Agents; Aortic Valve; Chest Pain; DNA, Fungal; Endocarditis; Exophiala; Female; Fever; Humans; Kidney Transplantation; Middle Aged; Phaeohyphomycosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
Treatment of refractory cerebral aspergillosis in a liver transplant recipient with voriconazole: case report and review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Encephalitis; Humans; Liver Transplantation; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
[The development of appropriate dosage of anti-bacterial and anti-fungal agents based on pharmacokinetics and pharmacodynamics].
Topics: Anti-Bacterial Agents; Antifungal Agents; Female; HMGB1 Protein; Humans; Liposomes; Male; Pyrimidines; Teicoplanin; Triazoles; Voriconazole | 2012 |
Fungal infections associated with contaminated methylprednisolone injections.
Topics: Antifungal Agents; Aspergillus fumigatus; Cerebrospinal Fluid; Disease Outbreaks; Drug Compounding; Drug Contamination; Drug Monitoring; Humans; Injections, Spinal; Meningitis, Fungal; Methylprednisolone; Pyrimidines; Saccharomycetales; Tennessee; Triazoles; United States; Voriconazole | 2013 |
Voriconazole in clinical practice.
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Fungal; Evidence-Based Medicine; Fungi; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Neuroaspergillosis; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2013 |
Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Cause of Death; Eye Infections, Fungal; Female; Fungi; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Risk Factors; Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective review.
Topics: Body Mass Index; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Obesity; Overweight; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2013 |
Pharmacoeconomic assessment of therapy for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Cost-Benefit Analysis; Empirical Research; Humans; Length of Stay; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Use of voriconazole for the treatment of Paecilomyces lilacinus cutaneous infections: case presentation and review of published literature.
Topics: Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Male; Middle Aged; Paecilomyces; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Diagnosis of airway-invasive pulmonary aspergillosis by tree-in-bud sign in an immunocompetent patient: case report and literature review.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biopsy; Bronchiolitis; Bronchoscopy; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Humans; Immunocompetence; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Lung; Male; Pyrimidines; Sputum; Tomography, X-Ray Computed; Triazoles; Tuberculosis, Pulmonary; Voriconazole; Young Adult | 2013 |
Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis.
Topics: Aged; Aneurysm, Infected; Antifungal Agents; Aortic Aneurysm; Drug Resistance, Fungal; Female; Humans; Lung Transplantation; Mycoses; Pericarditis; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Bibliographical investigation (domestic and overseas) on the treatment of endogenous Candida endophthalmitis over an 11-year period.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Female; Fluconazole; Humans; Infant; Japan; Male; MEDLINE; Middle Aged; Pyrimidines; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole; Young Adult | 2013 |
Aspergillus terreus-related ureteral obstruction in a diabetic patient.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Diabetes Complications; Humans; Lithotripsy; Male; Middle Aged; Pyrimidines; Stents; Tomography, X-Ray Computed; Triazoles; Ureter; Ureteral Obstruction; Voriconazole | 2013 |
Cervical spondylitis due to Phaeoacremonium venezuelense in an immunocompetent patient. A first case report.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Cervical Vertebrae; Epidural Abscess; Humans; Immunocompetence; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Species Specificity; Spondylitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Combination therapy of voriconazole and terbinafine for disseminated fusariosis: case report and literature review.
Topics: Adult; Aged; Antifungal Agents; Child; Child, Preschool; Drug Therapy, Combination; Fusariosis; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2013 |
Aspergillus vertebral osteomyelitis in immunocompetent subjects: case report and review of the literature.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Diabetes Complications; Humans; Male; Osteomyelitis; Pyrimidines; Spondylitis; Triazoles; Voriconazole | 2013 |
Combination antifungal therapy for invasive fungal infections in children and adults.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Child; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Pyrimidines; Triazoles; Voriconazole | 2013 |
Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.
Topics: Aged; Antifungal Agents; Chemoprevention; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
Background changing patterns of neonatal fungal sepsis in a developing country.
Topics: Antifungal Agents; Birth Weight; Candida; Candidemia; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Humans; Incidence; Infant, Newborn; Male; Microbial Sensitivity Tests; Pyrimidines; Risk Factors; Socioeconomic Factors; South Africa; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Echinocandins; Fluconazole; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Neonatology; Pyrimidines; Triazoles; Voriconazole | 2013 |
Fusarium falciforme infection of foot in a patient with type 2 diabetes mellitus: a case report and review of the literature.
Topics: Antifungal Agents; Biopsy, Fine-Needle; Diabetes Complications; Diabetes Mellitus, Type 2; Foot; Fusariosis; Fusarium; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2013 |
Mold infections in lung transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bronchiolitis Obliterans; Fungi; Humans; Lung Diseases, Fungal; Lung Transplantation; Neoplasms, Squamous Cell; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2013 |
Disseminated histoplasmosis in a renal transplant patient.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow; Dermatomycoses; Histoplasmosis; Humans; Immunocompromised Host; Kidney Transplantation; Lung; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2013 |
[Pharmaceutical applications of sulfobuthylether-beta-cyclodextrin].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antiemetics; Antifungal Agents; Antipsychotic Agents; Aripiprazole; beta-Cyclodextrins; Chemistry, Pharmaceutical; Dosage Forms; Drug Stability; Humans; Hungary; Multiple Myeloma; Oligopeptides; Piperazines; Pyrimidines; Quinolones; Quinuclidines; Solubility; Thiazoles; Triazoles; Voriconazole | 2013 |
Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Clinical Trials as Topic; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Drug Resistance, Fungal; Humans; Pyrimidines; Triazoles; Voriconazole | 2013 |
Fungal infections and treatment in cystic fibrosis.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Candida; Candidiasis; Cystic Fibrosis; DNA, Fungal; Female; Humans; Itraconazole; Male; Pyrimidines; Scedosporium; Sputum; Triazoles; Vital Capacity; Voriconazole | 2013 |
Iatrogenic fungal infections of central nervous system.
Topics: Animals; Antifungal Agents; Central Nervous System Fungal Infections; Drug Contamination; Humans; Iatrogenic Disease; Pyrimidines; Triazoles; Voriconazole | 2013 |
Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Drug Therapy, Combination; Echinocandins; Humans; Practice Guidelines as Topic; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2013 |
Rhodotorula minuta as onychomycosis agent in a Chinese patient: first report and literature review.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Asian People; China; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Rhodotorula; Triazoles; Voriconazole | 2014 |
Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal.
Topics: Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Evidence-Based Medicine; Humans; Mucormycosis; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2013 |
A case of pediatric gastrointestinal basidiobolomycosis mimicking Crohn`s disease. A review of pediatric literature.
Topics: Antifungal Agents; Child, Preschool; Crohn Disease; Diagnosis, Differential; Humans; Male; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2013 |
Scedosporium aurantiacum brain abscess after near-drowning in a survivor of a tsunami in Japan.
Topics: Aged; Amphotericin B; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Delayed Diagnosis; Female; Humans; Japan; Lung Diseases, Fungal; Magnetic Resonance Imaging; Near Drowning; Pyrimidines; Scedosporium; Survivors; Tomography, X-Ray Computed; Triazoles; Tsunamis; Voriconazole | 2013 |
Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Incidence; Mycoses; Pyrimidines; Risk Factors; Time Factors; Triazoles; Voriconazole | 2014 |
Treatment of fungal disease in the setting of neutropenia.
Topics: Anemia, Aplastic; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
[Invasive fungal rhinosinusitis in an apparently immunocompetant patient].
Topics: Aged; Antifungal Agents; Aortic Valve Stenosis; Aspergillosis; Chronic Disease; Female; Humans; Immunocompetence; Incidental Findings; Maxillary Sinusitis; Preoperative Care; Pyrimidines; Recurrence; Rhinitis; Triazoles; Voriconazole | 2013 |
Invasive Trichosporon infection in solid organ transplant patients: a report of two cases identified using IGS1 ribosomal DNA sequencing and a review of the literature.
Topics: Adult; Antifungal Agents; DNA, Fungal; DNA, Intergenic; DNA, Ribosomal; Drug Resistance, Fungal; Empyema; Graft Rejection; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Fungal; Lung Transplantation; Male; Mediastinitis; Microbial Sensitivity Tests; Pericarditis; Pleural Effusion; Pyrimidines; Sequence Analysis, DNA; Triazoles; Trichosporon; Trichosporonosis; Voriconazole; Young Adult | 2014 |
Clinically relevant drug-drug interactions between antiretrovirals and antifungals.
Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Carbamates; Cyclopropanes; Drug Interactions; Drug Monitoring; Echinocandins; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Itraconazole; Mycoses; Organophosphates; Pyrimidines; Ritonavir; Sulfonamides; Triazoles; Voriconazole | 2014 |
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2014 |
Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cholesterol; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2014 |
The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Models, Biological; Mutation; Translational Research, Biomedical; Triazoles; Voriconazole | 2014 |
Optimizing azole antifungal therapy in the prophylaxis and treatment of fungal infections.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Itraconazole; Mycoses; Population Surveillance; Precision Medicine; Triazoles; Voriconazole | 2014 |
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.
Topics: Antifungal Agents; Consensus; Drug Administration Schedule; Drug Delivery Systems; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Hematologic Neoplasms; Humans; Molecular Sequence Data; Mycoses; Opportunistic Infections; Practice Guidelines as Topic; Rehydration Solutions; Triazoles; Voriconazole | 2014 |
Isavuconazole: A New Option for the Management of Invasive Fungal Infections.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidemia; Candidiasis; Candidiasis, Invasive; Clinical Trials as Topic; Drug Resistance, Fungal; Humans; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Role of Non-Culture-Based Tests, with an Emphasis on Galactomannan Testing for the Diagnosis of Invasive Aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Bronchoalveolar Lavage Fluid; Galactose; Humans; Mannans; Proteoglycans; Triazoles; Voriconazole | 2015 |
Invasive Aspergillosis: Epidemiology, Clinical Aspects, and Treatment.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lung Transplantation; Magnetic Resonance Imaging; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2015 |
Emergence of Azole Resistance in Aspergillus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Humans; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2015 |
Coccidioidomycosis: Recent Updates.
Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Humans; Nitriles; Pneumonia; Pyridines; Risk Factors; Triazoles; Voriconazole | 2015 |
Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
Topics: Adult; Antifungal Agents; Aspergillus; Candida; Cost-Benefit Analysis; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Mycoses; Singapore; Survival Analysis; Triazoles; Voriconazole | 2016 |
Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation.
Topics: Antifungal Agents; Cost-Benefit Analysis; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Practice Guidelines as Topic; Primary Prevention; Transplantation, Homologous; Triazoles; Voriconazole | 2017 |
Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.
Topics: Antifungal Agents; Biological Availability; Drug Monitoring; Fungi; Humans; Invasive Fungal Infections; Itraconazole; Nitriles; Pyridines; Triazoles; Voriconazole | 2017 |
Invasive mould infections in the ICU setting: complexities and solutions.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Critical Illness; Galactose; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Lung Diseases, Fungal; Mannans; Mucor; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory System; Triazoles; Voriconazole | 2017 |
Graded isavuconazole introduction in a patient with voriconazole allergy.
Topics: Amphotericin B; Angioedema; Antifungal Agents; Aspergillus; Desensitization, Immunologic; Drug Administration Schedule; Drug Hypersensitivity; Female; Humans; Liver Cirrhosis; Liver Transplantation; Lung; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.
Topics: Amphotericin B; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Female; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Scedosporium apiospermum infection of the urinary system with a review of treatment options and cases in the literature.
Topics: Adult; Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Immunocompromised Host; Itraconazole; Male; Mycoses; Pyrimidines; Scedosporium; Triazoles; Urinary Tract Infections; Voriconazole | 2018 |
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Monitoring; Hematology; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Medical Oncology; Myelodysplastic Syndromes; Primary Prevention; Societies, Medical; Triazoles; Voriconazole | 2018 |
Case of femoral pseudarthrosis due to Scedosporium apiospermum in an immunocompetent patient with successful conservative treatment and review of literature.
Topics: Antifungal Agents; Conservative Treatment; Disease Management; Femur; Humans; Immunocompetence; Male; Middle Aged; Pseudarthrosis; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Voriconazole as mono-therapy in orbitofrontal erosive aspergillosis without gross total resection: A case report and review of literature.
Topics: Antifungal Agents; Aspergillosis; Biopsy; Humans; Immunocompetence; Male; Middle Aged; Triazoles; Voriconazole | 2018 |
Systematic review and network meta-analysis of clinical outcomes associated with isavuconazole versus relevant comparators for patients with invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Humans; Network Meta-Analysis; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Clinical Pharmacokinetics of Second-Generation Triazoles for the Treatment of Invasive Aspergillosis and Candidiasis.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Humans; Triazoles; Voriconazole | 2019 |
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
Topics: Adult; Amphotericin B; Antifungal Agents; Central Venous Catheters; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mortality; Neutropenia; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2020 |
Blastomycosis.
Topics: Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Humans; Immunocompromised Host; Itraconazole; Triazoles; Voriconazole | 2020 |
An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Disease Management; Echinocandins; Humans; Itraconazole; Nitriles; Practice Guidelines as Topic; Pulmonary Aspergillosis; Pyridines; Triazoles; Voriconazole | 2020 |
From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Antimicrobial Stewardship; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis, Invasive; Echinocandins; Fluconazole; Flucytosine; Humans; Species Specificity; Triazoles; Voriconazole | 2020 |
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Triazoles; Voriconazole | 2020 |
Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pre-Exposure Prophylaxis; Triazoles; Voriconazole | 2020 |
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
Topics: Amphotericin B; Antifungal Agents; Azoles; Coinfection; COVID-19; Humans; Nitriles; Pulmonary Aspergillosis; Pyridines; SARS-CoV-2; Triazoles; Voriconazole | 2021 |
Clinical Pharmacokinetics of Triazoles in Pediatric Patients.
Topics: Adult; Antifungal Agents; Child; Fluconazole; Humans; Itraconazole; Mycoses; Triazoles; Voriconazole | 2021 |
How different is invasive fusariosis in pediatric patients than in adults? A systematic review.
Topics: Adult; Antifungal Agents; Child; Fusariosis; Hematologic Neoplasms; Humans; Triazoles; Voriconazole | 2021 |
Inhaled antifungal therapy: benefits, challenges, and clinical applications.
Topics: Antifungal Agents; Drug Interactions; Triazoles; Voriconazole | 2022 |
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal disease.
Topics: Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Healthy Volunteers; Humans; Invasive Fungal Infections; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2022 |
New Perspectives on Antimicrobial Agents: Isavuconazole.
Topics: Antifungal Agents; Candidiasis, Invasive; Caspofungin; Fungi; Humans; Invasive Fungal Infections; Nitriles; Pyridines; Triazoles; Voriconazole | 2022 |
A systematic review and meta-analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections.
Topics: Antifungal Agents; Humans; Invasive Fungal Infections; Triazoles; Voriconazole | 2023 |
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium.
Topics: Antifungal Agents; Communicable Diseases; Drug Monitoring; Humans; Mycoses; Pharmacists; Triazoles; Voriconazole | 2023 |
CRYPTOCOCCOSIS: A bibliographic narrative review on antifungal resistance.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2023 |
Performances of disk diffusion method for determining triazole susceptibility of Aspergillus species: Systematic review.
Topics: Agar; Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Reproducibility of Results; Triazoles; Voriconazole | 2023 |
139 trial(s) available for triazoles and voriconazole
| Article | Year |
|---|---|
A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Consumer Product Safety; Double-Blind Method; Esophageal Diseases; Female; Fluconazole; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2001 |
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Chronic Disease; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2002 |
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.
Topics: Administration, Oral; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Graft Rejection; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2002 |
Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients.
Topics: Adult; Aged; Analysis of Variance; Antifungal Agents; Area Under Curve; Confidence Intervals; Cross-Over Studies; Cyclosporine; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Patients; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Female; Granulomatous Disease, Chronic; Hematologic Neoplasms; Humans; Infant; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2002 |
Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.
Topics: Administration, Oral; Adolescent; Adult; Alanine Transaminase; Antifungal Agents; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Injections, Intravenous; Liver Function Tests; Male; Pyrimidines; Saliva; Triazoles; Voriconazole | 2002 |
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2002 |
Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes.
Topics: Antifungal Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Humans; Immunosuppressive Agents; In Vitro Techniques; Kinetics; Liver Transplantation; Microsomes, Liver; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2002 |
Improving the outcome of invasive aspergillosis: new diagnostic tools and new therapeutic strategies.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Voriconazole treatment for less-common, emerging, or refractory fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
The pharmacokinetics and safety of intravenous voriconazole - a novel wide-spectrum antifungal agent.
Topics: Adolescent; Adult; Antifungal Agents; Area Under Curve; Humans; Infusions, Intravenous; Male; Middle Aged; Plasma; Pyrimidines; Saliva; Single-Blind Method; Triazoles; Voriconazole | 2003 |
Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Plasma; Pyrimidines; Single-Blind Method; Triazoles; Voriconazole | 2003 |
Effect of food on the pharmacokinetics of multiple-dose oral voriconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Biological Availability; Cross-Over Studies; Food; Food-Drug Interactions; Humans; Intestinal Absorption; Male; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2003 |
Voriconazole potentiates warfarin-induced prothrombin time prolongation.
Topics: Administration, Oral; Adult; Anticoagulants; Antifungal Agents; Cross-Over Studies; Double-Blind Method; Drug Combinations; Drug Interactions; Drug Synergism; Humans; Male; Prothrombin Time; Pyrimidines; Triazoles; Voriconazole; Warfarin | 2003 |
No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Area Under Curve; Azithromycin; Drug Combinations; Drug Interactions; Erythromycin; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2003 |
Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration.
Topics: Adult; Anticonvulsants; Antifungal Agents; Drug Combinations; Drug Interactions; Humans; Male; Phenytoin; Pyrimidines; Triazoles; Voriconazole | 2003 |
Voriconazole does not affect the steady-state pharmacokinetics of digoxin.
Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Cardiotonic Agents; Digoxin; Double-Blind Method; Drug Combinations; Drug Interactions; Humans; Male; Plasma; Pyrimidines; Triazoles; Voriconazole | 2003 |
Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Cimetidine; Cross-Over Studies; Drug Combinations; Drug Interactions; Histamine H2 Antagonists; Humans; Male; Pyrimidines; Ranitidine; Triazoles; Voriconazole | 2003 |
Effect of omeprazole on the steady-state pharmacokinetics of voriconazole.
Topics: Administration, Oral; Adult; Anti-Ulcer Agents; Antifungal Agents; Cross-Over Studies; Drug Combinations; Drug Interactions; Humans; Male; Omeprazole; Pyrimidines; Triazoles; Voriconazole | 2003 |
No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers.
Topics: Administration, Oral; Adult; Antifungal Agents; Cross-Over Studies; Drug Combinations; Drug Interactions; HIV Protease Inhibitors; Humans; Indinavir; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2003 |
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration.
Topics: Aging; Alleles; Antifungal Agents; Body Weight; Child; Child, Preschool; Cohort Studies; Female; Genotype; Humans; Immunocompromised Host; Injections, Intravenous; Liver Function Tests; Male; Models, Biological; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Child, Preschool; Humans; Middle Aged; Osteitis; Osteomyelitis; Pyrimidines; Salvage Therapy; Spondylitis; Triazoles; Voriconazole | 2005 |
Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.
Topics: Aged; Antifungal Agents; Critical Illness; Female; Humans; Intubation, Gastrointestinal; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2005 |
Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics.
Topics: Administration, Oral; Adult; Alleles; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Chromatography, Liquid; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Gas Chromatography-Mass Spectrometry; Genotype; Half-Life; Humans; Hypericum; Male; Metabolic Clearance Rate; Mixed Function Oxygenases; Patient Selection; Plant Extracts; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2005 |
Clinical use and tolerability of voriconazole in the treatment of fungal infections in critically ill patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fungemia; Humans; Intensive Care Units; Logistic Models; Male; Maximum Tolerated Dose; Middle Aged; Probability; Prospective Studies; Pyrimidines; Risk Assessment; Single-Blind Method; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Humans; Itraconazole; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Safety and pharmacokinetics of coadministered voriconazole and anidulafungin.
Topics: Adult; Anidulafungin; Antifungal Agents; Cross-Over Studies; Drug Therapy, Combination; Echinocandins; Humans; Male; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.
Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Aqueous Humor; Dose-Response Relationship, Drug; Female; Horses; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.
Topics: Antifungal Agents; Candida; Candidiasis; Data Interpretation, Statistical; Drug Resistance, Fungal; Endpoint Determination; Fluconazole; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2006 |
Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.
Topics: Administration, Oral; Adult; Anesthetics, Intravenous; Antifungal Agents; Area Under Curve; Cross-Over Studies; Humans; Infusions, Intravenous; Male; Midazolam; Pyrimidines; Triazoles; Voriconazole | 2006 |
Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(-)-Ibuprofen.
Topics: Adult; Analgesics, Non-Narcotic; Antifungal Agents; Area Under Curve; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fluconazole; Half-Life; Humans; Ibuprofen; Male; Pyrimidines; Therapeutic Equivalency; Triazoles; Voriconazole | 2006 |
Pharmacokinetics of voriconazole after oral and intravenous administration to horses.
Topics: Administration, Oral; Animals; Antifungal Agents; Biological Availability; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Stability; Female; Horses; Injections, Intravenous; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Female; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects.
Topics: Adult; Antifungal Agents; Cross-Over Studies; Drug Interactions; Humans; Hypnotics and Sedatives; Male; Pyridines; Pyrimidines; Triazoles; Voriconazole; Zolpidem | 2007 |
Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir.
Topics: Adult; Alleles; Anti-HIV Agents; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Genotype; Humans; Male; Mixed Function Oxygenases; Pyrimidines; Ritonavir; Triazoles; Voriconazole | 2006 |
Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Aqueous Humor; Aspergillus fumigatus; Candida albicans; Humans; Keratitis; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy.
Topics: Adult; Antifungal Agents; Area Under Curve; Back Pain; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Headache; Humans; Male; Metabolic Clearance Rate; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Pyrimidines; Sleep Initiation and Maintenance Disorders; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods.
Topics: Adult; Antifungal Agents; Area Under Curve; Biological Assay; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Female; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Mutation; Pyrimidines; Reproducibility of Results; Spectrophotometry, Ultraviolet; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life.
Topics: Administration, Oral; Adult; Alfentanil; Analgesics, Opioid; Antifungal Agents; Area Under Curve; Color Vision Defects; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Naphthalenes; Photophobia; Pyrimidines; Sex Factors; Terbinafine; Triazoles; Vomiting; Voriconazole | 2006 |
Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets.
Topics: Adolescent; Adult; Antifungal Agents; Area Under Curve; Cross-Over Studies; Female; Humans; Male; Middle Aged; Pyrimidines; Tablets; Triazoles; Voriconazole | 2007 |
Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunocompetence; Lung; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Costs; Humans; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2007 |
Steady-state pharmacokinetic and safety profiles of voriconazole and ritonavir in healthy male subjects.
Topics: Adult; Anti-HIV Agents; Antifungal Agents; Area Under Curve; Drug Interactions; Humans; Male; Middle Aged; Pyrimidines; Ritonavir; Sample Size; Triazoles; Voriconazole | 2007 |
Voriconazole and fluconazole increase the exposure to oral diazepam.
Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cognition; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diazepam; Drug Interactions; Enzyme Inhibitors; Female; Fluconazole; Genotype; Half-Life; Humans; Hypnotics and Sedatives; Male; Mixed Function Oxygenases; Nordazepam; Pyrimidines; Triazoles; Voriconazole; Wakefulness | 2007 |
Effect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Biotransformation; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dealkylation; Desvenlafaxine Succinate; Drug Interactions; Enzyme Inhibitors; Genotype; Half-Life; Humans; Male; Naphthalenes; Phenotype; Polymorphism, Genetic; Pyrimidines; Reference Values; Terbinafine; Triazoles; Venlafaxine Hydrochloride; Voriconazole | 2008 |
A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Humans; Incidence; Length of Stay; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Placebos; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2007 |
Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl.
Topics: Administration, Oral; Analgesics, Opioid; Antifungal Agents; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Inhibitors; Female; Fentanyl; Fluconazole; Humans; Injections, Intravenous; Male; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2008 |
An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Female; Humans; Itraconazole; Male; Middle Aged; Paracoccidioidomycosis; Pilot Projects; Pyrimidines; Triazoles; Voriconazole | 2007 |
Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy male subjects.
Topics: Adolescent; Adult; Age Factors; Alkynes; Antifungal Agents; Area Under Curve; Benzoxazines; Body Weight; Capsules; Creatine Kinase; Cyclopropanes; Drug Interactions; Heart Block; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pyrimidines; Reverse Transcriptase Inhibitors; Rhabdomyolysis; Tablets; Triazoles; Voriconazole | 2008 |
Effect of voriconazole on the pharmacokinetics of diclofenac.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C9; Diclofenac; Drug Interactions; Half-Life; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2007 |
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Pharmacokinetics of voriconazole after oral administration of single and multiple doses in African grey parrots (Psittacus erithacus timneh).
Topics: Administration, Oral; Animals; Antifungal Agents; Drug Administration Schedule; Psittaciformes; Pyrimidines; Triazoles; Voriconazole | 2008 |
Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies.
Topics: Amphotericin B; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Changes in causes of death over time after treatment for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cause of Death; Graft vs Host Disease; Humans; Neoplasms; Pyrimidines; Survival Rate; Time Factors; Triazoles; Voriconazole | 2008 |
Pharmacokinetics, safety and tolerance of voriconazole in renally impaired subjects: two prospective, multicentre, open-label, parallel-group volunteer studies.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; beta-Cyclodextrins; Creatinine; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Renal Insufficiency; Severity of Illness Index; Solubility; Triazoles; Voriconazole | 2008 |
Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Biotransformation; Cross-Over Studies; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Etoricoxib; Gels; Humans; Male; Miconazole; Pyridines; Pyrimidines; Sulfones; Thromboxane B2; Triazoles; Voriconazole; Young Adult | 2009 |
Voriconazole drastically increases exposure to oral oxycodone.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Antifungal Agents; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Male; Oxycodone; Pyrimidines; Triazoles; Voriconazole | 2009 |
Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia.
Topics: Amphotericin B; Australia; Cost-Benefit Analysis; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Voriconazole increases while itraconazole decreases plasma meloxicam concentrations.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Blood Coagulation; Cross-Over Studies; Cyclooxygenase 1; Cytochrome P-450 Enzyme System; Drug Interactions; Genotype; Half-Life; Humans; Itraconazole; Male; Meloxicam; Protein Binding; Pyrimidines; Thiazines; Thiazoles; Thromboxane B2; Triazoles; Voriconazole; Young Adult | 2009 |
Lack of effect of Ginkgo biloba on voriconazole pharmacokinetics in Chinese volunteers identified as CYP2C19 poor and extensive metabolizers.
Topics: Adolescent; Alleles; Aryl Hydrocarbon Hydroxylases; Asian People; Cross-Over Studies; Cytochrome P-450 CYP2C19; Drug Interactions; Enzyme Induction; Ginkgo biloba; Humans; Male; Phytotherapy; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
Penetration of 1% voriconazole eye drops into human vitreous humour: a prospective, open-label study.
Topics: Aged; Antifungal Agents; Biological Availability; Chromatography, High Pressure Liquid; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Ophthalmic Solutions; Prospective Studies; Pyrimidines; Triazoles; Vitreous Body; Voriconazole | 2009 |
Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults.
Topics: Adult; Anidulafungin; Antifungal Agents; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Echinocandins; Female; Humans; Injections, Intravenous; Male; Pulmonary Alveoli; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole; Young Adult | 2010 |
Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Area Under Curve; Biological Availability; Cyclosporine; Drug Synergism; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole.
Topics: Adult; Analgesics, Opioid; Analysis of Variance; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Double-Blind Method; Drug Interactions; Female; Humans; Male; Middle Aged; Pyrimidines; Tilidine; Triazoles; Voriconazole; Young Adult | 2009 |
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Bilirubin; Drug Monitoring; Female; Humans; Infusions, Intravenous; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring.
Topics: Adult; Antifungal Agents; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pyrimidines; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Triazoles; Voriconazole | 2010 |
Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype.
Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biological Availability; Cross-Over Studies; Cytochrome P-450 CYP2C19; Female; Genotype; Germany; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
Pharmacokinetics of voriconazole after oral administration of single and multiple doses in Hispaniolan Amazon parrots (Amazona ventralis).
Topics: Administration, Oral; Amazona; Animals; Antifungal Agents; Area Under Curve; Drug Administration Schedule; Half-Life; Pyrimidines; Triazoles; Voriconazole | 2010 |
Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration.
Topics: Adult; Aged; Antifungal Agents; beta-Cyclodextrins; Cross-Over Studies; Female; Half-Life; Hemodiafiltration; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Pyrimidines; Renal Dialysis; Solvents; Triazoles; Voriconazole | 2010 |
Distribution of voriconazole in seven body fluids of adult horses after repeated oral dosing.
Topics: Animals; Antifungal Agents; Body Fluids; Drug Administration Schedule; Female; Horses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole pharmacokinetics and safety in immunocompromised children compared to adult patients.
Topics: Adult; Antifungal Agents; Area Under Curve; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Immunocompromised Host; Injections, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
Topics: Administration, Topical; Anti-Infective Agents, Local; Antifungal Agents; Cornea; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2010 |
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.
Topics: Adult; Aged; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Leukemia; Male; Middle Aged; Mycoses; Pyrimidines; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children.
Topics: Antifungal Agents; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism.
Topics: Anti-Bacterial Agents; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Asian People; China; Chromatography, High Pressure Liquid; Cross-Over Studies; Cytochrome P-450 CYP2C19; Erythromycin; Humans; Male; Polymorphism, Single Nucleotide; Protein Synthesis Inhibitors; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2010 |
Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Chronic Disease; Echinocandins; Female; Humans; Infusions, Intravenous; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Single and multidose ocular kinetics and stability analysis of extemporaneous formulation of topical voriconazole in humans.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifungal Agents; Aqueous Humor; Area Under Curve; Cataract Extraction; Chromatography, High Pressure Liquid; Corneal Ulcer; Drug Stability; Eye Infections, Fungal; Female; Half-Life; Humans; Male; Middle Aged; Preservatives, Pharmaceutical; Pyrimidines; Tandem Mass Spectrometry; Tissue Distribution; Triazoles; Voriconazole | 2010 |
Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Microbiological Techniques; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pilot Projects; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2011 |
Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Injections, Intravenous; Male; Middle Aged; Mycoses; Professional Practice; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Long-term visual safety of voriconazole in adult patients with paracoccidioidomycosis.
Topics: Antifungal Agents; Brazil; Drug Administration Schedule; Eye; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ophthalmoscopes; Paracoccidioidomycosis; Pyrimidines; Time Factors; Triazoles; Vision, Ocular; Visual Acuity; Visual Field Tests; Voriconazole | 2010 |
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Steady-state plasma pharmacokinetics of oral voriconazole in obese adults.
Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Cross-Over Studies; Female; Humans; Male; Middle Aged; Obesity; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2011 |
Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT.
Topics: Acute Disease; Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Time Factors; Triazoles; Voriconazole | 2012 |
Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Topics: Anti-Infective Agents; Area Under Curve; Critical Illness; Drug Monitoring; Half-Life; Hemofiltration; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Ocular manifestations of candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidemia; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Incidence; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Factors; Triazoles; Voriconazole; Young Adult | 2011 |
[Modern antifungals in therapy of nosocomial mycosis in oncologic patients].
Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Cross Infection; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Neoplasms; Pyrimidines; Triazoles; Voriconazole | 2011 |
Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia.
Topics: Antifungal Agents; Australia; Caspofungin; Echinocandins; Economics, Pharmaceutical; Fever; Humans; Lipopeptides; Male; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2012 |
Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cystic Fibrosis; Female; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.
Topics: Adult; Alleles; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Aspergillus; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Genotype; Hematologic Neoplasms; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Republic of Korea; Risk Factors; Triazoles; Voriconazole; Young Adult | 2011 |
Pharmacokinetics of voriconazole administered concomitantly with fluconazole and population-based simulation for sequential use.
Topics: Adult; Body Mass Index; Cross-Over Studies; Fluconazole; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2011 |
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2011 |
Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised adolescents and healthy adults.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Child; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Genotype; Humans; Immunocompromised Host; Injections, Intravenous; Liver Function Tests; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using A limited sampling strategy.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Male; Midazolam; Middle Aged; Pyrimidines; Ritonavir; Time Factors; Triazoles; Voriconazole; Young Adult | 2011 |
Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adults.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Child; Child, Preschool; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Humans; Immunocompromised Host; Infusions, Intravenous; Liver Function Tests; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Gender differences in re-epithelialisation time in fungal corneal ulcers.
Topics: Antifungal Agents; Corneal Ulcer; Epithelium, Corneal; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Natamycin; Prospective Studies; Pyrimidines; Sex Characteristics; Triazoles; Voriconazole; Wound Healing | 2012 |
Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Mycoses; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Voriconazole pharmacokinetics and photosensitivity in children with cystic fibrosis.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Child; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Prospective Studies; Pyrimidines; Sunlight; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial.
Topics: Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2012 |
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Integrated population pharmacokinetic analysis of voriconazole in children, adolescents, and adults.
Topics: Adolescent; Adult; Antifungal Agents; Female; Humans; Immunocompromised Host; Male; Models, Theoretical; Pyrimidines; Triazoles; Voriconazole | 2012 |
Voriconazole for fungal corneal ulcers.
Topics: Acremonium; Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Ascomycota; Aspergillus flavus; Aspergillus niger; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Itraconazole; Middle Aged; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
Topics: Adult; Aged; Antifungal Agents; China; Echinocandins; Female; Humans; Kidney Transplantation; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Predictors of outcome in fungal keratitis.
Topics: Administration, Topical; Antifungal Agents; Corneal Perforation; Corneal Ulcer; Debridement; Double-Blind Method; Eye Infections, Fungal; Female; Humans; Male; Natamycin; Ophthalmic Solutions; Outcome and Process Assessment, Health Care; Prognosis; Prospective Studies; Pyrimidines; Re-Epithelialization; Risk Factors; Time Factors; Triazoles; Visual Acuity; Voriconazole | 2012 |
The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial.
Topics: Adult; Aged; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Chi-Square Distribution; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Single-Blind Method; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Endoscopy; Female; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Phase II study on voriconazole for treatment of Chinese patients with malignant hematological disorders and invasive aspergillosis.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Male; Middle Aged; Prognosis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Ontogeny and sorafenib metabolism.
Topics: Adolescent; Age Factors; Azoles; Child; Child, Preschool; Cytochrome P-450 CYP3A; Female; Humans; Infant; Infant, Newborn; Liver; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrimidines; Sex Factors; Sorafenib; Triazoles; Voriconazole; Young Adult | 2012 |
Determination of voriconazole in human plasma by HPLC-ESI-MS and application to pharmacokinetic study.
Topics: Chromatography, High Pressure Liquid; Drug Stability; Humans; Least-Squares Analysis; Male; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Triazoles; Voriconazole | 2013 |
Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.
Topics: Adult; Antifungal Agents; Corneal Stroma; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eye Infections, Fungal; Female; Follow-Up Studies; Humans; Injections; Keratitis; Male; Middle Aged; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Double-Blind Method; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Mycoses; Neutropenia; Placebos; Pyrimidines; Triazoles; Voriconazole | 2013 |
Pharmacokinetics and short-term safety of etravirine in combination with fluconazole or voriconazole in HIV-negative volunteers.
Topics: Adolescent; Adult; Anti-HIV Agents; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Female; Fluconazole; Genotype; HIV Infections; Humans; Male; Middle Aged; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Triazoles; Voriconazole; Young Adult | 2013 |
Steady-state pharmacokinetics of oral voriconazole and its primary metabolite, N-oxide voriconazole, pre- and post-autologous peripheral stem cell transplantation.
Topics: Aged; Antifungal Agents; Aspergillosis; Cyclic N-Oxides; Female; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Triazoles; Voriconazole | 2013 |
A semiphysiological population pharmacokinetic model for dynamic inhibition of liver and gut wall cytochrome P450 3A by voriconazole.
Topics: Antifungal Agents; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Liver; Male; Midazolam; Models, Biological; Pyrimidines; Triazoles; Voriconazole | 2013 |
Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Anidulafungin; Antifungal Agents; Candidemia; Echinocandins; Female; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.
Topics: Antifungal Agents; Bayes Theorem; Corneal Ulcer; Expert Testimony; Eye Infections, Fungal; Fusariosis; Humans; Natamycin; Pyrimidines; Surveys and Questionnaires; Triazoles; Voriconazole | 2013 |
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Perforation; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole; Wound Healing | 2013 |
An open-label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Echinocandins; Female; Humans; Latin America; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antigens, Fungal; Febrile Neutropenia; Female; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2013 |
Quantification of brain voriconazole levels in healthy adults using fluorine magnetic resonance spectroscopy.
Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Blood-Brain Barrier; Brain; Drug Administration Schedule; Humans; Magnetic Resonance Spectroscopy; Male; Pyrimidines; Triazoles; Voriconazole | 2013 |
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
Topics: Antifungal Agents; Case-Control Studies; Cohort Studies; Cost-Benefit Analysis; Decision Support Techniques; Double-Blind Method; Fluconazole; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2013 |
Identification of factors influencing the pharmacokinetics of voriconazole and the optimization of dosage regimens based on Monte Carlo simulation in patients with invasive fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Monte Carlo Method; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2014 |
In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.
Topics: Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Inhibitory Concentration 50; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole | 2014 |
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Biomarkers; Female; Fungal Polysaccharides; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2016 |
Hospital resource use of patients receiving isavuconazole vs voriconazole for invasive mold infections in the phase III SECURE trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Double-Blind Method; Female; Glomerular Filtration Rate; Hospital Charges; Humans; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult | 2016 |
Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction.
Topics: Administration, Sublingual; Adult; Analgesics, Opioid; Antifungal Agents; Buprenorphine; Cross-Over Studies; Cytochrome P-450 Enzyme System; Drug Interactions; Healthy Volunteers; Humans; Male; Pain; Single-Blind Method; Triazoles; Voriconazole; Young Adult | 2016 |
Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Fees, Pharmaceutical; Female; Hospitalization; Humans; Male; Models, Econometric; Nitriles; Pyridines; Triazoles; Voriconazole | 2017 |
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
Topics: Adult; Aged; Antifungal Agents; Aspergillus; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Neutropenia; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects.
Topics: Acetates; Administration, Oral; Adult; Antifungal Agents; Antiviral Agents; Area Under Curve; Drug Combinations; Drug Interactions; Female; Healthy Volunteers; Humans; Middle Aged; Quinazolines; Triazoles; Voriconazole | 2018 |
Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole.
Topics: Adult; Aged; Antifungal Agents; Female; Fungi; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2019 |
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antifungal Agents; Double-Blind Method; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prospective Studies; Triazoles; Voriconazole; Young Adult | 2021 |
Single oral or intravenous administration of voriconazole achieved recommended therapeutic minimum inhibitory concentrations against Aspergillus in the common raven (Corvus corax).
Topics: Administration, Intravenous; Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Aspergillus; Crows; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2022 |
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Invasive Fungal Infections; Japan; Mucormycosis; Pulmonary Aspergillosis; Triazoles; Voriconazole | 2023 |
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.
Topics: Aspergillosis; Double-Blind Method; Humans; Triazoles; Voriconazole | 2023 |
2032 other study(ies) available for triazoles and voriconazole
| Article | Year |
|---|---|
Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.
Topics: Animals; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Azoles; Female; Kidney Diseases; Liver Diseases; Lung Diseases, Fungal; Pyrimidines; Rabbits; Triazoles; Voriconazole | 1996 |
In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species.
Topics: Antifungal Agents; Candida; Candida albicans; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1996 |
Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Dose-Response Relationship, Drug; Endocarditis; Guinea Pigs; Itraconazole; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1997 |
In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests; Mouth; Pyrimidines; Triazoles; Voriconazole | 1997 |
Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Itraconazole; Lung; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Triazoles; Voriconazole | 1997 |
In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens.
Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1997 |
Determination of a new antifungal agent, voriconazole, by multidimensional high-performance liquid chromatography with direct plasma injection onto a size-exclusion column.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Stability; Humans; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 1997 |
Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.
Topics: Acute Disease; Adolescent; Antifungal Agents; Aspergillosis; Brain Diseases; Humans; Leukemia; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 1997 |
In vitro evaluation of voriconazole against some clinically important fungi.
Topics: Antifungal Agents; Evaluation Studies as Topic; Fungi; In Vitro Techniques; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1997 |
Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida species.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Microscopy, Electron; Pyrimidines; Time Factors; Triazoles; Voriconazole | 1997 |
A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
Topics: Antifungal Agents; Candida; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Sterols; Triazoles; Voriconazole | 1997 |
In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Culture Media; Fluconazole; Fungi; Griseofulvin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 1997 |
In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 1998 |
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates.
Topics: Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
The effect of the new triazole, voriconazole (UK-109,496), on the interactions of Candida albicans and Candida krusei with endothelial cells.
Topics: Antifungal Agents; Candida albicans; Cell Adhesion; Cells, Cultured; Endothelium, Vascular; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Monocytes; Neutrophils; Pyrimidines; Recombinant Proteins; T-Lymphocytes, Regulatory; Triazoles; Voriconazole | 1998 |
Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 1998 |
Use of voriconazole in treatment of Scedosporium apiospermum infection: case report.
Topics: Acute Disease; Adult; Antifungal Agents; Dermatomycoses; Fatal Outcome; Humans; Leukemia, Myeloid; Male; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro activity of voriconazole against Candida species.
Topics: Antifungal Agents; Candida; Drug Evaluation, Preclinical; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus nidulans; Child, Preschool; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole | 1998 |
In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Topics: Antifungal Agents; Aspergillus fumigatus; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Monocytes; Neutrophils; Pyrimidines; Triazoles; Voriconazole | 1998 |
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Genotype; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth; North America; Pharynx; Phenotype; Pyrimidines; Triazoles; Voriconazole | 1998 |
Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Damage to yeast cells of Cryptococcus neoformans by voriconazole and fluconazole: a culture and microscopic study.
Topics: Antifungal Agents; Coloring Agents; Cryptococcus neoformans; Fluconazole; Humans; Pyrimidines; Time Factors; Triazoles; Voriconazole | 1998 |
In vitro activity of voriconazole against selected fungi.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Basidiomycota; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Environmental Microbiology; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 1998 |
[Antifungal drugs: the new frontier].
Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Caspofungin; Drug Resistance, Microbial; Echinocandins; Female; Fungi; Humans; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Trypanocidal Agents; Voriconazole | 1998 |
In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species.
Topics: Antifungal Agents; Aspergillus; Drug Evaluation, Preclinical; Fusarium; Pyrimidines; Triazoles; Voriconazole | 1998 |
Organism-dependent fungicidal activities of azoles.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Dose-Response Relationship, Drug; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
A rapid HPLC assay for voriconazole in human plasma.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 1998 |
Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole.
Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1998 |
Anticryptococcal activity of voriconazole against Cryptococcus neoformans var. gatti vs var. neoformans: comparison with fluconazole and effect of human serum.
Topics: Antifungal Agents; Colony Count, Microbial; Cryptococcus neoformans; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.
Topics: Africa; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; United States; Voriconazole | 1999 |
[Rare pulmonary mycoses in patients with hematologic diseases].
Topics: Acremonium; Adolescent; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Bone Marrow Transplantation; Female; Hematologic Neoplasms; Humans; Imidazoles; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Middle Aged; Multiple Myeloma; Neutropenia; Penicillium; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 1998 |
Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Itraconazole; Kinetics; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 1999 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1999 |
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1998 |
Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management.
Topics: Aged; Amphotericin B; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; DNA, Fungal; Drug Resistance, Microbial; Female; Galactose; Humans; Mannans; Meningitis, Fungal; Mycology; Polymerase Chain Reaction; Pyrimidines; Time Factors; Triazoles; Voriconazole | 1999 |
Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Drug Resistance, Microbial; Fluconazole; Guinea Pigs; Male; Neutropenia; Pyrimidines; Random Allocation; Triazoles; Voriconazole | 1999 |
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients.
Topics: Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 1999 |
In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 1999 |
Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.
Topics: Antifungal Agents; Humans; Microbial Sensitivity Tests; Pseudallescheria; Pyrimidines; Spain; Triazoles; Voriconazole | 1999 |
Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; Hydrogen-Ion Concentration; Itraconazole; Male; Meningitis, Fungal; Microbial Sensitivity Tests; Osmolar Concentration; Phenotype; Pyrimidines; Staining and Labeling; Temperature; Triazoles; Voriconazole | 1999 |
Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 1999 |
Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Glucose; Microbial Sensitivity Tests; Pyrimidines; Spectrophotometry; Time Factors; Triazoles; Voriconazole | 1999 |
Effects of voriconazole on Candida glabrata in vitro.
Topics: Antifungal Agents; Candida; Fluconazole; Humans; Microbial Sensitivity Tests; Phospholipids; Pyrimidines; Sterols; Triazoles; Voriconazole | 1999 |
Separation of the voriconazole stereoisomers by capillary electrophoresis and liquid chromatography.
Topics: Antifungal Agents; Chromatography, Liquid; Electrophoresis, Capillary; Pyrimidines; Stereoisomerism; Triazoles; Voriconazole | 1999 |
In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Oral; Echinocandins; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 1999 |
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1999 |
Voriconazole. UK 109496.
Topics: Animals; Antifungal Agents; Aspergillosis; Drug Interactions; Drugs, Investigational; Fungi; Guinea Pigs; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1999 |
Activity of voriconazole: post-antifungal effect, effects of low concentrations and of pretreatment on the susceptibility of Candida albicans to leucocytes.
Topics: Antifungal Agents; Blood; Candida albicans; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Leukocytes; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 1999 |
Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species.
Topics: Antifungal Agents; Candida; Colorimetry; Coloring Agents; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Oxazines; Pyrimidines; Triazoles; Voriconazole; Xanthenes | 1999 |
Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma.
Topics: Antifungal Agents; Biological Assay; Candida; Chromatography, High Pressure Liquid; Evaluation Studies as Topic; Humans; In Vitro Techniques; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2000 |
Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Fungemia; Guinea Pigs; Humans; Lung Diseases, Fungal; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2000 |
In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
Topics: Amphotericin B; Antifungal Agents; Blastomyces; Coccidioides; Histoplasma; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2000 |
In vitro susceptibility of environmental Cryptococcus neoformans variety neoformans isolates from Turkey to six antifungal agents, including SCH56592 and voriconazole.
Topics: Animals; Antifungal Agents; Columbidae; Cryptococcus neoformans; Environmental Microbiology; Feces; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole | 2000 |
Evaluation of voriconazole pharmacodynamics using time-kill methodology.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2000 |
Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole.
Topics: Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Triazoles; Voriconazole | 2000 |
Meningitis caused by Pseudallescheria boydii treated with voriconazole.
Topics: Adult; Antifungal Agents; Humans; Immunocompetence; Male; Meningitis, Fungal; Mycetoma; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole | 2000 |
Effect of grapefruit juice on serum voriconazole concentrations in the mouse.
Topics: Administration, Oral; Animals; Antifungal Agents; Beverages; Citrus; Drug Administration Schedule; Food-Drug Interactions; Male; Mice; Mice, Inbred ICR; Pyrimidines; Triazoles; Voriconazole | 2000 |
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2000 |
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2000 |
Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole.
Topics: Adolescent; Antifungal Agents; Eye Infections, Fungal; Female; Fusarium; Humans; Pyrimidines; Triazoles; Voriconazole | 2000 |
In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2000 |
Voriconazole: a new triazole antifungal.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Controlled Clinical Trials as Topic; Drug Interactions; Drug Resistance, Microbial; Humans; Pyrimidines; Retrospective Studies; Tissue Distribution; Triazoles; Voriconazole | 2000 |
Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Fluocinolone Acetonide; Glucocorticoids; Guinea Pigs; Immunocompromised Host; Immunosuppressive Agents; Male; Organ Culture Techniques; Pyrimidines; Triazoles; Voriconazole | 2000 |
Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media.
Topics: Agar; Antifungal Agents; Candida; Candida albicans; Candidiasis; Culture Media; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2000 |
Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biopsy, Needle; Child, Preschool; Diagnostic Errors; DNA, Fungal; Galactose; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung Abscess; Lung Diseases, Fungal; Male; Mannans; Pyrimidines; Triazoles; Voriconazole | 2000 |
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reference Standards; Time Factors; Triazoles; Trichosporon; Turkey; Voriconazole | 2000 |
Activity of voriconazole against Candida albicans and Candida krusei isolated since 1984.
Topics: Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2000 |
Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy.
Topics: Adrenal Cortex Hormones; Aged; Antifungal Agents; Asthma; Dermatomycoses; Female; Humans; Lung Diseases, Fungal; Mycetoma; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2000 |
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Child, Preschool; Combined Modality Therapy; Drug Resistance, Microbial; Flucytosine; Granulocyte Colony-Stimulating Factor; Granulocytes; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Neutrophils; Osteomyelitis; Pyrimidines; Respiratory Burst; Ribs; Triazoles; Voriconazole | 2000 |
Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining.
Topics: Antifungal Agents; Aspergillus; Coloring Agents; Dye Dilution Technique; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
Efficacy of voriconazole in treatment of murine pulmonary blastomycosis.
Topics: Animals; Antifungal Agents; Blastomycosis; Colony Count, Microbial; Lung; Male; Mice; Mice, Inbred BALB C; Pyrimidines; Survival Analysis; Time Factors; Triazoles; Voriconazole | 2001 |
Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Drug Synergism; HIV Infections; Humans; Microbial Sensitivity Tests; Naphthalenes; Pharyngitis; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2001 |
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2001 |
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2001 |
Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation.
Topics: Antifungal Agents; Calibration; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
[Invasive aspergillosis on a surgical intensive care unit].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Therapy, Combination; Fatal Outcome; Female; Flucytosine; Humans; Intensive Care Units; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2000 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
Clinical activity of the new triazole drug voriconazole (UK 109, 496) against disseminated hepatosplenic aspergillosis in a patient with relapsed leukemia.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Child; Humans; Immunosuppression Therapy; Leukemia, Myeloid; Liver Diseases; Male; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole | 2001 |
In vitro activities of four novel triazoles against Scedosporium spp.
Topics: Antifungal Agents; Humans; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Scedosporium; Thiazoles; Triazoles; Voriconazole | 2001 |
Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus; Bone Marrow Transplantation; Drug Therapy, Combination; Humans; Male; Maxillary Sinus; Neuroaspergillosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2000 |
Application of capillary zone electrophoresis with off-line solid-phase extraction to in vitro metabolism studies of antifungals.
Topics: Acetic Acid; Acetonitriles; Antifungal Agents; Clotrimazole; Drug Stability; Electrophoresis, Capillary; Fluconazole; Humans; Itraconazole; Ketoconazole; Methanol; Microsomes, Liver; Molecular Structure; Molecular Weight; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Solvents; Triazoles; Verapamil; Voriconazole | 2001 |
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surv
Topics: Antifungal Agents; Candida; Candidiasis; Europe; Fluconazole; Fungemia; Humans; Latin America; North America; Pyrimidines; Sentinel Surveillance; Thiazoles; Triazoles; Voriconazole | 2001 |
Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2001 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2001 |
Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Cheilitis; Erythema; Female; Humans; Lung Diseases, Fungal; Lupus Erythematosus, Discoid; Male; Middle Aged; Pyrimidines; Retinoids; Sinusitis; Triazoles; Voriconazole | 2001 |
Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Hemoptysis; Humans; Lung Diseases, Fungal; Magnetic Resonance Imaging; Pyrimidines; Sputum; Triazoles; Voriconazole | 2001 |
In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
Antifungal activity of the new azole UK-109 496 (voriconazole): addition and clarification.
Topics: Antifungal Agents; Cyclodextrins; Pyrimidines; Triazoles; Voriconazole | 2001 |
Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2001 |
Azole cross-resistance in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Microbial; Drug Resistance, Multiple; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2002 |
Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2002 |
Empirical antifungal therapy--new options, new tradeoffs.
Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
Topics: Amphotericin B; Antifungal Agents; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Antifungal activity of a new triazole, voriconazole (UK-109496), against clinical isolates of Aspergillus spp.
Topics: Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Drug Resistance, Microbial; Humans; Pyrimidines; Triazoles; Voriconazole | 2000 |
The 2001 Garrod lecture. The treatment of cytomegalovirus infection.
Topics: Antifungal Agents; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Infections; Humans; Immunity, Cellular; Pyrimidines; Triazoles; Voriconazole | 2002 |
Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcus neoformans; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Macrophages; Monocytes; Neutrophils; Pyrimidines; Triazoles; Voriconazole | 2002 |
[Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia].
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Itraconazole; Male; Middle Aged; Neutropenia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Canada; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Quality Control; Thiazoles; Triazoles; United States; Voriconazole | 2002 |
A multidrug, including voriconazole, resistant oral Candida infection in an AIDS patient effectively treated with echinocandin.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Male; Peptides; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazole.
Topics: Antifungal Agents; Candida; Freezing; Humans; Microbial Sensitivity Tests; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles.
Topics: Antifungal Agents; Azoles; Candida; Dose-Response Relationship, Drug; Fluconazole; HIV Infections; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Mouth; Naphthalenes; Pyrimidines; Quality Control; Terbinafine; Triazoles; Voriconazole | 2002 |
Decisions about voriconazole versus liposomal amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Clinical Protocols; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Triazoles; Voriconazole | 2002 |
Voriconazole and fluconazole susceptibility of Candida isolates.
Topics: Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.
Topics: Antifungal Agents; Aspergillus; Humans; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2002 |
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fever; Humans; Neutropenia; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2002 |
Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.
Topics: Adult; Antifungal Agents; Humans; Hyphae; Itraconazole; Neutrophils; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2002 |
Broth medium for microdilution susceptibility tests of fluconazole and voriconazole.
Topics: Antifungal Agents; Candida; Culture Media; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Pyrimidines; Triazoles; Voriconazole | 2002 |
Influence of voriconazole and fluconazole on Candida albicans in long-time continuous flow culture.
Topics: Aerobiosis; Antifungal Agents; Biofilms; Candida albicans; Fluconazole; Kinetics; Microbial Sensitivity Tests; Mycology; Pyrimidines; Triazoles; Voriconazole | 2002 |
Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Netherlands; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2002 |
In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients.
Topics: Antifungal Agents; Blood; Candida; Candidiasis; Echinocandins; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: a multicenter study.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Culture Media; France; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Naphthalenes; Observer Variation; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2002 |
Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Guinea Pigs; Lipopeptides; Male; Organ Culture Techniques; Peptides; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2002 |
Determination of voriconazole in aqueous humor by liquid chromatography-electrospray ionization-mass spectrometry.
Topics: Animals; Antifungal Agents; Aqueous Humor; Chromatography, High Pressure Liquid; Pyrimidines; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Triazoles; Voriconazole | 2002 |
Voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fusarium; Humans; Injections, Intravenous; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2002 |
In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Drug Interactions; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results.
Topics: Antifungal Agents; Colony Count, Microbial; Culture Media; Fusarium; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2002 |
Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility test
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Quality Control; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2002 |
New drugs, old drugs - dear drugs, cheap drugs.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Marrow Transplantation; Caspofungin; Cyclosporine; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole | 2002 |
Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection.
Topics: Amphotericin B; Antifungal Agents; Area Under Curve; Candidiasis; Catheterization; Fluconazole; Half-Life; Microbial Sensitivity Tests; Microscopy, Electron; Pyrimidines; Triazoles; Voriconazole | 2002 |
An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
The safety of voriconazole.
Topics: Antifungal Agents; Aspergillosis; Humans; Immunocompromised Host; Liver Function Tests; Pyrimidines; Triazoles; Voriconazole | 2002 |
In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole, voriconazole and posaconazole (SCH56592).
Topics: Antifungal Agents; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxycholic Acid; Drug Combinations; Drug Resistance, Fungal; Etoposide; Fatal Outcome; Humans; Immunocompromised Host; Itraconazole; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelomonocytic, Acute; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2002 |
Successful treatment of Candida glabrata myocarditis with voriconazole.
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Transesophageal; Follow-Up Studies; Fungemia; Humans; Male; Myocarditis; Pyrimidines; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Voriconazole versus amphotericin B for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Patient Dropouts; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus amphotericin B for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Liposomes; Pyrimidines; Triazoles; Voriconazole | 2002 |
In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.
Topics: Antifungal Agents; Drug Interactions; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Scedosporium; Terbinafine; Triazoles; Voriconazole | 2003 |
Activity of voriconazole against corneal isolates of Scedosporium apiospermum.
Topics: Antifungal Agents; Cornea; Eye Infections, Fungal; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2003 |
In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.
Topics: Antifungal Agents; Blood; Candida; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Humans; Microbial Sensitivity Tests; Microbiological Techniques; Pyrimidines; Triazoles; Voriconazole | 2003 |
Usefulness of a colorimetric method for testing antifungal drug susceptibilities of Aspergillus species to voriconazole.
Topics: Antifungal Agents; Aspergillus; Colorimetry; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2002 |
Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole.
Topics: Antifungal Agents; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2003 |
Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Base Sequence; Blotting, Northern; Candida; Chromosome Mapping; Cloning, Molecular; Cytochrome P-450 Enzyme System; DNA, Complementary; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Fluconazole; Gene Deletion; Immunoblotting; Itraconazole; Lung; Molecular Sequence Data; Mutagenesis, Site-Directed; Oxidoreductases; Pneumocystis; Polymerase Chain Reaction; Protein Biosynthesis; Pyrimidines; Rats; Recombinant Proteins; RNA, Messenger; RNA, Ribosomal; Saccharomyces cerevisiae; Sequence Homology, Amino Acid; Sterol 14-Demethylase; Triazoles; Voriconazole | 2003 |
In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2003 |
Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood.
Topics: Antifungal Agents; Blood; Candida; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs.
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Pyrimidines; Triazoles; Voriconazole | 2003 |
Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycetoma; Naphthalenes; Opportunistic Infections; Pyrimidines; Risk Assessment; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Successful treatment of disseminated fusariosis.
Topics: Amphotericin B; Child, Preschool; Female; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2003 |
Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Humans; In Vitro Techniques; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2003 |
Successful treatment with voriconazole of cerebral aspergillosis in an hematologic patient.
Topics: Antifungal Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Neuroaspergillosis; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei.
Topics: Amino Acid Sequence; Antifungal Agents; Candida; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Enzyme Inhibitors; Fluconazole; Models, Molecular; Molecular Sequence Data; Oxidoreductases; Protein Structure, Secondary; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2003 |
Comment: caspofungin acetate for treatment of invasive fungal infections.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Guinea Pigs; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2003 |
Safety of voriconazole and dose individualization.
Topics: Antifungal Agents; Humans; Immunocompromised Host; Liver Function Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
Voriconazole inhibition of tacrolimus metabolism.
Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Middle Aged; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2003 |
Lack of cross-hepatotoxicity between fluconazole and voriconazole.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Liver; Liver Function Tests; Male; Pyrimidines; Transaminases; Triazoles; Voriconazole | 2003 |
Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Cyclic N-Oxides; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Humans; In Vitro Techniques; Ketoconazole; Microsomes, Liver; Oxidation-Reduction; Pyrimidines; Quinidine; Sulfaphenazole; Theophylline; Triazoles; Voriconazole | 2003 |
Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole.
Topics: Antifungal Agents; Candida; Diffusion; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.
Topics: Agar; Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2003 |
Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole.
Topics: Antifungal Agents; Ascomycota; Corneal Transplantation; Corneal Ulcer; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2003 |
Two cases of cerebral aspergillosis successfully treated with voriconazole.
Topics: Administration, Oral; Antifungal Agents; Brain Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Voriconazole treatment of fungal scleritis and epibulbar abscess resulting from scleral buckle infection.
Topics: Abscess; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Eye Infections, Fungal; Female; Humans; Orbital Diseases; Pyrimidines; Scleral Buckling; Scleritis; Surgical Wound Infection; Triazoles; Voriconazole | 2003 |
Improving the mouse model for studying the efficacy of voriconazole.
Topics: Animals; Beverages; Citrus paradisi; Disease Models, Animal; Fusarium; Kidney; Mice; Mice, Inbred ICR; Mycoses; Pyrimidines; Spleen; Triazoles; Voriconazole | 2003 |
An unusual dematiaceous fungal infection of the skin caused by Fonsecaea pedrosoi: a case report and review of the literature.
Topics: Adult; Antifungal Agents; Ascomycota; Chromoblastomycosis; Humans; Itraconazole; Male; Pyrimidines; Skin; Triazoles; Voriconazole | 2003 |
The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human.
Topics: Adult; Animals; Area Under Curve; Chromatography, High Pressure Liquid; Cyclic N-Oxides; Dogs; Dose-Response Relationship, Drug; Feces; Female; Glucuronic Acid; Guinea Pigs; Humans; Male; Mice; Oxides; Protein Binding; Pyrimidines; Rabbits; Rats; Rats, Sprague-Dawley; Scintillation Counting; Sex Characteristics; Species Specificity; Triazoles; Ultraviolet Rays; Voriconazole | 2003 |
Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antigen Presentation; Aspergillosis; Aspergillus fumigatus; Caspofungin; Dendritic Cells; Echinocandins; Lipopeptides; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptides; Peptides, Cyclic; Pyrimidines; Specific Pathogen-Free Organisms; T-Lymphocytes; Triazoles; Voriconazole | 2003 |
Use of voriconazole in Scedosporium apiospermum keratitis.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Humans; Keratitis; Male; Mycetoma; Pyrimidines; Scedosporium; Treatment Failure; Triazoles; Voriconazole | 2003 |
Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery.
Topics: Aged; Ankle Injuries; Antifungal Agents; Debridement; Drug Synergism; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Mycetoma; Naphthalenes; Pyrimidines; Scedosporium; Terbinafine; Triazoles; Voriconazole | 2003 |
Successful treatment of coccidioidal meningitis with voriconazole.
Topics: Antifungal Agents; Coccidioidomycosis; Humans; Magnetic Resonance Imaging; Male; Meningitis, Fungal; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2003 |
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole | 2003 |
Development and validation of a high-performance liquid chromatography assay for voriconazole.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2003 |
Voriconazole in the treatment of invasive mold infections in transplant recipients.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Organ Transplantation; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2003 |
Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
Topics: Aged; Amphotericin B; Antifungal Agents; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Three drug reviews: one reformulated and one new antifungal agent and optimal dosing of the anticonvulsant gabapentin.
Topics: Acetates; Amines; Amphotericin B; Anticonvulsants; Antifungal Agents; Chemistry, Pharmaceutical; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Gabapentin; gamma-Aminobutyric Acid; Humans; Pyrimidines; Triazoles; Voriconazole | 2003 |
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Penicillium; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2003 |
Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazole.
Topics: Aged; Aged, 80 and over; Antifungal Agents; DNA Fingerprinting; Humans; Male; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2003 |
Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antifungal Agents; Brain; Brain Chemistry; Child; Child, Preschool; Drug Administration Schedule; Female; Guinea Pigs; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2003 |
Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001).
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Spain; Triazoles; Voriconazole | 2003 |
Liver failure in a child receiving highly active antiretroviral therapy and voriconazole.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Child; Fatal Outcome; Female; Humans; Infectious Disease Transmission, Vertical; Liver Failure; Pyrimidines; Triazoles; Voriconazole | 2003 |
Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy.
Topics: Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Brain Abscess; Brain Diseases; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Immunologic Deficiency Syndromes; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[Update on voriconazole].
Topics: Adult; Age Factors; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2003 |
Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
Topics: Acute Disease; Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Female; Hepatitis; Humans; Leukemia; Lung Diseases, Fungal; Opportunistic Infections; Osteomyelitis; Pyrimidines; Remission Induction; Sacroiliac Joint; Splenic Diseases; Triazoles; Voriconazole | 2003 |
[In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2003 |
Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Anemia, Refractory; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Leukemia, Myelomonocytic, Acute; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2003 |
In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Spain; Triazoles; Voriconazole | 2003 |
In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization.
Topics: Antifungal Agents; Chaetomium; Colony Count, Microbial; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Pyrimidines; Reference Standards; Thiazoles; Triazoles; Voriconazole | 2003 |
In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Female; Fluconazole; Kidney; Mice; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2003 |
Serum voriconazole levels following administration via percutaneous jejunostomy tube.
Topics: Aged; Candida glabrata; Candidiasis; Drug Administration Routes; Humans; Jejunostomy; Male; Pyrimidines; Triazoles; Voriconazole | 2003 |
Successful treatment of Scedosporium pneumonia with voriconazole during AML therapy and bone marrow transplantation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Mycetoma; Opportunistic Infections; Pyrimidines; Risk Assessment; Scedosporium; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole | 2003 |
High-risk AML complicated by pulmonary aspergillosis: successful treatment with nonmyeloablative stem cell transplantation and long-term administration of voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Female; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Myeloablative Agonists; Pyrimidines; Radiography, Thoracic; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation Conditioning; Triazoles; Voriconazole | 2004 |
Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Burkitt Lymphoma; Dermatomycoses; Drug Therapy, Combination; Female; Fusarium; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Successful treatment of pulmonary invasive aspergillosis with voriconazole in patients who failed conventional therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Follow-Up Studies; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Sampling Studies; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Voriconazole--superior in antimycotic treatment.
Topics: Antifungal Agents; Candida; Candidiasis; Clinical Trials as Topic; Female; Humans; Male; Pyrimidines; Sensitivity and Specificity; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Voriconazole salvage treatment of invasive candidiasis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fungemia; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Assessment; Salvage Therapy; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Fungemia; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Polymerase Chain Reaction; Pyrimidines; Sensitivity and Specificity; Serologic Tests; Treatment Outcome; Triazoles; Voriconazole | 2003 |
[In vitro activity of voriconazole and three other antifungal agents against dermatophytes].
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Pyrimidines; Species Specificity; Terbinafine; Triazoles; Trichophyton; Voriconazole | 2003 |
Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.
Topics: Antifungal Agents; Aspergillus fumigatus; Colorimetry; Fluconazole; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole | 2003 |
Flow cytometry antifungal susceptibility testing of Aspergillus fumigatus and comparison of mode of action of voriconazole vis-à-vis amphotericin B and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Flow Cytometry; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
Comparison of Etest with modified broth microdilution method for testing susceptibility of Aspergillus spp. to voriconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
The pharmacokinetics of voriconazole.
Topics: Antifungal Agents; Humans; Intestinal Absorption; Pyrimidines; Triazoles; Voriconazole | 2003 |
Changes in Candida albicans colonization and morphology under influence of voriconazole.
Topics: Antifungal Agents; Biofilms; Candida albicans; Fluorescent Dyes; In Vitro Techniques; Microscopy, Fluorescence; Mycelium; Nucleic Acids; Pyrimidines; Triazoles; Vacuoles; Voriconazole | 2003 |
Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection.
Topics: Antifungal Agents; Fatal Outcome; Humans; Infant; Mycoses; Neutropenia; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2003 |
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice.
Topics: Animals; Antifungal Agents; Brain; Colony Count, Microbial; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Scedosporium; Spleen; Survival Analysis; Triazoles; Voriconazole | 2003 |
Successful treatment of Acremonium fungemia with voriconazole.
Topics: Acremonium; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Female; Fungemia; Humans; Lymphoma, Mantle-Cell; Middle Aged; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2003 |
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.
Topics: Adolescent; Antifungal Agents; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion.
Topics: Antifungal Agents; Candida; Candidiasis; Diffusion; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Leukemia, Myelomonocytic, Acute; Lipopeptides; Male; Middle Aged; Peptides; Peptides, Cyclic; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2004 |
In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates.
Topics: Amphotericin B; Antifungal Agents; Fungi; Fusarium; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Thiazoles; Triazoles; Voriconazole | 2003 |
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Salvage Therapy; Transplantation; Treatment Failure; Triazoles; Voriconazole | 2003 |
Invasive aspergillosis: current and future challenges in diagnosis and therapy.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aqueous Humor; Biological Availability; Biological Transport; Chromatography, High Pressure Liquid; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2004 |
Unsuccessful treatment with voriconazole of a brain abscess due to Cladophialophora bantiana.
Topics: Aged; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Cladosporium; Combined Modality Therapy; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatal Outcome; Fungemia; Humans; Male; Pyrimidines; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole | 2003 |
Novel effect of voriconazole on conidiation of Aspergillus species.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole | 2004 |
Voriconazole in fungal keratitis caused by Scedosporium apiospermum.
Topics: Adult; Antifungal Agents; Eye Injuries; Humans; Keratitis; Male; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Resistance, Fungal; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Quinazolines; Sensitivity and Specificity; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2004 |
Comparison of two microdilution methods for testing susceptibility of Candida spp. to voriconazole.
Topics: Antifungal Agents; Candida; Candidiasis; Colorimetry; Microbial Sensitivity Tests; Mycology; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2004 |
Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Humans; Infusions, Intravenous; Liposomes; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2004 |
[symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2004 |
Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.
Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Electroretinography; Injections; Necrosis; Osmolar Concentration; Pyrimidines; Rats; Rats, Sprague-Dawley; Retina; Triazoles; Vitreous Body; Voriconazole | 2003 |
Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diffusion; Empyema, Pleural; Humans; Male; Pleura; Pyrimidines; Triazoles; Voriconazole | 2004 |
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
Topics: Adult; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2004 |
Stability of Mueller-Hinton agar supplemented with glucose and methylene blue for disk diffusion testing of fluconazole and voriconazole.
Topics: Agar; Candida; Candida albicans; Culture Media; Fluconazole; Glucose; Methylene Blue; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2004 |
Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.
Topics: Adolescent; Amphotericin B; Bone Marrow Transplantation; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Humans; Leukemia; Lipopeptides; Liposomes; Male; Peptides; Peptides, Cyclic; Pneumonia; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2004 |
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.
Topics: Candida; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multicenter Studies as Topic; Probability; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2004 |
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged; Prognosis; Prospective Studies; Pyrimidines; Recurrence; Risk; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2004 |
Fever and eosinophilia associated with voriconazole.
Topics: Adult; Antifungal Agents; Eosinophilia; Fever; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole for the treatment of disseminated nodular cutaneous aspergillosis in a patient affected by acute myeloid leukemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Dermatomycoses; Female; Humans; Leukemia, Myeloid, Acute; Pyrimidines; Triazoles; Voriconazole | 2004 |
Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lipopeptides; Lung; Middle Aged; Peptides, Cyclic; Pyrimidines; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Histological examination of an eye with endogenous Aspergillus endophthalmitis treated with oral voriconazole: a case report.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Fungemia; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2004 |
A comparative study of the disc diffusion method with the broth microdilution and Etest methods for voriconazole susceptibility testing of Aspergillus spp.
Topics: Antifungal Agents; Aspergillus; Culture Media; Diffusion; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2004 |
Quality control limits for voriconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue.
Topics: Agar; Antifungal Agents; Candida; Candida albicans; Culture Media; Europe; Glucose; International Cooperation; Laboratories; Methylene Blue; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2004 |
Endogenous endophthalmitis caused by Scedosporium apiospermum treated with voriconazole.
Topics: Adult; Antifungal Agents; Endophthalmitis; Fundus Oculi; Humans; Male; Mycetoma; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Cutaneous infection by Fusarium: successful treatment with oral voriconazole.
Topics: Administration, Oral; Aged; Antifungal Agents; Dermatomycoses; Female; Fusarium; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2004 |
In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Spain; Terbinafine; Triazoles; Voriconazole | 2004 |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillus fumigatus; Calcineurin; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Drug Interactions; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2004 |
In vitro activity of anidulafungin against selected clinically important mold isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Echinocandins; Fungi; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Use of voriconazole in candida retinitis.
Topics: Adult; Antifungal Agents; Candidiasis; Eye Infections, Fungal; Fatal Outcome; Female; Humans; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2005 |
Resolution of orbitocerebral aspergillosis during combination treatment with voriconazole and amphotericin plus adjunctive cytokine therapy.
Topics: Amphotericin B; Antifungal Agents; Blindness; Brain Diseases; Child, Preschool; Cytokines; Drug Therapy, Combination; Female; Humans; Neuroaspergillosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents.
Topics: Antifungal Agents; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
Topics: Antifungal Agents; Cornea; Databases, Factual; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Fungi; Humans; In Vitro Techniques; Keratitis; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Successful treatment of chronic meningitis caused by Scedosporium apiospermum with oral voriconazole.
Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Female; Humans; Meningitis, Fungal; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
Pseudoallescheria boydii pneumonia and empyema: a rare complication of heart transplantation cured with voriconazole.
Topics: Antifungal Agents; Empyema; Heart Transplantation; Humans; Immunosuppression Therapy; Lung Diseases, Fungal; Male; Middle Aged; Mycetoma; Pneumonia; Postoperative Complications; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole | 2004 |
In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia.
Topics: Africa; Amphotericin B; Antifungal Agents; Cambodia; Cryptococcosis; Cryptococcus neoformans; Developing Countries; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pyrimidines; Risk Assessment; Sampling Studies; Triazoles; Voriconazole | 2004 |
Effects of voriconazole on Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antibodies, Monoclonal; Antifungal Agents; Cell Line; Cryptococcus neoformans; Levodopa; Melanins; Mice; Microbial Sensitivity Tests; Microscopy, Electron; Phagocytosis; Polysaccharides; Pyrimidines; Triazoles; Voriconazole | 2004 |
Successful use of voriconazole for treatment of Coccidioides meningitis.
Topics: Adult; Antifungal Agents; Coccidioidomycosis; Humans; Male; Meningitis, Fungal; Pyrimidines; Triazoles; Voriconazole | 2004 |
Images in cardiovascular medicine. Left ventricular mass after treatment with chemotherapic drugs.
Topics: Acute Disease; Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Combined Modality Therapy; Echocardiography; Heart Septum; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia, Myeloid; Male; Myelodysplastic Syndromes; Pyrimidines; Triazoles; Ventricular Outflow Obstruction; Voriconazole | 2004 |
Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patient.
Topics: Aged; Antifungal Agents; Area Under Curve; Chromatography, High Pressure Liquid; Fatal Outcome; Female; Half-Life; Hemofiltration; Humans; Kidney Failure, Chronic; Pneumonia, Pneumocystis; Pyrimidines; Respiratory Distress Syndrome; Triazoles; Voriconazole | 2004 |
Pharmacokinetics of voriconazole and cytochrome P450 2C19 genetic status.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Humans; Mixed Function Oxygenases; Pyrimidines; Triazoles; Voriconazole | 2004 |
Adverse effects of voriconazole.
Topics: Antifungal Agents; Contraindications; Drug Interactions; Humans; Pyrimidines; Triazoles; Voriconazole | 2004 |
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Child; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Liposomes; Male; Mycoses; Myelodysplastic Syndromes; Peptides; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2004 |
In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2004 |
Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease.
Topics: Adolescent; Amphotericin B; Aspergillosis; Aspergillus nidulans; Caspofungin; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Granulomatous Disease, Chronic; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Risk Assessment; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Alternatives to amphotericin B for Candida rugosa infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Fluconazole; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Organ Size; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole | 2004 |
Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Serotyping; Taiwan; Triazoles; Voriconazole | 2004 |
Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair.
Topics: Anti-Bacterial Agents; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Foreign Bodies; Eye Infections, Fungal; Foreign-Body Migration; Hair; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Paecilomyces; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2004 |
Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Female; Humans; Lipopeptides; Liver Transplantation; Peptides; Peptides, Cyclic; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Pfizer's Vfend as effective in treating candidemia as two-drug standard of care according to study.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Two cases of severe phototoxic reactions related to long-term outpatient treatment with voriconazole.
Topics: Adult; Ambulatory Care; Aspergillosis; Dermatitis, Phototoxic; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Leg Dermatoses; Long-Term Care; Male; Middle Aged; Outpatients; Pyrimidines; Risk Assessment; Severity of Illness Index; Triazoles; Voriconazole | 2004 |
In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.
Topics: Antifungal Agents; Candida; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Humans; In Vitro Techniques; Italy; Microbial Sensitivity Tests; Pyrimidines; Sampling Studies; Sensitivity and Specificity; Triazoles; Voriconazole | 2004 |
Fatal peripheral neuropathy following FLA chemotherapy.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Interactions; Fatal Outcome; Humans; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Triazoles; Vidarabine; Voriconazole | 2004 |
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.
Topics: Antifungal Agents; Aspergillosis; Cohort Studies; Female; Graft vs Host Disease; Humans; Logistic Models; Male; Proportional Hazards Models; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole | 2004 |
Influence of voriconazole and fluconazole on reconstituted multilayered oesophageal epithelium infected by Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cell Line, Tumor; Epithelial Cells; Esophagitis; Esophagus; Fluconazole; Humans; Microbial Sensitivity Tests; Models, Biological; Pyrimidines; Triazoles; Voriconazole | 2004 |
In vitro activity of voriconazole against Candida species isolated in Taiwan.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole | 2004 |
Penetration of Candida biofilms by antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Colony Count, Microbial; Culture Media; Diffusion; Fluconazole; Flucytosine; Microscopy, Electron, Scanning; Mutation; Pyrimidines; Staphylococcus epidermidis; Triazoles; Voriconazole | 2004 |
In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Drug Combinations; Drug Synergism; Flucytosine; Kinetics; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2004 |
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
Topics: Adult; Aspergillosis; Aspergillus; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Female; Fungemia; Fungi; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2004 |
Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.
Topics: Adult; Antifungal Agents; Female; Fungi; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pyrimidines; Rhizopus; Triazoles; Voriconazole; Zygomycosis | 2004 |
Pharmacokinetics of voriconazole in the cerebrospinal fluid of an immunocompromised patient with a brain abscess due to Aspergillus fumigatus.
Topics: Aspergillosis; Aspergillus fumigatus; Brain Abscess; Cerebrospinal Fluid; Female; Humans; Immunocompromised Host; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2004 |
Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole.
Topics: Adult; Anemia, Aplastic; Antifungal Agents; Female; Fusarium; Humans; Mycoses; Pyrimidines; Radiography, Thoracic; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Base Sequence; Bronchoalveolar Lavage Fluid; DNA Primers; DNA, Fungal; Humans; Leukemia; Middle Aged; Neoplasms; Polymerase Chain Reaction; Pyrimidines; Transplantation; Triazoles; Voriconazole | 2004 |
Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus spp.
Topics: Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus niger; Colorimetry; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2004 |
Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Echinocandins; Fatal Outcome; Female; Humans; Kidney Transplantation; Lipopeptides; Lymphoma, Non-Hodgkin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2004 |
Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Guinea Pigs; Lipopeptides; Lipoproteins; Lung; Lung Diseases, Fungal; Micafungin; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2004 |
Successful treatment of brain aspergillosis with voriconazole.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Brain Diseases; Critical Care; Female; Humans; Immunocompromised Host; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2004 |
Models for time-varying covariates in population pharmacokinetic-pharmacodynamic analysis.
Topics: Gentamicins; Humans; Models, Chemical; Pefloxacin; Pharmacokinetics; Pharmacology; Pyrimidines; Regression Analysis; Time Factors; Triazoles; Voriconazole | 2004 |
Direct injection HPLC micro method for the determination of voriconazole in plasma using an internal surface reversed-phase column.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Pyrimidines; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Triazoles; Voriconazole | 2004 |
Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs.
Topics: Animals; Antifungal Agents; Brain; Colony Count, Microbial; Culture Media; Guinea Pigs; Kidney; Microbial Sensitivity Tests; Mycetoma; Organ Culture Techniques; Pyrimidines; Scedosporium; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2004 |
[Successful treatment with voriconazol of a Pseudallescheria boydii fungus ball in a HIV positive patient and previous tuberculosis].
Topics: Adult; Antifungal Agents; Female; HIV Infections; Humans; Lung Diseases, Fungal; Pseudallescheria; Pyrimidines; Remission Induction; Triazoles; Tuberculosis, Pulmonary; Voriconazole | 2003 |
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Post-antifungal effect of amphotericin B and voriconazole against Aspergillus fumigatus analysed by an automated method based on fungal CO2 production: dependence on exposure time and drug concentration.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Carbon Dioxide; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2004 |
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole.
Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Thiazoles; Triazoles; Voriconazole | 2004 |
Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Humans; Lung Diseases, Fungal; Male; Pneumonectomy; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.
Topics: Adolescent; Antifungal Agents; Bradycardia; Female; Fusarium; Humans; Mycoses; Opportunistic Infections; Pyrimidines; Tachycardia, Ventricular; Torsades de Pointes; Triazoles; Voriconazole | 2004 |
Combination antifungal therapy for invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Combination therapy for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole.
Topics: Adult; Antifungal Agents; Coccidioidomycosis; Humans; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Pseudoporphyria as a result of voriconazole use: a case report.
Topics: Aged; Antifungal Agents; Diagnosis, Differential; Drug Eruptions; Humans; Lung Diseases, Fungal; Male; Mycetoma; Porphyria, Acute Intermittent; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
Adverse reactions to voriconazole.
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2004 |
How does a patient maximally benefit from anti-infective chemotherapy?
Topics: Antifungal Agents; Cytochrome P-450 Enzyme System; Humans; Pyrimidines; Triazoles; Voriconazole | 2004 |
Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
Topics: Adult; Aged; Antifungal Agents; Azoles; Candida; Candidiasis, Oral; Carcinoma, Squamous Cell; Cranial Irradiation; Drug Resistance, Fungal; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Pyrimidines; Stomatitis; Triazoles; Voriconazole | 2004 |
Altered susceptibility of Candida glabrata bloodstream isolates to triazoles at clinically relevant pH values: comparison of the NCCLS M27-A2, Sensititre YeastOne, and Etest methods.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Hydrogen-Ion Concentration; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2004 |
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Fluconazole; Hematologic Neoplasms; Humans; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure.
Topics: Antifungal Agents; Brain Abscess; Chronic Disease; Cryptococcus neoformans; Fluconazole; HIV Seronegativity; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Renal Insufficiency; Time Factors; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2004 |
Intravitreal voriconazole: an electroretinographic and histopathologic study.
Topics: Animals; Antifungal Agents; Electroretinography; Endophthalmitis; Eye Infections, Fungal; Injections; Ophthalmic Solutions; Pyrimidines; Rats; Rats, Sprague-Dawley; Retina; Triazoles; Vitreous Body; Voriconazole | 2004 |
Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation.
Topics: Antifungal Agents; Double-Blind Method; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Research Design; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2004 |
Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Fluoresceins; Fluorescence; Fluorescent Dyes; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Some new drugs: valdecoxib (Betra), voriconazole (Vfend), ezetimide (Ezetrol), teriparatide (Forsteo)].
Topics: Antifungal Agents; Azetidines; Cyclooxygenase Inhibitors; Ezetimibe; Female; Humans; Hypolipidemic Agents; Isoxazoles; Osteoporosis, Postmenopausal; Pyrimidines; Sulfonamides; Teriparatide; Triazoles; Voriconazole | 2004 |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Echinocandins; Humans; Immunosuppressive Agents; Lipopeptides; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2004 |
In vitro testing of Aspergillus fumigatus clinical isolates for susceptibility to voriconazole, amphotericin B and itraconazole: comparison of sensititre versus NCCLS M38-A using two different inocula.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Predictive Value of Tests; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2004 |
Validation of an assay for voriconazole in serum samples using liquid chromatography-tandem mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Humans; Mass Spectrometry; Pyrimidines; Spectrometry, Mass, Electrospray Ionization; Triazoles; Voriconazole | 2004 |
[Efficiency of voriconazole in fungal keratitis caused by candida albicans].
Topics: Aged; Antifungal Agents; Candidiasis; Female; Humans; Keratitis; Pyrimidines; Triazoles; Voriconazole | 2004 |
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
Topics: Antifungal Agents; Candida glabrata; Candidiasis, Oral; Fluconazole; Head and Neck Neoplasms; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2004 |
Toxic epidermal necrolysis as a complication of treatment with voriconazole.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Immunoglobulins, Intravenous; Pyrimidines; Stevens-Johnson Syndrome; Triazoles; Voriconazole | 2004 |
Effect of voriconazole on a corneal abscess caused by fusarium.
Topics: Abscess; Antifungal Agents; Corneal Diseases; Eye Infections, Fungal; Fusarium; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Transplantation; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Postoperative Complications; Pyrimidines; Sirolimus; Triazoles; Voriconazole | 2004 |
Voriconazole-induced musical hallucinations.
Topics: Aged; Antifungal Agents; Hallucinations; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child.
Topics: Absidia; Antifungal Agents; Child; Drug Resistance, Fungal; Female; Humans; Neutropenia; Positron-Emission Tomography; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2005 |
Candida infection of the subacromial bursa. A case report.
Topics: Acromion; Aged; Anti-Inflammatory Agents; Antifungal Agents; Bupivacaine; Bursa, Synovial; Bursitis; Candidiasis; Decompression, Surgical; Humans; Injections, Intra-Articular; Lidocaine; Male; Methylprednisolone; Methylprednisolone Acetate; Pyrimidines; Shoulder Impingement Syndrome; Triazoles; Voriconazole | 2005 |
Susceptibility of filamentous fungi to voriconazole tested by two microdilution methods.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Reference Standards; Triazoles; Voriconazole | 2005 |
Fast, fully automated analysis of voriconazole from serum by LC-LC-ESI-MS-MS with parallel column-switching technique.
Topics: Antifungal Agents; Automation; Calibration; Chromatography, Liquid; Pyrimidines; Reference Standards; Spectrometry, Mass, Electrospray Ionization; Triazoles; Voriconazole | 2005 |
Painful peripheral neuropathy associated with voriconazole use.
Topics: Adult; Antifungal Agents; Female; Humans; Liver Transplantation; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Pyrimidines; Triazoles; Voriconazole | 2005 |
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aqueous Humor; Biological Availability; Candidiasis; Caspofungin; Chromatography, High Pressure Liquid; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Female; Fungemia; Humans; Infusions, Intravenous; Injections; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Triazoles; Vitreous Body; Voriconazole | 2005 |
Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Heart Transplantation; Humans; Lung Diseases, Fungal; Middle Aged; Myocardial Ischemia; Postoperative Complications; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2005 |
Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients.
Topics: Alkaline Phosphatase; Antifungal Agents; Aspartate Aminotransferases; Chromatography, High Pressure Liquid; Drug Monitoring; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Premedication; Pyrimidines; Retrospective Studies; Transplantation, Homologous; Triazoles; Voriconazole | 2005 |
Emergence of invasive cerebral aspergillosis in an HIV-positive patient on voriconazole therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Fatal Outcome; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2005 |
Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors.
Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Cell Membrane; Cholesterol; Culture Media, Conditioned; Ergosterol; Humans; Itraconazole; Magnetic Resonance Spectroscopy; Oxygen Consumption; Pyrimidines; Spores, Fungal; Sterols; Triazoles; Voriconazole | 2005 |
Caspofungin versus liposomal amphotericin B for empirical therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Infusions, Intravenous; Lipopeptides; Liposomes; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Caspofungin versus liposomal amphotericin B for empirical therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2005 |
[Voriconazol and liposomal amphotericin B: true evidence of their differences with regard to effectiveness and safety].
Topics: Amphotericin B; Antifungal Agents; Humans; Liposomes; Meta-Analysis as Topic; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Neoplasms; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2004 |
Clinical relevance of sirolimus drug interactions in transplant patients.
Topics: Aged; Antifungal Agents; Area Under Curve; Biotransformation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Pyrimidines; Sirolimus; Triazoles; Voriconazole | 2004 |
Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients.
Topics: Administration, Oral; Adult; Antifungal Agents; Dialysis Solutions; Drug Administration Schedule; Drug Evaluation; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Pyrimidines; Triazoles; Voriconazole | 2005 |
Successful antifungal combination therapy with voriconazole and caspofungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Child, Preschool; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Stability of voriconazole in infusion bags].
Topics: Antifungal Agents; Drug Packaging; Drug Stability; Drug Storage; Infusions, Parenteral; Pharmaceutical Solutions; Pyrimidines; Spectrophotometry, Ultraviolet; Triazoles; Voriconazole | 2005 |
[In vitro activity of amphotericin B, itraconazole and voriconazole against 20 species of Aspergillus using the Sensititre microdilution method].
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2005 |
Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.
Topics: Absidia; Adult; Antifungal Agents; Child, Preschool; Female; Hematologic Diseases; Humans; Immunocompromised Host; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizomucor; Rhizopus; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia.
Topics: Aged; Antifungal Agents; Fever; Humans; Mucormycosis; Neutropenia; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2005 |
Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost Savings; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Health Care Costs; Humans; Immunocompromised Host; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Colorimetry; Fluorescence; Fusarium; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Species Specificity; Triazoles; Voriconazole | 2005 |
Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Interaction between voriconazole and tacrolimus in a kidney-transplanted patient.
Topics: Antifungal Agents; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2005 |
Potential fungicidal effect of voriconazole against Candida spp.
Topics: Antifungal Agents; Candida; Candida albicans; Candida tropicalis; Humans; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 2005 |
Mycotic brain abscess caused by opportunistic reptile pathogen.
Topics: Adult; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Chrysosporium; HIV Seropositivity; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Pyrimidines; Triazoles; Voriconazole | 2005 |
Cerebral aspergillosis in the critically ill: two cases of successful medical treatment.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Male; Middle Aged; Neuroaspergillosis; Peptides, Cyclic; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2005 |
In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2005 |
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis.
Topics: Adult; Antifungal Agents; Fusarium; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2005 |
Infection of a total knee prosthesis by Candida glabrata: a case report.
Topics: Aged; Antifungal Agents; Arthroplasty, Replacement, Knee; Candida glabrata; Candidiasis; Female; Humans; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods.
Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2005 |
Sinus zygomycosis in a patient receiving voriconazole prophylaxis.
Topics: Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Leukemia, Myeloid; Maxillary Sinusitis; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole; Zygomycosis | 2005 |
In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Saccharomyces cerevisiae; Species Specificity; Triazoles; Voriconazole | 2005 |
Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Granulocytes; Humans; Leukocyte Transfusion; Lipopeptides; Magnetic Resonance Imaging; Male; Melphalan; Middle Aged; Multiple Myeloma; Necrosis; Peptides, Cyclic; Pyrimidines; Radiography; Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2005 |
Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia.
Topics: Antifungal Agents; Child; Female; Fungemia; Humans; Immunocompromised Host; Mycetoma; Naphthalenes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2005 |
A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Dose-Response Relationship, Drug; Hyphae; Pyrimidines; Triazoles; Voriconazole | 2005 |
Uptake and intracellular activity of voriconazole in human polymorphonuclear leucocytes.
Topics: Antifungal Agents; Candida; Cell Survival; Humans; Kinetics; Neutrophils; Pyrimidines; Triazoles; Voriconazole | 2005 |
Combination antifungal therapy for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Successful treatment of cerebral blastomycosis with voriconazole.
Topics: Antifungal Agents; Blastomycosis; Brain Diseases; Female; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Chemoprevention; Humans; Itraconazole; Lung Transplantation; Pyrimidines; Triazoles; Voriconazole | 2005 |
Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl.
Topics: Adolescent; Antifungal Agents; Blister; Cheilitis; Erythema; Female; Humans; Pyrimidines; Sinusitis; Skin Aging; Triazoles; Voriconazole | 2005 |
In vitro activity of voriconazole against Prototheca wickerhamii: comparative evaluation of sensititre and NCCLS M27-A2 methods of detection.
Topics: Antifungal Agents; Microbial Sensitivity Tests; Prototheca; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2005 |
Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes.
Topics: Absidia; Antifungal Agents; Caspofungin; Culture Media; Cunninghamella; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Mucor; Mucorales; Peptides, Cyclic; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2005 |
Madurella mycetomatis mycetoma treated successfully with oral voriconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Foot Dermatoses; Humans; Magnetic Resonance Imaging; Male; Mycetoma; Pyrimidines; Triazoles; Voriconazole | 2005 |
Lack of efficacy of voriconazole therapy in 2 patients with pulmonary fungus balls.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Paecilomyces; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2005 |
Economic effects of aspergillosis management in high-risk patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Hospitalization; Humans; Insurance, Health, Reimbursement; Pyrimidines; Triazoles; United States; Voriconazole | 2005 |
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Fungemia; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole | 2005 |
Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages.
Topics: Antifungal Agents; Candida; Candida glabrata; Colony Count, Microbial; Drug Resistance, Fungal; Fluconazole; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferon-gamma; Macrophages; Monocytes; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2005 |
Rethinking the use of voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Drug Monitoring; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Male; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2005 |
Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; Fusarium; Humans; Itraconazole; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro activities of amphotericin B and voriconazole against aleurioconidia from Aspergillus terreus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Humans; Hyphae; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Disseminated cutaneous and visceral fusariosis in an aplastic patient: an unusual digestive entry].
Topics: Adult; Amsacrine; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diet; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Subcutaneous phaeohyphomycosis due to Exophiala spinifera in a renal transplant recipient].
Topics: Antifungal Agents; Cyclosporine; Exophiala; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Leg; Middle Aged; Mycoses; Prednisone; Pyrimidines; Triazoles; Voriconazole | 2005 |
Cost advantage of voriconazole over amphotericin B deoxycholate for primary treatment of invasive aspergillosis.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Economics, Pharmaceutical; Humans; Injections, Intravenous; Multicenter Studies as Topic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2005 |
Intravenous voriconazole therapy in a preterm infant.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Pyrimidines; Triazoles; Voriconazole | 2005 |
Treatment of candida chorioretinitis with voriconazole.
Topics: Antifungal Agents; Candidiasis; Chorioretinitis; Eye Infections, Fungal; Female; Fungemia; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Disseminated fusarium infection in two neutropenic children].
Topics: Amphotericin B; Antifungal Agents; Child; Drug Combinations; Fatal Outcome; Female; Fusarium; Humans; Immunocompromised Host; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole in the treatment of invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Critical Care; Drug Interactions; Drug Monitoring; Humans; Immunocompromised Host; Infusions, Intravenous; Mycoses; Patient Selection; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Improved outcome in central nervous system aspergillosis, using voriconazole treatment.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Central Nervous System Fungal Infections; Child; Child, Preschool; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2005 |
In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Species Specificity; Thiazoles; Triazoles; Voriconazole | 2005 |
Scedosporium prolificans sclerokeratitis 10 years after pterygium excision with adjunctive mitomycin C.
Topics: Amphotericin B; Antibiotics, Antineoplastic; Antifungal Agents; Chemotherapy, Adjuvant; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Keratitis; Male; Middle Aged; Mitomycin; Mycetoma; Naphthalenes; Postoperative Complications; Pterygium; Pyrimidines; Scedosporium; Scleritis; Terbinafine; Triazoles; Voriconazole | 2005 |
Treatment of disseminated aspergillosis with voriconazole/liposomal amphotericin B in a child with leukemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Child, Preschool; Humans; Male; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2005 |
Isocratic high-performance liquid chromatographic method with ultraviolet detection for simultaneous determination of levels of voriconazole and itraconazole and its hydroxy metabolite in human serum.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Itraconazole; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Ultraviolet Rays; Voriconazole | 2005 |
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus; Drug Synergism; Echinocandins; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole activity against clinical yeast isolates: a multicentre Italian study.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Fungal; Fungi; Geotrichum; Humans; Inpatients; Italy; Microbial Sensitivity Tests; Mycoses; Outpatients; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Trichosporon; Voriconazole | 2005 |
Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Brain Diseases; Drug Therapy, Combination; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole; Weil Disease | 2005 |
Successful treatment of Aspergillus prosthetic valve endocarditis with oral voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Endocarditis; Heart Valve Prosthesis; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2005 |
International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
Topics: Antifungal Agents; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2005 |
Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bone Marrow Transplantation; Drug Resistance, Fungal; Fungemia; Gastrointestinal Diseases; Graft vs Host Disease; Granuloma; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro investigation of antifungal activities of phenotypic variation Candida albicans strains against fluconazole, itraconazole and voriconazole.
Topics: Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Phenotype; Pyrimidines; Triazoles; Voriconazole | 2005 |
Endogeneous endophthalmitis caused by Sporobolomyces salmonicolor.
Topics: Adult; Antifungal Agents; Basidiomycota; Endophthalmitis; Female; Humans; Pyrimidines; Triazoles; Voriconazole | 2006 |
[In vitro susceptibility of fungal and yeast clinical isolates to itraconazole and voriconazole].
Topics: Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Scedosporium; Sporothrix; Triazoles; Voriconazole; Yeasts | 2005 |
[In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis].
Topics: Antifungal Agents; Arthrodermataceae; Ascomycota; Dermatomycoses; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2005 |
Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry.
Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Drug Synergism; Flow Cytometry; Fluconazole; Fungal Proteins; Ibuprofen; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Staining and Labeling; Triazoles; Voriconazole | 2005 |
Zygomycete infection following voriconazole prophylaxis.
Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Drug Resistance, Fungal; Fatal Outcome; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Male; Microbial Sensitivity Tests; Pyrimidines; Rhizopus; Triazoles; Voriconazole; Zygomycosis | 2005 |
Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Echinocandins; Guinea Pigs; Kidney; Lipopeptides; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2005 |
[Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Spain; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Cataract Extraction; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Lens Implantation, Intraocular; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2005 |
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Reproducibility of Results; Spectrophotometry; Triazoles; Voriconazole | 2005 |
Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry.
Topics: Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Flow Cytometry; Fluorescent Dyes; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Propidium; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth Diseases; Mycoses; Neoplasms; Palliative Care; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2005 |
DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Soil Microbiology; Spain; Triazoles; Voriconazole | 2005 |
Breakthrough zygomycosis and voriconazole.
Topics: Antifungal Agents; Humans; Immunocompromised Host; Immunosuppressive Agents; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2005 |
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Israel; Itraconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2005 |
Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.
Topics: Antifungal Agents; Aspergillus; Drug Combinations; Echinocandins; Fluorescence; Fungal Proteins; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Fluorescence; Peptides, Cyclic; Pyrimidines; Staining and Labeling; Triazoles; Voriconazole | 2005 |
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Austria; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Genes, Fungal; Hematologic Neoplasms; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Peptides, Cyclic; Prevalence; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Successful treatment with voriconazole of fungal cerebral abscess due to Cladophialophora bantiana.
Topics: Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Cladosporium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Quantification of voriconazole in plasma by liquid chromatography-tandem mass spectrometry.
Topics: Antifungal Agents; Blood Chemical Analysis; Chromatography, Liquid; Humans; Pyrimidines; Spectrometry, Mass, Electrospray Ionization; Triazoles; Voriconazole | 2005 |
Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.
Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Humans; Laboratories; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2005 |
Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2005 |
Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole.
Topics: Adolescent; Adult; Candida glabrata; Female; Fluconazole; Fungemia; Humans; Leukemia; Male; Microbial Sensitivity Tests; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2005 |
Fatal Trichosporon asahii septicemia in a Guatemalan farmer with acute lymphoblastic leukemia.
Topics: Adult; Agriculture; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Catheterization, Peripheral; Emigration and Immigration; Fatal Outcome; Fever; Guatemala; Humans; Male; Mycoses; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sepsis; Triazoles; Trichosporon; United States; Urease; Voriconazole; Yeasts | 2005 |
Advances in antifungal therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Endogenous Phialemonium curvatum endophthalmitis.
Topics: Aged; Antifungal Agents; Ascomycota; Cataract Extraction; Drug Contamination; Endocarditis; Endophthalmitis; Erectile Dysfunction; Eye Infections, Fungal; Fungemia; Humans; Male; Muscle, Smooth; Mycoses; Parasympatholytics; Pyrimidines; Triazoles; Ultrasonography; Vitrectomy; Vitreous Body; Voriconazole | 2005 |
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Emergence of Candida albicans fungemia during voriconazole therapy.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fatal Outcome; Female; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2005 |
Economic evaluation of voriconazole in the treatment of invasive aspergillosis in the Netherlands.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Markov Chains; Netherlands; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole therapy in children with cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Retrospective Studies; Sputum; Statistics, Nonparametric; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Echinocandins; Electroretinography; Endophthalmitis; Eye Infections, Fungal; Follow-Up Studies; Lipopeptides; Lipoproteins; Micafungin; Ophthalmoscopy; Peptides, Cyclic; Pyrimidines; Rabbits; Retina; Triazoles; Vitreous Body; Voriconazole | 2005 |
Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia and liver failure.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Brain Abscess; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Liver Failure, Acute; Magnetic Resonance Imaging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Triazoles; Voriconazole | 2005 |
To treat or not to treat with antifungal agents?
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Sputum; Triazoles; Voriconazole | 2005 |
Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
Topics: Aged; Amphotericin B; Anemia, Aplastic; Ascomycota; Aspergillosis; Body Fluids; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Mycoses; Peptides, Cyclic; Pyrimidines; Saccharomycetales; Shock, Septic; Triazoles; Voriconazole | 2005 |
Hypercalcemia due to all trans retinoic acid in the treatment of acute promyelocytic leukemia potentiated by voriconazole.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; Female; Humans; Hypercalcemia; Leukemia, Promyelocytic, Acute; Pyrimidines; Treatment Outcome; Tretinoin; Triazoles; Voriconazole | 2005 |
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole | 2005 |
[Aspergillus bronchitis and aspergilloma treated successfully with voriconazole].
Topics: Antifungal Agents; Aspergillosis; Bronchitis; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2005 |
Severe pustular eruption associated with imatinib and voriconazole in a patient with chronic myeloid leukemia.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Benzamides; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Eruptions; Drug Interactions; Enzyme Inhibitors; Exanthema; Humans; Imatinib Mesylate; Irritants; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Neutropenia; Paecilomyces; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Disseminated Pseudallescheria boydii infection successfully treated with voriconazole.
Topics: Antifungal Agents; Cerebral Infarction; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mycetoma; Pseudallescheria; Pyrimidines; Subarachnoid Hemorrhage; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Magnetic Resonance Imaging; Mediastinal Diseases; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Recurrence; Thoracoscopy; Triazoles; Voriconazole | 2005 |
Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia.
Topics: AC133 Antigen; Amphotericin B; Antifungal Agents; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Caspofungin; Child; Combined Modality Therapy; Contraindications; Dexamethasone; Drug Therapy, Combination; Echinocandins; Glycoproteins; Humans; Immunomagnetic Separation; Lipopeptides; Male; Mercaptopurine; Methotrexate; Peptides; Peptides, Cyclic; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Vincristine; Voriconazole; Zygomycosis | 2007 |
Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Central Nervous System Fungal Infections; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Lipopeptides; Lipoproteins; Liposomes; Micafungin; Mice; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
Topics: Antifungal Agents; Aspergillus; Candida; Drug Synergism; Drug Therapy, Combination; Echinocandins; Fusarium; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2005 |
Cryptococcus gattii: in vitro susceptibility to the new antifungal albaconazole versus fluconazole and voriconazole.
Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Soil Microbiology; Triazoles; Voriconazole | 2005 |
Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2005 |
Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.
Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2005 |
Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
Topics: Administration, Oral; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Brain Abscess; Carboplatin; Cerebral Ventricle Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Diagnostic Errors; Etoposide; Humans; Immunocompromised Host; Infusions, Intravenous; Lomustine; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuroaspergillosis; Pyrimidines; Surgical Wound Infection; Triazoles; Vincristine; Voriconazole | 2007 |
Voriconazole in the treatment of fungal osteomyelitis of the orbit in the immunocompromised host.
Topics: Adult; Antifungal Agents; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Mycetoma; Orbital Diseases; Osteomyelitis; Pyrimidines; Scedosporium; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2005 |
Voriconazole in the management of Alternaria keratitis.
Topics: Administration, Oral; Aged; Alternaria; Antifungal Agents; Cornea; Diagnosis, Differential; Eye Infections, Fungal; Follow-Up Studies; Humans; Keratitis; Male; Ophthalmic Solutions; Pyrimidines; Triazoles; Voriconazole | 2006 |
Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole.
Topics: Animals; Antifungal Agents; Drug Synergism; Fungi; Lovastatin; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Topical voriconazole as a novel treatment for fungal keratitis.
Topics: Administration, Topical; Animals; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Fungal; Humans; Keratitis; Paecilomyces; Pilot Projects; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2006 |
A 43-year-old woman with acquired immunodeficiency syndrome and fever of undetermined origin. Disseminated histoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Bone Marrow; Female; Fever of Unknown Origin; Histoplasma; Histoplasmosis; Humans; Immunocompromised Host; Pyrimidines; Silver Staining; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Scleritis; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy.
Topics: Adult; Anticonvulsants; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Breast Neoplasms; Drug Interactions; Humans; Lung Diseases, Fungal; Male; Phenytoin; Pyrimidines; Stevens-Johnson Syndrome; Triazoles; Voriconazole | 2006 |
Human albumin promotes germination, hyphal growth and antifungal resistance by Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Drug Resistance, Fungal; Growth Substances; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Serum Albumin; Triazoles; Voriconazole | 2005 |
Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Intensive Care Units; Lipopeptides; Peptides, Cyclic; Pyrimidines; Thrombophlebitis; Triazoles; Vena Cava, Inferior; Voriconazole | 2005 |
Voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Humans; Pyrimidines; Triazoles; Voriconazole | 2005 |
The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Chronic Disease; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |
Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities.
Topics: Alanine Transaminase; Alkaline Phosphatase; Antifungal Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Humans; Liver Function Tests; Male; Pyrimidines; Regression Analysis; Retrospective Studies; Risk Assessment; ROC Curve; Triazoles; Vision Disorders; Voriconazole | 2006 |
[Activity of voriconazole against yeasts isolated from blood culture determined by two methods].
Topics: Antifungal Agents; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2005 |
Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.
Topics: Candida albicans; Candidiasis; Drug Resistance; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |
[Invasive multisystemic aspergillosis in an immunocompetent child: case report].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Deoxycholic Acid; Drug Combinations; Fatal Outcome; Humans; Immunocompromised Host; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
Cyclomyces tabacinus as a cause of deep tissue infection: the first case report.
Topics: Aged; Antifungal Agents; Arthritis, Infectious; Basidiomycota; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Chronic endophthalmitis due to verticillium species after cataract surgery treated (or managed) with pars plana vitrectomy and oral and intravitreal voriconazole.
Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mitosporic Fungi; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2006 |
Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
Topics: Antifungal Agents; Female; Fusarium; Humans; Immunocompromised Host; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Fast and reliable determination of the antifungal drug voriconazole in plasma using monolithic silica rod liquid chromatography.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Silicon Dioxide; Spectrophotometry, Ultraviolet; Triazoles; Voriconazole | 2006 |
[Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Mycoses; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Biomass; Caspofungin; Cryptococcus neoformans; Dose-Response Relationship, Drug; Echinocandins; Enzyme-Linked Immunosorbent Assay; Fluconazole; Formazans; Lipopeptides; Melanins; Microbial Sensitivity Tests; Microscopy, Confocal; Peptides, Cyclic; Plankton; Pyrimidines; Triazoles; Voriconazole | 2006 |
Coccidioidomycosis in HIV-infected persons.
Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Coccidioidomycosis; HIV-1; Humans; Pyrimidines; Triazoles; Voriconazole | 2006 |
Candidaemia secondary to intravascular catheter colonisation?
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Equipment Contamination; Humans; Pyrimidines; Triazoles; Voriconazole | 2006 |
Concomitant late soft tissue infections by Cladophialophora bantiana and Mycobacterium abscessus following tsunami injuries.
Topics: Amikacin; Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Clarithromycin; Dermatomycoses; Disasters; Female; Humans; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Pyrimidines; Soft Tissue Infections; Soft Tissue Injuries; Triazoles; Voriconazole; Wounds and Injuries | 2006 |
Rare lower extremity invasive fungal infection in an immunosuppressed patient: Exserohilum longirostratum.
Topics: Aged; Antifungal Agents; Cellulitis; Comorbidity; Debridement; Disease Progression; Hepatitis C, Chronic; Humans; Immunocompromised Host; Leg Ulcer; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Hallucinosis as side effect of voriconazole].
Topics: Aged; Antifungal Agents; Hallucinations; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2005 |
Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome.
Topics: Antifungal Agents; Aspergillosis; France; Humans; Immunocompromised Host; Male; Middle Aged; Outcome Assessment, Health Care; Pericardium; Pleura; Pyrimidines; Triazoles; Ultrasonography; Voriconazole | 2006 |
Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Hematologic Diseases; Humans; Injections, Intravenous; Liver; Liver Function Tests; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |
Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Drug Administration Schedule; Humans; Immunocompetence; Male; Pyrimidines; Recurrence; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Disease Models, Animal; Drug Therapy, Combination; Guinea Pigs; Liposomes; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
Voriconazole therapeutic drug monitoring.
Topics: Adult; Aged; Antifungal Agents; Disease Progression; Drug Monitoring; Female; Humans; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B.
Topics: Adult; Amphotericin B; Antifungal Agents; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Aspergillus fumigatus tricuspid native valve endocarditis in a non-intravenous drug user.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Endocarditis; Heart Valve Diseases; Humans; Male; Pulmonary Embolism; Pyrimidines; Sepsis; Triazoles; Tricuspid Valve; Voriconazole | 2006 |
Improved outcome in central nervous system aspergillosis.
Topics: Antifungal Agents; Bone Marrow Transplantation; Disease-Free Survival; Female; Humans; Immunosuppression Therapy; Male; Neuroaspergillosis; Organ Transplantation; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Allergic broncho-pulmonary aspergillosis treated with voriconazole].
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2006 |
Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole.
Topics: Antifungal Agents; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Endocarditis; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
[A case of resistant pulmonary and cerebral aspergillosis successfully treated with voriconazole].
Topics: Antifungal Agents; Aspergillosis; Diagnosis, Differential; Humans; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Telencephalon; Triazoles; Voriconazole | 2006 |
Transcriptome analysis of Aspergillus fumigatus exposed to voriconazole.
Topics: Antifungal Agents; Aspergillus fumigatus; Gene Expression Profiling; Gene Expression Regulation, Fungal; Genes, Fungal; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Triazoles; Voriconazole | 2006 |
Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
Topics: Adult; Antifungal Agents; Aspergillosis; Chi-Square Distribution; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Middle Aged; Pyrimidines; Retrospective Studies; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Aspergillus brain abscess in a patient with acute myeloid leukaemia successfully treated with voriconazole.
Topics: Adult; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Central Nervous System Fungal Infections; Humans; Leukemia, Erythroblastic, Acute; Male; Pyrimidines; Telencephalon; Triazoles; Voriconazole | 2006 |
Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antifungal Agents; Cord Blood Stem Cell Transplantation; Creatinine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Leukemia; Lipids; Male; Middle Aged; Mycoses; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Pyrimidines; Retrospective Studies; Sirolimus; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chromatography, High Pressure Liquid; Clinical Protocols; Epithelial Cells; Female; Humans; Lung; Lung Diseases, Fungal; Male; Middle Aged; Pilot Projects; Pleura; Prospective Studies; Pyrimidines; Reference Standards; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Urea; Voriconazole | 2006 |
Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2006 |
Black fluid from a traumatic wound.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Fractures, Open; Humans; Male; Meropenem; Mycoses; Pyrimidines; Soft Tissue Infections; Thienamycins; Triazoles; Voriconazole; Wound Infection | 2006 |
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2006 |
Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Discitis; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Middle Aged; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation.
Topics: Adult; Antifungal Agents; Bronchi; Chorioretinitis; Cystic Fibrosis; Fatal Outcome; Female; Humans; Immunocompromised Host; Lung Transplantation; Meningitis, Fungal; Mycetoma; Pyrimidines; Scedosporium; Sputum; Triazoles; Voriconazole | 2006 |
Nodular erythema as early sign of systemic aspergillosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Diagnosis, Differential; Erythema Nodosum; Humans; Immunocompromised Host; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Communicable Diseases, Emerging; Drug Resistance, Multiple, Fungal; Humans; Immunocompromised Host; Mycoses; Organ Transplantation; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Recurrence; Triazoles; Voriconazole; Zygomycosis | 2006 |
Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Immunosuppressive Agents; Injections; Lung Transplantation; Opportunistic Infections; Pyrimidines; Triazoles; Visual Acuity; Vitrectomy; Vitreous Body; Voriconazole | 2006 |
Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole.
Topics: Antifungal Agents; Bone Diseases, Infectious; Female; Humans; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Tarsal Bones; Tibia; Treatment Outcome; Triazoles; Voriconazole | 2006 |
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Guinea Pigs; Humans; Kidney; Liver; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Trichosporon; Voriconazole | 2006 |
In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Peptides, Cyclic; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2006 |
[Voriconazole photosensitivity: 7 cases].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Humans; Male; Middle Aged; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole | 2006 |
Unclear fever 7 weeks after renal transplantation in a 56-year-old patient.
Topics: Abscess; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biopsy, Fine-Needle; Caspofungin; Contraindications; Cyclosporine; Delayed Graft Function; Drug Interactions; Echinocandins; Fever of Unknown Origin; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lipopeptides; Male; Middle Aged; Mycophenolic Acid; Peptides, Cyclic; Postoperative Complications; Prednisone; Pyrimidines; Radionuclide Imaging; Stenotrophomonas maltophilia; Surgical Wound Infection; Thyroiditis; Triazoles; Ultrasonography; Voriconazole | 2006 |
Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Galactose; Graft vs Host Disease; Humans; Liver Diseases; Lymphoproliferative Disorders; Mannans; Middle Aged; Pyrimidines; Rituximab; Splenic Diseases; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Central Nervous System Infections; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Kidney; Mice; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2006 |
Antifungal effect of voriconazole on intracellular Candida glabrata, Candida krusei and Candida parapsilosis in human monocyte-derived macrophages.
Topics: Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Humans; Macrophages; Pyrimidines; Triazoles; Voriconazole | 2006 |
Successful use of combination antifungal therapy in the treatment of coccidioides meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Coccidioides; Coccidioidomycosis; Diagnosis, Differential; Drug Therapy, Combination; Humans; Male; Meningitis, Fungal; Pyrimidines; Triazoles; Voriconazole | 2006 |
Candida peritonitis in a patient with necrotising cholecystitis and pancreatitis.
Topics: Aged; Aged, 80 and over; Candida albicans; Cholecystitis; Humans; Male; Pancreatitis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2006 |
Amphotericin B is still the drug of choice for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Lung Diseases, Fungal; Pyrimidines; Research Design; Triazoles; Voriconazole | 2006 |
Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient.
Topics: Aged; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Pyrimidines; Tacrolimus; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Scedosporium apiospermum soft-tissue infection: a case report and review of kidney transplant literature.
Topics: Antifungal Agents; Drainage; Environmental Pollution; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2006 |
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Bone Marrow Transplantation; Cefepime; Cephalosporins; Combined Modality Therapy; Cunninghamella; Daunorubicin; Drug Resistance, Multiple, Fungal; Female; Humans; Imatinib Mesylate; Immunocompromised Host; Lung Diseases, Fungal; Middle Aged; Neutropenia; Piperazines; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Transplantation Conditioning; Triazoles; Vancomycin; Vincristine; Voriconazole; Zygomycosis | 2006 |
Fusarium oxysporum pneumonia in an immunocompetent host.
Topics: Aged; Antifungal Agents; Bronchoscopy; Female; Fusarium; Humans; Immunocompetence; Mycoses; Pneumonia; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2006 |
Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
Topics: Administration, Cutaneous; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bone Marrow Transplantation; Combined Modality Therapy; Debridement; Dermatomycoses; Disease Susceptibility; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Injections, Subcutaneous; Nystatin; Postoperative Complications; Pyrimidines; Skin; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial.
Topics: Antifungal Agents; Arthrodermataceae; Clinical Trials as Topic; Fluconazole; Griseofulvin; Humans; Microbial Sensitivity Tests; Pyrimidines; Tinea Capitis; Triazoles; Voriconazole | 2006 |
Management of paecilomyces keratitis.
Topics: Adult; Antifungal Agents; Corneal Transplantation; Eye Infections, Fungal; Female; Humans; Keratitis; Paecilomyces; Pyrimidines; Recurrence; Sclera; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Radiological resolution of cavitating Aspergillus fumigatus infection following treatment with oral voriconazole in two lung transplant recipients.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2006 |
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Echinocandins; Fungemia; Humans; Leukemia, Myeloid; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2006 |
Stability of voriconazole injection in 0.9% sodium chloride and 5% dextrose injections.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Excipients; Glucose; Hydrogen-Ion Concentration; Injections; Pyrimidines; Sodium Chloride; Solutions; Temperature; Time Factors; Triazoles; Voriconazole | 2006 |
A case of pulmonary aspergillosis with lack of response to caspofungin.
Topics: Acute Disease; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Diseases; Candidiasis; Caspofungin; Combined Modality Therapy; Contraindications; Echinocandins; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid; Lipopeptides; Lung Diseases, Fungal; Middle Aged; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole | 2006 |
[Clinical cases in medical mycology. Case no. 21].
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Endophthalmitis; Exophiala; Female; Fungemia; Humans; Itraconazole; Middle Aged; Mycoses; Opportunistic Infections; Osteolysis; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Th2 Cells; Triazoles; Voriconazole | 2006 |
Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
Topics: Adult; Aged; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2006 |
Combination antifungal therapy in solid organ transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Humans; Kidney Transplantation; Liver Transplantation; Organ Transplantation; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole | 2006 |
Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Drug Resistance, Fungal; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.
Topics: Antifungal Agents; Aspergillus; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2006 |
Application of fluorescent probes to study structural changes in Aspergillus fumigatus exposed to amphotericin B, itraconazole, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Benzenesulfonates; Fluorescent Dyes; Itraconazole; Microbial Sensitivity Tests; Microscopy, Fluorescence; Propidium; Pyrimidines; Triazoles; Voriconazole | 2006 |
Efficacy of voriconazole in experimental Cryptococcus neoformans infection.
Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Lung Diseases, Fungal; Mice; Mice, Inbred C57BL; Polysaccharides; Pyrimidines; Triazoles; Voriconazole | 2006 |
Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman.
Topics: Adult; Amphotericin B; Antifungal Agents; Arthritis; Aspergillus fumigatus; Brain; Brain Abscess; Caspofungin; Chromatography, Liquid; Echinocandins; Female; Humans; Lipopeptides; Magnetic Resonance Imaging; Mass Spectrometry; Neuroaspergillosis; Paranasal Sinus Diseases; Peptides, Cyclic; Pyrimidines; Staphylococcus aureus; Triazoles; Voriconazole | 2006 |
Aspergillus infection limited to renal allograft: case report and review of literature.
Topics: Adult; Aspergillosis; Aspergillus; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Pyrimidines; Triazoles; Voriconazole | 2006 |
Disseminated invasive aspergillosis in a patient with acute leukaemia.
Topics: Acute Kidney Injury; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bacteremia; Caspofungin; Chlamydophila Infections; Chlamydophila pneumoniae; Doxorubicin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Liposomes; Lung Diseases, Fungal; Medical Futility; Methotrexate; Middle Aged; Neuroaspergillosis; Peptides, Cyclic; Pneumonia, Bacterial; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Streptococcal Infections; Triazoles; Vincristine; Voriconazole | 2006 |
AmBisome treatment of fungal sinusitis in severe immunocompromised patient with acute lymphoblastic leukemia relapsed after autologous peripheral blood transplantation.
Topics: Adult; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Combined Modality Therapy; Cytarabine; Cytomegalovirus Infections; Enterococcus faecalis; Fatal Outcome; Humans; Idarubicin; Immunocompromised Host; Immunoglobulins, Intravenous; Liposomes; Male; Mycoses; Peripheral Blood Stem Cell Transplantation; Pneumonia; Postoperative Complications; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas putida; Pulmonary Edema; Pyrimidines; Sinusitis; Staphylococcus epidermidis; Transplantation, Autologous; Triazoles; Voriconazole | 2006 |
A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
Topics: Abscess; Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Foot Dermatoses; Fusarium; Humans; Imatinib Mesylate; Immunocompromised Host; Liposomes; Male; Middle Aged; Muscular Diseases; Onychomycosis; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Reoperation; Rituximab; Teniposide; Triazoles; Voriconazole | 2006 |
Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype.
Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Genotype; Humans; Mixed Function Oxygenases; Pyrimidines; Triazoles; Voriconazole | 2006 |
Aspergillus meningitis following spinal anaesthesia for caesarean section in Colombo, Sri Lanka.
Topics: Abducens Nerve Diseases; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antifungal Agents; Aspergillosis; Brain; Cesarean Section; Diabetes, Gestational; Fatal Outcome; Female; Fluconazole; Glasgow Coma Scale; Humans; Meningitis, Fungal; Pregnancy; Pyrimidines; Respiration, Artificial; Sri Lanka; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2007 |
Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
Topics: Air Sacs; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Bird Diseases; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Falconiformes; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole | 2006 |
A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Culture Media; Dermatomycoses; HIV Infections; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Polysorbates; Pyrimidines; Triazoles; Urea; Voriconazole | 2006 |
Use of the BIOMIC Video System to evaluate the susceptibility of clinical yeast isolates to fluconazole and voriconazole by a disk diffusion method.
Topics: Candida; Candidiasis; Fluconazole; Humans; Image Processing, Computer-Assisted; Microbial Sensitivity Tests; Microscopy, Video; Pyrimidines; Triazoles; Voriconazole | 2006 |
Severe osteomyelitis caused by Myceliophthora thermophila after a pitchfork injury.
Topics: Child, Preschool; Humans; Knee Injuries; Male; Mitosporic Fungi; Mycoses; Osteomyelitis; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Candida albicans induced spondylodiscitis of the cervical spine of a polytraumatized patient].
Topics: Adult; Antifungal Agents; Candidiasis; Cervical Vertebrae; Combined Modality Therapy; Discitis; Epidural Abscess; Fluconazole; Follow-Up Studies; Head Movements; Humans; Lung Diseases, Fungal; Male; Multiple Trauma; Pyrimidines; Radiography; Triazoles; Voriconazole | 2006 |
Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy.
Topics: Aged; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Pyrimidines; Renal Insufficiency; Renal Replacement Therapy; Solvents; Triazoles; Voriconazole | 2006 |
Antifungal effects on metabolite profiles of medically important yeast species measured by nuclear magnetic resonance spectroscopy.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Caspofungin; Echinocandins; Indicator Dilution Techniques; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2006 |
[Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia].
Topics: Antifungal Agents; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Azoles; Chlorhexidine; Communicable Diseases, Emerging; Drug Synergism; Fluconazole; Guanidines; Humans; Microbial Sensitivity Tests; Mycoses; Polymers; Pyrimidines; Triazoles; Trichoderma; Voriconazole | 2006 |
Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; Hydroxycorticosteroids; Itraconazole; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Pyrimidines; Sarcoidosis; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Male; Middle Aged; Panophthalmitis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
Topics: Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Global Health; Humans; Lipopeptides; Peptides, Cyclic; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2006 |
Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Keratomycosis due to Cylindrocarpon lichenicola].
Topics: Aged; Amphotericin B; Antifungal Agents; Clematis; Eye Infections, Fungal; Fusarium; Humans; Hypocreales; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Successful treatment of an Aspergillus fumigatus Infection with voriconazole via a nasogastric tube.
Topics: Administration, Intranasal; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Intubation, Gastrointestinal; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2006 |
Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Injections; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Visual Acuity; Vitreous Body; Voriconazole | 2006 |
Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Aspergillosis; Aspergillus niger; Humans; Immunologic Factors; Male; Purpura, Thrombocytopenic, Idiopathic; Pyrimidines; Rituximab; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Multi-azole resistance in Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2006 |
Treatment of protothecosis with voriconazole.
Topics: Aged; Antifungal Agents; Humans; Infections; Male; Prototheca; Pyrimidines; Triazoles; Voriconazole | 2006 |
Voriconazole prophylaxis in lung transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Chemoprevention; Female; Humans; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Probability; Pyrimidines; Retrospective Studies; Survival Analysis; Time Factors; Triazoles; Voriconazole | 2006 |
Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen.
Topics: Adult; Antifungal Agents; Blastomycosis; Brain Diseases; Central Nervous System Fungal Infections; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2006 |
Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Drug Antagonism; Drug Combinations; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Brain; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluorescence Resonance Energy Transfer; Immunocompromised Host; Immunosuppression Therapy; Itraconazole; Kidney; Lipopeptides; Liver; Lung; Male; Mice; Neutropenia; Nitriles; Peptides, Cyclic; Polymerase Chain Reaction; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2006 |
Successful early voriconazole treatment of Aspergillus infection in two non immunocompromised patients in Intensive Care Unit.
Topics: Antifungal Agents; Aspergillosis; Critical Care; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2007 |
Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.
Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Humans; Laboratories; Microbial Sensitivity Tests; Predictive Value of Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole | 2007 |
Invasive aspergillosis: is treatment with "inexpensive" amphotericin B cost saving if "expensive" voriconazole is only used on demand?
Topics: Acute Kidney Injury; Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Models, Economic; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Successful treatment by voliconazole for pulmonary and adductor magnus muscle aspergillosis induced by immunosuppressive therapy for hypersensitivity pneumonia].
Topics: Aged; Alveolitis, Extrinsic Allergic; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cyclosporine; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Fungal; Myositis; Opportunistic Infections; Prednisolone; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Treatment of cutaneous infection by Alternaria alternata with voriconazole in a liver transplant patient.
Topics: Alternaria; Antifungal Agents; Dermatomycoses; Fatal Outcome; Humans; Liver Transplantation; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Skin; Triazoles; Voriconazole | 2006 |
Successful topical therapy with voriconazole: pseudallescheriasis after injury.
Topics: Administration, Topical; Adolescent; Antifungal Agents; Fibula; Fracture Fixation; Humans; Male; Mycetoma; Pseudallescheria; Pyrimidines; Surgical Wound Infection; Tibial Fractures; Triazoles; Voriconazole | 2007 |
Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease.
Topics: Antifungal Agents; Biopsy, Fine-Needle; Blood Sedimentation; Child; DNA, Fungal; Genetic Diseases, X-Linked; Granulomatous Disease, Chronic; Humans; Male; Microscopy; Molecular Sequence Data; Mycoses; Osteomyelitis; Penicillium; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Triazoles; Voriconazole | 2006 |
[Susceptibility of fungi isolated from clinical materials to voriconazole].
Topics: Antifungal Agents; Aspergillus; Candida albicans; Fungi; Humans; Microbial Sensitivity Tests; Mycological Typing Techniques; Pyrimidines; Triazoles; Trichophyton; Voriconazole; Yeasts | 2006 |
Effect of antifungal treatment in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Geotrichosis; Geotrichum; Immunocompromised Host; Immunosuppressive Agents; Kidney; Liver; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2007 |
In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates.
Topics: Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2007 |
Change of the blood concentration of tacrolimus after the switch from fluconazole to voriconazole in patients receiving allogeneic hematopoietic stem cell transplantation.
Topics: Fluconazole; Humans; Immunosuppressive Agents; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Tacrolimus; Triazoles; Voriconazole | 2006 |
Invasive sphenoidal aspergillosis: successful treatment with sphenoidotomy and voriconazole.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Endoscopy; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Otorhinolaryngologic Surgical Procedures; Pyrimidines; Severity of Illness Index; Sphenoid Sinus; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2007 |
Successful treatment of black-grain mycetoma with voriconazole.
Topics: Antifungal Agents; Humans; Madurella; Male; Middle Aged; Mycetoma; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2006 |
[Therapy with voriconazol for a case of chronic mucocutaneous candidiasis].
Topics: Adult; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Drug Resistance, Multiple, Fungal; Female; Humans; Onychomycosis; Pyrimidines; Triazoles; Voriconazole | 2006 |
Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillus fumigatus; Cells, Cultured; Chemokine CCL2; Chemokine CCL3; Chemokine CCL4; DNA, Complementary; Gene Expression Regulation; Humans; Hyphae; Immunity, Innate; Interleukin-10; Interleukin-12; Interleukin-1beta; Macrophage Inflammatory Proteins; Monocytes; Oligonucleotide Array Sequence Analysis; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole | 2007 |
Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring.
Topics: Adult; Antifungal Agents; Asthenia; Cognition Disorders; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hallucinations; Humans; Irritable Mood; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Triazoles; Vision Disorders; Voriconazole | 2006 |
Pseudoporphyria.
Topics: Antifungal Agents; Diagnosis, Differential; Humans; Porphyrias; Pyrimidines; Triazoles; Voriconazole | 2006 |
Topical and oral voriconazole in the treatment of fungal keratitis.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Eye Infections, Fungal; Female; Fungi; Humans; Keratitis; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
Topics: Air Microbiology; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Cross Infection; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole; Water Microbiology | 2007 |
Echinocandins for candidemia.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Fungemia; Humans; Pyrimidines; Triazoles; Voriconazole | 2006 |
Unexplained increase in Paecilomyces variotii blood culture isolates in the UK.
Topics: Amphotericin B; Antifungal Agents; Blood; Caspofungin; Diagnosis, Differential; Echinocandins; Equipment Contamination; False Positive Reactions; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Paecilomyces; Peptides, Cyclic; Pyrimidines; Species Specificity; Triazoles; United Kingdom; Voriconazole | 2006 |
Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, cas
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Triazoles; Voriconazole | 2007 |
Antifungal activities of azole agents against the Malassezia species.
Topics: Antifungal Agents; Azoles; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Tinea Versicolor; Triazoles; Voriconazole | 2007 |
In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: comparison of CLSI M27-A2, Sensititre YeastOne, disk diffusion, and Etest methods.
Topics: Antifungal Agents; Candida; Candidiasis; Colorimetry; Indicator Dilution Techniques; Microbial Sensitivity Tests; Mycological Typing Techniques; Pyrimidines; Reference Standards; Triazoles; Voriconazole; Yeasts | 2006 |
Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphoma.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus niger; Chronic Disease; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lung Diseases, Fungal; Lymphatic Irradiation; Necrosis; Pneumonia, Bacterial; Pyrimidines; Radiation Injuries; Radiography; Staphylococcal Infections; Staphylococcus epidermidis; Triazoles; Virginiamycin; Voriconazole | 2006 |
Voriconazole and fungal keratitis: a report of two treatment failures.
Topics: Administration, Topical; Aged, 80 and over; Antifungal Agents; Colletotrichum; Fusarium; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2006 |
Voriconazole-induced pseudoporphyria.
Topics: Antifungal Agents; Candidiasis; Drug Eruptions; Female; Humans; Middle Aged; Porphyria, Acute Intermittent; Pyrimidines; Triazoles; Voriconazole | 2007 |
[Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis].
Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2007 |
Caspofungin for the treatment of azole resistant candidemia in a premature infant.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Microbial; Echinocandins; Humans; Hypercalcemia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Male; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Pacemaker endocarditis with pulmonary cavitary lesion due to Scedosporium prolificans.
Topics: Aged; Antifungal Agents; Device Removal; Endocarditis; Humans; Lung; Male; Mycetoma; Pacemaker, Artificial; Postoperative Complications; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy.
Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Female; Granulomatous Disease, Chronic; Humans; Photosensitivity Disorders; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole | 2007 |
Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Body Weight; Caspofungin; Cost-Benefit Analysis; Echinocandins; Health Care Costs; Humans; Injections, Intravenous; Lipopeptides; Multivariate Analysis; Peptides, Cyclic; Pyrimidines; Severity of Illness Index; Spain; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Voriconazole and multidrug resistance in Candida albicans.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Candida albicans; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Genes, MDR; Membrane Transport Proteins; Microbial Sensitivity Tests; Pyrimidines; Rhodamines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2007 |
Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Triazoles; Voriconazole | 2007 |
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy.
Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2007 |
Torsades de pointes associated with voriconazole use.
Topics: Administration, Oral; Anthracyclines; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Cardiomyopathies; Dermatomycoses; Drug Synergism; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Voriconazole | 2007 |
A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient.
Topics: Acanthamoeba; Acute Disease; Amebiasis; Amphotericin B; Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Female; Humans; Injections, Intravenous; Lipids; Lung Transplantation; Middle Aged; Postoperative Complications; Pyrimidines; Skin Diseases, Parasitic; Treatment Outcome; Triazoles; Voriconazole | 2007 |
A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Mutation; Oxidative Phosphorylation; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
Invasive cutaneous infection with Geotrichum candidum: sequential treatment with amphotericin B and voriconazole.
Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Diabetes Mellitus; Geotrichosis; Geotrichum; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2007 |
Voriconazole concentrations in synovial fluid and bone tissues.
Topics: Aged, 80 and over; Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Bone and Bones; Chromatography, High Pressure Liquid; Female; Humans; Microbial Sensitivity Tests; Pyrimidines; Synovial Fluid; Triazoles; Voriconazole | 2007 |
Antifungal susceptibility testing of Trichophyton rubrum by E-test.
Topics: Antifungal Agents; Cells, Cultured; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Tinea; Triazoles; Trichophyton; Voriconazole | 2007 |
Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients.
Topics: Antifungal Agents; Graft Rejection; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Pharmacoeconomic analysis of liposomal amphotericin B versus voriconazole for empirical treatment of febrile neutropenia.
Topics: Amphotericin B; Antifungal Agents; Decision Support Techniques; Economics, Pharmaceutical; Fever; Health Care Costs; Humans; Liposomes; Neutropenia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2007 |
The effects of caspofungin and voriconazole in experimental Candida endophthalmitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Cornea; Disease Models, Animal; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Itraconazole; Lipopeptides; Peptides, Cyclic; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2007 |
Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine.
Topics: Adult; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Drug Resistance, Fungal; Granulomatous Disease, Chronic; Humans; Male; Naphthalenes; Pyrimidines; Scedosporium; Terbinafine; Triazoles; Voriconazole | 2007 |
Voriconazole resistant Candida spp. and Saccharomyces spp. isolates from oropharyngeal candidiasis from Cambodian children with AIDS not pretreated with azoles (letter).
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Cambodia; Candida; Candidiasis, Oral; Child; Drug Resistance, Multiple, Fungal; Humans; Oropharynx; Pharyngeal Diseases; Pyrimidines; Saccharomyces; Triazoles; Voriconazole | 2007 |
Successful treatment of aspergillus granuloma involving the cavernous sinus and the middle fossa by using surgery and voriconazole. Case illustration.
Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Cavernous Sinus; Combined Modality Therapy; Cranial Fossa, Middle; Granuloma; Humans; Male; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole | 2007 |
A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Colony Count, Microbial; Half-Life; Microbial Sensitivity Tests; Microbial Viability; Models, Biological; Pyrimidines; Triazoles; Voriconazole | 2007 |
Invasive Aspergillus fumigatus associated with liver and bone involvement in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bone Diseases; Humans; Liver Diseases; Male; Pyrimidines; Triazoles; Voriconazole | 2007 |
Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
[Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani].
Topics: Antifungal Agents; Cellulitis; Ciclopirox; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Foot Dermatoses; Fusarium; Humans; Imidazoles; Immunocompetence; Itraconazole; Male; Middle Aged; Mozambique; Onychomycosis; Pyridones; Pyrimidines; Recurrence; Toes; Travel; Triazoles; Urea; Voriconazole | 2006 |
[Acanthamoeba keratitis: about the first two Tunisian cases].
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Amebicides; Animals; Antifungal Agents; Benzamidines; Biguanides; Contact Lenses, Hydrophilic; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoplasty, Penetrating; Ketoconazole; Pyrimidines; Triazoles; Tunisia; Voriconazole | 2007 |
Chronic invasive sinus aspergillosis in an immunocompetent patient: a case report.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Endoscopy; Humans; Immunocompetence; Male; Paranasal Sinus Diseases; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2007 |
Multiple-triazole-resistant aspergillosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Multiple, Fungal; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Pyrimidines; Tandem Repeat Sequences; Triazoles; Voriconazole | 2007 |
Efficacy and safety of voriconazole as an additive in Optisol GS: a preservation medium for corneal donor tissue.
Topics: Antifungal Agents; Cell Count; Cell Survival; Chondroitin Sulfates; Complex Mixtures; Cornea; Culture Media, Serum-Free; Dextrans; Drug Combinations; Endothelium, Corneal; Fungi; Gentamicins; Humans; Middle Aged; Organ Preservation; Organ Preservation Solutions; Pyrimidines; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Nasofacial phycomycosis: persistence pays.
Topics: Adult; Antifungal Agents; Conidiobolus; Drug Resistance, Fungal; Facial Dermatoses; Female; Humans; Itraconazole; Pyrimidines; Timor-Leste; Triazoles; Voriconazole; Zygomycosis | 2007 |
Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Echinocandins; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Disseminated fusariosis presenting with pulmonary nodules following a line infection.
Topics: Antifungal Agents; Catheterization, Central Venous; Fusarium; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Solitary Pulmonary Nodule; Triazoles; Voriconazole | 2006 |
Successful control of Scedosporium prolificans septic arthritis and probable osteomyelitis without radical surgery in a long-term renal transplant recipient.
Topics: Aged; Antifungal Agents; Arthritis, Infectious; Debridement; Drug Therapy, Combination; Humans; Kidney Transplantation; Male; Mycetoma; Naphthalenes; Osteomyelitis; Pyrimidines; Scedosporium; Terbinafine; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Culture Media; Disk Diffusion Antimicrobial Tests; Echinocandins; Fungi; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2007 |
Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia.
Topics: Acute Disease; Adult; Aspergillosis; Aspergillus; Humans; Leukemia, Myeloid; Male; Meningitis, Fungal; Pyrimidines; Sarcoma, Myeloid; Thyroid Neoplasms; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.
Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Chromatography, Liquid; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Escherichia coli; Humans; Hydroxylation; Isoenzymes; Kinetics; Magnetic Resonance Spectroscopy; Microsomes, Liver; Mixed Function Oxygenases; Models, Chemical; Molecular Structure; Oxidation-Reduction; Pyrimidines; Recombinant Proteins; Spectrophotometry, Ultraviolet; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2007 |
Comparison of tablet and disk diffusion methods for fluconazole and voriconazole in vitro activity testing against clinical yeast isolates.
Topics: Antifungal Agents; Candida; Cells, Cultured; Drug Resistance, Fungal; Fluconazole; Humans; In Vitro Techniques; Linear Models; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Saccharomyces; Triazoles; Voriconazole | 2007 |
Relationship of blood level and susceptibility in voriconazole treatment of histoplasmosis.
Topics: Antifungal Agents; Cohort Studies; Histoplasma; Histoplasmosis; Humans; Microbial Sensitivity Tests; Pyrimidines; Secondary Prevention; Triazoles; Voriconazole | 2007 |
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2007 |
Early fatal Rhizopus infection on voriconazole prophylaxis following allogeneic stem cell transplantation.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizopus; Transplantation, Homologous; Triazoles; Voriconazole | 2007 |
Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Topics: Antifungal Agents; Candida; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Population Surveillance; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Combined therapies in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole | 2007 |
Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Drug Interactions; Female; France; Humans; Liver Function Tests; Male; Middle Aged; Pyrimidines; Skin Diseases; Triazoles; Vision Disorders; Voriconazole | 2007 |
Clearance of intravitreal voriconazole.
Topics: Animals; Antifungal Agents; Aqueous Humor; Biological Availability; Chromatography, High Pressure Liquid; Half-Life; Injections; Metabolic Clearance Rate; Pyrimidines; Rabbits; Triazoles; Vitreous Body; Voriconazole | 2007 |
Successful management of Aspergillus liver abscess in a patient with necrotizing fasciitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Fasciitis, Necrotizing; Female; Humans; Lipopeptides; Liver Abscess; Peptides, Cyclic; Pregnancy; Pyrimidines; Triazoles; Voriconazole | 2007 |
Management of tunnel fungal infection with voriconazole.
Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Cataract Extraction; Corneal Ulcer; Eye Infections, Fungal; Female; Fusarium; Humans; Microsurgery; Mycoses; Pyrimidines; Surgical Wound Infection; Triazoles; Visual Acuity; Voriconazole | 2007 |
Acquired resistance to echinocandins in Candida albicans: case report and review.
Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Genotype; HIV Infections; HIV-1; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2007 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |
Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection.
Topics: Animals; Antifungal Agents; Brain; Central Nervous System Fungal Infections; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Humans; Lung; Male; Mice; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Inherited long QT syndrome revealed by antifungals drug-drug interaction.
Topics: Acute Disease; Adolescent; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Female; Genotype; Humans; Injections, Intravenous; Leukemia, Myeloid; Long QT Syndrome; Mixed Function Oxygenases; Mucormycosis; Pyrimidines; Torsades de Pointes; Triazoles; Voriconazole | 2007 |
Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Female; Fusarium; Humans; Lipopeptides; Mycoses; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcus neoformans; Drug Resistance, Viral; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Time Factors; Triazoles; Voriconazole | 2007 |
[Correlations among itraconazole, voriconazole and posaconazole MICs in Aspergillus fumigatus].
Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chromatography, High Pressure Liquid; Culture Media; Dose-Response Relationship, Drug; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2007 |
Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).
Topics: Antifungal Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line; Cell Survival; Chlorophyll; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Flow Cytometry; Fluconazole; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Itraconazole; Ketoconazole; Neoplasm Proteins; Pyrimidines; Topotecan; Transfection; Triazoles; Voriconazole | 2007 |
[Perspectives on allergic bronchopulmonary aspergillosis].
Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Humans; Itraconazole; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Diagnostic and therapeutic challenge of Aspergillus flavus scleritis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Scleritis; Substance Abuse, Intravenous; Triazoles; Voriconazole | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Humans; Mucositis; Mycoses; Opportunistic Infections; Oxidoreductases; Point Mutation; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2007 |
Secular trends in severe renal failure associated with the use of new antimicrobial agents in critically ill surgical patients.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Caspofungin; Cohort Studies; Critical Illness; Echinocandins; Female; Humans; Intensive Care Units; Linezolid; Lipopeptides; Male; Middle Aged; Oxazolidinones; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Renal Insufficiency; Renal Replacement Therapy; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Validation of rapid and simple LC-MS/MS method for determination of voriconazole in rat plasma.
Topics: Animals; Antifungal Agents; Chromatography, Liquid; Injections, Intravenous; Male; Mass Spectrometry; Pyrimidines; Quality Control; Rats; Rats, Wistar; Reference Standards; Reproducibility of Results; Solvents; Triazoles; Voriconazole | 2007 |
Does one voriconazole breakpoint suit all Candida species?
Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2007 |
Acremonium vertebral osteomyelitis: molecular diagnosis and response to voriconazole.
Topics: Acremonium; Aged; Antifungal Agents; Drug Resistance, Fungal; Humans; Male; Osteomyelitis; Pyrimidines; Triazoles; Voriconazole | 2007 |
In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
Topics: Antifungal Agents; Arthrodermataceae; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Triazoles; Voriconazole | 2007 |
Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cost-Benefit Analysis; Costs and Cost Analysis; Data Interpretation, Statistical; Decision Trees; Drug Combinations; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Models, Economic; Models, Statistical; Netherlands; Pyrimidines; Reproducibility of Results; Survival Analysis; Triazoles; Voriconazole | 2007 |
New guinea pig model of Cryptococcal meningitis.
Topics: Animals; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Fluconazole; Guinea Pigs; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2007 |
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Corneal Ulcer; Echinocandins; Eye Infections, Fungal; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Natamycin; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2007 |
Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient.
Topics: Adult; Antifungal Agents; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Male; Mycetoma; Pleurisy; Pyrimidines; Scedosporium; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole | 2008 |
[Treatment with voriconazole for invasive fungal infection during chemotherapy for leukemia: doses and plasma concentration of voriconazole in children].
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunocompromised Host; Infant; Leukemia; Male; Metabolic Clearance Rate; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2007 |
[Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cord Blood Stem Cell Transplantation; Echinocandins; Fatal Outcome; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole | 2007 |
In vivo efficacy and pharmacokinetics of voriconazole in an animal model of dermatophytosis.
Topics: Animals; Antifungal Agents; Chromatography, High Pressure Liquid; Colony Count, Microbial; Dermatomycoses; Extracellular Fluid; Female; Guinea Pigs; Microbial Sensitivity Tests; Microdialysis; Microsporum; Pyrimidines; Skin; Triazoles; Voriconazole | 2007 |
Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Colony Count, Microbial; Colorimetry; Culture Media; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Regression Analysis; Reproducibility of Results; Species Specificity; Spores, Fungal; Tetrazolium Salts; Triazoles; Vitamin K 3; Voriconazole | 2007 |
In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing.
Topics: Antifungal Agents; Fluconazole; France; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2007 |
[A case of orbital apex syndrome caused by localized invasive aspergillosis successfully treated with voriconazole].
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Male; Orbital Diseases; Pyrimidines; Triazoles; Voriconazole | 2007 |
Pulmonary mucormycosis in a nondiabetic renal allograft recipient successfully managed by medical therapy alone.
Topics: Antifungal Agents; Humans; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Mucorales; Mucormycosis; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Data Collection; Drug Evaluation; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Premedication; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis | 2007 |
Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
Topics: Amphotericin B; Antifungal Agents; Female; Fever; Health Care Costs; Hospitalization; Humans; Male; Middle Aged; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
In vitro activity of fluconazole, voriconazole and caspofungin against clinical yeast isolates.
Topics: Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Antifungal susceptibility of Candida species using the Clinical and Laboratory Standards Institute disk diffusion and broth microdilution methods.
Topics: Antifungal Agents; Candida; Disk Diffusion Antimicrobial Tests; Fluconazole; Humans; Microbial Sensitivity Tests; Microbiological Techniques; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2007 |
Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease.
Topics: Adult; Antifungal Agents; Basidiomycota; Caspofungin; Echinocandins; Granulomatous Disease, Chronic; HMGB1 Protein; Humans; Lipopeptides; Male; Mycoses; Osteomyelitis; Peptides, Cyclic; Pyrimidines; Sacrum; Triazoles; Voriconazole | 2007 |
Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Heart Transplantation; Heart-Assist Devices; Humans; Lipopeptides; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2008 |
Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient.
Topics: Antifungal Agents; Drug Synergism; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppression Therapy; Male; Middle Aged; Mycetoma; Naphthalenes; Pyrimidines; Scedosporium; Stem Cell Transplantation; Terbinafine; Triazoles; Voriconazole | 2007 |
Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Induction of voriconazole metabolism by rifampin in a patient with acute myeloid leukemia: importance of interdisciplinary communication to prevent treatment errors with complex medications.
Topics: Antibiotics, Antitubercular; Antifungal Agents; Area Under Curve; Communication; Drug Interactions; Humans; Leukemia, Myeloid; Medication Errors; Pyrimidines; Rifampin; Staphylococcal Infections; Triazoles; Voriconazole | 2007 |
Altered pharmacokinetics of voriconazole in a patient with liver cirrhosis.
Topics: Antifungal Agents; Fatty Liver; Humans; Liver Cirrhosis; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2007 |
The fusarium keratitis outbreak: not done yet?
Topics: Adult; Amphotericin B; Antifungal Agents; Child; Combined Modality Therapy; Corneal Ulcer; Disease Outbreaks; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoplasty, Penetrating; Microbial Sensitivity Tests; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole | 2007 |
Scedosporium apiospermum lung infection with fatal subsequent postoperative outcome in an immunocompetent host.
Topics: Aged; Antifungal Agents; Combined Modality Therapy; Diagnosis, Differential; Fatal Outcome; Humans; Immunocompetence; Lung Diseases, Fungal; Male; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2007 |
The use of voriconazole in the treatment of Aspergillus fumigatus keratitis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Keratitis; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Third-time lung transplant using extended criteria lungs.
Topics: Adult; Antifungal Agents; Brain Death; Humans; Lung Transplantation; Male; Mycoses; Patient Selection; Postoperative Complications; Pyrimidines; Reoperation; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole | 2007 |
[Case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy].
Topics: Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cytochrome P-450 Enzyme System; Humans; Lung Diseases, Fungal; Male; Pituitary ACTH Hypersecretion; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Lecythophora mutabilis prosthetic valve endocarditis in a diabetic patient.
Topics: Amphotericin B; Antifungal Agents; Aortic Valve; Ascomycota; Diabetes Complications; Drug Combinations; Endocarditis; Heart Valve Prosthesis; Humans; Male; Middle Aged; Molecular Sequence Data; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prosthesis-Related Infections; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation; Drug Resistance, Fungal; Fluconazole; Humans; Injections, Intravenous; Molecular Structure; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole.
Topics: Antifungal Agents; Candida albicans; Culture Media; Drug Resistance, Fungal; Fluconazole; Histidine Kinase; Microbial Sensitivity Tests; Mutation; Phenotype; Phosphorylation; Protein Kinases; Pyrimidines; Signal Transduction; Triazoles; Voriconazole | 2007 |
Images in HIV/AIDS. Invasive aspergillosis presenting as a neck mass in a person with HIV/AIDS.
Topics: Adult; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Fatal Outcome; HIV Infections; Humans; Male; Neck; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2007 |
Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Ascomycota; Aspergillus flavus; Caspofungin; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Humans; Lipopeptides; Male; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole | 2007 |
Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Humans; Male; Mycoses; Penicillium; Pyrimidines; Triazoles; Voriconazole | 2007 |
Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
Topics: Aged; Amphotericin B; Antifungal Agents; Cross Infection; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2007 |
Lack of cross-hepatotoxicity between voriconazole and posaconazole.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chemical and Drug Induced Liver Injury; Humans; Pyrimidines; Triazoles; Voriconazole | 2007 |
Plasma concentrations of voriconazole in falcons.
Topics: Animals; Antifungal Agents; Aspergillosis; Biological Availability; Bird Diseases; Dose-Response Relationship, Drug; Falconiformes; Female; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Recalcitrant Beauveria bassiana keratitis: confocal microscopy findings and treatment with posaconazole (Noxafil).
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Beauveria; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Microscopy, Confocal; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Necrosis; Pyrimidines; Radiography; Triazoles; Voriconazole | 2007 |
Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole.
Topics: Adult; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Encephalitis; Humans; Lipopeptides; Male; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole | 2007 |
Development and validation of a simple and rapid HPLC method for the quantitative determination of voriconazole in rat and beagle dog plasma.
Topics: Animals; Antifungal Agents; Chromatography, High Pressure Liquid; Dogs; Female; Male; Pyrimidines; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2007 |
Random plasma concentrations of voriconazole decline over time.
Topics: Antifungal Agents; Female; Humans; Male; Middle Aged; Neoplasms; Plasma; Pyrimidines; Retrospective Studies; Time Factors; Triazoles; Voriconazole | 2007 |
Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole.
Topics: Antifungal Agents; Arthritis, Infectious; Candida; Humans; Knee Joint; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mycoses; Pyrimidines; Synovial Fluid; Triazoles; Voriconazole | 2007 |
Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Female; Genetic Predisposition to Disease; Humans; Injections, Intravenous; Liver; Male; Middle Aged; Polymorphism, Genetic; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Endogenous Scedosporium apiospermum endophthalmitis.
Topics: Adult; Antifungal Agents; Aqueous Humor; Biological Availability; Endophthalmitis; Eye Infections, Fungal; Fatal Outcome; Female; Fungemia; Humans; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Vitreous Body; Voriconazole | 2007 |
Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
Topics: Acute Kidney Injury; Adult; Aged; Antifungal Agents; Area Under Curve; Critical Illness; Female; Half-Life; Hemodiafiltration; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
[Present and future of voriconazole in the treatment of invasive mycoses: the inseparable binomial diagnosis-treatment].
Topics: Antifungal Agents; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Comparison of 2 studies of treatment of invasive aspergillosis.
Topics: Amphotericin B; Aspergillosis; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
In vitro activities of voriconazole as a triazole derivative and caspofungin as an echinocandin were compared with those of some antifungal agents against Candida species isolated from clinical specimens.
Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Sputum; Triazoles; Voriconazole | 2007 |
Aspergillus fumigatus keratitis following laser in situ keratomileusis.
Topics: Adult; Amputation, Surgical; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Corneal Ulcer; Debridement; Eye Infections, Fungal; Female; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Pyrimidines; Surgical Flaps; Triazoles; Voriconazole | 2007 |
Secondary prophylaxis with voriconazole in a leukemic patient with pulmonary aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Child, Preschool; Female; Humans; Immunocompromised Host; Leukemia; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2007 |
Scedosporium apiospermum traumatic endophthalmitis successfully treated with voriconazole.
Topics: Antifungal Agents; Child; Endophthalmitis; Eye Infections, Fungal; Eye Injuries, Penetrating; Female; Humans; Injections; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Vitreous Body; Voriconazole | 2007 |
Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Itraconazole; Mycoses; Pyrimidines; Rabbits; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Time Factors; Triazoles; Voriconazole | 2007 |
Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses.
Topics: Administration, Oral; Animals; Antifungal Agents; Biological Availability; Body Fluids; Cross-Over Studies; Half-Life; Horses; Pyrimidines; Reference Values; Triazoles; Voriconazole | 2007 |
Voriconazole inhibits melanization in Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Cell Line; Cryptococcus neoformans; Fluconazole; Gene Expression Regulation, Fungal; Laccase; Macrophages; Melanins; Mice; Microbial Sensitivity Tests; Phagocytosis; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
Aspiration cytology of brain abscess from a fatal case of cerebral phaeohyphomycosis due to Ramichloridium mackenziei.
Topics: Aged; Amphotericin B; Antifungal Agents; Ascomycota; Biopsy, Needle; Brain Abscess; Central Nervous System Fungal Infections; Combined Modality Therapy; Diabetes Complications; Diabetes Mellitus; Fatal Outcome; Female; Humans; Lupus Erythematosus, Systemic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient.
Topics: Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Leukemia, Plasma Cell; Lipopeptides; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2008 |
Measurement of voriconazole in serum and plasma.
Topics: Anticoagulants; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Interactions; Drug Monitoring; Drug Stability; Humans; Models, Biological; Pyrimidines; Serum; Triazoles; Voriconazole | 2007 |
Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Lipopeptides; Liposomes; Male; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Transplantation, Homologous; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear Diseases; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
Multiple Scedosporium apiospermum brain abscesses after near-drowning successfully treated with surgery and long-term voriconazole: a case report.
Topics: Adult; Antifungal Agents; Brain Abscess; Humans; Male; Mycetoma; Near Drowning; Pyrimidines; Scedosporium; Thailand; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Aspergillus fumigatus-related spondylodiscitis in a heart transplant patient successfully treated with voriconazole.
Topics: Adolescent; Antifungal Agents; Antilymphocyte Serum; Aspergillosis; Aspergillus fumigatus; Discitis; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea.
Topics: Antifungal Agents; Azoles; Bacteremia; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2007 |
Pseudoporphyria associated with voriconazole.
Topics: Antifungal Agents; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Lung Transplantation; Middle Aged; Photosensitivity Disorders; Porphyrias; Pyrimidines; Skin; Skin Diseases, Vesiculobullous; Triazoles; Voriconazole | 2007 |
[Case of invasive sino-orbital aspergillosis developing orbital apex syndrome].
Topics: Aged; Antifungal Agents; Aspergillosis; Cavernous Sinus; Cranial Nerve Diseases; Female; Headache; Humans; Orbit; Orbital Diseases; Otorhinolaryngologic Surgical Procedures; Paranasal Sinus Diseases; Pyrimidines; Syndrome; Treatment Outcome; Triazoles; Vision Disorders; Voriconazole | 2007 |
Invasive tracheal aspergillosis treated successfully with voriconazole: clinical report and review of the literature.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus flavus; Fatal Outcome; Female; Humans; Laryngoscopy; Leukemia, Myeloid, Acute; Opportunistic Infections; Pyrimidines; Tracheitis; Triazoles; Voriconazole | 2007 |
[Case of pulmonary pseudallescheriasis responding successfully to treatment with voriconazole].
Topics: Adult; Antifungal Agents; Diagnosis, Differential; Humans; Lung Diseases, Fungal; Male; Mycetoma; Pneumonectomy; Pseudallescheria; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Images in haematology. Cerebral fungal abscess in a patient with acute promyelocytic leukaemia.
Topics: Antifungal Agents; Brain Abscess; Combined Modality Therapy; Female; Fusarium; Humans; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2007 |
Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chemotherapy, Adjuvant; Drug Evaluation; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Subgingival distribution of yeast and their antifungal susceptibility in immunocompetent subjects with and without dental devices.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Dental Plaque; Drug Resistance, Fungal; Female; Fluconazole; Gingivitis; Humans; Immunocompetence; Male; Microbial Sensitivity Tests; Middle Aged; Orthodontic Appliances; Periodontitis; Pyrimidines; Triazoles; Voriconazole | 2007 |
Voriconazole into PLGA nanoparticles: improving agglomeration and antifungal efficacy.
Topics: Animals; Antifungal Agents; Candida albicans; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Ethanol; Feasibility Studies; Kidney; Kinetics; Mice; Nanoparticles; Particle Size; Phosphates; Polyglactin 910; Pyrimidines; Solubility; Solvents; Surface Properties; Technology, Pharmaceutical; Triazoles; Voriconazole | 2008 |
In vitro efficacy of voriconazole against clinical isolates of Scytalidium spp. from clinical lesions.
Topics: Antifungal Agents; Humans; Mitosporic Fungi; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 2008 |
In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2008 |
In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.
Topics: Animals; Antifungal Agents; Brazil; Dog Diseases; Dogs; Drug Synergism; Horse Diseases; Horses; Infections; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Sheep; Sheep Diseases; Terbinafine; Triazoles; Voriconazole | 2008 |
Comparative cost-effectiveness of voriconazole and amphotericin B in treatment of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Lung Diseases, Fungal; Models, Economic; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2007 |
Managing Candida endophthalmitis (Recurrent Candida albicans endophthalmitis in an immunocompromised host. Vol. 42[1]).
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Immunocompromised Host; Postoperative Complications; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2007 |
Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Child; Child, Preschool; Fluconazole; Flucytosine; Hospitals, Public; Humans; Infant; Infant, Newborn; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2007 |
High-performance liquid chromatographic evaluation of a coated cellulose tris(3,5-dimethylphenylcarbamate) chiral stationary phase having a small-pore silica support.
Topics: Cellulose; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Phenylcarbamates; Pyrimidines; Silicon Dioxide; Triazoles; Voriconazole | 2008 |
In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Pyrimidines; Rhodotorula; Triazoles; Trichosporon; Voriconazole | 2008 |
Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Drug Combinations; Drug Therapy, Combination; Female; Humans; Middle Aged; Neuroaspergillosis; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Triazoles; Voriconazole | 2008 |
Solitary cutaneous nodule in an immunocompromised patient.
Topics: Alternaria; Ankle; Dermatomycoses; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Middle Aged; Pyrimidines; Retreatment; Tacrolimus; Triazoles; Voriconazole | 2007 |
A case of successful resection after long-term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Liver Transplantation; Living Donors; Lung Diseases, Fungal; Middle Aged; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.
Topics: Antifungal Agents; Biomarkers; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Regression Analysis; Triazoles; Voriconazole | 2008 |
Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Humans; Hypersensitivity; Male; Middle Aged; Mycoses; Pyrimidines; Remission Induction; Sinusitis; Triazoles; Voriconazole | 2007 |
Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Bilirubin; Creatinine; Exanthema; Female; Fever; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report.
Topics: Acute Disease; Adolescent; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Child; Child, Preschool; Humans; Leukemia; Male; Middle Aged; Mycetoma; Pyrimidines; Retrospective Studies; Scedosporium; Triazoles; Voriconazole | 2008 |
Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia: the role of voriconazole.
Topics: Acute Disease; Adolescent; Adult; Aged; Anemia, Aplastic; Aspergillosis; Child; Cohort Studies; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2008 |
What is the "therapeutic range" for voriconazole?
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Humans; Pyrimidines; Triazoles; Voriconazole | 2008 |
High-dose voriconazole in a critically ill pediatric patient with neuroblastoma.
Topics: Antifungal Agents; Candidiasis; Child, Preschool; Critical Illness; Humans; Lung Diseases; Male; Neuroblastoma; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Successful treatment by voriconazole for pulmonary aspergilloma of elderly patient].
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2007 |
Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster.
Topics: Animals; Drosophila melanogaster; Drosophila Proteins; Female; Fusarium; Humans; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Spores, Fungal; Toll-Like Receptors; Triazoles; Virulence; Voriconazole | 2007 |
Simultaneous mold infections in an orthotopic heart transplant recipient.
Topics: Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Aspergillus fumigatus; Basiliximab; Cardiomyopathy, Dilated; Debridement; Dermatomycoses; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Mucormycosis; Prosthesis-Related Infections; Pulmonary Aspergillosis; Pyrimidines; Recombinant Fusion Proteins; Rhizopus; Triazoles; Voriconazole | 2008 |
Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans.
Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Aqueous Humor; Biological Availability; Candida; Chromatography, High Pressure Liquid; Humans; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2008 |
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
Topics: Africa; Antifungal Agents; Asia; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Europe; Fluconazole; Fungemia; Global Health; Humans; Latin America; Microbial Sensitivity Tests; Middle East; North America; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2008 |
Breakthrough cutaneous alternariosis in a patient with acute lymphoblastic leukemia: clinical features and diagnostic issues.
Topics: Adult; Alternaria; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Skin Diseases; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2008 |
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
Topics: Antifungal Agents; Aspergillus; Candida; Fluconazole; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2008 |
Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Clinical Trials as Topic; Female; Health Surveys; Humans; Infant; Male; Middle Aged; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2008 |
A pharmacokinetic/pharmacodynamic mathematical model accurately describes the activity of voriconazole against Candida spp. in vitro.
Topics: Algorithms; Antifungal Agents; Area Under Curve; Biological Availability; Candida; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Models, Statistical; Pyrimidines; Triazoles; Voriconazole | 2008 |
The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient.
Topics: Acute Kidney Injury; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Critical Illness; Fatal Outcome; Half-Life; Hemofiltration; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Triazoles; Voriconazole | 2008 |
Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Laboratories; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2008 |
Cervical spondylodiscitis caused by Blastoschizomyces capitatus.
Topics: Adult; Amphotericin B; Antifungal Agents; Cervical Vertebrae; Dipodascus; Discitis; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Neck; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Ultrasonography; Voriconazole | 2009 |
Use of voriconazole in fungal keratitis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Aspergillosis; Chloramphenicol; Contact Lenses; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Humans; Middle Aged; Pyrimidines; Staphylococcal Infections; Triazoles; Visual Acuity; Voriconazole | 2008 |
Voriconazole plasma monitoring.
Topics: Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Drug Monitoring; Humans; Leukemia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2008 |
Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes.
Topics: Absidia; Adult; Amphotericin B; Antifungal Agents; Drug Combinations; Drug Interactions; Humans; Hyphae; Liposomes; Microbial Sensitivity Tests; Neutrophils; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2008 |
Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient.
Topics: Aged; Antifungal Agents; Aspergillosis; Carcinoma, Squamous Cell; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Postoperative Complications; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole | 2008 |
Invasive Aspergillus terreus sinusitis with orbitocranial extension: case report.
Topics: Antifungal Agents; Aspergillosis; Humans; Male; Middle Aged; Pyrimidines; Sphenoid Sinusitis; Triazoles; Voriconazole | 2008 |
Aspergillus "fungus ball" of the bladder after hematopoietic transplantation in a pediatric patient: successful treatment with intravesical voriconazole and surgery.
Topics: Administration, Intravesical; Adolescent; Anemia, Sickle Cell; Antifungal Agents; Aspergillosis; Cystitis; Hematopoietic Stem Cell Transplantation; Humans; Male; Pyrimidines; Triazoles; Urinary Bladder Diseases; Voriconazole | 2008 |
Neuromuscular painful disorders: a rare side effect of voriconazole in lung transplant patients under tacrolimus.
Topics: Adolescent; Adult; Aspergillosis; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Lung Transplantation; Male; Middle Aged; Neuromuscular Diseases; Pain; Postoperative Complications; Pyrimidines; Retrospective Studies; Risk Assessment; Severity of Illness Index; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients.
Topics: Adult; Antifungal Agents; Blister; Bone Marrow Transplantation; Extremities; Female; Fusarium; Graft vs Host Disease; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Clinical case of the month. Pulmonary aspergillosis: chimic necrotizing aspergillosis].
Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis; Chronic Disease; Glucocorticoids; Humans; Lung Diseases, Fungal; Male; Methylprednisolone; Middle Aged; Necrosis; Pneumonia; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Sputum; Triazoles; Voriconazole | 2007 |
Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects.
Topics: Adolescent; Adult; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Contraceptives, Oral, Combined; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Epidemiologic Methods; Female; Humans; Isoenzymes; Mass Spectrometry; Mixed Function Oxygenases; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers.
Topics: Adult; Alkynes; Antifungal Agents; Benzoxazines; Body Weight; Cyclopropanes; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Epidemiologic Methods; Humans; Male; Pyrimidines; Reverse Transcriptase Inhibitors; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Voriconazole in an infant with cryptococcal meningitis.
Topics: Antifungal Agents; Humans; Infant; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2008 |
Determination of the antifungal agent voriconazole in human plasma using a simple column-switching high-performance liquid chromatography and its application to a pharmacokinetic study.
Topics: Antifungal Agents; Area Under Curve; Calibration; Chromatography, High Pressure Liquid; Half-Life; Humans; Pyrimidines; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet; Triazoles; Voriconazole | 2008 |
Successful treatment of postoperative fungal endophthalmitis using intravitreal and intracameral voriconazole.
Topics: Aged; Anterior Chamber; Antifungal Agents; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Injections; Male; Middle Aged; Postoperative Complications; Pyrimidines; Retrospective Studies; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2008 |
Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Aspergillus; Disk Diffusion Antimicrobial Tests; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Bile aspiration for diagnosis of Candida glabrata cholecystitis.
Topics: Acalculous Cholecystitis; Aged; Animals; Antifungal Agents; Bile; Biopsy, Needle; Candida glabrata; Candidiasis; Female; Humans; Pyrimidines; Triazoles; Voriconazole | 2008 |
Penetration of voriconazole, 1%, eyedrops into human aqueous humor: a prospective open-label study.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aqueous Humor; Biological Availability; Humans; Ophthalmic Solutions; Prospective Studies; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2008 |
Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Itraconazole; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2008 |
Recurrent Trichosporon asahii glossitis: a case report.
Topics: Administration, Inhalation; Adult; Antifungal Agents; Asthma; Bronchodilator Agents; Budesonide; Drug Resistance, Fungal; Glossitis; Humans; Immunocompromised Host; Male; Mycoses; Pyrimidines; Recurrence; Triazoles; Trichosporon; Voriconazole | 2008 |
Successful treatment of subcutaneous Scytalidium hyalinum infection with voriconazole and topical terbinafine in a cardiac transplant patient.
Topics: Administration, Topical; Antifungal Agents; Ascomycota; Erythema; Heart Transplantation; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Postoperative Complications; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2008 |
Determination of voriconazole in human plasma and saliva using high-performance liquid chromatography with fluorescence detection.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Pyrimidines; Reference Standards; Reproducibility of Results; Saliva; Sensitivity and Specificity; Spectrometry, Fluorescence; Triazoles; Voriconazole | 2008 |
Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Disk Diffusion Antimicrobial Tests; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function.
Topics: Adult; Aged; Antifungal Agents; Cohort Studies; Critical Illness; Female; Humans; Infusions, Intravenous; Kidney; Liver; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole | 2008 |
Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions.
Topics: Anaerobiosis; Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Echinocandins; Hyphae; Microbial Sensitivity Tests; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole | 2008 |
The use of voriconazole for the treatment of aspergillosis in falcons (Falco species).
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Bird Diseases; Dose-Response Relationship, Drug; Falconiformes; Female; Male; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Role of flavin-containing monooxygenase in oxidative metabolism of voriconazole by human liver microsomes.
Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Humans; Microsomes, Liver; Oxidation-Reduction; Oxygenases; Pyrimidines; Recombinant Proteins; Triazoles; Voriconazole | 2008 |
Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Carbon Dioxide; Dose-Response Relationship, Drug; Microbial Viability; Pyrimidines; Spores, Fungal; Time Factors; Triazoles; Voriconazole | 2008 |
Voriconazole in newborns.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Critical Illness; Humans; Infant, Newborn; Pyrimidines; Triazoles; Voriconazole | 2008 |
Unusual pharmacokinetics of intravitreal and systemic voriconazole in a patient with Scedosporium apiospermum endophthalmitis.
Topics: Adult; Antifungal Agents; Endophthalmitis; Eye Injuries; Humans; Light Coagulation; Male; Ophthalmologic Surgical Procedures; Pyrimidines; Retina; Scedosporium; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2008 |
[Cutaneous, pulmonary and bone aspergillosis in a patient presumed immunocompetent presenting subacute cutaneous lupus erythematosus].
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bone Diseases, Infectious; Caspofungin; Echinocandins; Humans; Lipopeptides; Lung; Lung Diseases, Fungal; Lupus Erythematosus, Systemic; Male; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2008 |
MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii.
Topics: Animals; Antifungal Agents; Bird Diseases; Columbidae; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Triazoles; Voriconazole | 2008 |
Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works.
Topics: Antifungal Agents; Aspergillosis; Chemoprevention; Cross Infection; Disease Outbreaks; Environmental Exposure; Hematology; Hospital Design and Construction; Hospital Units; Humans; Infection Control; Pyrimidines; Triazoles; Voriconazole | 2008 |
Microdialysis as a tool to determine free kidney levels of voriconazole in rodents: a model to study the technique feasibility for a moderately lipophilic drug.
Topics: Animals; Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Feasibility Studies; Kidney; Lipids; Male; Microdialysis; Models, Theoretical; Pyrimidines; Rats; Rats, Wistar; Reference Standards; Reproducibility of Results; Technology, Pharmaceutical; Triazoles; Voriconazole | 2008 |
Successful treatment of disseminated Geotrichum capitatum infection with a combination of caspofungin and voriconazole in an immunocompromised patient.
Topics: Antifungal Agents; Caspofungin; Drug Combinations; Echinocandins; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Usefulness of voriconazole in treatment of Phoma glomerata after penetrating injury].
Topics: Aged; Antifungal Agents; Ascomycota; Eye Injuries, Penetrating; Humans; Male; Mycoses; Pyrimidines; Retinal Detachment; Triazoles; Voriconazole | 2008 |
Absidia corymbifera necrotizing cellulitis in an immunocompromised patient while on voriconazole treatment.
Topics: Absidia; Aged; Antifungal Agents; Diabetes Complications; Foot Injuries; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Mucormycosis; Pyrimidines; Triazoles; Voriconazole | 2008 |
Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Dose-Response Relationship, Drug; Drug Antagonism; Humans; Microbial Sensitivity Tests; Microbial Viability; Models, Biological; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2008 |
[Case of Scedosporium apiospermum cutaneous soft tissue infection treated with voriconazole].
Topics: Administration, Oral; Aged; Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Mycetoma; Pyrimidines; Scedosporium; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Non-Candida albicans Candida mediastinitis of odontogenic origin in a diabetic patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Diabetes Mellitus, Type 2; Female; Humans; Mediastinitis; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2008 |
Disseminated infection by Bipolaris spicifera in an immunocompetent subject.
Topics: Adult; Amphotericin B; Ascomycota; DNA, Fungal; DNA, Ribosomal; Humans; Immunocompetence; Itraconazole; Lymph Nodes; Male; Mycoses; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2008 |
Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin.
Topics: Adolescent; Antifungal Agents; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Hematologic Neoplasms; Humans; Lipopeptides; Male; Mycoses; Neutropenia; Pneumonia; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles; Trichoderma; Voriconazole | 2008 |
Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Endocarditis; Flucytosine; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Models, Biological; Pyrimidines; Triazoles; Voriconazole | 2008 |
Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy.
Topics: Antifungal Agents; Carcinoma, Squamous Cell; HIV; HIV Infections; Humans; Male; Middle Aged; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole | 2008 |
Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Corneal Stroma; Corneal Ulcer; Eye Infections, Fungal; Fusarium; Humans; Injections, Intralesional; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Interactions; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2008 |
[Diagnosis and treatment of pulmonary aspergillosis. Role of voriconazole (discussion)].
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Biomarkers; Clinical Trials as Topic; Galactose; Humans; Immunoglobulin E; Lung Diseases, Fungal; Lung Diseases, Interstitial; Mannans; Practice Guidelines as Topic; Pyrimidines; Serologic Tests; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole; Yeasts | 2008 |
[New systemic antifungal drugs].
Topics: Antifungal Agents; Humans; Pyrimidines; Triazoles; Voriconazole | 2008 |
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2008 |
Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Base Sequence; Colony Count, Microbial; Disease Models, Animal; DNA Primers; DNA, Fungal; Galactose; Guinea Pigs; Humans; Immunoenzyme Techniques; Lung; Lung Diseases, Fungal; Male; Mannans; Mycology; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole | 2008 |
Successful treatment of histoplasmosis brain abscess with voriconazole.
Topics: Adult; Antifungal Agents; Arm; Bone Marrow Diseases; Brain Abscess; Cerebellar Ataxia; Cerebellum; Frontal Lobe; Histoplasmosis; Humans; Itraconazole; Liver Abscess; Magnetic Resonance Imaging; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia.
Topics: Adolescent; Aspergillosis; Aspergillus fumigatus; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Thyroid Diseases; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2008 |
Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B.
Topics: Aminoglycosides; Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Aqueous humor concentration of voriconazole after topical administration in rabbits.
Topics: Administration, Topical; Animals; Antifungal Agents; Aqueous Humor; Biological Availability; Chromatography, High Pressure Liquid; Cornea; Male; Microbial Sensitivity Tests; Ophthalmic Solutions; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2008 |
Hallucinations during voriconazole therapy.
Topics: Adolescent; Adult; Aged; Female; Hallucinations; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2008 |
Combined therapy in treatment of murine infection by Fusarium solani.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Drug Therapy, Combination; Echinocandins; Fusarium; Immunocompromised Host; Kidney; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole | 2008 |
Rhino-cerebral zygomycosis resistant to antimycotic treatment: a case report.
Topics: Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Central Nervous System Diseases; Drug Resistance, Fungal; Fatal Outcome; Humans; Male; Methylprednisolone; Purpura, Thrombocytopenic, Idiopathic; Pyrimidines; Rhinitis; Rhizopus; Triazoles; Voriconazole; Zygomycosis | 2009 |
Concurrent administration of sirolimus and voriconazole: a pilot study assessing safety and approaches to appropriate management.
Topics: Antifungal Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Humans; Immunosuppressive Agents; Pilot Projects; Pyrimidines; Retrospective Studies; Sirolimus; Triazoles; Voriconazole | 2008 |
Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis.
Topics: Administration, Oral; Antifungal Agents; Antineoplastic Agents; Fatal Outcome; Humans; Leukemia; Male; Middle Aged; Mycetoma; Opportunistic Infections; Pyrimidines; Recurrence; Scedosporium; Triazoles; Voriconazole | 2008 |
[A suspected case of voriconazole-induced lung injury].
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Lung Diseases; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2008 |
Osteomyelitis of the rib caused by Aspergillus flavus following cardiac surgery.
Topics: Abscess; Aged; Antifungal Agents; Aspergillosis; Aspergillus flavus; Humans; Male; Osteomyelitis; Pyrimidines; Ribs; Surgical Wound Infection; Thoracic Surgery; Triazoles; Voriconazole | 2009 |
Endogenous mycotic endophthalmitis in an immunocompetent patient.
Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Fluorescein Angiography; Fundus Oculi; Humans; Immunocompetence; Injections; Male; Pyrimidines; Treatment Outcome; Triazoles; Vision Disorders; Vitrectomy; Vitreous Body; Voriconazole; Zygomycosis | 2009 |
Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drosophila melanogaster; Drosophila Proteins; Pyrimidines; Survival Analysis; Toll-Like Receptors; Triazoles; Virulence; Voriconazole | 2008 |
Voriconazole-induced neuropathy.
Topics: Adolescent; Adult; Female; Humans; Leukemia; Male; Nervous System Diseases; Pyrimidines; Triazoles; Voriconazole | 2008 |
Pharmacokinetic-pharmacodynamic analysis of voriconazole in Japanese patients with hematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hematologic Neoplasms; Humans; Male; Metabolic Clearance Rate; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2008 |
Visual disturbance comorbid with hallucination caused by voriconazole in the Japanese population.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hallucinations; Hematologic Neoplasms; Humans; Japan; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2008 |
Voriconazole treatment of invasive aspergillosis: real-world versus health-economic model results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Belgium; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Immunocompromised Host; Male; Middle Aged; Models, Economic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2008 |
Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole era.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pyrimidines; Spain; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Effective management of pulmonary aspergillosis invading the thoracic spine in a child with high risk ALL requiring allogeneic bone marrow transplantation.
Topics: Adoptive Transfer; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bone Marrow Transplantation; Caspofungin; Child; Echinocandins; Female; Graft vs Host Disease; Granulocytes; Humans; Lipopeptides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography, Thoracic; Spine; Triazoles; Voriconazole | 2008 |
Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors.
Topics: Antifungal Agents; Aspergillus fumigatus; Cell Line; Cells, Cultured; Gene Expression Regulation; Humans; Hyphae; Monocytes; NF-kappa B; Pyrimidines; RNA, Messenger; Toll-Like Receptor 2; Toll-Like Receptors; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole | 2008 |
Angio-oedema as an unusual tolerable side effect of voriconazole therapy.
Topics: Adult; Angioedema; Antifungal Agents; Aspergillosis; Female; Histamine H1 Antagonists; Humans; Infusions, Intravenous; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult | 2008 |
Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Pyrimidines; Triazoles; Venezuela; Voriconazole; Young Adult | 2009 |
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Concomitant use of voriconazole and rifabutin in a patient with multiple infections.
Topics: Adult; Antibiotics, Antitubercular; Antifungal Agents; Aspergillus fumigatus; Drug Interactions; Female; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Pulmonary Aspergillosis; Pyrimidines; Rifabutin; Triazoles; Voriconazole | 2008 |
[Use of topical voriconazole in Alternaria keratitis].
Topics: Administration, Oral; Adult; Alternaria; Antifungal Agents; Eye Infections, Fungal; Eye Injuries; Humans; Keratitis; Keratoplasty, Penetrating; Male; Mycoses; Ophthalmic Solutions; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Post-traumatic osteomyelitis due to Aspergillus flavus successfully treated with voriconazole: a case report.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillus flavus; Diabetes Complications; Humans; Male; Osteomyelitis; Pyrimidines; Superinfection; Tibia; Triazoles; Voriconazole | 2008 |
Development and validation of an efficient HPLC method for quantification of voriconazole in plasma and microdialysate reflecting an important target site.
Topics: Calibration; Chromatography, High Pressure Liquid; Humans; Microdialysis; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2008 |
Designing voriconazole treatment for racing pigeons: balancing between hepatic enzyme auto induction and toxicity.
Topics: Administration, Inhalation; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Bird Diseases; Chromatography, High Pressure Liquid; Columbidae; Female; Injections, Intravenous; Liver; Lung; Male; Plasma; Pyrimidines; Triazoles; Voriconazole | 2009 |
First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Bronchoalveolar Lavage Fluid; Drug Resistance, Fungal; Fanconi Anemia; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases, Fungal; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2008 |
Comparison of posaconazole and voriconazole in vitro killing against Candida krusei.
Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Drug Resistance, Fungal; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2008 |
Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole.
Topics: Acanthamoeba; Amebiasis; Animals; Antifungal Agents; Antiprotozoal Agents; Drug Therapy, Combination; Encephalitis; Fatal Outcome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lung; Male; Middle Aged; Phosphorylcholine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Skin; Triazoles; Voriconazole | 2008 |
In vitro synergy of caspofungin with licensed and novel antifungal drugs against clinical isolates of Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Fusarium; Humans; Hyphae; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Tacrolimus; Terbinafine; Triazoles; Voriconazole | 2009 |
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2008 |
Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes.
Topics: Antifungal Agents; Candida glabrata; Caspofungin; Cells, Cultured; Drug Interactions; Echinocandins; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Monocytes; Pyrimidines; Triazoles; Voriconazole | 2008 |
Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.
Topics: Amino Acid Sequence; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pyrimidines; Triazoles; Voriconazole | 2008 |
[What distinctions do Candida biofilms have to offer?].
Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Culture Media; Drug Resistance, Fungal; Echinocandins; Glucose; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2008 |
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2008 |
Inhibition of voriconazole metabolism by chloramphenicol in an adolescent with central nervous system aspergillosis.
Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Chloramphenicol; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Humans; Liver; Male; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole | 2008 |
Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation.
Topics: Adult; Antifungal Agents; Caspofungin; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Myocarditis; Pyrimidines; Shock, Cardiogenic; Triazoles; Voriconazole | 2009 |
Voriconazole-induced photosensitivity.
Topics: Antifungal Agents; Candidiasis; Endocarditis; Humans; Male; Middle Aged; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole | 2008 |
Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
Topics: Aged; Antifungal Agents; Aspergillosis; Drug Interactions; Everolimus; Fatal Outcome; Fluconazole; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Pyrimidines; Sirolimus; Triazoles; Voriconazole | 2008 |
Successful medical treatment of a case of Paecilomyces lilacinus keratitis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Drug Resistance, Fungal; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Keratitis; Middle Aged; Naphthalenes; Paecilomyces; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2008 |
Alternaria infectoria brain abscess in a child with chronic granulomatous disease.
Topics: Alternaria; Antifungal Agents; Brain; Brain Abscess; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Granulomatous Disease, Chronic; Humans; Lipopeptides; Male; Mycoses; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 5.8S; Seizures; Triazoles; Voriconazole | 2009 |
National surveillance of antifungal susceptibility of Candida species in South Korean hospitals.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Republic of Korea; Triazoles; Voriconazole | 2009 |
Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biofilms; Caspofungin; Echinocandins; Formazans; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Mycelium; Oxidation-Reduction; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole | 2008 |
EUCAST Technical Note on voriconazole.
Topics: Antifungal Agents; Europe; Fungi; Humans; Microbial Sensitivity Tests; Mycology; Pyrimidines; Triazoles; Voriconazole | 2008 |
Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.
Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Humans; Indicators and Reagents; Microbial Sensitivity Tests; Microbial Viability; Mycology; Naphthalenes; Pyridones; Pyrimidines; Sensitivity and Specificity; Spectrophotometry; Terbinafine; Tetrazolium Salts; Triazoles; Vitamin K 3; Voriconazole | 2008 |
Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
Topics: Antifungal Agents; Culture Media; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X.
Topics: Charcot-Marie-Tooth Disease; Child, Preschool; Drug Synergism; Female; Humans; Peripheral Nervous System Diseases; Pyrimidines; Triazoles; Vincristine; Voriconazole | 2009 |
[Chronic necrotizing aspergillosis].
Topics: Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; Chronic Disease; Cough; Female; Fever; Humans; Lung Diseases, Fungal; Middle Aged; Necrosis; Pyrimidines; Triazoles; Voriconazole | 2008 |
Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Debridement; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Pyrimidines; Soft Tissue Infections; Terbinafine; Triazoles; Voriconazole | 2008 |
[Ocular penetration and pharmacokinetics of topical voriconazole in rabbit eyes].
Topics: Administration, Topical; Animals; Chromatography, High Pressure Liquid; Ophthalmic Solutions; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2008 |
Quantitative PCR assay used to monitor serum Trichosporon asahii DNA concentrations in disseminated trichosporonosis.
Topics: Adolescent; Antifungal Agents; Antigens, Fungal; Bone Marrow Transplantation; DNA, Fungal; Graft vs Host Disease; Humans; Immunocompromised Host; Latex Fixation Tests; Male; Microbial Sensitivity Tests; Mycoses; Polymerase Chain Reaction; Polysaccharides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2008 |
Comparison of the anti-inflammatory activities of imidazole antimycotics in relation to molecular structure.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Cells, Cultured; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Leukotriene B4; Molecular Structure; Neutrophils; Platelet Activating Factor; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Case of an HTLV-1 carrier complicated with chronic pulmonary histoplasmosis].
Topics: Antibodies, Fungal; Antibodies, Viral; Antifungal Agents; Carrier State; Chronic Disease; Histoplasma; Histoplasmosis; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunodiffusion; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Serologic Tests; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
Topics: Adolescent; Adult; Aged; Argentina; Candida; Candidiasis, Oral; Dental Plaque; DNA, Fungal; Drug Resistance, Fungal; Female; Fluconazole; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Periodontal Pocket; Phenotype; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2008 |
Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Serotyping; Triazoles; Voriconazole | 2009 |
Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient.
Topics: Adrenal Cortex Hormones; Anti-Retroviral Agents; Antifungal Agents; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Immune System; Inflammation; Liver Transplantation; Magnetic Resonance Imaging; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2008 |
Pulmonary aspergillosis in hematologic malignancies: lights and shadows.
Topics: Antifungal Agents; Aspergillosis; Hematologic Neoplasms; Humans; Lung Diseases; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2008 |
In vitro susceptibility of Pythium insidiosum and a Lagenidium sp to itraconazole, posaconazole, voriconazole, terbinafine, caspofungin, and mefenoxam.
Topics: Alanine; Anti-Infective Agents; Caspofungin; Echinocandins; In Vitro Techniques; Itraconazole; Lagenidium; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Terbinafine; Triazoles; Voriconazole | 2008 |
The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers.
Topics: Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Asian People; China; Cytochrome P-450 CYP2C19; Genotype; Humans; Male; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Drug Therapy; Female; Health Care Costs; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Intravitreal voriconazole: in vitro safety-profile for fungal endophthalmitis.
Topics: Adult; Aged; Antifungal Agents; Cell Proliferation; Cells, Cultured; Colorimetry; Endophthalmitis; Eye Infections, Fungal; Humans; Injections; Middle Aged; Oxidative Stress; Pyrimidines; Retinal Pigment Epithelium; Treatment Outcome; Triazoles; Vitreous Body; Voriconazole | 2009 |
Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Multiple, Fungal; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2008 |
Preparation and stability of voriconazole eye drop solution.
Topics: Antifungal Agents; Chemistry, Pharmaceutical; Drug Compounding; Drug Stability; Excipients; Hydrogen-Ion Concentration; Ophthalmic Solutions; Pyrimidines; Triazoles; Voriconazole | 2009 |
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Topics: Africa; Antifungal Agents; Asia, Southeastern; Drug Resistance, Fungal; Europe; Fluconazole; Humans; Latin America; Microbial Sensitivity Tests; Middle East; Mycoses; North America; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2009 |
Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Child; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2009 |
Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.
Topics: Animals; Antifungal Agents; Brain; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Fluconazole; Kidney; Male; Mice; Neutropenia; Nitriles; Pyridines; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Free renal levels of voriconazole determined by microdialysis in healthy and Candida sp.-infected Wistar rats.
Topics: Animals; Antifungal Agents; Area Under Curve; Candidiasis; Kidney; Male; Microdialysis; Models, Animal; Protein Binding; Pyrimidines; Rats; Rats, Wistar; Serum; Triazoles; Voriconazole | 2009 |
Pharmacokinetics, tissue concentrations, and safety of the antifungal agent voriconazole in chickens.
Topics: Animals; Antifungal Agents; Biological Availability; Brain; Chickens; Kidney; Liver; Lung; Muscle, Skeletal; Pyrimidines; Skin; Specific Pathogen-Free Organisms; Tissue Distribution; Triazoles; Voriconazole | 2008 |
International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations.
Topics: Antifungal Agents; Azoles; Biological Assay; Fluconazole; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2009 |
A multi-centre comparison of nursing staff time required for the preparation and administration of liposomal amphotericin B and amphotericin B deoxycholate vs. voriconazole.
Topics: Amphotericin B; Antifungal Agents; Costs and Cost Analysis; Deoxycholic Acid; Drug Combinations; Humans; Pyrimidines; Time Management; Triazoles; United Kingdom; Voriconazole | 2009 |
Paecilomyces lilacinus peritonitis complicating peritoneal dialysis cured by oral voriconazole and terbinafine combination therapy.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Drug Therapy, Combination; Humans; Male; Mycoses; Naphthalenes; Paecilomyces; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A.
Topics: Antifungal Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Data Interpretation, Statistical; Enzyme Inhibitors; Humans; In Vitro Techniques; Isoenzymes; Kinetics; Microsomes, Liver; Pilot Projects; Pyrimidines; Spectrophotometry, Ultraviolet; Triazoles; Voriconazole | 2009 |
Hypotension due to the drug interaction of voriconazole with eplerenone and nifedipine.
Topics: Antifungal Agents; Antihypertensive Agents; Drug Interactions; Drug Therapy, Combination; Eplerenone; Humans; Hypotension; Male; Middle Aged; Nifedipine; Pyrimidines; Spironolactone; Triazoles; Voriconazole | 2009 |
Adverse drug events complicate antifungal therapy for pulmonary aspergilloma.
Topics: Aged; Antifungal Agents; Aspergillosis; Drug Interactions; Follow-Up Studies; Hallucinations; Heart Failure; Humans; Itraconazole; Liver Function Tests; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2008 |
CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.
Topics: Adult; Alleles; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Controlled Clinical Trials as Topic; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Female; Genotype; Heterozygote; Homozygote; Humans; Male; Polymorphism, Genetic; Pyrimidines; Regression Analysis; Triazoles; Voriconazole; Young Adult | 2009 |
Retrospective serological tests for determining the optimal blood concentration of voriconazole for treating fungal infection.
Topics: Antifungal Agents; Antigens, Fungal; Aspergillus; beta-Glucans; Biomarkers; Drug Monitoring; Female; Humans; Male; Pyrimidines; Retrospective Studies; Serologic Tests; Triazoles; Voriconazole | 2008 |
Aspergillus mastoiditis, presenting with unexplained progressive otalgia, in an immunocompetent (older) patient.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Drug Therapy, Combination; Earache; Humans; Immunocompetence; Male; Mastoid; Mastoiditis; Miconazole; Postoperative Care; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Tympanic Membrane Perforation; Voriconazole | 2009 |
Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation.
Topics: Antifungal Agents; Aspergillosis; Child, Preschool; Drug Monitoring; Extracorporeal Membrane Oxygenation; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Clinical features of chronic necrotizing pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease].
Topics: Adult; Aged; Aged, 80 and over; Aspergillosis; Chronic Disease; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Respiratory Tract Diseases; Treatment Outcome; Triazoles; Voriconazole | 2008 |
A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Global Health; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2009 |
Evaluation of the Neo-Sensitabs diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media.
Topics: Agar; Amphotericin B; Antifungal Agents; Cryptococcus; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2008 |
Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies.
Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Child; Child, Preschool; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Models, Biological; Pyrimidines; Triazoles; Voriconazole | 2009 |
Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring?
Topics: Antifungal Agents; Drug Monitoring; Hallucinations; Humans; Neurotoxicity Syndromes; Pyrimidines; Risk Assessment; Triazoles; Voriconazole | 2009 |
[Case of orbital apex syndrome caused by invasive aspergillosis successfully treated during the diagnostic procedure by the use of voriconazole].
Topics: Aged; Antifungal Agents; Aspergillosis; Female; Humans; Ocular Motility Disorders; Orbital Diseases; Pyrimidines; Syndrome; Treatment Outcome; Triazoles; Vision Disorders; Voriconazole | 2008 |
Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin.
Topics: Administration, Topical; Adult; Aged; Alternaria; Antifungal Agents; Caspofungin; Cataract Extraction; Contact Lenses; Corneal Stroma; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Eye Injuries; Female; Fluconazole; Humans; Injections; Keratitis; Lipopeptides; Male; Medical Records; Middle Aged; Pyrimidines; Steroids; Treatment Outcome; Triazoles; Voriconazole | 2009 |
High voriconazole trough levels in relation to hepatic function: how to adjust the dosage?
Topics: Antifungal Agents; Humans; Liver Diseases; Pyrimidines; Triazoles; Voriconazole | 2009 |
Voriconazole and posaconazole resistant Candida pelliculosa fungemia after cardiac surgery.
Topics: Amphotericin B; Antifungal Agents; Candida; Cardiac Surgical Procedures; Child; Drug Resistance, Multiple, Fungal; Fungemia; Humans; Infant; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole | 2009 |
Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Deoxycholic Acid; Drug Combinations; Female; Fungi; Hematopoietic Stem Cell Transplantation; Humans; Logistic Models; Male; Middle Aged; Mucorales; Mycoses; North America; Prevalence; Prospective Studies; Pyrimidines; Risk Factors; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Susceptibility to voriconazole, fluconazole, and ketoconazole of yeast isolated from patients with hematological malignancies.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hematologic Neoplasms; Humans; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Early detection of breakthrough trichosporonosis by serum PCR in a cord blood transplant recipient being prophylactically treated with voriconazole.
Topics: Adolescent; Antifungal Agents; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; DNA, Fungal; Fungemia; Humans; Male; Mycoses; Myelodysplastic Syndromes; Polymerase Chain Reaction; Prognosis; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2008 |
Voriconazole use for endemic fungal infections.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Female; Histoplasmosis; Humans; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2009 |
[Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; HIV Seropositivity; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2009 |
Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Lung; Male; Mice; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report.
Topics: Adrenal Cortex Hormones; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Ciprofloxacin; Fatal Outcome; Humans; Itraconazole; Male; Mucormycosis; Prednisolone; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2009 |
[Saccharomyces cerevisiae fungemia associated with multifocal pneumonia in a patient with alcohol-related hepatic cirrhosis].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Liver Cirrhosis, Alcoholic; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography; Saccharomyces cerevisiae; Treatment Outcome; Triazoles; Voriconazole | 2008 |
The use of voriconazole in the treatment of cylindrocarpon keratomycosis.
Topics: Antifungal Agents; Ascomycota; Cornea; Corneal Ulcer; Drug Resistance, Fungal; Female; Humans; Keratitis; Microscopy, Confocal; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
In vitro activity of caspofungin and voriconazole against uncommon Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Lack of allergic cross-reactivity between fluconazole and voriconazole.
Topics: Aged; Antifungal Agents; Cross Reactions; Drug Hypersensitivity; Fluconazole; Humans; Liver; Male; Pyrimidines; Triazoles; Voriconazole | 2009 |
Accelerated metabolism of voriconazole and its partial reversal by cimetidine.
Topics: Antifungal Agents; Cimetidine; Cytochrome P-450 CYP3A; Drug Interactions; Hemofiltration; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2009 |
Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation.
Topics: Adult; Amphotericin B; Aspergillosis; Cerebrum; Female; Flucytosine; Humans; Immunocompromised Host; Intestines; Kidney Transplantation; Lung Diseases, Fungal; Neuroaspergillosis; Pyrimidines; Sphenoid Sinus; Triazoles; Voriconazole | 2009 |
Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2008 |
In vitro activities of fluconazole and voriconazole against clinical isolates of Candida spp. determined by disk diffusion testing in Turin, Italy.
Topics: Antifungal Agents; Candida; Diffusion; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Scedosporium apiospermum skeletal infection in an immunocompetent child.
Topics: Antifungal Agents; Child; Female; Humans; Knee; Mycoses; Osteomyelitis; Pyrimidines; Radiography; Scedosporium; Triazoles; Voriconazole | 2009 |
Cerebral aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Brain; Brain Abscess; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mood Disorders; Myelodysplastic Syndromes; Personality; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2009 |
Cryptococcus neoformans serotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazole and voriconazole.
Topics: Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Wood | 2009 |
Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.
Topics: Adolescent; Adult; Antifungal Agents; Child; Dermatitis, Phototoxic; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2009 |
Successful treatment of disseminated fusariosis in a child with acute myelogenous leukaemia with medical and surgical approach.
Topics: Antifungal Agents; Child; Debridement; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Prolonged survival of a patient with AIDS and central nervous system aspergillosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Aspergillus fumigatus; Brain; Head; Humans; Male; Neuroaspergillosis; Pyrimidines; Radiography; Survival; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.
Topics: Adolescent; Adult; Antifungal Agents; Caspofungin; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Humans; Lipopeptides; Male; Plasma; Pyrimidines; Triazoles; Voriconazole | 2009 |
Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Packaging; Drug Stability; Drug Storage; Hydrogen-Ion Concentration; Infusions, Parenteral; Mycoses; Polyenes; Polyvinyl Chloride; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2008 |
Blastomycosis.
Topics: Adult; Antifungal Agents; Blastomycosis; Contrast Media; Headache; Humans; Magnetic Resonance Imaging; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Humans; Kidney; Lipopeptides; Male; Micafungin; Mice; Microbial Sensitivity Tests; Mycetoma; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antifungal Agents; Chemoprevention; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2009 |
Candida parapsilosis endocarditis in aged patient.
Topics: Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Endocarditis; Female; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole | 2009 |
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin.
Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillus fumigatus; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Rats; Treatment Outcome; Triazoles; Voriconazole | 2009 |
[Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis].
Topics: Abdomen; Antifungal Agents; Caspofungin; Colonic Neoplasms; Critical Illness; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Laparotomy; Lipopeptides; Middle Aged; Peritonitis; Physical Therapy Modalities; Postoperative Complications; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2009 |
Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance registry.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Female; Humans; Male; Middle Aged; Osteomyelitis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
Topics: Amphotericin B; Animals; Animals, Domestic; Animals, Wild; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Pharmacokinetics of intracameral voriconazole injection.
Topics: Animals; Antifungal Agents; Aqueous Humor; Half-Life; Injections; Pyrimidines; Rabbits; Triazoles; Vitreous Body; Voriconazole | 2009 |
[Usefulness of monitoring plasma voriconazole concentration in patients with chronic necrotizing pulmonary aspergillosis].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes.
Topics: Adult; Aged; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Liver; Male; Middle Aged; Plasma; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole | 2009 |
Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients.
Topics: Adult; Antifungal Agents; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pyrimidines; Statistics, Nonparametric; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2009 |
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2009 |
Successful treatment with voriconazole of prolonged Paecilomyces lilacinus fungemia in a chronic hemodialyzed patient.
Topics: Aged; Antifungal Agents; Catheter-Related Infections; Catheters, Indwelling; Female; Fungemia; Humans; Paecilomyces; Pyrimidines; Renal Dialysis; Triazoles; Voriconazole | 2009 |
Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents, Phytogenic; Drug Interactions; Female; Fluconazole; Humans; Male; Middle Aged; Peristalsis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Retrospective Studies; Triazoles; Vincristine; Voriconazole | 2009 |
Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Confidence Intervals; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Immunoglobulin E; Male; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2009 |
The use of voriconazole in the management of post-penetrating keratoplasty Paecilomyces keratitis.
Topics: Antifungal Agents; Combined Modality Therapy; Drug Administration Routes; Endophthalmitis; Eye Infections, Fungal; Humans; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Paecilomyces; Pyrimidines; Triazoles; Voriconazole | 2009 |
Case of cutaneous Scedosporium apiospermum infection successfully treated with voriconazole.
Topics: Antifungal Agents; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Mycetoma; Nephrotic Syndrome; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2009 |
Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.
Topics: Administration, Inhalation; Amphotericin B; Animals; Antifungal Agents; Invasive Pulmonary Aspergillosis; Mice; Mice, Inbred ICR; Pyrimidines; Triazoles; Voriconazole | 2009 |
Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis.
Topics: Adult; Antifungal Agents; Antiviral Agents; Bronchiolitis Obliterans; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Graft Rejection; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Pyrimidines; Syndrome; Triazoles; Valganciclovir; Voriconazole | 2009 |
Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Cross Infection; Echinocandins; Fungemia; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant.
Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Male; Meningitis, Cryptococcal; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2009 |
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cystic Fibrosis; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Mycoses; Pyrimidines; Scedosporium; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2009 |
[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Caspofungin; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Leukoencephalopathy, Progressive Multifocal; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.
Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Galactose; Humans; Mannans; Pulmonary Aspergillosis; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2009 |
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.
Topics: Antifungal Agents; Child; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Mycoses; Naphthalenes; Osteomyelitis; Phosphorylcholine; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries | 2009 |
Concentrations of voriconazole in healthy and inflamed lung in rats.
Topics: Animals; Antifungal Agents; Lung; Male; Muscle, Skeletal; Pneumonia; Protein Binding; Pyrimidines; Rats; Rats, Wistar; Triazoles; Voriconazole | 2009 |
Topical and oral voriconazole in the treatment of fungal keratitis.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Cornea; Diagnosis, Differential; Dose-Response Relationship, Drug; Eye Infections, Fungal; Follow-Up Studies; Humans; Keratitis; Male; Middle Aged; Ophthalmic Solutions; Pyrimidines; Triazoles; Voriconazole | 2009 |
Pharmacokinetic/pharmacodynamic modelling and in vitro simulation of dynamic voriconazole-Candida interactions.
Topics: Administration, Oral; Algorithms; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Models, Theoretical; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2009 |
The effects of caspofungin and voriconazole in an experimental fungal infection of the ear due to Aspergillus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cyclophosphamide; Disease Models, Animal; Echinocandins; Immunocompromised Host; Immunosuppressive Agents; Lipopeptides; Otitis Media; Pyrimidines; Rabbits; Triamcinolone Acetonide; Triazoles; Voriconazole | 2009 |
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Humans; Liver Diseases; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
[Two cases of mycoses associated with hematologic disease].
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cunninghamella; Fatal Outcome; Humans; Liposomes; Male; Mucormycosis; Myelodysplastic Syndromes; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Case of pulmonary mycoses associated with malignant lymphoma during chemotherapy].
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Immunocompromised Host; Lung Diseases, Fungal; Lymphoma; Male; Middle Aged; Muscle Neoplasms; Prednisolone; Psoas Muscles; Pyrimidines; Treatment Outcome; Triazoles; Vincristine; Voriconazole | 2008 |
Characterization and pharmacokinetic analysis of aerosolized aqueous voriconazole solution.
Topics: Aerosols; Animals; Area Under Curve; beta-Cyclodextrins; Chemistry, Pharmaceutical; Drug Delivery Systems; Lipopeptides; Lung; Male; Mice; Particle Size; Pharmaceutical Solutions; Plasma; Pyrimidines; Solutions; Triazoles; Voriconazole | 2009 |
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2009 |
Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Drosophila; Fungi; Humans; Itraconazole; Mice; Mucor; Pyrimidines; Rhizopus; Triazoles; Virulence; Voriconazole; Zygomycosis | 2009 |
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2009 |
Fusarium keratitis and endophthalmitis associated with lens contact wear.
Topics: Adult; Antifungal Agents; Contact Lens Solutions; Contact Lenses; Cornea; Corneal Transplantation; Disease Progression; Drug Resistance, Fungal; Endophthalmitis; Fusarium; Humans; Keratitis; Male; Patient Compliance; Pyrimidines; Time Factors; Triazoles; Visual Acuity; Voriconazole | 2010 |
Peritonitis due to Neosartorya pseudofischeri in an elderly patient undergoing peritoneal dialysis successfully treated with voriconazole.
Topics: Antifungal Agents; Female; Humans; Kidney Failure, Chronic; Middle Aged; Mycoses; Neosartorya; Peritoneal Dialysis; Peritonitis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Simultaneous determination of voriconazole and posaconazole concentrations in human plasma by high-performance liquid chromatography.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2009 |
Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazines; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; Humans; Liver Cirrhosis; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2009 |
Dynamics of in vitro acquisition of resistance by Candida parapsilosis to different azoles.
Topics: Antifungal Agents; Biosynthetic Pathways; Candida; Drug Resistance, Fungal; Ergosterol; Fluconazole; Humans; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2009 |
In vitro activity of voriconazole against Mexican oral yeast isolates.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; HIV Infections; Humans; Mexico; Microbial Sensitivity Tests; Mouth; Pharynx; Pyrimidines; Triazoles; Voriconazole | 2010 |
Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata.
Topics: Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2009 |
[Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis].
Topics: Amphotericin B; Antifungal Agents; Bioprosthesis; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Endocarditis; Heart Valve Prosthesis; Humans; Lipopeptides; Liposomes; Male; Middle Aged; Photosensitivity Disorders; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole | 2010 |
Fatal cerebral zygomycosis breakthrough in a patient with acute lymphoblastic leukemia on voriconazole prophylaxis after cord blood SCT.
Topics: Adult; Antifungal Agents; Central Nervous System Fungal Infections; Cord Blood Stem Cell Transplantation; Fatal Outcome; Female; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2009 |
Aspergillus vertebral osteomyelitis and epidural abscess.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Epidural Abscess; Fatal Outcome; Humans; Infusions, Intravenous; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pneumonectomy; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Spinal Cord Compression; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole | 2009 |
Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Infant; Infant, Newborn; Lipopeptides; Male; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Salvage Therapy; Triazoles; Voriconazole | 2009 |
Intracameral voriconazole: in vitro safety for human ocular cells.
Topics: Antifungal Agents; Cell Count; Cell Proliferation; Cell Survival; Cells, Cultured; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelium, Corneal; Eye; Formazans; Humans; Hydrogen Peroxide; Interleukin-6; Lipopolysaccharides; Molecular Structure; Organ Culture Techniques; Pigment Epithelium of Eye; Pyrimidines; Tetrazolium Salts; Time Factors; Trabecular Meshwork; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole | 2009 |
Antifungal activity of itraconazole and voriconazole against clinical isolates obtained from animals with mycoses.
Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Prospective open-label study of the administration of two-percent voriconazole eye drops.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aqueous Humor; Female; Humans; Keratitis; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2009 |
Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
Topics: Administration, Topical; Antifungal Agents; Cost-Benefit Analysis; Eye Infections, Fungal; Female; Humans; Keratitis; Microbial Sensitivity Tests; Middle Aged; Natamycin; Pyrimidines; Recurrence; Salvage Therapy; Scedosporium; Triazoles; Visual Acuity; Voriconazole | 2009 |
Isolated cerebral aspergilloma in a young immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Brain Edema; Female; Humans; Muscle Weakness; Pyrimidines; Seizures; Treatment Outcome; Triazoles; Voriconazole | 2009 |
In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens.
Topics: Antifungal Agents; Aspergillus; Candida albicans; Candidiasis; Colony Count, Microbial; Ear Diseases; Fluconazole; Humans; Itraconazole; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
[Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis].
Topics: Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Humans; Male; Pain; Peripheral Nervous System Diseases; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals.
Topics: Anisomycin; Antifungal Agents; Biological Transport; Candida albicans; Curcumin; Cycloheximide; Drug Synergism; Enzyme Inhibitors; Fluconazole; Itraconazole; Ketoconazole; Methotrexate; Miconazole; Multidrug Resistance-Associated Proteins; Pyrimidines; Rhodamines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2009 |
Efficacy of triazoles in a murine disseminated infection by Candida krusei.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Kidney; Male; Mice; Pyrimidines; Random Allocation; Triazoles; Voriconazole | 2009 |
The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo.
Topics: Animals; Antifungal Agents; Brain; Cattle; Cholesterol; Cholesterol 24-Hydroxylase; Enzyme Inhibitors; Gene Expression Regulation; Homeostasis; Humans; Hydroxycholesterols; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Pyrimidines; RNA, Messenger; Steroid Hydroxylases; Triazoles; Voriconazole | 2010 |
Subcutaneous mycosis and fungemia by Aureobasidium pullulans: a rare pathogenic fungus in a post allogeneic BM transplant patient.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Fungemia; Humans; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2010 |
Infections caused by Candida krusei in five transplant and two surgical patients.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Caspofungin; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Fungal; Echinocandins; Female; Genotype; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycological Typing Techniques; Organ Transplantation; Postoperative Complications; Pyrimidines; Random Amplified Polymorphic DNA Technique; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Successful treatment of choroidal blastomycosis with oral administration of voriconazole.
Topics: Administration, Oral; Antifungal Agents; Blastomycosis; Choroid Diseases; Dose-Response Relationship, Drug; Eye Infections, Fungal; Follow-Up Studies; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2009 |
Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin.
Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Female; Humans; Lipopeptides; Male; Middle Aged; Pneumonectomy; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Management of metabolic cytochrome P450 3A4 drug-drug interaction between everolimus and azole antifungals in a renal transplant patient.
Topics: Antifungal Agents; Aspergillosis; Cytochrome P-450 CYP3A; Drug Interactions; Drug Monitoring; Everolimus; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyrimidines; Sirolimus; Triazoles; Voriconazole | 2009 |
Anidulafungin treatment of candidal central nervous system infection in a murine model.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Central Nervous System Infections; Disease Models, Animal; Echinocandins; Female; Mice; Pyrimidines; Triazoles; Voriconazole | 2009 |
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2009 |
Dose tolerability of chronically inhaled voriconazole solution in rodents.
Topics: Administration, Inhalation; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Invasive Pulmonary Aspergillosis; Lung; Macrophages, Alveolar; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Tissue Distribution; Triazoles; Voriconazole | 2009 |
Systemic phaeohyphomycosis resembling primary sclerosing cholangitis caused by Exophiala dermatitidis.
Topics: Amphotericin B; Antifungal Agents; Cholangitis, Sclerosing; Diagnosis, Differential; Exophiala; Female; Humans; Lymph Nodes; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
Toxicokinetics of voriconazole during massive intentional poisoning.
Topics: Antifungal Agents; Humans; Male; Middle Aged; Poisoning; Pyrimidines; Serum; Triazoles; Voriconazole | 2009 |
[Complex visual hallucinations induced by voriconazole].
Topics: Aged; Antifungal Agents; Female; Hallucinations; Humans; Pyrimidines; Triazoles; Voriconazole | 2009 |
In vitro interactions between antifungals and methotrexate against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Itraconazole; Methotrexate; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2009 |
Efficacy of voriconazole in Japanese quail (Coturnix japonica) experimentally infected with Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Coturnix; Disease Models, Animal; Female; Histocytochemistry; Lung; Male; Microbial Sensitivity Tests; Pyrimidines; Statistics, Nonparametric; Triazoles; Voriconazole | 2010 |
New treatment for invasive fungal sinusitis: three cases of chronic invasive fungal sinusitis treated with surgery and voriconazole.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Maxillary Sinusitis; Pyrimidines; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Stability and uniformity of extemporaneous preparations of voriconazole in two liquid suspension vehicles at two storage temperatures.
Topics: Antifungal Agents; Drug Compounding; Drug Stability; Pharmaceutical Vehicles; Pyrimidines; Suspensions; Tablets; Temperature; Time Factors; Triazoles; Voriconazole | 2009 |
Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
Topics: Administration, Intravaginal; Administration, Oral; Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Drug Resistance, Fungal; Female; Fluconazole; Mice; Mice, Inbred BALB C; Pyrimidines; Treatment Outcome; Triazoles; Vagina; Voriconazole | 2009 |
Comparison of 24-hour and 48-hour voriconazole MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) in three laboratories: results obtained with 2,162 clinical isolates of Candida spp. and othe
Topics: Antifungal Agents; Candida; Diagnostic Errors; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2009 |
Designing a treatment protocol with voriconazole to eliminate Aspergillus fumigatus from experimentally inoculated pigeons.
Topics: Administration, Inhalation; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Columbidae; Invasive Pulmonary Aspergillosis; Liver; Pyrimidines; Triazoles; Voriconazole | 2009 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole | 2009 |
Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Italy; Microbial Sensitivity Tests; Outpatient Clinics, Hospital; Prevalence; Pyrimidines; Recurrence; Triazoles; Vagina; Voriconazole | 2009 |
Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole | 2009 |
Neuroaspergillosis in an immunocompetent patient successfully treated with voriconazole and a corticosteroid.
Topics: Aged; Antifungal Agents; Brain Diseases; Humans; Immunocompetence; Male; Neuroaspergillosis; Pyrimidines; Remission Induction; Triazoles; Voriconazole | 2009 |
Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection.
Topics: Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Fluconazole; Humans; Itraconazole; Ketoconazole; Pyrimidines; Quality Control; Reproducibility of Results; Spectrophotometry, Ultraviolet; Time Factors; Triazoles; Ultraviolet Rays; Voriconazole | 2009 |
Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Drug Resistance, Multiple, Fungal; Genetic Variation; Genome, Fungal; Geography; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Sequence Analysis, DNA; Thailand; Triazoles; Trichosporon; Voriconazole | 2010 |
[Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces capitatus (Geotrichum capitatum) by two different methods].
Topics: Antifungal Agents; Dipodascus; Fluconazole; Geotrichosis; Humans; Itraconazole; Microbial Sensitivity Tests; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Cutaneous aspergillosis in a lung transplant recipient.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dermatomycoses; Female; Humans; Lung Transplantation; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2009 |
Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Disease Progression; Drug Resistance, Fungal; Evolution, Molecular; Fungal Proteins; Humans; Itraconazole; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2009 |
Fusarium endophthalmitis following refractive lens exchange for correction of high myopia.
Topics: Anterior Chamber; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Middle Aged; Mycoses; Myopia, Degenerative; Pyrimidines; Reoperation; Triazoles; Visual Acuity; Voriconazole | 2009 |
Can density functional theory (DFT) be used as an aid to a deeper understanding of tandem mass spectrometric fragmentation pathways?
Topics: Antifungal Agents; Fluconazole; Molecular Structure; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2009 |
A newly developed lung nodule during chemotherapy for small cell lung cancer. Chronic necrotising pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chronic Disease; Etoposide; Humans; Lung Neoplasms; Male; Pulmonary Aspergillosis; Pyrimidines; Small Cell Lung Carcinoma; Triazoles; Voriconazole | 2009 |
Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.
Topics: Aged; Antifungal Agents; Cohort Studies; Female; Humans; Itraconazole; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Pharmacokinetics of voriconazole after single dose intravenous and oral administration to alpacas.
Topics: Administration, Oral; Animals; Antifungal Agents; Camelids, New World; Chromatography, High Pressure Liquid; Female; Injections, Intravenous; Linear Models; Male; Pyrimidines; Triazoles; Voriconazole | 2009 |
Fungal keratitis with intracameral extension following penetrating keratoplasty.
Topics: Administration, Oral; Administration, Topical; Anterior Chamber; Antifungal Agents; Aspergillosis; Corneal Stroma; Debridement; Drug Administration Schedule; Graft Rejection; Humans; Injections; Keratitis; Keratoconus; Keratoplasty, Penetrating; Male; Middle Aged; Postoperative Care; Prednisolone; Pyrimidines; Triazoles; Visual Acuity; Voriconazole | 2009 |
Practice patterns in the management of fungal corneal ulcers.
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Corneal Ulcer; Debridement; Drug Costs; Drug Therapy, Combination; Humans; Mycoses; Natamycin; Ophthalmology; Patients; Practice Patterns, Physicians'; Pyrimidines; Surveys and Questionnaires; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Atypical Aspergillus flavus isolates associated with chronic azole therapy.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Azoles; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2009 |
Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis.
Topics: Adult; Antifungal Agents; Cryptococcus neoformans; Drug Interactions; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Meningitis, Cryptococcal; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2010 |
Stability of extemporaneously prepared voriconazole ophthalmic solution.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Compounding; Drug Packaging; Drug Stability; Drug Storage; Humans; Ophthalmic Solutions; Pyrimidines; Temperature; Triazoles; Voriconazole | 2009 |
Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis.
Topics: Adult; Amino Acid Substitution; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Azoles; Bronchitis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Middle Aged; Mutation, Missense; Plasma; Pyrimidines; Triazoles; Voriconazole | 2010 |
Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.
Topics: Antifungal Agents; Candida; Diagnostic Errors; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Quality Assurance, Health Care; Sensitivity and Specificity; Triazoles; Voriconazole | 2009 |
"Soft"or "hard" ionisation? Investigation of metastable gas temperature effect on direct analysis in real-time analysis of Voriconazole.
Topics: Pyrimidines; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2009 |
[Cryptococcal meningitis with a fatal outcome in an immunocompetent adult].
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Fatal Outcome; Fluconazole; Headache; Hearing Loss, Bilateral; Humans; Immunocompetence; Intracranial Hypertension; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Spinal Puncture; Triazoles; Voriconazole | 2010 |
Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis.
Topics: Antifungal Agents; Caspofungin; Echinocandins; Endophthalmitis; Fusarium; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.
Topics: Adult; Antifungal Agents; Chemoprevention; Female; Fluconazole; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2010 |
Effects of antifungal agents in sap activity of Candida albicans isolates.
Topics: Antifungal Agents; Aspartic Acid Proteases; Candida albicans; Candidiasis; Culture Media; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests; Mouth Mucosa; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole | 2010 |
Primary renal zygomycotic infarction mimicking renal neoplasia in an immunocompetent patient.
Topics: Adrenalectomy; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Humans; Immunocompetence; Kidney Diseases; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole; Zygomycosis | 2009 |
A novel fungal pathogen under the spotlight--Acremonium spp. associated fungaemia in an immunocompetent host.
Topics: Acremonium; Antifungal Agents; Female; Fungemia; Humans; Immunocompromised Host; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2011 |
Concomitant Aspergillus and Cytomegalovirus infection in heart transplant: early diagnosis is the key to successful treatment.
Topics: Acute Disease; Antifungal Agents; Antiviral Agents; Cardiomyopathy, Dilated; Cytomegalovirus Infections; Early Diagnosis; Ganciclovir; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Opportunistic Infections; Pulse Therapy, Drug; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Central nervous system Aspergillus infection after epidural analgesia: diagnosis, therapeutic challenges, and literature review.
Topics: Adult; Analgesia, Epidural; Antifungal Agents; Aspergillosis; Aspergillus; Central Nervous System Infections; Female; Humans; Pyrimidines; Triazoles; Voriconazole | 2009 |
Keratitis resulting from Thielavia subthermophila Mouchacca.
Topics: Amphotericin B; Antifungal Agents; Child; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Retrospective Studies; Sordariales; Triazoles; Voriconazole | 2009 |
Successful voriconazole treatment of invasive pulmonary aspergillosis in a patient with acute biphenotypic leukemia.
Topics: Adult; Antifungal Agents; Female; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Biphenotypic, Acute; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2009 |
Phenytoin-induced reduction of voriconazole serum concentration is not compensated by doubling the dosage.
Topics: Anticonvulsants; Antifungal Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Middle Aged; Phenytoin; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Discovery of highly potent novel antifungal azoles by structure-based rational design.
Topics: Antifungal Agents; Azoles; Binding Sites; Computer Simulation; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Hydrogen Bonding; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole | 2009 |
The effects of an hsp90 inhibitor on the paradoxical effect.
Topics: Animals; Antifungal Agents; Candida albicans; Echinocandins; Enzyme Inhibitors; Fungi; HSP90 Heat-Shock Proteins; Lipopeptides; Macrolides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Hyalohyphomycosis caused by Paecilomyces lilacinus after kidney transplantation.
Topics: Antifungal Agents; Diabetes Mellitus; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferons; Kidney Transplantation; Middle Aged; Mycoses; Paecilomyces; Polycystic Kidney Diseases; Postoperative Complications; Pyrimidines; Renal Replacement Therapy; Ribavirin; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Endogenous Aspergillus endophthalmitis occurring after liver transplantation: a case report.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Aspergillus; Endophthalmitis; Eye Enucleation; Humans; Liver Cirrhosis; Liver Transplantation; Male; Polymerase Chain Reaction; Pyrimidines; Triazoles; Vancomycin; Voriconazole; Young Adult | 2009 |
Penetrating keratoplasty for invasive fungal keratitis resulting from a thorn injury involving Phomopsis species.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Ascomycota; Cataract; Cataract Extraction; Corneal Ulcer; Eye Infections, Fungal; Eye Injuries, Penetrating; Gardening; Humans; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Plant Diseases; Postoperative Care; Pyrimidines; Reoperation; Triazoles; Voriconazole | 2009 |
Development and validation of a stability-indicating HPLC method for determination of voriconazole and its related substances.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; Hydrolysis; Oxidation-Reduction; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2009 |
Scedosporium apiospermum: an emerging opportunistic pathogen that must be distinguished from Aspergillus and other hyalohyphomycetes.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Diagnosis, Differential; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycetoma; Opportunistic Infections; Pyrimidines; Scedosporium; Skin Diseases; Triazoles; Voriconazole | 2009 |
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts | 2010 |
Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chemoprevention; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Mycoses; Pyrimidines; Time Factors; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2010 |
[Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus flavus; Caspofungin; Chemotherapy, Adjuvant; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Injections, Intraventricular; Lipopeptides; Male; Neuroaspergillosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2009 |
Scedosporium scleritis or keratitis or both: case series.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Eye Enucleation; Eye Infections, Fungal; Female; Humans; Keratitis; Keratoplasty, Penetrating; Male; Medical Records; Ophthalmic Solutions; Postoperative Complications; Pterygium; Pyrimidines; Scedosporium; Scleritis; Treatment Outcome; Triazoles; Voriconazole | 2009 |
[Effects of voriconazole and vascular lesions in invasion of aspergillosis into the central nerve system].
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Cerebral Infarction; Drug Resistance, Fungal; Fatal Outcome; Female; Humans; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Sphenoid Sinusitis; Triazoles; Voriconazole | 2009 |
Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir.
Topics: Anti-HIV Agents; Antifungal Agents; Cerebrospinal Fluid; Dideoxynucleosides; Drug Monitoring; HIV Infections; Humans; Interferon-gamma; Lamivudine; Male; Meningitis, Cryptococcal; Pyrimidines; Ritonavir; Serum; Triazoles; Voriconazole; Young Adult | 2010 |
In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3.
Topics: Adult; Aging; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Biocatalysis; Child; Child, Preschool; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Humans; Kinetics; Liver; Microsomes, Liver; Middle Aged; Models, Biological; Oxygenases; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2010 |
Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Caspofungin; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fluconazole; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2010 |
Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.
Topics: Adult; Aged; Alkaline Phosphatase; Antifungal Agents; Female; Humans; Lung Transplantation; Male; Middle Aged; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Voriconazole concentrations and outcome of invasive fungal infections.
Topics: Adult; Aged; Antifungal Agents; Australia; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Monitoring; Female; Humans; Immunosuppression Therapy; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Prospective Studies; Pyrimidines; Registries; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Blood; Candida tropicalis; Candidiasis; Catheterization; Cell Adhesion; Cells, Cultured; Enzymes; Epithelial Cells; Equipment and Supplies; Fluconazole; Fungal Proteins; Hemolysin Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Urine; Virulence Factors; Voriconazole | 2010 |
Successful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis.
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Humans; Keratitis; Male; Middle Aged; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Topics: Analysis of Variance; Antifungal Agents; Arthrodermataceae; Candida; Colombia; Dose-Response Relationship, Drug; Fluconazole; Fungi; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2010 |
Pseudomembranous Aspergillus tracheobronchitis in a heart transplant recipient.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchitis; Bronchoscopy; Female; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Pyrimidines; Tracheitis; Triazoles; Voriconazole | 2010 |
Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Topical; Adolescent; Antiprotozoal Agents; Contact Lenses; Cornea; Drug Resistance; Female; Humans; Keratoplasty, Penetrating; Middle Aged; Ophthalmic Solutions; Pyrimidines; Retrospective Studies; Triazoles; Visual Acuity; Voriconazole | 2010 |
Pythium insidiosum keratitis in an Australian child.
Topics: Antifungal Agents; Australia; Biguanides; Child, Preschool; Corneal Transplantation; Corneal Ulcer; Disinfectants; Drug Therapy, Combination; Female; Genes, rRNA; Humans; Pyrimidines; Pythium; Triazoles; Voriconazole | 2009 |
A 19-year-old man with progressive lung infiltrates.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Bronchoscopy; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole; Young Adult; Zygomycosis | 2009 |
Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cervical Vertebrae; Drainage; Echinocandins; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Itraconazole; Lipopeptides; Male; Osteomyelitis; Pyrimidines; Saudi Arabia; Thoracic Vertebrae; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients.
Topics: Adolescent; Aged; Antifungal Agents; Chemoprevention; Drug Monitoring; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Pyrimidines; Serum; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods.
Topics: Amphotericin B; Antifungal Agents; Automation; Candida; Candidiasis; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pyrimidines; Statistics as Topic; Triazoles; Voriconazole | 2010 |
Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.
Topics: Adolescent; Adult; Antifungal Agents; Carcinoma, Squamous Cell; Child; Comorbidity; Dermatitis, Phototoxic; DNA Damage; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Middle Aged; Pyrimidines; Retrospective Studies; Skin Neoplasms; Triazoles; Voriconazole; Young Adult | 2010 |
[Designing a tool to describe drug interactions and adverse events for learning and clinical routine].
Topics: Antifungal Agents; Audiovisual Aids; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Education, Pharmacy, Continuing; Immunosuppressive Agents; Leukocyte Count; Pharmacists; Pyrimidines; Software; Students, Pharmacy; Tacrolimus; Triazoles; Voriconazole | 2009 |
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Lipopeptides; Male; Mycoses; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Management of obstructive renal failure caused by bilateral renal aspergilloma in an immunocompetent newborn.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bladder Exstrophy; Humans; Infant, Newborn; Male; Nephrostomy, Percutaneous; Pyrimidines; Renal Insufficiency; Treatment Outcome; Triazoles; Ureterostomy; Voriconazole | 2010 |
Primary cutaneous infection with Scedosporium apiospermum successfully treated with voriconazole.
Topics: Adrenal Cortex Hormones; Antifungal Agents; Arm; Biopsy; Dermatomycoses; Drug Resistance, Fungal; Histocytochemistry; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Microbial Sensitivity Tests; Microscopy; Middle Aged; Pyrimidines; Scedosporium; Skin; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients.
Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Female; Humans; Immunocompromised Host; Male; Middle Aged; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2010 |
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Blood Chemical Analysis; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Transplantation; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2010 |
Voriconazole pharmacokinetics in liver transplant recipients.
Topics: Adult; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Female; Genotype; Humans; Liver Transplantation; Male; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2010 |
Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Prevalence; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2010 |
[Cerebral aspergilloma in an immunocompetent patient: radiological and histopathological findings].
Topics: Antifungal Agents; Aspergillosis; Brain; Central Nervous System Fungal Infections; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
How many steps along the path is too far?
Topics: Antifungal Agents; Child; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole pharmacokinetics and pharmacodynamics in children.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Computer Simulation; Female; Humans; Infant; Linear Models; Male; Models, Biological; Mycoses; Proportional Hazards Models; Pyrimidines; Retrospective Studies; Statistics, Nonparametric; Triazoles; Voriconazole; Young Adult | 2010 |
An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery.
Topics: Aged; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Disease Outbreaks; Drug Therapy, Combination; Endophthalmitis; Eye Evisceration; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Retrospective Studies; Triazoles; Turkey; Visual Acuity; Vitrectomy; Voriconazole | 2009 |
Anti-Candida-biofilm activity of micafungin is attenuated by voriconazole but restored by pharmacological inhibition of Hsp90-related stress responses.
Topics: Antifungal Agents; Biofilms; Calcineurin; Candida albicans; Dose-Response Relationship, Drug; Echinocandins; Gene Expression Regulation, Fungal; HSP90 Heat-Shock Proteins; Lipopeptides; Micafungin; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2010 |
Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumi
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Colorimetry; Confidence Intervals; Drug Therapy, Combination; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Monte Carlo Method; Pyrimidines; Triazoles; Voriconazole | 2010 |
Subcutaneous phaeohyphomycosis in a renal transplant recipient successfully treated with voriconazole.
Topics: Adult; Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Alternaria sinusitis in children with acute myeloid leukemia: case reports from the Childhood Acute Myeloid Leukemia Infection Research Group.
Topics: Adolescent; Alternaria; Amphotericin B; Antifungal Agents; Child, Preschool; Female; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2010 |
Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Colony Count, Microbial; Disease Models, Animal; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Sepsis; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia.
Topics: Adolescent; Adult; Aged; Air Pollutants; Caspofungin; Cohort Studies; Construction Materials; Echinocandins; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2010 |
Voriconazole-associated myositis.
Topics: Acute Disease; Adult; Antifungal Agents; Aspergillosis; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Myositis; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Beauveria keratitis and biopesticides: case histories and a random amplification of polymorphic DNA comparison.
Topics: Adult; Antifungal Agents; Beauveria; Contact Lenses, Hydrophilic; Corneal Ulcer; DNA, Fungal; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Middle Aged; Mycoses; Pest Control; Pyrimidines; Random Amplified Polymorphic DNA Technique; Triazoles; Voriconazole | 2010 |
In vivo and in vitro investigations of fungal keratitis caused by Colletotrichum gloeosporioides.
Topics: Aged, 80 and over; Antifungal Agents; Colletotrichum; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Keratitis; Natamycin; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Oral voriconazole for invasive fungal skull base infection.
Topics: Adult; Antifungal Agents; Aspergillosis; Biopsy; Diagnosis, Differential; Exophthalmos; Female; Humans; Magnetic Resonance Imaging; Pyrimidines; Radiography; Skull Base; Triazoles; Voriconazole | 2010 |
In vitro activities of azole antifungal agents against Propionibacterium acnes isolated from patients with acne vulgaris.
Topics: Acne Vulgaris; Antifungal Agents; Azoles; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Phytotherapy; Propionibacterium acnes; Pyrimidines; Triazoles; Voriconazole | 2010 |
Management of endogenous cryptococcal endophthalmitis with voriconazole.
Topics: Aged, 80 and over; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Pyrimidines; Triazoles; Voriconazole | 2009 |
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Cohort Studies; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Liver; Liver Function Tests; Lymphocyte Depletion; Male; Opportunistic Infections; Pyrimidines; Retrospective Studies; Risk Factors; Statistics as Topic; T-Lymphocytes; Triazoles; Voriconazole | 2010 |
The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Hyphae; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Spores, Fungal; Tetrazolium Salts; Triazoles; Voriconazole | 2010 |
Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Fungal Proteins; Humans; Itraconazole; Male; Middle Aged; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2010 |
Mycetoma of the foot.
Topics: Adult; Antifungal Agents; Female; Foot Dermatoses; Humans; Madurella; Magnetic Resonance Imaging; Mycetoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2009 |
Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity.
Topics: Adult; Antifungal Agents; Biopsy; Chronic Disease; Coccidioidomycosis; Diagnosis, Differential; Ear; Female; Follow-Up Studies; Forearm; Granulomatous Disease, Chronic; Humans; Male; Melanoma; Meningitis, Fungal; Photosensitivity Disorders; Pyrimidines; Skin Neoplasms; Time Factors; Triazoles; Voriconazole; Young Adult | 2010 |
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Current controversies in treating invasive zygomycosis.
Topics: Amphotericin B; Antifungal Agents; Cunninghamella; Drug Therapy, Combination; Humans; Lung Diseases, Fungal; Mucormycosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Impact of mold infections in explanted lungs on outcomes of lung transplantation.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antifungal Agents; Female; Heart-Lung Transplantation; Humans; Incidence; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Retrospective Studies; Survival Rate; Survivors; Triazoles; Voriconazole | 2010 |
The successful medical treatment of a case of Paecilomyces lilacinus keratitis.
Topics: Administration, Topical; Aged; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole | 2010 |
Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp.
Topics: Adult; Antifungal Agents; Caspofungin; Cells, Cultured; Cunninghamella; Echinocandins; Enzyme-Linked Immunosorbent Assay; Humans; Interleukin-6; Interleukin-8; Lipopeptides; Microbial Viability; Neutrophils; Pyrimidines; Rhizopus; Tetrazolium Salts; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole | 2010 |
[Porphyria cutanea tarda revealed by voriconazole].
Topics: Aged; Alcoholism; Antifungal Agents; Cheilitis; Feces; Humans; Liver; Male; Photosensitivity Disorders; Porphyria Cutanea Tarda; Porphyrins; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Uroporphyrinogen Decarboxylase; Voriconazole | 2010 |
Resolution of secondary pulmonary alveolar proteinosis following treatment of rhinocerebral aspergillosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Female; Humans; Magnetic Resonance Imaging; Neuroaspergillosis; Pulmonary Alveolar Proteinosis; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Efficacy of voriconazole in a murine model of invasive paecilomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Citrus paradisi; Colony Count, Microbial; Diet; Immunocompromised Host; Kidney; Liver; Male; Mice; Mycoses; Paecilomyces; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Antifungal susceptibility testing of Candida isolates from the Candida surveillance study.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3 years of age.
Topics: Administration, Oral; Adolescent; Age Factors; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Neoplasms; Pyrimidines; Triazoles; Voriconazole | 2010 |
Antifungal management.
Topics: Amphotericin B; Antifungal Agents; Cord Blood Stem Cell Transplantation; Echinocandins; Humans; Leukemia; Lung; Male; Middle Aged; Neutropenia; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Immunomodulatory effects of antifungal agents on the response of human monocytic cells to Aspergillus fumigatus conidia.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Cell Line; Cell Survival; Echinocandins; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Lipopeptides; Micafungin; Monocytes; Pyrimidines; Spores, Fungal; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole | 2010 |
Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida tropicalis; Candidiasis; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Fungemia; Humans; Infant; Lipopeptides; Male; Micafungin; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Post-traumatic fungal keratitis caused by Carpoligna sp.
Topics: Adult; Amphotericin B; Antifungal Agents; Base Sequence; Corneal Injuries; Corneal Ulcer; DNA, Fungal; Eye Infections, Fungal; Eye Injuries; Humans; Lacerations; Male; Mitosporic Fungi; Molecular Sequence Data; Natamycin; Polymerase Chain Reaction; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 28S; Triazoles; Voriconazole | 2010 |
Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillus; Caspofungin; Cystic Fibrosis; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient.
Topics: Adult; Antifungal Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Pyrimidines; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Recalcitrant fungal tunnel infection treated with intrastromal injection of voriconazole.
Topics: Administration, Topical; Antifungal Agents; Aspergillosis; Aspergillus flavus; Cataract Extraction; Corneal Stroma; Eye Infections, Fungal; Female; Follow-Up Studies; Humans; Injections, Intraocular; Middle Aged; Phacoemulsification; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Critical Illness; Drug Monitoring; Female; Humans; Injections, Intravenous; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Male; Middle Aged; Plasma; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2010 |
Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.
Topics: Antifungal Agents; Candida glabrata; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Endpoint Determination; Fluconazole; Itraconazole; Lipopeptides; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2010 |
In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2010 |
Determination of saliva trough levels for monitoring voriconazole therapy in immunocompromised children and adults.
Topics: Adult; Age Factors; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Pyrimidines; Saliva; Triazoles; Voriconazole | 2010 |
Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Brain; Caspofungin; Chemoprevention; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Lung Transplantation; Magnetic Resonance Imaging; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Naphthalenes; Pseudallescheria; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 28S; Scedosporium; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2010 |
[Infectious keratitis and cosmetic lenses: a five-case retrospective study].
Topics: Abscess; Acanthamoeba Keratitis; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Antifungal Agents; Benzamidines; Biguanides; Blindness; Contact Lenses; Corneal Opacity; Corneal Surgery, Laser; Female; Gentamicins; Humans; Keratitis; Middle Aged; Pseudomonas Infections; Pyrimidines; Retrospective Studies; Risk Factors; Serratia Infections; Staphylococcal Infections; Ticarcillin; Triazoles; Vancomycin; Voriconazole; Young Adult | 2010 |
[Near-drowning and cerebral infections caused by fungi belonging to the Pseudallescheria / Scedosporium-complex].
Topics: Adolescent; Adult; Antifungal Agents; Brain; Central Nervous System Infections; Child, Preschool; Female; Germany; Humans; Male; Middle Aged; Mycoses; Near Drowning; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Young Adult | 2010 |
Successful allogeneic stem cell transplantation in two patients with acute myelogenous leukaemia and invasive aspergillosis by antifungal combination therapy.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Micafungin; Middle Aged; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Chemoprevention; Cost-Benefit Analysis; Female; Hospitals; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Chronic necrotizing and allergic bronchopulmonary aspergillosis in an asthmatic patient--a therapeutic challenge.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Asthma; Bronchoscopy; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Prognosis; Pyrimidines; Radiography, Thoracic; Recurrence; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Aspergillus niger; Female; Humans; Lung; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Cellulitis and nodular skin lesions due to Fusarium spp in liver transplant: case report.
Topics: Amphotericin B; Biopsy; Cellulitis; Fusarium; Graft Rejection; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Alternaria and paecilomyces keratitis associated with soft contact lens wear.
Topics: Adult; Alternaria; Antifungal Agents; Contact Lens Solutions; Contact Lenses, Hydrophilic; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2010 |
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
Topics: Africa; Americas; Antifungal Agents; Asia; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Europe; Fluconazole; Geography; Humans; Microbial Sensitivity Tests; Middle East; Pyrimidines; Triazoles; Voriconazole | 2010 |
Acremonium strictum fungaemia in a paediatric immunocompromised patient: diagnosis and treatment difficulties.
Topics: Acremonium; Amphotericin B; Antifungal Agents; Blood; Child; Fever; Fungemia; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2010 |
Renal allograft loss due to overwhelming invasive Candida infection.
Topics: Adult; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
EUCAST breakpoints for antifungals.
Topics: Antifungal Agents; Candida; Computer Simulation; Drug Resistance, Fungal; Europe; Fluconazole; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole, a safe alternative for treating infections caused by the Chrysosporium anamorph of Nannizziopsis vriesii in bearded dragons (Pogona vitticeps).
Topics: Animals; Antifungal Agents; Chordata; Chrysosporium; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reptiles; Triazoles; Voriconazole | 2010 |
Truncated Afyap1 attenuates antifungal susceptibility of Aspergillus fumigatus to voriconazole and confers adaptation of the fungus to oxidative stress.
Topics: Adaptation, Physiological; Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Fungal; Fungal Proteins; Humans; Oxidative Stress; Pyrimidines; Sequence Deletion; Stress, Physiological; Transcription Factors; Triazoles; Voriconazole | 2010 |
New onset of bilateral multifocal coccidioidomycosal choroiditis in a patient on oral fluconazole.
Topics: Administration, Oral; Antifungal Agents; Choroiditis; Coccidioides; Coccidioidomycosis; Eye Infections, Fungal; Fluconazole; Functional Laterality; Fungemia; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Visual Acuity; Voriconazole | 2010 |
Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.
Topics: Aged; Animals; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Renal Dialysis; Renal Insufficiency; Triazoles; Voriconazole | 2010 |
Intravenous voriconazole after toxic oral administration.
Topics: Administration, Oral; Antifungal Agents; Drug Eruptions; Humans; Injections, Intravenous; Liver; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Sphenoid Sinusitis; Triazoles; Voriconazole | 2010 |
Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.
Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Cytokines; Echinocandins; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Microbial Viability; Microscopy, Confocal; Oxidation-Reduction; Phagocytes; Pyrimidines; Respiratory Burst; Rhodamines; Staining and Labeling; Triazoles; Voriconazole | 2010 |
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.
Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Pyrimidines; Triazoles; Voriconazole | 2010 |
Isolation of Exophiala dermatitidis from pigmented sputum in a cystic fibrosis patient.
Topics: Adolescent; Adrenal Cortex Hormones; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Humans; Lung Diseases, Fungal; Mycoses; Pyrimidines; Recurrence; Sputum; Triazoles; Voriconazole | 2010 |
Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Child, Preschool; Female; Humans; Immunocompromised Host; Infant; Male; Mycoses; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole | 2010 |
Intracameral voriconazole injection in the treatment of fungal endophthalmitis resulting from keratitis.
Topics: Acremonium; Adult; Aged; Alternaria; Anterior Chamber; Antifungal Agents; Aspergillus; Corneal Ulcer; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Injections; Male; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2010 |
Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia.
Topics: Antifungal Agents; Cord Blood Stem Cell Transplantation; Female; Humans; Infant; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2011 |
[Susceptibility to fluconazole and voriconazole of Candida species isolated from intensive care units patients in Medellin, Colombia (2001-2007)].
Topics: Antifungal Agents; Candida; Colombia; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
AfMkk2 is required for cell wall integrity signaling, adhesion, and full virulence of the human pathogen Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cell Adhesion; Cell Wall; Disease Models, Animal; Glass; Humans; Hydrogen-Ion Concentration; Mice; Mitogen-Activated Protein Kinase Kinases; Plastics; Pyrimidines; Signal Transduction; Survival Analysis; Temperature; Triazoles; Virulence; Virulence Factors; Voriconazole | 2010 |
Drug interaction between voriconazole and tacrolimus in allogeneic hematopoietic SCT recipients.
Topics: Drug Interactions; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Pyrimidines; Tacrolimus; Transplantation, Homologous; Triazoles; Voriconazole | 2011 |
Fatal peritonitis caused by Rhizopus microsporus.
Topics: Antifungal Agents; Colon; Crohn Disease; Fatal Outcome; Female; Humans; Intestinal Perforation; Middle Aged; Mucormycosis; Peritonitis; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2010 |
[Primary cutaneous aspergillosis in an immunocompetent farmworker].
Topics: Adult; Agricultural Workers' Diseases; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biopsy; Dermatomycoses; Dermis; Facial Dermatoses; Humans; Immunocompetence; Male; Neutrophils; Periodic Acid-Schiff Reaction; Pyrimidines; Triazoles; Voriconazole | 2010 |
X-linked chronic granulomatous disease with voriconazole-induced photosensitivity/ photoaging reaction.
Topics: Antifungal Agents; Child; Granulomatous Disease, Chronic; Humans; Male; Photosensitivity Disorders; Pyrimidines; Serratia Infections; Skin Aging; Triazoles; Voriconazole | 2010 |
Fusarium sepsis, voriconazole, and the skin.
Topics: Antifungal Agents; Fusarium; Humans; Mycoses; Pyrimidines; Sepsis; Skin; Triazoles; Voriconazole | 2010 |
Characterization of yeasts colonizing in healthy individuals.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Carrier State; Female; Fluconazole; Human Experimentation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Pyrimidines; Taiwan; Triazoles; Voriconazole; Yeasts; Young Adult | 2011 |
Cutaneous hyalohyphomycosis in a girdled lizard (Cordylus giganteus) caused by the Chrysosporium anamorph of Nannizziopsis vriesii and successful treatment with voriconazole.
Topics: Animals; Antifungal Agents; Chrysosporium; Hyalohyphomycosis; Lizards; Pyrimidines; Triazoles; Voriconazole | 2010 |
A case series of unilateral orbital aspergillosis in three cats and treatment with voriconazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Cat Diseases; Cats; Eye Diseases; Pyrimidines; Triazoles; Voriconazole | 2010 |
Identification of Paecilomyces variotii in clinical samples and settings.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Flucytosine; Fungal Proteins; Genes, rRNA; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Paecilomyces; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 5.8S; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole | 2010 |
Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.
Topics: Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Itraconazole; Mass Spectrometry; Pyrimidines; Reference Standards; Triazoles; Voriconazole | 2010 |
Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.
Topics: Antifungal Agents; Carcinoma, Squamous Cell; Fatal Outcome; Female; Heart Transplantation; Humans; Lung Transplantation; Middle Aged; Mycoses; Neoplasm Invasiveness; Neoplasm Metastasis; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole | 2010 |
Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy.
Topics: Acanthamoeba Keratitis; Administration, Oral; Adolescent; Antiprotozoal Agents; Chronic Disease; Corneal Stroma; Female; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2010 |
Determination of voriconazole in human serum and plasma by micellar electrokinetic chromatography.
Topics: Animals; Cattle; Chromatography, Micellar Electrokinetic Capillary; Humans; Male; Plasma; Pyrimidines; Reproducibility of Results; Serum; Triazoles; Voriconazole | 2010 |
Fixed-ratio combination testing of an echinocandin, anidulafungin, and an azole, voriconazole, against 1,467 Candida species isolates.
Topics: Anidulafungin; Antifungal Agents; Candida; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Experimental murine scedosporiosis: histopathology and azole treatment.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Brain; Kidney; Mice; Mycetoma; Pyrimidines; Scedosporium; Spleen; Treatment Outcome; Triazoles; Voriconazole | 2010 |
In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test.
Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Cohort Studies; Echinocandins; Female; Hospital Costs; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Length of Stay; Lipopeptides; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole | 2011 |
A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.
Topics: Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Pleural Effusion; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Use of intralesional voriconazole for the treatment of cutaneous Scedosporium apiospermum infection.
Topics: Administration, Topical; Aged; Antifungal Agents; Dermatomycoses; Female; Hand; Humans; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2010 |
Comparison of Vitek identification and antifungal susceptibility testing methods to DNA sequencing and Sensititre YeastOne antifungal testing.
Topics: Amphotericin B; Candida; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Microbial Sensitivity Tests; Mycological Typing Techniques; Pyrimidines; Triazoles; Voriconazole | 2011 |
Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.
Topics: Antifungal Agents; Area Under Curve; Cytochrome P-450 CYP3A; Drug Interactions; Fluconazole; Humans; Itraconazole; Microsomes, Liver; Pyrimidines; Triazoles; Voriconazole | 2010 |
Increasing the dose of voriconazole compensates for enzyme induction by phenytoin.
Topics: Administration, Oral; Adult; Anticonvulsants; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Interactions; Female; Humans; Phenytoin; Pyrimidines; Triazoles; Voriconazole | 2010 |
In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens.
Topics: Antifungal Agents; Dipodascus; Fluconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Rhodotorula; Saccharomyces cerevisiae; Triazoles; Trichosporon; Voriconazole | 2010 |
Voriconazole-associated salt-losing nephropathy.
Topics: Aged; Antifungal Agents; Biomarkers; Chemical and Drug Induced Liver Injury; Fluid Therapy; Humans; Hyponatremia; Kidney Diseases; Liver; Male; Neurophysins; Protein Precursors; Pyrimidines; Renin; Sodium; Sodium Chloride; Time Factors; Treatment Outcome; Triazoles; Vasopressins; Voriconazole; Water-Electrolyte Balance | 2010 |
Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?
Topics: Adolescent; Antifungal Agents; Child; Cohort Studies; Cystic Fibrosis; Dietary Supplements; Female; Humans; Male; Photosensitivity Disorders; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Vision Disorders; Vitamin A; Voriconazole | 2010 |
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Early Diagnosis; Echinocandins; Female; Fever; Hematologic Neoplasms; Humans; Lipopeptides; Male; Neutropenia; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Case report 2: Fungal infections in chronic obstructive pulmonary disease.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillus fumigatus; Belgium; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Radiography, Thoracic; Steroids; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
Topics: Adult; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Case-Control Studies; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Multivariate Analysis; Mycoses; Opportunistic Infections; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Sunlight; Triazoles; Voriconazole | 2010 |
Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Europe; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; United States; Voriconazole | 2010 |
Comparison of voriconazole concentration in the aqueous humor and vitreous between non-scraped and scraped corneal epithelium groups after topical 1% voriconazole application.
Topics: Administration, Topical; Animals; Antifungal Agents; Aqueous Humor; Biological Availability; Biological Transport; Chromatography, High Pressure Liquid; Debridement; Epithelium, Corneal; Microbial Sensitivity Tests; Ophthalmic Solutions; Pyrimidines; Rabbits; Triazoles; Vitreous Body; Voriconazole | 2010 |
Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antiviral Agents; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Pyrimidines; Reoperation; Retrospective Studies; Survivors; Time Factors; Tissue Donors; Triazoles; Valganciclovir; Voriconazole | 2010 |
Using sweeping-micellar electrokinetic chromatography to determine voriconazole in patient plasma.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Chromatography, Micellar Electrokinetic Capillary; Humans; Limit of Detection; Micelles; Molecular Structure; Pyrimidines; Triazoles; Voriconazole | 2010 |
Successful treatment of Scedosporium apiospermum soft tissue abscess with caspofungin and voriconazole in a severely immunocompromised patient with acute myeloid leukemia.
Topics: Abscess; Antifungal Agents; Caspofungin; Echinocandins; Female; Forearm; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lipopeptides; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Aspergillus endocarditis 2003-2009.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Endocarditis; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Pyrimidines; Retrospective Studies; Surgical Procedures, Operative; Triazoles; Voriconazole; Young Adult | 2011 |
[Rhodotorula glutinis sepsis. A case report].
Topics: Aged; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Communicable Diseases, Emerging; Comorbidity; Diabetes Complications; Fungemia; Humans; Immunocompromised Host; Liver Cirrhosis; Male; Mycoses; Pyrimidines; Rhodotorula; Sepsis; Triazoles; Voriconazole | 2010 |
Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Hepatitis, Chronic; Humans; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2010 |
Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole.
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Caspofungin; Corneal Ulcer; Drug Resistance, Fungal; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2010 |
Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Male; Mice; Pyrimidines; Triazoles; Voriconazole | 2010 |
Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).
Topics: Antifungal Agents; Azoles; Candida albicans; Econazole; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Protein Binding; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2010 |
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Female; Fusarium; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Caspofungin; CD11b Antigen; Cells, Cultured; Echinocandins; Gene Expression; Gene Expression Profiling; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Interleukin-8; Lipopeptides; Neutrophils; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Toll-Like Receptors; Triazoles; Up-Regulation; Voriconazole | 2010 |
Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Geotrichum; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Characterization of Candida parapsilosis complex isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candidemia; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Random Amplified Polymorphic DNA Technique; Triazoles; Voriconazole | 2011 |
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study).
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Guideline Adherence; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Pharmacokinetic variability of voriconazole and N-oxide voriconazole measured as therapeutic drug monitoring.
Topics: Adult; Antifungal Agents; Drug Monitoring; Female; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2010 |
Persistent photopsia following course of oral voriconazole.
Topics: Administration, Oral; Antifungal Agents; Female; Histoplasmosis; Humans; Middle Aged; Ocular Physiological Phenomena; Pyrimidines; Treatment Outcome; Triazoles; Vision Disorders; Voriconazole | 2010 |
Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B.
Topics: Amino Acid Sequence; Aspergillus fumigatus; Azoles; Clotrimazole; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Isoenzymes; Itraconazole; Lanosterol; Molecular Sequence Data; Protein Binding; Pyrimidines; Sequence Homology, Amino Acid; Sterol 14-Demethylase; Substrate Specificity; Triazoles; Voriconazole | 2010 |
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2011 |
Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy.
Topics: Adult; Aged; Antifungal Agents; Ascomycota; Chromoblastomycosis; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2011 |
Comparison and evaluation of a novel bioassay and high-performance liquid chromatography for the clinical measurement of serum voriconazole concentrations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Biological Assay; Candida; Child; Chromatography, High Pressure Liquid; Humans; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Serum; Triazoles; Voriconazole; Young Adult | 2011 |
Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain.
Topics: Amino Acid Substitution; Anticonvulsants; Antidepressive Agents; Antifungal Agents; Brain; Catalytic Domain; Cholesterol; Cholesterol 24-Hydroxylase; Clotrimazole; Crystallography, X-Ray; Humans; Mutation, Missense; Piperidines; Protein Binding; Pyrimidines; Steroid Hydroxylases; Structure-Activity Relationship; Tranylcypromine; Triazoles; Voriconazole | 2010 |
Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients.
Topics: Adult; Aged; Antifungal Agents; Biological Availability; Female; Humans; Lung Transplantation; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2010 |
Analysis of amorphous solid dispersions using 2D solid-state NMR and (1)H T(1) relaxation measurements.
Topics: Acetaminophen; Chemistry, Pharmaceutical; Crystallization; Dextrans; Dosage Forms; Indomethacin; Ketolides; Magnetic Resonance Spectroscopy; Pyrimidines; Solubility; Suspensions; Trehalose; Triazoles; Voriconazole | 2010 |
Are disk diffusion and Etest methods reliable for detecting Candida glabrata and other species' susceptibility to fluconazole and voriconazole?
Topics: Antifungal Agents; Candida glabrata; Disk Diffusion Antimicrobial Tests; False Positive Reactions; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2010 |
Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2010 |
Scedosporium apiospermum infection presenting as a pneumothorax and cavitary lung lesions in a patient with acquired immune deficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Humans; Itraconazole; Lung; Mycetoma; Pneumothorax; Pyrimidines; Scedosporium; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Safety of moxifloxacin and voriconazole in corneal storage media on porcine corneal endothelial cells.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Cell Count; Cell Survival; Chondroitin Sulfates; Complex Mixtures; Cornea; Cryopreservation; Culture Media, Serum-Free; Dextrans; Endothelium, Corneal; Fluoroquinolones; Gentamicins; Moxifloxacin; Organ Preservation Solutions; Pyrimidines; Quinolines; Swine; Tissue Preservation; Triazoles; Voriconazole | 2010 |
An alternative approach to determine oral bioavailability of drugs that follow Michaelis-Menten elimination: a case study with voriconazole.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Biological Availability; Injections, Intravenous; Male; Nonlinear Dynamics; Pyrimidines; Rats; Rats, Wistar; Triazoles; Voriconazole | 2010 |
Developing a safe antifungal treatment protocol to eliminate Batrachochytrium dendrobatidis from amphibians.
Topics: Amphotericin B; Animals; Antifungal Agents; Anura; Chytridiomycota; Clinical Protocols; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Clinician ordering practices for voriconazole therapeutic drug monitoring: experiences of a referral laboratory.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Drug Monitoring; Female; Humans; Laboratories; Male; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pyrimidines; Referral and Consultation; Triazoles; Voriconazole | 2010 |
Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1->3)-beta-D-glucan detection in serum samples as an adjunct to diagnosis.
Topics: Antifungal Agents; beta-Glucans; Child; Galactose; Humans; Lung Diseases, Fungal; Male; Mannans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteoglycans; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Fungal spinal cord compression in metastatic synovial sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Fractures, Spontaneous; Humans; Lung Neoplasms; Mycoses; Neoplasm Recurrence, Local; Neoplasm Staging; Osteomyelitis; Pneumonectomy; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma, Synovial; Spinal Cord Compression; Spinal Cord Neoplasms; Triazoles; Voriconazole | 2011 |
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2010 |
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Ergosterol; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; Pyrimidines; Triazoles; Voriconazole | 2010 |
Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (sterol 14α-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isoenzymes CYP51A and CYP51B.
Topics: Anti-Bacterial Agents; Aspergillus fumigatus; Azoles; Clotrimazole; Cytochrome P-450 Enzyme System; Doxycycline; Ergosterol; Fluconazole; Fungal Proteins; Genetic Complementation Test; Itraconazole; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole | 2010 |
Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Female; Fungal Proteins; Mice; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2010 |
Cystoid macular edema secondary to fluconazole toxicity.
Topics: Administration, Oral; Aged; Antifungal Agents; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluconazole; Fluorescein Angiography; Fundus Oculi; Humans; Macular Edema; Pyrimidines; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Increasing incidence of mucormycosis in University Hospital, Belgium.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Belgium; Child; Female; Hematologic Neoplasms; Hospitals, University; Humans; Incidence; Male; Middle Aged; Mucormycosis; Pyrimidines; Risk Factors; Triazoles; Voriconazole; Young Adult | 2010 |
Catheter-associated aspergillosis of the chest wall following allogeneic hematopoietic stem cell transplantation.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Catheters; Child, Preschool; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Pyrimidines; Thoracic Wall; Transplantation, Homologous; Triazoles; Voriconazole | 2011 |
Aspergillus thyroiditis in a renal transplant recipient mimicking subacute thyroiditis.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Kidney Transplantation; Lipopeptides; Pyrimidines; Thyroid Gland; Thyroiditis; Triazoles; Voriconazole | 2011 |
Fusarium keratitis 3 weeks after healed corneal cross-linking.
Topics: Collagen; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoconus; Mycoses; Photosensitizing Agents; Pyrimidines; Riboflavin; Surgical Wound Infection; Tobramycin; Triazoles; Ultraviolet Rays; Voriconazole; Wound Healing; Young Adult | 2010 |
Successful treatment of sellar aspergillus abscess.
Topics: Aged; Antifungal Agents; Brain Abscess; Caspofungin; Diagnosis, Differential; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Neuroaspergillosis; Neurosurgical Procedures; Pituitary Diseases; Pituitary Neoplasms; Pyrimidines; Triazoles; Voriconazole | 2010 |
Ulcerated plaque under a ruby ring in an immunosuppressed patient.
Topics: Adenine Nucleotides; Aged; Antineoplastic Agents; Arabinonucleosides; Candida; Candidiasis, Cutaneous; Clofarabine; Cytarabine; Dermatologic Agents; Dermatomycoses; Fusarium; Humans; Immunocompromised Host; Itraconazole; Jewelry; Leukemia, Myeloid, Acute; Male; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole | 2010 |
In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.
Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Cunninghamella; Diabetes Mellitus, Experimental; Echinocandins; Itraconazole; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2010 |
Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain.
Topics: Antifungal Agents; Aspergillus fumigatus; Austria; Azoles; Denmark; Drug Resistance, Fungal; Environmental Microbiology; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 2010 |
[Multiple myeloma complicated with disseminated zygomycosis after bortezomib therapy].
Topics: Acidosis; Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Male; Micafungin; Multiple Myeloma; Pyrazines; Pyrimidines; Triazoles; Tumor Lysis Syndrome; Voriconazole; Zygomycosis | 2010 |
[Species distribution and antifungal susceptibilities of yeast clinical isolates from three hospitals in Korea, 2001 to 2007].
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Hospitals; Humans; Pyrimidines; Republic of Korea; Rhodotorula; Triazoles; Trichosporon; Voriconazole; Yeasts | 2010 |
Bloodstream yeast infections in a university hospital in Northeast Turkey: a 4-year survey.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole | 2011 |
Rapid detection of Acanthamoeba cysts in frozen sections of corneal scrapings with Fungiflora Y.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Anti-Infective Agents, Local; Chlorhexidine; Coloring Agents; Corneal Diseases; Epithelium, Corneal; Eye Infections, Parasitic; Frozen Sections; Humans; Organic Chemicals; Pyrimidines; Triazoles; Voriconazole | 2010 |
Oral voriconazole dose in children: one size does not fit all.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Trichosporon surgical wound infection in a renal allograft recipient successfully treated with voriconazole.
Topics: Adult; Antifungal Agents; Biopsy; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules; Male; Mycoses; Necrosis; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole | 2010 |
Comparison of a glucose consumption based method with the CLSI M38-A method for testing antifungal susceptibility of Trichophyton rubrum and Trichophyton mentagrophytes.
Topics: Antifungal Agents; Econazole; Glucose; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Trichophyton; Voriconazole | 2010 |
Intracavitary voriconazole for the treatment of hemoptysis complicating Pseudallescheria angusta pulmonary mycetomas in fibrocystic sarcoidosis.
Topics: Aged; Antifungal Agents; Hemoptysis; Humans; Immunocompromised Host; Kidney Transplantation; Lung Diseases, Fungal; Male; Mycetoma; Pseudallescheria; Pyrimidines; Sarcoidosis; Triazoles; Voriconazole | 2011 |
Keratomycosis in a dog treated with topical 1% voriconazole solution.
Topics: Administration, Topical; Animals; Antifungal Agents; Dog Diseases; Dogs; Eye Infections, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2010 |
Combined therapy against murine-disseminated infection by Fusarium verticillioides.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Mice; Mycoses; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2011 |
In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Animals; Antifungal Agents; Cryptococcus gattii; Environmental Microbiology; Fluconazole; Flucytosine; Genotype; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspo
Topics: Anidulafungin; Antifungal Agents; Blood Chemical Analysis; Caspofungin; Chromatography, Liquid; Echinocandins; Humans; Itraconazole; Lipopeptides; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2010 |
[Treatment of ABPA: a place for voriconazole and omalizumab?].
Topics: Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Humans; Omalizumab; Pyrimidines; Triazoles; Voriconazole | 2010 |
[Rebound after ABPA treatment with voriconazole].
Topics: Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Male; Middle Aged; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2010 |
Pulmonary aspergillosis in a non-neutropenic critical patient.
Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Burns, Inhalation; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Humans; Hydrogen Sulfide; Intensive Care Units; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
[Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis of Aspergillus fumigatus].
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Delayed-Action Preparations; Endophthalmitis; Eye; Female; Intravitreal Injections; Lactic Acid; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Rabbits; Random Allocation; Triazoles; Voriconazole | 2010 |
Fast and reliable determination of voriconazole in human plasma by LC-APCI-MS/MS.
Topics: Aged; Atmospheric Pressure; Blood Chemical Analysis; Chromatography, Liquid; Female; Humans; Male; Pyrimidines; Reproducibility of Results; Tandem Mass Spectrometry; Time Factors; Triazoles; Voriconazole | 2010 |
Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Fatal Outcome; Female; Fungemia; Humans; Immunocompromised Host; Molecular Sequence Data; Mycoses; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole; Young Adult | 2011 |
In vitro activity of fluconazole and voriconazole against clinical isolates of Candida spp. by E-test method.
Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2010 |
Voriconazole plasma levels in children are highly variable.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Humans; Infant; Male; Plasma; Pyrimidines; Spectrophotometry; Triazoles; Voriconazole | 2011 |
Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro?
Topics: Anidulafungin; Antifungal Agents; Drug Carriers; Drug Implants; Echinocandins; Polymethyl Methacrylate; Pyrimidines; Solubility; Time Factors; Triazoles; Voriconazole | 2011 |
Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Lung; Mice; Mice, Inbred BALB C; Mice, SCID; Pyrimidines; Rodent Diseases; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole; Yeasts | 2011 |
Evaluation of hepatotoxicity with off-label oral-treatment doses of voriconazole for invasive fungal infections.
Topics: Aged; Antifungal Agents; Female; Humans; Liver; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2011 |
[Clinical implication of therapeutic drug monitoring on voriconazole from the aspect of the analysis for CYP2C19 gene].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Humans; Liver; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2010 |
Microdialysis feasibility investigations with the non-hydrophilic antifungal voriconazole for potential applications in nonclinical and clinical settings.
Topics: Antifungal Agents; Drug Stability; Feasibility Studies; Humans; Microdialysis; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2010 |
In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients.
Topics: Adolescent; Adult; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cystic Fibrosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Humans; Lung Transplantation; Male; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
Severe Arthrographis kalrae keratomycosis in an immunocompetent patient.
Topics: Adult; Antifungal Agents; Candida albicans; Contact Lenses, Hydrophilic; Corneal Perforation; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Keratoplasty, Penetrating; Mitosporic Fungi; Mycoses; Pyrimidines; Reoperation; Triazoles; Voriconazole | 2011 |
The treatment of pulmonary Wangiella dermatitidis infection with oral voriconazole.
Topics: Administration, Oral; Aged, 80 and over; Antifungal Agents; Bronchoalveolar Lavage Fluid; Exophiala; Female; Humans; Lung Diseases, Fungal; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Cystic Fibrosis; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycetoma; Pyrimidines; Random Amplified Polymorphic DNA Technique; Scedosporium; Triazoles; Voriconazole | 2010 |
Human tissue distribution of voriconazole.
Topics: Adult; Aged; Aspergillosis; Autopsy; Brain; Female; Humans; Kidney; Liver; Lung; Male; Middle Aged; Myocardium; Pyrimidines; Spleen; Tissue Distribution; Triazoles; Voriconazole; Young Adult | 2011 |
Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Biomarkers; Biopsy; Bronchoalveolar Lavage Fluid; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Postoperative Complications; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Triazoles; Voriconazole | 2011 |
Successful treatment of systemic Geotrichum capitatum infection by liposomal amphotericin-B, itraconazole, and voriconazole in a Japanese man.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Geotrichosis; Humans; Itraconazole; Japan; Male; Middle Aged; Pyrimidines; Remission Induction; Triazoles; Voriconazole | 2010 |
Intracameral voriconazole injection in the treatment of fungal endophthalmitis resulting from keratitis.
Topics: Acremonium; Alternaria; Anterior Chamber; Antifungal Agents; Aspergillus; Corneal Ulcer; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Injections; Pyrimidines; Risk Factors; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2010 |
Fatal dysrhythmia following initiation of lansoprazole during a long-term course of voriconazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Antifungal Agents; Aspergillosis; Drug Interactions; Fatal Outcome; Humans; Lansoprazole; Male; Pyrimidines; Tachycardia, Ventricular; Triazoles; Voriconazole | 2011 |
In vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis.
Topics: Administration, Topical; Aged; Alternaria; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Microscopy, Confocal; Mycoses; Pyrimidines; Tomography, Optical Coherence; Triazoles; Voriconazole | 2011 |
A case of bovine valve endocarditis caused by Engyodontium album.
Topics: Adult; Antifungal Agents; Arthritis, Juvenile; Ascomycota; Beauveria; DNA, Fungal; Endocarditis; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Mycoses; Prosthesis-Related Infections; Pyrimidines; Reoperation; Sequence Analysis, DNA; Triazoles; Voriconazole | 2011 |
Impact of therapeutic drug monitoring of voriconazole in a pediatric population.
Topics: Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Male; Mycoses; Plasma; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Pulmonary aspergillosis caused by a pan-azole-resistant Aspergillus fumigatus in a 10-year-old boy.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Chemoprevention; Child; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; France; Fungal Proteins; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pyrimidines; Triazoles; Tubulin; Voriconazole | 2011 |
Clinical features and outcomes of four patients with invasive fungal sinusitis.
Topics: Aged; Antifungal Agents; Aspergillosis; Biopsy; Blindness; Brain Infarction; Candidiasis; Cavernous Sinus; Combined Modality Therapy; Debridement; Early Diagnosis; Echinocandins; Fatal Outcome; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lipopeptides; Magnetic Resonance Imaging; Male; Maxillary Sinusitis; Micafungin; Middle Aged; Orbit Evisceration; Orbital Diseases; Postoperative Complications; Pyrimidines; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
[Cryptococcal meningitis successfully treated with liposomal amphotericin B and voriconazole in an elderly patient].
Topics: Administration, Oral; Aged, 80 and over; Amphotericin B; Antigens, Fungal; Cerebrospinal Fluid; Cryptococcus neoformans; Drug Therapy, Combination; Female; Humans; Liposomes; Meningitis, Cryptococcal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Clinical importance of the CYP2C19*17 variant allele for voriconazole.
Topics: Alleles; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Humans; Pharmaceutical Preparations; Pyrimidines; Triazoles; Voriconazole | 2011 |
Aspergillus infection of supramid orbital implant and hyperostosis of orbital bone: report of a unique case.
Topics: Adult; Aspergillosis; Aspergillus; Combined Modality Therapy; Device Removal; Follow-Up Studies; Humans; Hyperostosis; Male; Nylons; Orbital Fractures; Orbital Implants; Prosthesis-Related Infections; Pyrimidines; Radiography; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Treatment for fungal endophthalmitis resulting from keratitis.
Topics: Acremonium; Alternaria; Anterior Chamber; Antifungal Agents; Aspergillus; Corneal Ulcer; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2011 |
In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Catheter-Related Infections; Catheterization, Central Venous; Drug Administration Routes; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Opportunistic Infections; Periostitis; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Radiography; Radionuclide Imaging; Triazoles; Voriconazole | 2011 |
Resolution of recurrent fusarium arthritis after prolonged antifungal therapy.
Topics: Ankle Joint; Antifungal Agents; Arthritis, Infectious; Drug Therapy, Combination; Fusarium; Humans; Immunocompromised Host; Mycoses; Pyrimidines; Recurrence; Toe Joint; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Tunisia; Voriconazole | 2011 |
Pharmacokinetics of voriconazole in adult mallard ducks (Anas platyrhynchos).
Topics: Administration, Oral; Animals; Anseriformes; Antifungal Agents; Biological Assay; Chromatography, Liquid; Female; Injections, Intravenous; Male; Plasma; Pyrimidines; Triazoles; Voriconazole | 2011 |
Invasive fungal rhinitis caused by Paecilomyces lilacinus infection: Report of a case and a novel treatment.
Topics: Aged; Antifungal Agents; Combined Modality Therapy; Debridement; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Lung Transplantation; Mycoses; Paecilomyces; Pulmonary Fibrosis; Pyrimidines; Rhinitis; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Management of voriconazole hepatotoxicity in a lung transplant patient.
Topics: Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Lung Transplantation; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole | 2011 |
Case collection study of the safety of AmBisome in association with voriconazole in the treatment of patients with invasive fungal infection.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Mycoses; Pyrimidines; Survival Analysis; Triazoles; Voriconazole; Young Adult | 2010 |
Modulators of very low voriconazole concentrations in routine therapeutic drug monitoring.
Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Enzyme Induction; Female; Genotype; Humans; Male; Medication Adherence; Polymorphism, Genetic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates.
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Recurrent Lecythophora mutabilis keratitis and endophthalmitis after deep anterior lamellar keratoplasty.
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Microscopy, Acoustic; Middle Aged; Mycoses; Phialophora; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2011 |
Interaction of oxycodone and voriconazole-a case series of patients with cancer pain supports the findings of randomised controlled studies with healthy subjects.
Topics: Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Female; Humans; Male; Oxycodone; Pyrimidines; Triazoles; Voriconazole | 2011 |
Effects of voriconazole co-administration on oxycodone-induced adverse events: a case in the retrospective survey.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Mycoses; Oxycodone; Pyrimidines; Receptors, Opioid, mu; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of ep
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Treatment of invasive aspergillosis with nonmyeloablative allogeneic stem cell transplantation: one stone two birds.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Immunosuppression Therapy; Invasive Pulmonary Aspergillosis; Leukemia; Pyrimidines; Radiography; Remission Induction; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Triazoles; Voriconazole | 2011 |
Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.
Topics: Adult; Aged; Alkaline Phosphatase; Antifungal Agents; Exostoses; Female; Fluorides; Heart Transplantation; Humans; Male; Middle Aged; Periostitis; Plasma; Pyrimidines; Transplantation; Triazoles; Voriconazole | 2011 |
[Fatal outcome of invasive tracheal aspergillosis].
Topics: Antifungal Agents; Bronchi; Carotid Artery, External; Caspofungin; Contrast Media; Echinocandins; Fatal Outcome; Hemoptysis; Humans; Image Processing, Computer-Assisted; Iohexol; Lipopeptides; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, Spiral Computed; Trachea; Tracheal Diseases; Triazoles; Voriconazole; Young Adult | 2011 |
Severe acute hypokalaemia secondary to voriconazole. Uncommon pharmacological causes of hypokalaemia.
Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Invasive; Drug Therapy, Combination; Humans; Hypokalemia; Linezolid; Lung Diseases, Fungal; Male; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Potassium Chloride; Pyrimidines; Triazoles; Voriconazole | 2011 |
Frequency of voriconazole resistance in vitro among Spanish clinical isolates of Candida spp. According to breakpoints established by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Drug Resistance, Fungal; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an effect not predicted by the MIC value alone.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Drug Interactions; Drug Resistance, Fungal; Fungal Proteins; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Drug Combinations; Echinocandins; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients.
Topics: Antifungal Agents; Humans; Leukemia; Mycoses; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2011 |
A case of periostitis secondary to voriconazole therapy in a heart transplant recipient.
Topics: Aged; Antifungal Agents; Heart Transplantation; Humans; Male; Periostitis; Pyrimidines; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Triazoles; Voriconazole; Whole Body Imaging | 2011 |
Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance program.
Topics: Antifungal Agents; Candida; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2011 |
Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia.
Topics: Anti-Retroviral Agents; Aspergillosis; Aspergillus; Drug Interactions; Female; HIV Infections; HIV-1; Humans; Male; Nitriles; Pneumonia, Aspiration; Pyridazines; Pyrimidines; Ritonavir; Triazoles; Voriconazole | 2011 |
Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipients.
Topics: Adult; Aged; Antifungal Agents; Bayes Theorem; Female; Humans; Liver Transplantation; Male; Middle Aged; Nonlinear Dynamics; Pyrimidines; Triazoles; Voriconazole | 2011 |
The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Tetrazolium Salts; Time Factors; Triazoles; Voriconazole | 2011 |
Clinical experience of anidulafungin for the treatment of patients with documented candidemia.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidemia; Catheters, Indwelling; Cross Infection; Echinocandins; Female; Fluconazole; Humans; Italy; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Biofilms; Drug Resistance, Fungal; Fungal Proteins; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Mutation; Pyrimidines; Triazoles; Voriconazole | 2011 |
Cerebral phaeohyphomycosis caused by Bipolaris spicifera after heart transplantation.
Topics: Antifungal Agents; Ascomycota; Brain Abscess; Cerebral Phaeohyphomycosis; Heart Transplantation; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2011 |
[Fungal keratitis in an immunocompetent patient].
Topics: Adult; Antifungal Agents; Corneal Opacity; Corneal Transplantation; Corneal Ulcer; Diagnostic Errors; Drug Resistance, Fungal; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Immunocompetence; Keratitis, Herpetic; Male; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole | 2011 |
Antifungal use in hospitalized adults in U.S. academic health centers.
Topics: Academic Medical Centers; Adult; Antifungal Agents; Azoles; Caspofungin; Echinocandins; Humans; Lipopeptides; Multivariate Analysis; Practice Patterns, Physicians'; Pyrimidines; Regression Analysis; Triazoles; United States; Voriconazole | 2011 |
Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.
Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Plankton; Pyrimidines; Triazoles; Voriconazole | 2011 |
A retrospective analysis of the effect of patient-specific factors on voriconazole concentrations in oncology patients.
Topics: Adult; Age Factors; Aged; Alkaline Phosphatase; Antifungal Agents; Female; Humans; International Normalized Ratio; Linear Models; Male; Middle Aged; Multivariate Analysis; Mycoses; Neoplasms; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2012 |
Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematology; Hospital Costs; Humans; Length of Stay; Lipopeptides; Male; Middle Aged; Models, Economic; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Disseminated Rhizomucor pusillus causing early multiorgan failure during hematopoietic stem cell transplantation for severe aplastic anemia.
Topics: Amphotericin B; Anemia, Aplastic; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Mucormycosis; Multiple Organ Failure; Pyrimidines; Rhizomucor; Triazoles; Voriconazole | 2011 |
Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Biopsy; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole | 2011 |
Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis caused by Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Delayed-Action Preparations; Endophthalmitis; Eye; Humans; Intravitreal Injections; Microspheres; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2011 |
Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Child; Fever; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
A case of Candida haemulonii osteitis: clinical features, biochemical characteristics, and antifungal resistance profile.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Histocytochemistry; Humans; Male; Microbial Sensitivity Tests; Microscopy; Osteitis; Pyrimidines; Triazoles; United States; Vascular Surgical Procedures; Voriconazole | 2011 |
Voriconazole-associated phototoxicity.
Topics: Antifungal Agents; Bone Marrow Transplantation; Dermatitis, Phototoxic; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Sunlight; Triazoles; Voriconazole | 2011 |
A vascular graft infection by aspergillus treated without graft removal.
Topics: Abscess; Adult; Anti-Bacterial Agents; Antifungal Agents; Aortic Aneurysm, Abdominal; Aspergillosis; Aspergillus fumigatus; Blood Vessel Prosthesis; Combined Modality Therapy; Coronary Sinus; Coronary Vessels; Debridement; Drug Therapy, Combination; Fever; Heart Valve Prosthesis; Humans; Male; Postoperative Complications; Povidone-Iodine; Prosthesis-Related Infections; Pyrimidines; Replantation; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Bipolaris hawaiiensis as etiologic agent of allergic bronchopulmonary mycosis: first case in a paediatric patient.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Aspergillus fumigatus; beta-Glucans; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Female; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Mycological Typing Techniques; Phylogeny; Prednisone; Pyrimidines; Sequence Analysis, DNA; Sputum; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Voriconazole: may be an option for treatment of cryptococcal meningitis.
Topics: Animals; Antifungal Agents; Humans; Infant, Newborn; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2011 |
Postoperative endophthalmitis caused by Candida parapsilosis: clinical features and treatment outcomes.
Topics: Aged; Antifungal Agents; Candidiasis; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Intravitreal Injections; Male; Middle Aged; Postoperative Complications; Pseudophakia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Vitrectomy; Voriconazole | 2011 |
Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.
Topics: Antifungal Agents; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole | 2011 |
Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing.
Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Dermatomycoses; Female; Humans; Liver Cirrhosis; Mycoses; Nystatin; Paecilomyces; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole | 2011 |
A 61 year-old female with a prior history of tuberculosis presenting with hemoptysis.
Topics: Antifungal Agents; Emigrants and Immigrants; Female; Hemoptysis; Humans; Microscopy; Middle Aged; Mycetoma; Mycology; Pakistan; Pyrimidines; Radiography, Thoracic; Scedosporium; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; United States; Voriconazole | 2011 |
Quantification of voriconazole in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry: application to a bioequivalence study.
Topics: Adult; Antifungal Agents; Area Under Curve; Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Half-Life; Humans; Male; Pyrimidines; Quality Control; Reference Standards; Reproducibility of Results; Solutions; Solvents; Spectrometry, Mass, Electrospray Ionization; Therapeutic Equivalency; Triazoles; Voriconazole | 2011 |
Highly activated oral bioavailability of tacrolimus on coadministration of oral voriconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Biological Availability; Drug Interactions; Female; Humans; Immunosuppressive Agents; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2011 |
Fatal mycotic aneurysms due to Scedosporium and Pseudallescheria infection.
Topics: Aneurysm, Infected; Antifungal Agents; Aorta; Cerebral Arteries; Fatal Outcome; Humans; Male; Middle Aged; Mycetoma; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Vascular Surgical Procedures; Voriconazole | 2011 |
Mechanism of voriconazole-induced transient visual disturbance: reversible dysfunction of retinal ON-bipolar cells in monkeys.
Topics: Aminobutyrates; Animals; Antifungal Agents; Electroretinography; Infusions, Intravenous; Intravitreal Injections; Macaca fascicularis; Photic Stimulation; Photoreceptor Cells, Vertebrate; Pyrimidines; Retinal Bipolar Cells; Triazoles; Vision Disorders; Voriconazole | 2011 |
Breakthrough lung Scedosporium prolificans infection with multiple cavity lesions in a patient receiving voriconazole for probable invasive aspergillosis associated with monoclonal gammopathy of undetermined significance (MGUS).
Topics: Antifungal Agents; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mycetoma; Paraproteinemias; Pulmonary Aspergillosis; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2011 |
The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis.
Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Eye Infections, Fungal; Fusarium; Humans; Injections, Intraocular; Male; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series.
Topics: Administration, Ophthalmic; Adult; Aged; Antifungal Agents; Aspergillosis; Corneal Ulcer; Eye Infections, Fungal; Female; Fusariosis; Humans; Injections, Intralesional; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility testing and candidaemia at a tertiary referral hospital.
Topics: Antifungal Agents; Candidemia; Cross Infection; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole is effective as secondary antifungal prophylaxis in leukemia patients with prior pulmonary fungal disease: case series and review of literature.
Topics: Adult; Aged; Antifungal Agents; Antineoplastic Agents; Female; Humans; Leukemia; Lung Diseases, Fungal; Male; Middle Aged; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Oral voriconazole for neutropenia: a leukemia patient with probable pulmonary aspergillosis and scedosporidiosis.
Topics: Administration, Oral; Aged; Antifungal Agents; Female; Humans; Leukemia; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2011 |
Treatment of microsporidia keratitis with topical voriconazole monotherapy.
Topics: Administration, Topical; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Microsporidia; Microsporidiosis; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2011 |
Successful treatment of intra-abdominal Exophiala dermatitidis infection in a dog.
Topics: Abdomen; Abdominal Abscess; Animals; Antifungal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Exophiala; Female; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Fungal endophthalmitis successfully treated with intravitreal voriconazole injection.
Topics: Adult; Antifungal Agents; Cord Blood Stem Cell Transplantation; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Intravitreal Injections; Leukemia, Erythroblastic, Acute; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole toxicity related to polymorphisms in CYP2C19.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Female; Hallucinations; Humans; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole | 2011 |
The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Central Nervous System Fungal Infections; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; Pyrimidines; Retrospective Studies; Scedosporium; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Lupus-like lesions in a 28-month-old boy with chronic granulomatous disease on long-term voriconazole prophylaxis.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Child, Preschool; Granulomatous Disease, Chronic; Humans; Lupus Erythematosus, Discoid; Male; Pyrimidines; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole | 2011 |
Transcriptional profiling of azole-resistant Candida parapsilosis strains.
Topics: Antifungal Agents; Azoles; Candida; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Profiling; Microbial Sensitivity Tests; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2011 |
Treatment of Alternaria keratitis with intrastromal and topical caspofungin in combination with intrastromal, topical, and oral voriconazole.
Topics: Administration, Oral; Administration, Topical; Aged; Alternaria; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Female; Humans; Injections, Intraocular; Keratitis; Lipopeptides; Pyrimidines; Triazoles; Voriconazole | 2011 |
Oral Candida isolates among HIV-infected subjects in Nigeria.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole | 2011 |
Scopulariopsis brevicaulis abscess in a child treated for myeloblastic leukaemia.
Topics: Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Humans; Infant; Leukemia, Myeloid, Acute; Lipopeptides; Lung Abscess; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2011 |
Design, synthesis and molecular docking studies of novel triazole as antifungal agent.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Propanols; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole | 2011 |
Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Deoxycholic Acid; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Mice; Mice, Inbred DBA; Pyrimidines; Triazoles; Voriconazole | 2011 |
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Denmark; Drug Resistance, Fungal; Female; Hospitals; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Pyrimidines; Respiratory System; Respiratory Tract Infections; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Diagnosis and treatment of fungal infection after liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Liver Transplantation; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Ascomycota; Caspofungin; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Fungemia; Heart Transplantation; Histocytochemistry; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Male; Microscopy; Molecular Sequence Data; Mycoses; Pleura; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Pharmacokinetics of voriconazole during continuous venovenous hemofiltration.
Topics: Aged; Antifungal Agents; Area Under Curve; Hemofiltration; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Triazoles; Voriconazole | 2011 |
Eumycetoma of the hand caused by Leptosphaeria tompkinsii and refractory to medical therapy with voriconazole.
Topics: Antifungal Agents; Ascomycota; Debridement; DNA, Fungal; Hand; Histocytochemistry; Humans; Male; Middle Aged; Molecular Sequence Data; Mycetoma; Polymerase Chain Reaction; Pyrimidines; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Failure; Triazoles; United Kingdom; Voriconazole | 2011 |
Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
Topics: Antifungal Agents; Candida; Candidemia; Cross Infection; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Intensive Care Units; Italy; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
Topics: Animals; Antifungal Agents; Ascomycota; Chromoblastomycosis; Itraconazole; Male; Mice; Mice, Nude; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Eye Infections, Fungal; Fungi; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
An accidental mass.
Topics: Accidents, Traffic; Adult; Aspergillus flavus; Caspofungin; Combined Modality Therapy; Coronary Thrombosis; Diagnosis, Differential; Disease Progression; Echinocandins; Echocardiography; Echocardiography, Transesophageal; Embolism; Emergency Service, Hospital; Endocarditis; Female; Fractures, Bone; Humans; Incidental Findings; Invasive Pulmonary Aspergillosis; Lipopeptides; Mediastinal Diseases; Pelvic Bones; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Intravitreally implantable voriconazole delivery system for experimental fungal endophthalmitis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Endophthalmitis; Eye Infections, Fungal; Female; Lactic Acid; Male; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Rabbits; Triazoles; Vitreous Body; Voriconazole | 2011 |
[Intralobar pulmonary sequestration with aspergillosis in an asymptomatic 39-year-old man].
Topics: Adult; Bronchopulmonary Sequestration; Humans; Male; Pulmonary Aspergillosis; Pyrimidines; Radiography; Thoracotomy; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist.
Topics: Antifungal Agents; Exophiala; Genotype; Humans; Microbial Sensitivity Tests; Phaeohyphomycosis; Pyrimidines; Triazoles; Voriconazole | 2011 |
Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Drug Interactions; Genotype; Half-Life; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Triazoles; Vincristine; Voriconazole | 2011 |
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay.
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Base Sequence; Cross Reactions; Diagnosis, Differential; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Molecular Sequence Data; Mycoses; Neutropenia; Pyrimidines; Sensitivity and Specificity; Sordariales; Spores, Fungal; Triazoles; Voriconazole | 2011 |
Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation.
Topics: Adult; Antifungal Agents; Aspergillosis; Dermatomycoses; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Stem Cell Transplantation; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Cutaneous fusariosis developing in a post-irradiation site.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Debridement; Dermatomycoses; Female; Fusarium; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg Ulcer; Lymphoma, Non-Hodgkin; Opportunistic Infections; Postoperative Complications; Prednisone; Pyrimidines; Radiodermatitis; Radiotherapy; Skin Neoplasms; Triazoles; Voriconazole | 2011 |
In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Resolution of galactomannan antigenemia in a patient receiving oral voriconazole for chronic necrotizing pulmonary aspergillosis.
Topics: Antifungal Agents; Antigens, Fungal; Drug Monitoring; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2011 |
Invasive aspergillosis of orbit in immunocompetent patients: treatment and outcome.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Infant; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Orbital Diseases; Paranasal Sinus Diseases; Pyrimidines; Retrospective Studies; Tomography, X-Ray Computed; Triazoles; Voriconazole; Young Adult | 2011 |
Failure of haematopoietic recovery overcome by SCT despite invasive mucormycosis infection.
Topics: Adult; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mucormycosis; Pyrimidines; Radiography; Remission Induction; Transplantation, Homologous; Triazoles; Voriconazole | 2012 |
Natamycin and voriconazole in fungal keratitis.
Topics: Antifungal Agents; Eye Infections, Fungal; Humans; Keratitis; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Voriconazole-associated severe hyponatremia.
Topics: Aged; Antifungal Agents; Aspergillosis; Drug Monitoring; Female; Humans; Hyponatremia; Male; Middle Aged; Pyrimidines; Serum; Triazoles; Voriconazole | 2012 |
Efficacy of anidulafungin against biofilms of different Candida species in long-term trials of continuous flow cultivation.
Topics: Aerobiosis; Anaerobiosis; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candidemia; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Deep skin infection of Scedosporium apiospermum in a patient with refractory idiopathic thrombocytopenic purpura.
Topics: Antifungal Agents; Female; Humans; Immunocompromised Host; Lymphangitis; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Mycetoma; Purpura, Thrombocytopenic, Idiopathic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2011 |
Pseudallescheria boydii infection of a prosthetic hip joint--an uncommon infection in a rare location.
Topics: Antifungal Agents; Female; Hip Prosthesis; Humans; Middle Aged; Mycetoma; Prosthesis-Related Infections; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole | 2011 |
Peripheral neuropathy in patients on long-term triazole antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cohort Studies; Female; Humans; Itraconazole; Long-Term Care; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
[A case of lung scedosporiosis successfully treated with monitoring of plasma voriconazole concentration level].
Topics: Aged; Antifungal Agents; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2011 |
Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.
Topics: Antitubercular Agents; Drug Combinations; Drug Interactions; Ethambutol; Fluconazole; Histoplasma; Isoniazid; Itraconazole; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2011 |
In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2011 |
Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation.
Topics: Administration, Topical; Animals; Antifungal Agents; Chemistry, Pharmaceutical; Deoxycholic Acid; Drug Carriers; Drug Stability; Emulsions; Guinea Pigs; Hydrogen-Ion Concentration; Oleic Acid; Permeability; Plant Oils; Polyethylene Glycols; Polysorbates; Pyrimidines; Rheology; Solubility; Surface-Active Agents; Triazoles; Voriconazole; Water; Waxes | 2012 |
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method.
Topics: Antifungal Agents; Candida; Caspofungin; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Delayed recalcitrant fungal endophthalmitis secondary to Curvularia.
Topics: Abscess; Aged; Amphotericin B; Ascomycota; Cataract Extraction; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Recurrence; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2011 |
Role of voriconazole in combined acanthamoeba and fungal corneal ulcer.
Topics: Amebiasis; Amebicides; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Eye Infections, Parasitic; Humans; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
The effect of enteral nutrition supplements on serum voriconazole levels.
Topics: Adolescent; Antifungal Agents; Enteral Nutrition; Food-Drug Interactions; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pyrimidines; Suspensions; Triazoles; Voriconazole | 2012 |
[Cutaneous neutrophils infiltrates. Case 4. Pseudo-tumoral cutaneous alternariosis].
Topics: Aged, 80 and over; Alternaria; Antifungal Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carcinoma, Verrucous; Combined Modality Therapy; Dacarbazine; Dermatomycoses; Diagnosis, Differential; Ependymoma; Fatal Outcome; Folliculitis; Frontal Lobe; Hand Dermatoses; Humans; Immunocompromised Host; Keratosis; Male; Neutrophils; Pyrimidines; Skin Neoplasms; Staining and Labeling; Temozolomide; Triazoles; Voriconazole | 2011 |
Therapeutic drug monitoring of voriconazole after intravenous administration in infants and children with primary immunodeficiency.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunologic Deficiency Syndromes; Infant; Injections, Intravenous; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2011 |
Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.
Topics: Amphotericin B; Antifungal Agents; Environmental Microbiology; Fusariosis; Fusarium; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
Targeted disruption of nonribosomal peptide synthetase pes3 augments the virulence of Aspergillus fumigatus.
Topics: Animals; Animals, Outbred Strains; Antifungal Agents; Aspergillus fumigatus; Cell Line; Fungal Proteins; Gene Deletion; Macrophages; Mice; Moths; Peptide Synthases; Phenotype; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Virulence; Voriconazole | 2011 |
Cutaneous alternariosis microscopically mimicking blastomycosis.
Topics: Alternaria; Alternariosis; Antifungal Agents; Blastomycosis; Combined Modality Therapy; Dermatologic Surgical Procedures; Diagnosis, Differential; Humans; Immunocompromised Host; Immunosuppressive Agents; Knee; Male; Middle Aged; Pyrimidines; Skin; Triazoles; Voriconazole | 2011 |
Pigmented fruiting bodies and birefringent crystals in a surgical wound: A clue to Aspergillus niger infection.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus niger; Crystallization; Debridement; Fruiting Bodies, Fungal; Humans; Male; Opportunistic Infections; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Time-kill studies with micafungin and voriconazole against Candida glabrata intracellularly in human monocyte-derived macrophages and extracellularly in broth.
Topics: Antifungal Agents; Candida glabrata; Drug Synergism; Echinocandins; Humans; Lipopeptides; Macrophages; Micafungin; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2011 |
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Necrosis; Pentamidine; Phosphorylcholine; Pyrimidines; Skin Diseases, Parasitic; Skin Ulcer; Sulfadoxine; Triazoles; Voriconazole | 2011 |
Cytotoxicity of voriconazole on cultured human corneal endothelial cells.
Topics: Apoptosis; Cell Proliferation; Cell Survival; Cells, Cultured; Coloring Agents; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Corneal; Flow Cytometry; Humans; Membrane Proteins; Necrosis; Phosphoproteins; Propidium; Pyrimidines; Triazoles; Voriconazole; Zonula Occludens-1 Protein | 2011 |
Intravitreal voriconazole for the treatment of Aspergillus chorioretinitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Chorioretinitis; Diagnosis, Differential; Eye Infections, Fungal; Follow-Up Studies; Humans; Intravitreal Injections; Male; Microscopy, Acoustic; Pyrimidines; Triazoles; Visual Acuity; Voriconazole | 2011 |
Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents -- a report of two cases.
Topics: Adult; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fluconazole; Humans; Lipopeptides; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Trichosporonosis; Voriconazole; Young Adult | 2011 |
Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cerebrum; Echinocandins; Humans; Larynx; Lipopeptides; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Paranasal Sinuses; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Sweden; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Disseminated Geosmithia argillacea infection in a patient with gastrointestinal GvHD.
Topics: Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Eurotiales; Fatal Outcome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infliximab; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2012 |
A case of pseudomembranous colitis after voriconazole therapy.
Topics: Adult; Antifungal Agents; Enterocolitis, Pseudomembranous; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2011 |
Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fusariosis; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Pyrimidines; Triazoles; Voriconazole | 2012 |
Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Female; Heart Defects, Congenital; Humans; Immunocompromised Host; Lipopeptides; Mediastinitis; Mycoses; Peritoneal Dialysis; Peritonitis; Postoperative Complications; Pyrimidines; Spleen; Triazoles; Trichoderma; Voriconazole | 2011 |
Hepatic drug interaction between tacrolimus and lansoprazole in a bone marrow transplant patient receiving voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Bone Marrow Transplantation; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lansoprazole; Liver; Male; Mutation; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2011 |
Comparative in vitro activities of fluconazole, voriconazole, and MXP-4509 against Romanian blood yeast isolates.
Topics: Antifungal Agents; Blood; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Romania; Triazoles; Voriconazole; Yeasts | 2011 |
The in vitro elution characteristics of antifungal-loaded PMMA bone cement and calcium sulfate bone substitute.
Topics: Antifungal Agents; Bone Cements; Bone Substitutes; Calcium Sulfate; Chromatography, High Pressure Liquid; Drug Carriers; In Vitro Techniques; Microbial Sensitivity Tests; Polymethyl Methacrylate; Pyrimidines; Solubility; Solvents; Time Factors; Triazoles; Voriconazole | 2011 |
Aspergillus fumigatus spondylodiskitis in renal transplant patient: voriconazole experience.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Back Pain; Discitis; Diskectomy; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Kidney Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Tuberculosis, Pulmonary; Voriconazole | 2011 |
Combination antifungal therapy for invasive pulmonary aspergillosis in a heart transplant recipient.
Topics: Antifungal Agents; Drug Therapy, Combination; Echinocandins; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2011 |
In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
Topics: Aminopyridines; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Cell Line; Echinocandins; Fluconazole; Fungi; Fusarium; Humans; Isoxazoles; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Paecilomyces; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Yeasts | 2011 |
Curvularia lunata endophthalmitis.
Topics: Antifungal Agents; Ascomycota; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Humans; Itraconazole; Male; Middle Aged; Phacoemulsification; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2011 |
Successful management of an intracranial phaeohyphomycotic fungal granuloma in a dog.
Topics: Animals; Antifungal Agents; Cerebral Phaeohyphomycosis; Dog Diseases; Dogs; Fluconazole; Granuloma; Male; Pyrimidines; Triazoles; Voriconazole | 2011 |
In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Synergism; Fungi; Fusarium; Ibuprofen; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Broth microdilution and time-kill testing of Caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of Candida krusei.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2012 |
In vitro activities of new triazole antifungal agents, posaconazole and voriconazole, against oral Candida isolates from patients suffering from denture stomatitis.
Topics: Antifungal Agents; Candida; Humans; Microbial Sensitivity Tests; Pyrimidines; Stomatitis, Denture; Triazoles; Voriconazole | 2012 |
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
Topics: Aminopyridines; Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Echinocandins; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Dosing voriconazole in an obese patient.
Topics: Adult; Antifungal Agents; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Mycoses; Obesity; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2011 |
Polyhexamethylene biguanide and calcineurin inhibitors as novel antifungal treatments for Aspergillus keratitis.
Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Biguanides; Calcineurin Inhibitors; Corneal Ulcer; Cyclosporine; Disinfectants; Drug Synergism; Eye Infections, Fungal; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Prospective Studies; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2011 |
Rhinocerebral mucormycosis: a diagnostic challenge and therapeutic dilemma in immunocompetent host.
Topics: Adult; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Eye Infections, Fungal; Female; Humans; Hyphae; Immunocompetence; Male; Maxilla; Middle Aged; Mucormycosis; Nose Diseases; Orbit; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole | 2012 |
Pharmacokinetics of sulfobutylether-β-cyclodextrin (SBECD) in subjects on hemodialysis.
Topics: Adult; Antifungal Agents; beta-Cyclodextrins; Case-Control Studies; Excipients; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Prognosis; Pyrimidines; Renal Dialysis; Tissue Distribution; Triazoles; Voriconazole | 2012 |
Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction.
Topics: Amino Acid Sequence; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Binding Sites; Catalytic Domain; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Pyrimidines; Saccharomyces cerevisiae; Sequence Analysis, DNA; Triazoles; Voriconazole | 2011 |
[Chromoblastomycosis caused by Fonsecaea monophora].
Topics: Administration, Oral; Antifungal Agents; Ascomycota; Base Sequence; Chromoblastomycosis; Humans; Hyperthermia, Induced; Japan; Male; Middle Aged; Philippines; Pyrimidines; RNA, Fungal; RNA, Ribosomal; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Voriconazole-induced periostitis.
Topics: Adult; Bone and Bones; Endophthalmitis; Female; Humans; Periostitis; Pyrimidines; Radionuclide Imaging; Time Factors; Triazoles; Voriconazole; Whole Body Imaging | 2012 |
Evaluation of saliva flow rates, Candida colonization and susceptibility of Candida strains after head and neck radiation.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Colony Count, Microbial; Dental Caries; Drug Resistance, Fungal; Female; Fluconazole; Head and Neck Neoplasms; Humans; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Pyrimidines; Radiation Injuries; Saliva; Salivary Glands; Secretory Rate; Triazoles; Voriconazole; Xerostomia | 2012 |
Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method.
Topics: Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole | 2011 |
Acremonium keratomycosis in a cat.
Topics: Acremonium; Animals; Antifungal Agents; Cat Diseases; Cats; Cornea; Corneal Diseases; Eye Infections, Fungal; Female; Miconazole; Pyrimidines; Triazoles; Voriconazole | 2011 |
Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biological Specimen Banks; DNA, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Phylogeny; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Subacute infectious endocarditis of unusual etiology: peculiarities of diagnostics and treatment].
Topics: Adult; Endocarditis; Female; Humans; Prototheca; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cross Infection; Echinocandins; Female; Fluconazole; Hospitals; Humans; Italy; Itraconazole; Lipopeptides; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
[Mucormycosis: retrospective evaluation of 12 cases].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Brain Diseases; Diabetes Complications; Female; Hematologic Diseases; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Nose Diseases; Orbital Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
Tenosynovitis caused by a pseudallescheria boydii infection and symptoms of reflex sympathetic dystrophy after a dog bite.
Topics: Animals; Antifungal Agents; Bites and Stings; Diagnosis, Differential; Dogs; Humans; Male; Middle Aged; Mycoses; Pseudallescheria; Pyrimidines; Reflex Sympathetic Dystrophy; Tenosynovitis; Triazoles; Voriconazole | 2011 |
Voriconazole-induced QT interval prolongation and torsades de pointes.
Topics: Adolescent; Antifungal Agents; Child; Electrocardiography; Endocarditis; Female; Humans; Long QT Syndrome; Male; Pulmonary Aspergillosis; Pyrimidines; Torsades de Pointes; Triazoles; Trichosporonosis; Voriconazole | 2011 |
In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Miconazole; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Fluorosis because of prolonged voriconazole therapy in a teenager with acute myelogenous leukemia.
Topics: Adolescent; Antifungal Agents; Fluorides; Fusariosis; Humans; Leukemia, Myeloid, Acute; Male; Periostitis; Pyrimidines; Triazoles; Voriconazole | 2011 |
An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Survival Analysis; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Trends in zygomycosis in children.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Humans; Incidence; Male; Prevalence; Pyrimidines; Retrospective Studies; Triazoles; United States; Voriconazole; Zygomycosis | 2012 |
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; Fever; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Nausea; Pyrimidines; Recurrence; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2011 |
Post-traumatic Pseudallescheria apiosperma osteomyelitis: positive outcome of a young immunocompetent male patient due to surgical intervention and voriconazole therapy.
Topics: Adolescent; Antifungal Agents; Bone Transplantation; Fractures, Open; Humans; Immunocompetence; Male; Microbial Sensitivity Tests; Mycoses; Osteomyelitis; Pseudallescheria; Pyrimidines; Tibial Fractures; Transplantation, Autologous; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Concurrent atazanavir and voriconazole in a patient with multidrug-resistant HIV and a mycetoma.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Atazanavir Sulfate; Drug Resistance, Multiple, Viral; Humans; Male; Middle Aged; Mycetoma; Oligopeptides; Pyridines; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Incidence; Infant; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Risk Factors; Survival Analysis; Taiwan; Triazoles; Voriconazole; Young Adult | 2012 |
A painful thigh lesion in an immunocompromised 11-year-old boy.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Humans; Hyphae; Immunocompromised Host; Lung Neoplasms; Male; Pyrimidines; Pythiosis; Pythium; Sarcoma, Ewing; Thigh; Triazoles; Voriconazole | 2011 |
Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Antiviral Agents; Fatal Outcome; Humans; Immunocompetence; Influenza A Virus, H1N1 Subtype; Influenza, Human; Invasive Pulmonary Aspergillosis; Male; Oseltamivir; Pyrimidines; Triazoles; Voriconazole | 2012 |
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Comorbidity; Early Diagnosis; Female; Galactose; Hospital Units; Hospitals, University; Humans; Invasive Pulmonary Aspergillosis; Italy; Leukocyte Count; Male; Mannans; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2011 |
Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles.
Topics: Adolescent; Adult; Antifungal Agents; Coccidioides; Coccidioidomycosis; Cohort Studies; Exostoses; Female; Fluconazole; Fluorides; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Periostitis; Pyrimidines; Triazoles; United States; Voriconazole | 2012 |
In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Codon; Culture Media; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Mycological Typing Techniques; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2012 |
SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A).
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genetic Complementation Test; Genotype; Humans; Microbial Sensitivity Tests; Organisms, Genetically Modified; Pyrimidines; Real-Time Polymerase Chain Reaction; Sterol Regulatory Element Binding Proteins; Transcription, Genetic; Triazoles; Voriconazole | 2012 |
Penicillium marneffei infection presenting as vulv-ulcer in an HIV-infected woman.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Diagnosis, Differential; Female; HIV; HIV Infections; Humans; Mycoses; Penicillium; Pyrimidines; Triazoles; Ulcer; Voriconazole; Vulvar Diseases; Young Adult | 2011 |
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Female; Fungal Proteins; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Mutation; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2012 |
Subcutaneous dematiaceous fungal infection.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antifungal Agents; Chromoblastomycosis; Combined Modality Therapy; Costa Rica; Diagnosis, Differential; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Leg; Male; Phaeohyphomycosis; Pneumonia; Pyrimidines; Soil Microbiology; Triazoles; Voriconazole | 2011 |
Treatment of refractory coccidioidomycosis with voriconazole or posaconazole.
Topics: Adult; Aged; Antifungal Agents; Coccidioidomycosis; Female; Humans; Male; Middle Aged; Pyrimidines; Retrospective Studies; Salvage Therapy; Southwestern United States; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Periostitis secondary to prolonged voriconazole therapy in a lung transplant recipient.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Drug Substitution; Female; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Lung Transplantation; Periostitis; Postoperative Complications; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2011 |
[Pulmonary aspergillosis and HIV infection: about two cases].
Topics: Adult; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; HIV Infections; Humans; Lung Diseases, Fungal; Male; Middle Aged; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Radiography; Risk Factors; Triazoles; Voriconazole | 2012 |
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Medication Adherence; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Population pharmacokinetics of voriconazole in adults.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus; Bayes Theorem; Case-Control Studies; Chromatography, High Pressure Liquid; Humans; Injections, Intravenous; Logistic Models; Male; Middle Aged; Monte Carlo Method; Pyrimidines; Triazoles; Voriconazole | 2012 |
Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Diffusion Chambers, Culture; Echinocandins; Galactose; Humans; Lipopeptides; Mannans; Microbial Sensitivity Tests; Pulsatile Flow; Pyrimidines; Species Specificity; Spores, Fungal; Triazoles; Voriconazole | 2012 |
Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Serum; Time Factors; Triazoles; Voriconazole; Young Adult | 2012 |
Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Therapy, Combination; Lung; Lung Diseases, Fungal; Mice; Mice, SCID; Pyrimidines; Severe Combined Immunodeficiency; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2012 |
[Careful: skins cancers and voriconazole].
Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Dermatitis, Phototoxic; Drug Eruptions; Female; Humans; Male; Melanoma; Photosensitizing Agents; Pyrimidines; Skin Aging; Skin Neoplasms; Triazoles; Voriconazole; Young Adult | 2011 |
Fusarium verticillioides fungemia in a liver transplantation patient: successful treatment with voriconazole.
Topics: Adult; Antifungal Agents; Female; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Liver Transplantation; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
Topics: Acylation; Aminopyridines; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Fusarium; Glycosylphosphatidylinositols; Humans; Inositol; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2012 |
Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Drug Therapy, Combination; Fatal Outcome; Fungemia; Humans; Leukemia, Myeloid, Acute; Male; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Voriconazole; Young Adult | 2012 |
Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus.
Topics: Amphotericin B; Animals; Aspergillus fumigatus; Biomass; Biosynthetic Pathways; Enoyl-CoA Hydratase; Ergosterol; Ferric Compounds; Gene Deletion; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Gene Silencing; Genes, Fungal; Hydroxamic Acids; Hydroxymethylglutaryl CoA Reductases; Iron Deficiencies; Ligases; Lovastatin; Mevalonic Acid; Mice; Microbial Sensitivity Tests; Oxidative Stress; Pulmonary Aspergillosis; Pyrimidines; Siderophores; Triazoles; Up-Regulation; Virulence; Voriconazole | 2012 |
Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes.
Topics: Adult; Aged; Antifungal Agents; Cytochrome P-450 CYP3A; Female; Humans; Inhibitory Concentration 50; Kinetics; Male; Microsomes, Liver; Pyrimidines; Substrate Specificity; Tacrolimus; Testosterone; Triazoles; Voriconazole | 2012 |
Ventricular bigeminy associated with voriconazole, methadone and esomeprazole.
Topics: Adult; Analgesics, Opioid; Antifungal Agents; Arrhythmias, Cardiac; Drug Interactions; Esomeprazole; Female; Humans; Methadone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proton Pump Inhibitors; Pyrimidines; Triazoles; Ventricular Dysfunction; Voriconazole | 2011 |
A case report of voriconazole therapy failure in a homozygous ultrarapid CYP2C19*17/*17 patient comedicated with carbamazepine.
Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Carbamazepine; Cytochrome P-450 CYP2C19; Drug Interactions; Female; Homozygote; Humans; Middle Aged; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2012 |
Successful treatment of disseminated fusariosis with voriconazole in an acute lymphoblastic leukaemia patient.
Topics: Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography, Thoracic; Skin; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Invasive pulmonary aspergillosis in a patient with seminomatous testicular cancer.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Pyrimidines; Testicular Neoplasms; Treatment Outcome; Triazoles; Voriconazole | 2011 |
[Invasive aspergillosis: new tools for a targeted medical management].
Topics: Adult; Aged; Antifungal Agents; Antigens, Fungal; Aspergillosis; beta-Glucans; Clinical Trials as Topic; Comorbidity; Disease Management; Female; France; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Factors; Survival Rate; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Rapid simultaneous determination of voriconazole and its N-oxide in human plasma using an isocratic high-performance liquid chromatography method and its clinical application.
Topics: Acetonitriles; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Models, Chemical; Oxides; Plasma; Pyrimidines; Reproducibility of Results; Time Factors; Triazoles; Ultraviolet Rays; Voriconazole | 2012 |
Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.
Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Drug Therapy, Combination; Echinocandins; Humans; Male; Mice; Pyrimidines; Triazoles; Voriconazole | 2012 |
A case of bronchial aspergillosis caused by Aspergillus udagawae and its mycological features.
Topics: Aged, 80 and over; Animals; Aspergillosis; Aspergillus; Bronchial Diseases; Bronchoscopy; Diabetes Mellitus; Female; Humans; Hydrogen Peroxide; Immunocompromised Host; Lung; Mice; Pyrimidines; Triazoles; Voriconazole | 2012 |
Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Genotype; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation, Missense; Phenylalanine; Pyrimidines; Sterol 14-Demethylase; Survival Rate; Triazoles; Tyrosine; Voriconazole | 2012 |
Chronic granulomatous disease in an adult recognized by an invasive aspergillosis.
Topics: Antifungal Agents; Aspergillus; Diagnosis, Differential; Germany; Granulomatous Disease, Chronic; Humans; Infusions, Parenteral; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Phagocytes; Pyrimidines; Respiratory Insufficiency; Tachypnea; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunocompromised Host; Incidence; Infant; Male; Mycoses; Plasma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation.
Topics: Administration, Cutaneous; Animals; Drug Carriers; Drug Delivery Systems; Elasticity; Liposomes; Male; Mice; Mice, Hairless; Pyrimidines; Skin; Skin Absorption; Triazoles; Voriconazole | 2012 |
New species of Madurella, causative agents of black-grain mycetoma.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Fungal Proteins; Humans; Leg; Madurella; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mycetoma; Phylogeny; Pyrimidines; RNA Polymerase II; Sequence Analysis, DNA; Sudan; Triazoles; Tubulin; Voriconazole | 2012 |
[Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Injections, Spinal; Male; Meningitis, Cryptococcal; Mice; Pyrimidines; Triazoles; Voriconazole | 2012 |
Effects of the CYP2B6*6 allele on catalytic properties and inhibition of CYP2B6 in vitro: implication for the mechanism of reduced efavirenz metabolism and other CYP2B6 substrates in vivo.
Topics: Alkynes; Alleles; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Biotransformation; Bupropion; Catalysis; Clopidogrel; Cyclopropanes; Cytochrome P-450 CYP2B6; Cytochromes b5; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Kinetics; Microsomes, Liver; Oxidoreductases, N-Demethylating; Pyrimidines; Substrate Specificity; Ticlopidine; Triazoles; Voriconazole | 2012 |
A case of fluconazole, voriconazole-resistant Cryptococcus neoformans isolated from and immunocompetent patient.
Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Immunocompetence; Male; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2011 |
Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
Topics: Administration, Inhalation; Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Chemoprevention; Colony Count, Microbial; Cortisone; Cyclophosphamide; Disease Models, Animal; Guinea Pigs; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lung; Male; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2012 |
Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit.
Topics: Aged, 80 and over; Air Microbiology; Antifungal Agents; Aspergillosis; Aspergillus; Cardiac Surgical Procedures; Caspofungin; Coronary Care Units; Disease Outbreaks; Echinocandins; Female; Humans; Incidence; Lipopeptides; Male; Middle Aged; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole | 2012 |
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cell Membrane; Cell Wall; Drug Resistance, Multiple, Fungal; Ergosterol; Gene Duplication; Genome, Fungal; Genomic Instability; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Species Specificity; Triazoles; Virulence Factors; Voriconazole | 2012 |
Future directions in mucormycosis research.
Topics: Antifungal Agents; Aspergillus; Biomedical Research; Early Diagnosis; Genome, Fungal; Humans; Immunocompromised Host; Mucormycosis; Pyrimidines; Rhizopus; Risk Factors; Triazoles; Voriconazole | 2012 |
Administration of voriconazole in patients with renal dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Creatinine; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2012 |
Fast and simple LC-MS/MS method for quantifying plasma voriconazole.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Pyrimidines; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2012 |
Lack of hepato- and nephrotoxicity induced by antifungal drug voriconazole in laboratory rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antifungal Agents; Aspartate Aminotransferases; Blood Urea Nitrogen; Body Weight; Creatinine; Dose-Response Relationship, Drug; gamma-Glutamyltransferase; Injections, Intraperitoneal; Kidney; Liver; Microscopy, Electron, Transmission; Molecular Structure; Organ Size; Pyrimidines; Rats; Rats, Sprague-Dawley; Toxicity Tests; Triazoles; Voriconazole | 2012 |
Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
Topics: Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Bacterial Typing Techniques; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pseudallescheria; Pyrimidines; Scedosporium; Species Specificity; Triazoles; Voriconazole | 2012 |
Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children.
Topics: Antifungal Agents; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Invasive Pulmonary Aspergillosis; Male; Plasma; Pyrimidines; Triazoles; Voriconazole | 2012 |
A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
Topics: Aminolevulinic Acid; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Photochemotherapy; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Expression turnover profiling to monitor the antifungal activities of amphotericin B, voriconazole, and micafungin against Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Echinocandins; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Fungal; Humans; Lipopeptides; Micafungin; Pyrimidines; RNA, Messenger; Transcriptome; Treatment Outcome; Triazoles; Voriconazole | 2012 |
The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis.
Topics: Adolescent; Agrobacterium tumefaciens; Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus flavus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Gene Transfer Techniques; Humans; Lung; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutation; Plasmids; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2012 |
Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm.
Topics: Ambroxol; Antifungal Agents; Biofilms; Candida; Colorimetry; Drug Synergism; Fungemia; Humans; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole | 2012 |
Impact of corneal cross-linking on drug penetration in an ex vivo porcine eye model.
Topics: Administration, Topical; Animals; Anterior Chamber; Anti-Bacterial Agents; Antifungal Agents; Aqueous Humor; Cornea; Models, Animal; Ofloxacin; Photosensitizing Agents; Pyrimidines; Random Allocation; Riboflavin; Swine; Triazoles; Ultraviolet Rays; Voriconazole | 2012 |
Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Meningoencephalitis; Microbial Sensitivity Tests; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2012 |
Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Taiwan; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2012 |
Purpureocillium lilacinum as a cause of cavitary pulmonary disease: a new clinical presentation and observations on atypical morphologic characteristics of the isolate.
Topics: Aged, 80 and over; Antifungal Agents; DNA, Fungal; Female; Humans; Hypocreales; Lung Diseases, Fungal; Microscopy; Molecular Sequence Data; Mycoses; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Longitudinal Studies; Mathematical Computing; Microbial Sensitivity Tests; Models, Statistical; Mutation; Netherlands; Promoter Regions, Genetic; Pyrimidines; Sequence Analysis, DNA; Tandem Repeat Sequences; Triazoles; Voriconazole | 2012 |
Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity.
Topics: Adult; Aged; Antifungal Agents; Central Nervous System; Chromatography, High Pressure Liquid; Cystic Fibrosis; Drug Monitoring; Female; Fungi; Humans; Liver; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Prospective Studies; Pulmonary Fibrosis; Pyrimidines; Treatment Outcome; Triazoles; United States; Voriconazole | 2012 |
[Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy.
Topics: Adult; Antifungal Agents; Cardiac Pacing, Artificial; Cardiopulmonary Resuscitation; Electric Countershock; Electrocardiography; Electrolytes; Female; Humans; Long QT Syndrome; Mitral Valve Insufficiency; Nephrotic Syndrome; Pyrimidines; Rheumatic Heart Disease; Torsades de Pointes; Triazoles; Voriconazole | 2012 |
Non-clinical safety assessment and toxicokinetics of voriconazole and anidulafungin in the juvenile rat: a combination study design in support of a Paediatric Investigation Plan.
Topics: Administration, Oral; Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Drug Combinations; Drug Evaluation, Preclinical; Echinocandins; Female; Injections, Subcutaneous; Male; Pyrimidines; Rats; Rats, Inbred F344; Research Design; Sex Factors; Toxicity Tests; Triazoles; Voriconazole | 2012 |
[Vertebral aspergillosis in a cirrhotic patient: an uncommon cause of spondylitis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomarkers; Cross Infection; Fatal Outcome; Galactose; Haemophilus influenzae; Hepatitis C, Chronic; Humans; Immunocompromised Host; Liver Cirrhosis; Low Back Pain; Lumbar Vertebrae; Male; Mannans; Middle Aged; Multiple Organ Failure; Opportunistic Infections; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Spondylitis; Triazoles; Voriconazole | 2012 |
High frequency of voriconazole-related phototoxicity in cystic fibrosis patients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Dermatitis, Phototoxic; Female; Humans; Male; Pyrimidines; Severity of Illness Index; Triazoles; Voriconazole; Young Adult | 2012 |
Aspergillus-associated cerebral aneurysm successfully treated by endovascular and surgical intervention with voriconazole in lupus nephritis patient.
Topics: Antifungal Agents; Female; Humans; Immunosuppressive Agents; Intracranial Aneurysm; Lupus Nephritis; Middle Aged; Neuroaspergillosis; Pyrimidines; Stents; Surgical Instruments; Triazoles; Voriconazole | 2012 |
Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Asthma; Comorbidity; Drug Utilization; Female; Health Services; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Quality of Life; Radiography, Thoracic; Retrospective Studies; Severity of Illness Index; Socioeconomic Factors; Spirometry; Triazoles; Voriconazole | 2012 |
Toxicity of voriconazole on corneal endothelial cells in an animal model.
Topics: Animals; Anterior Chamber; Antifungal Agents; Cell Count; Corneal Endothelial Cell Loss; Endothelium, Corneal; Injections, Intraocular; Microscopy, Electron, Scanning; Models, Animal; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2012 |
Gastrointestinal basidiobolomycosis in a child; an unusual fungal infection mimicking fistulising Crohn's disease.
Topics: Antifungal Agents; Child, Preschool; Colectomy; Crohn Disease; Diagnosis, Differential; Entomophthorales; Humans; Intestinal Diseases; Male; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2012 |
Intracameral and topical voriconazole for fungal corneal endoexudates.
Topics: Administration, Topical; Adult; Aged; Anterior Chamber; Antifungal Agents; Aspergillosis; Corneal Stroma; Corneal Ulcer; Exudates and Transudates; Eye Infections, Fungal; Humans; Injections, Intraocular; Male; Middle Aged; Pyrimidines; Triazoles; Visual Acuity; Voriconazole; Young Adult | 2012 |
Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hematologic Diseases; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Scedosporium apiospermum keratomycosis in a dog.
Topics: Animals; Antifungal Agents; Ascomycota; Dog Diseases; Dogs; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Effect of process variables on morphology and aerodynamic properties of voriconazole formulations produced by thin film freezing.
Topics: Administration, Inhalation; Antifungal Agents; Crystallization; Dioxanes; Dry Powder Inhalers; Excipients; Freezing; Nanostructures; Particle Size; Polymers; Povidone; Powders; Pyrimidines; Solvents; Technology, Pharmaceutical; Triazoles; Voriconazole | 2012 |
Systemic mycosis in a California sea lion (Zalophus californianus) with detection of cystofilobasidiales DNA.
Topics: Animals; Antifungal Agents; Basidiomycota; DNA, Fungal; Fatal Outcome; Itraconazole; Male; Mycoses; Pyrimidines; Sea Lions; Triazoles; Voriconazole | 2012 |
Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemia.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidemia; Female; Humans; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2012 |
Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy.
Topics: Antifungal Agents; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Mycoses; Neoplasms; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole | 2012 |
Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation.
Topics: Administration, Oral; Adult; Antifungal Agents; Biological Availability; Drug Interactions; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pyrimidines; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2012 |
Poststernotomy aspergillosis: successful treatment with voriconazole, surgical debridement and vacuum-assisted closure therapy.
Topics: Antifungal Agents; Aspergillosis; Debridement; Humans; Male; Middle Aged; Negative-Pressure Wound Therapy; Pyrimidines; Sternotomy; Treatment Outcome; Triazoles; Voriconazole | 2012 |
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole | 2012 |
Recurrent fungal iris granuloma in a 10-year-old child.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Granuloma; Humans; Iris Diseases; Pyrimidines; Recurrence; Treatment Outcome; Triazoles; Voriconazole | 2012 |
High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Immunocompromised Host; Immunosuppression Therapy; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole | 2012 |
Risk factors for voriconazole hepatotoxicity at 12 weeks in lung transplant recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Humans; Liver; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Voriconazole; Young Adult | 2012 |
Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology.
Topics: Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Colorimetry; Culture Media; Drug Combinations; Echinocandins; Humans; Microbial Sensitivity Tests; Protein Binding; Pyrimidines; Serum Albumin; Tetrazolium Salts; Time Factors; Triazoles; Voriconazole | 2012 |
Paecilomyces lilacinus endophthalmitis following cataract surgery: a therapeutic challenge.
Topics: Aged; Antifungal Agents; Cataract Extraction; Endophthalmitis; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis--case analysis to plan better targeted prophylactic or therapeutic measurement.
Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole | 2012 |
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Treatment of dematiaceous fungal keratitis in a dog.
Topics: Administration, Topical; Animals; Antifungal Agents; Cornea; Corneal Ulcer; Dog Diseases; Dogs; Eye Infections, Fungal; Keratitis; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Voriconazole-induced phototoxicity in children.
Topics: Chemoprevention; Child; Child, Preschool; Dermatitis, Phototoxic; Female; Humans; Immunocompromised Host; Incidence; Infant; Male; Mycoses; Neoplasms; Pyrimidines; Retrospective Studies; Risk Assessment; Triazoles; Voriconazole | 2012 |
[Ambulatory therapy of aspergillosis in hematological and oncological patients].
Topics: Ambulatory Care; Antifungal Agents; Caspofungin; Echinocandins; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Neutropenia; Pyrimidines; Salvage Therapy; Triazoles; Voriconazole | 2012 |
In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2013 |
Emergency hemicolectomy for intestinal primary aspergillosis in acute myeloid leukemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Colectomy; Emergencies; Enterocolitis, Necrotizing; Female; Humans; Ileostomy; Immunocompromised Host; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.
Topics: Antifungal Agents; Female; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole | 2012 |
The first Korean case of candidemia due to Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheterization, Central Venous; Female; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Dry powder insufflation of crystalline and amorphous voriconazole formulations produced by thin film freezing to mice.
Topics: Administration, Inhalation; Animals; Antifungal Agents; Area Under Curve; Crystallization; Dry Powder Inhalers; Excipients; Freezing; Lung; Male; Mice; Mice, Inbred ICR; Particle Size; Povidone; Pyrimidines; Solubility; Tissue Distribution; Triazoles; Voriconazole | 2012 |
Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Middle Aged; Mutation, Missense; Neuroaspergillosis; Pyrimidines; Spain; Triazoles; Voriconazole | 2012 |
Factors affecting treatment outcomes with voriconazole in cases with fungal keratitis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Eye Infections, Fungal; Female; Fusarium; Humans; Keratitis; Male; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Treatment Failure; Triazoles; Visual Acuity; Voriconazole; Young Adult | 2013 |
High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Fungal; France; Humans; In Vitro Techniques; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyrimidines; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole; Young Adult | 2012 |
Effects of anidulafungin and voriconazole, singly and in combination, on cytokine/chemokine production by human monocyte-derived macrophages infected with Candida glabrata or activated by lipopolysaccharide.
Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Chemokines; Cytokines; Echinocandins; Humans; Lipopolysaccharides; Macrophages; Pyrimidines; Triazoles; Voriconazole | 2012 |
In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.
Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungal Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Coccidioidal endophthalmitis in immunocompetent person, California, USA.
Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Eye Infections, Fungal; Fluconazole; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Ultrasonography; Voriconazole | 2012 |
Editorial commentary: Antifungal therapeutic drug monitoring progress: getting it right the first time.
Topics: Antifungal Agents; Female; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Plasma; Pyrimidines; Triazoles; Voriconazole | 2012 |
Pseudomembranous necrotizing tracheobronchial aspergillosis: an analysis of 16 cases.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Bronchoscopy; Caspofungin; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Azoles; Base Sequence; Biological Transport; Candida glabrata; Drug Resistance, Multiple, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Microbial Sensitivity Tests; Mutation, Missense; Pyrimidines; Saccharomyces cerevisiae; Sequence Analysis, DNA; Sterol 14-Demethylase; Sterols; Triazoles; Voriconazole | 2012 |
In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus spp.
Topics: Anidulafungin; Antifungal Agents; Aspergillus; Azoles; Drug Combinations; Echinocandins; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients.
Topics: Adult; Antifungal Agents; Biomarkers; Bronchoalveolar Lavage Fluid; Caspofungin; Drug Therapy, Combination; Echinocandins; Galactose; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Mannans; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Transplantation; Triazoles; Voriconazole | 2012 |
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Fatal bronchial invasion of Scopulariopsis brevicaulis in an acute monocytic leukemia patient.
Topics: Adult; Amphotericin B; Bronchi; Caspofungin; DNA, Fungal; DNA, Ribosomal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Genes, rRNA; Histocytochemistry; Humans; Leukemia, Monocytic, Acute; Lipopeptides; Lung; Lung Diseases, Fungal; Molecular Sequence Data; Pyrimidines; Radiography, Thoracic; RNA, Fungal; RNA, Ribosomal, 18S; Scopulariopsis; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole | 2012 |
Poly-lactide-co-glycolide nanoparticles containing voriconazole for pulmonary delivery: in vitro and in vivo study.
Topics: Animals; Antifungal Agents; Drug Carriers; Female; In Vitro Techniques; Lactic Acid; Lung; Male; Mice; Microscopy, Electron, Scanning; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Triazoles; Voriconazole | 2013 |
Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints.
Topics: Antifungal Agents; Aspergillus fumigatus; Bioreactors; Cell Culture Techniques; Cells, Cultured; Chromatography, High Pressure Liquid; Computer Simulation; Decision Support Techniques; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Fungal; Endothelial Cells; Epithelial Cells; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbial Sensitivity Tests; Models, Biological; Pulmonary Artery; Pyrimidines; Respiratory Mucosa; Triazoles; Voriconazole | 2012 |
Aspergillus endocarditis in a native valve without prior cardiac surgery.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Endocarditis; Humans; Male; Pyrimidines; Triazoles; Ultrasonography; Voriconazole | 2012 |
Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Multiple, Fungal; Etoposide; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Mitoxantrone; Neutropenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Premedication; Pyrimidines; Recurrence; Salvage Therapy; Transplantation, Homologous; Triazoles; Voriconazole | 2013 |
Fungal malignant otitis externa: pitfalls, diagnosis, and treatment.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Female; Humans; Male; Mycoses; Otitis Externa; Pseudomonas aeruginosa; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Corneal Ulcer; Disease Models, Animal; Disease Outbreaks; Drug Resistance, Fungal; Epithelium, Corneal; Eye Infections, Fungal; Fusariosis; Fusarium; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microscopy, Confocal; Natamycin; Pyrimidines; Triazoles; Virulence; Voriconazole | 2012 |
Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence.
Topics: Adult; Amino Acid Substitution; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cell Membrane; Chemoprevention; Drug Resistance, Fungal; Female; Fluconazole; Gas Chromatography-Mass Spectrometry; Gene Expression Profiling; Humans; Mice; Microbial Sensitivity Tests; Middle Aged; Mutant Proteins; Oxidoreductases; Pyrimidines; Sterols; Triazoles; Virulence; Voriconazole | 2012 |
A lung mass: when the history helps the diagnosis.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bone Marrow Transplantation; Child; Combined Modality Therapy; Diagnosis, Differential; Humans; Lymphadenitis; Male; Osteomyelitis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Cohort Studies; Demography; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Length of Stay; Lipopeptides; Lung; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Time Factors; Triazoles; Voriconazole | 2013 |
Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cyclophosphamide; Deoxycholic Acid; Drug Combinations; Echinocandins; Endothelial Cells; Heart; Immunosuppression Therapy; Intercellular Adhesion Molecule-1; Kidney; Lipopeptides; Lung; Male; Mice; Nephrosis; Neuroaspergillosis; P-Selectin; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Quantitative evaluation method of the informational value of initial symptoms based on Bayesian theory].
Topics: Antifungal Agents; Bayes Theorem; Chemical and Drug Induced Liver Injury; Drug Information Services; Drug-Related Side Effects and Adverse Reactions; Exanthema; Humans; Pharmacists; Probability; Pyrimidines; Symptom Assessment; Triazoles; Voriconazole | 2012 |
[Susceptibility to azoles and amphotericin B of isolates of Candida spp. Experience of a university health network, between 2004 and 2010].
Topics: Amphotericin B; Antifungal Agents; Candida; Chile; Cohort Studies; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2012 |
Craniocerebral maduromycosis.
Topics: Adolescent; Antifungal Agents; Bone Diseases; Brain Diseases; Female; Humans; India; Madurella; Magnetic Resonance Imaging; Mycetoma; Naphthalenes; Parietal Lobe; Pyrimidines; Scalp; Seizures; Terbinafine; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Caspofungin; CD4 Lymphocyte Count; Echinocandins; Female; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; L-Lactate Dehydrogenase; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Intra-articular injection of voriconazole for Fusarium solani arthritis after bone marrow transplantation.
Topics: Adolescent; Antifungal Agents; Arthritis; Bone Marrow Transplantation; Fusariosis; Fusarium; Histocytochemistry; Humans; Immunocompromised Host; Injections, Intra-Articular; Male; Microscopy; Pyrimidines; Skin; Triazoles; Voriconazole | 2012 |
Azole preexposure affects the Aspergillus fumigatus population in patients.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Multigene Family; Polymorphism, Single Nucleotide; Pyrimidines; Triazoles; Voriconazole | 2012 |
Benefit of polyhexamethylene biguanide in Fusarium keratitis.
Topics: Adult; Antifungal Agents; Benzamidines; Biguanides; Contact Lenses, Hydrophilic; Corneal Ulcer; Disinfectants; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fungi; Fusariosis; Fusarium; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Natamycin; Pyrimidines; Triazoles; Voriconazole | 2012 |
Pseudallescheria boydii infection of the brain.
Topics: Administration, Oral; Antifungal Agents; Brain Abscess; Burns; Central Nervous System Fungal Infections; Explosions; Humans; Infusions, Intravenous; Middle Aged; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole | 2012 |
Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies.
Topics: Adult; Aged; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Republic of Korea; Tertiary Care Centers; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Voriconazole-induced pancreatitis in a patient of acute myeloid leukemia and invasive aspergillosis.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myeloid, Acute; Pancreatitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
A retrospective analysis of voriconazole pharmacokinetics in Japanese pediatric and adolescent patients.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis; Candidemia; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Japan; Male; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2013 |
The efficacy of voriconazole in 24 ocular Fusarium infections.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2013 |
[Photo quiz: Deep-seated mycosis].
Topics: Antifungal Agents; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Middle Aged; Polymerase Chain Reaction; Pulmonary Aspergillosis; Pyrimidines; RNA, Fungal; Scedosporium; Sputum; Triazoles; Voriconazole | 2012 |
Voriconazole inhibits biofilm formation in different species of the genus Candida.
Topics: Antifungal Agents; Biofilms; Candida; Candidiasis; Humans; Pyrimidines; Staining and Labeling; Tetrazolium Salts; Triazoles; Voriconazole | 2012 |
Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2013 |
Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Australia; Drug Interactions; Drug Monitoring; Female; Glucocorticoids; Humans; Male; Middle Aged; Mitosporic Fungi; Mycoses; Nucleic Acid Synthesis Inhibitors; Phenytoin; Pyrimidines; Retrospective Studies; Rifampin; Treatment Outcome; Triazoles; Voltage-Gated Sodium Channel Blockers; Voriconazole | 2012 |
Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis.
Topics: Administration, Inhalation; Aged; Antifungal Agents; Humans; Male; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Development and validation of a fast HPLC/photodiode array detection method for the measurement of voriconazole in human serum samples. A reference laboratory experience.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Pyrimidines; Triazoles; Voriconazole | 2013 |
Multiple fungal brain abscesses in a child with acute lymphoblastic leukemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus niger; Brain Abscess; Child, Preschool; Female; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2012 |
Clinical images: voriconazole-induced periostitis deformans.
Topics: Antifungal Agents; Aspergillosis; Female; Humans; Middle Aged; Periostitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Voriconazole is delivered from antifungal-loaded bone cement.
Topics: Antifungal Agents; Bone Cements; Compressive Strength; Dose-Response Relationship, Drug; Drug Delivery Systems; Pyrimidines; Triazoles; Voriconazole | 2013 |
Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fungi; Humans; Immunoglobulin E; Incidence; India; Itraconazole; Male; Middle Aged; Mucins; Mycoses; Nasal Polyps; Pyrimidines; Retrospective Studies; Rhinitis, Allergic, Perennial; Sinusitis; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Monitoring of voriconazole plasma concentrations in immunocompromised paediatric patients.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Cohort Studies; Female; Humans; Immunocompromised Host; Infant; Male; Plasma; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2012 |
Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Chi-Square Distribution; Female; Humans; Incidence; Kaplan-Meier Estimate; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2012 |
Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Female; Humans; Lung Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Voriconazole | 2012 |
Combination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis.
Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cell Line; Chromatography, High Pressure Liquid; Drug Interactions; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Models, Theoretical; Pulmonary Alveoli; Pyrimidines; Triazoles; Voriconazole | 2012 |
The ghosts of departed quantities: approaches to dealing with observations below the limit of quantitation.
Topics: Antifungal Agents; Bias; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Data Interpretation, Statistical; Humans; Likelihood Functions; Models, Theoretical; Normal Distribution; Pharmacokinetics; Pyrimidines; Reproducibility of Results; Research Design; Triazoles; Voriconazole | 2012 |
VFEND® (voriconazole)-associated hypoglycaemia without identified drug interaction.
Topics: Antifungal Agents; Aspergillosis; Enterocolitis; Glucose; Humans; Hyperinsulinism; Hypoglycemia; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Syncope; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Female; Humans; Incidence; Logistic Models; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Time Factors; Transplantation; Triazoles; Voriconazole | 2012 |
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
Topics: Amphotericin B; Candida; Colorimetry; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Triazoles; Voriconazole | 2012 |
Sarcoid-like reaction in Cryptococcus neoformans infection.
Topics: Administration, Oral; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Radiography, Thoracic; Sarcoidosis; Triazoles; Voriconazole | 2012 |
Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Debridement; Drug Therapy, Combination; Heart Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2012 |
Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy.
Topics: Adolescent; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Cluster Analysis; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung; Male; Mice; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole; Young Adult | 2012 |
Are epidemiologic cut-off values predictors of the in vivo efficacy of azoles in experimental aspergillosis?
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus niger; Disease Models, Animal; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.
Topics: Adult; Antifungal Agents; Bone Diseases; Female; Fluorides; Hematologic Neoplasms; Humans; Itraconazole; Middle Aged; Muscle, Skeletal; Periostitis; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2012 |
Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patients.
Topics: Adult; Antibodies, Antinuclear; Antifungal Agents; Aspergillosis; Drug Eruptions; Female; Humans; Light; Male; Middle Aged; Patch Tests; Photosensitivity Disorders; Pyrimidines; Sunlight; Triazoles; Voriconazole | 2013 |
In vitro pharmacokinetic/pharmacodynamic modeling of voriconazole activity against Aspergillus species in a new in vitro dynamic model.
Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; Pyrimidines; Triazoles; Voriconazole | 2012 |
Treatment of granulomatous amoebic encephalitis with voriconazole and miltefosine in an immunocompetent soldier.
Topics: Acanthamoeba; Adult; Amebiasis; Animals; Encephalitis; Granuloma; Humans; Immunocompetence; Male; Military Personnel; Phosphorylcholine; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Mouse precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury.
Topics: Animals; Benzodiazepines; Biomarkers; Carbamazepine; Cell Survival; Chemical and Drug Induced Liver Injury; Chemokines; Chromans; Clozapine; Cytokines; Diclofenac; Drug Synergism; Female; Glutathione; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; In Vitro Techniques; Ketoconazole; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Nitrogen Oxides; Olanzapine; Pyrimidines; Thiazolidinediones; Triazoles; Troglitazone; Voriconazole | 2012 |
Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2013 |
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Candidemia; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
[Efficacy of voriconazole treatment in chronic vulvovaginal candidosis due to Candida glabrata].
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis, Vulvovaginal; Cesarean Section; Drug Evaluation; Drug Resistance, Multiple, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Pregnancy; Puerperal Disorders; Pyrimidines; Recurrence; Species Specificity; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis.
Topics: Adolescent; Age Factors; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Male; Pyrimidines; Triazoles; Voriconazole | 2013 |
Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Drug Administration Routes; Drug Administration Schedule; Drug Monitoring; Drug Synergism; Humans; Magnetic Resonance Imaging; Male; Omeprazole; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2012 |
In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Mice; Mice, Inbred ICR; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Voriconazole-associated phototoxic effects and lentigo formation in an African American man.
Topics: Antifungal Agents; Coccidioidomycosis; Dermatitis, Phototoxic; Drug Eruptions; Humans; Lentigo; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Keratitis; Natamycin; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2012 |
Evaluation of the effect of obesity on voriconazole serum concentrations.
Topics: Adult; Aged; Antifungal Agents; Cohort Studies; Female; Humans; Male; Middle Aged; Obesity; Pyrimidines; Retrospective Studies; Serum; Time Factors; Triazoles; Voriconazole | 2012 |
[Intraventricular cryptococcoma successfully treated with liposomal amphotericin B and voriconazole: a case report].
Topics: Amphotericin B; Humans; Liposomes; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Positron-Emission Tomography; Pyrimidines; Triazoles; Voriconazole | 2012 |
Effect of photodynamic therapy with methylene blue on Acanthamoeba in vitro.
Topics: Acanthamoeba castellanii; Amebiasis; Amebicides; Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Enzyme Inhibitors; Guanidines; Humans; In Vitro Techniques; Keratitis; Methylene Blue; Mice; Mice, Inbred C57BL; Photochemotherapy; Photosensitizing Agents; Polymers; Pyrimidines; Riboflavin; Triazoles; Ultraviolet Therapy; Voriconazole | 2012 |
Management of recurrent Paecilomyces lilacinus keratitis.
Topics: Aged; Humans; Keratitis; Male; Mycoses; Paecilomyces; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2013 |
Co-isolation of Vahlkampfia and acanthamoeba in acanthamoeba-like keratitis in a Spanish population.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Antifungal Agents; Antiprotozoal Agents; Benzamidines; Biguanides; Cell Line; Disinfectants; DNA, Protozoan; Drug Therapy, Combination; Female; Gene Amplification; Genotyping Techniques; Humans; Incidence; Male; Middle Aged; Polymerase Chain Reaction; Pyrimidines; Retrospective Studies; RNA, Ribosomal, 18S; Schizopyrenida; Spain; Triazoles; Voriconazole; Young Adult | 2013 |
[Fungal infection secondary to treatment of Escherichia coli in a critically ill patient].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillus; Candida; Candidiasis; Caspofungin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Echinocandins; Escherichia coli; Fungemia; Humans; Lipopeptides; Male; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2012 |
Effects of Pimenta pseudocaryophyllus (Gomes) L. R. Landrum, on melanized and non-melanized Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Fungal Capsules; Humans; Melanins; Microbial Sensitivity Tests; Pimenta; Plant Extracts; Pyrimidines; Triazoles; Voriconazole | 2012 |
The use of group sequential designs with common competing risks tests.
Topics: Blood Platelets; Clinical Trials as Topic; Computer Simulation; Cord Blood Stem Cell Transplantation; Fluconazole; Humans; Kidney Diseases; Pyrimidines; Research Design; Risk; Sample Size; Statistics as Topic; Triazoles; Voriconazole | 2013 |
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
Topics: Antifungal Agents; Australia; Cryptococcosis; Cryptococcus gattii; Drug Resistance, Fungal; Europe; Fluconazole; Humans; India; Itraconazole; Microbial Sensitivity Tests; North America; Pyrimidines; South Africa; South America; Triazoles; Voriconazole | 2012 |
Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.
Topics: Aged; Antifungal Agents; Chronic Disease; Dose-Response Relationship, Drug; Female; Humans; Japan; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Echinocandins; Female; Fluconazole; HIV Infections; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Mouth; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Pyrimidines; Triazoles; Voriconazole | 2012 |
Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cross Infection; DNA, Fungal; DNA, Intergenic; Drug Resistance, Multiple, Fungal; Female; Flucytosine; Genetic Variation; Genotype; Hemolysin Proteins; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Urinary Tract Infections; Virulence Factors; Voriconazole | 2012 |
Better hospital nutrition needed to prevent and treat Aspergillus infections.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Female; Humans; Lipopeptides; Male; Pyrimidines; Triazoles; Voriconazole | 2013 |
Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents.
Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Female; Genotype; Humans; Immunosuppressive Agents; Itraconazole; Lupus Nephritis; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2013 |
Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fever; Fungal Proteins; Germany; Humans; Leukemia, Myeloid, Acute; Male; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Pyrimidines; Sequence Analysis; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-γ.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; HIV Infections; Humans; Interferon-gamma; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2012 |
[Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients].
Topics: Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Interactions; Drug Therapy, Combination; Humans; Intestinal Pseudo-Obstruction; Itraconazole; Middle Aged; Multiple Myeloma; Mycoses; Pyrazines; Pyrimidines; Triazoles; Voriconazole | 2012 |
Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Caspofungin; Colony Count, Microbial; Dentures; Diabetes Complications; Echinocandins; Female; Fluconazole; Humans; Hypertension; Kidney Failure, Chronic; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Mycology; Nystatin; Phenotype; Pyrimidines; Renal Dialysis; Time Factors; Triazoles; Voriconazole | 2013 |
Disseminated subcutaneous phaeohyphomycosis caused by Exophiala oligosperma in a patient with Wegener's granulomatosis.
Topics: Aged; Antifungal Agents; Biopsy; DNA, Fungal; Exophiala; Female; Granulomatosis with Polyangiitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Phaeohyphomycosis; Pyrimidines; Ribotyping; Risk Factors; Skin; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Mixed Acanthamoeba and multidrug-resistant Achromobacter xyloxidans in late-onset keratitis after laser in situ keratomileusis.
Topics: Acanthamoeba Keratitis; Achromobacter denitrificans; Adult; Antifungal Agents; Corneal Stroma; Corneal Ulcer; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Keratomileusis, Laser In Situ; Lasers, Excimer; Polymerase Chain Reaction; Postoperative Complications; Pyrimidines; Surgical Flaps; Tomography, Optical Coherence; Triazoles; Voriconazole | 2012 |
Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis.
Topics: Animals; Antifungal Agents; Body Burden; C-Reactive Protein; Colony Count, Microbial; Cortisone; Drug Combinations; Galactose; Immunosuppressive Agents; Kaplan-Meier Estimate; Lung; Mannans; Organ Size; Pulmonary Aspergillosis; Pyrimidines; Rats; Respiratory Function Tests; Serum Amyloid P-Component; Survival; Triazoles; Voriconazole | 2012 |
2D solid-state NMR analysis of inclusion in drug-cyclodextrin complexes.
Topics: Adenine; Carbon Radioisotopes; Cyclodextrins; Diflunisal; Fluorine Radioisotopes; Hydrogen; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Organophosphonates; Phosphorus; Pyrimidines; Triazoles; Voriconazole | 2012 |
Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Biofilms; Caspofungin; Colorimetry; Coloring Agents; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole | 2012 |
Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2.
Topics: Amino Acid Sequence; Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Pyrimidines; Saccharomyces cerevisiae; Steroid Isomerases; Sterols; Triazoles; Voriconazole | 2012 |
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.
Topics: Antifungal Agents; China; Cross Infection; Drug Resistance, Fungal; Epidemiological Monitoring; Fluconazole; Humans; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2012 |
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Cyclosporine; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2012 |
Voriconazole hepatotoxicity in severe liver dysfunction.
Topics: Adult; Aged; Amphotericin B; Analysis of Variance; Antifungal Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Humans; Liver; Liver Function Tests; Male; Middle Aged; Observation; Pyrimidines; Triazoles; Voriconazole | 2013 |
Voriconazole stability in cement spacers.
Topics: Antifungal Agents; Arthroplasty, Replacement, Hip; Biofilms; Bone Cements; Candida glabrata; Candidiasis; Caspofungin; Device Removal; Dose-Response Relationship, Drug; Drug Implants; Drug Stability; Drug Therapy, Combination; Echinocandins; Hip Prosthesis; Humans; Infusions, Intravenous; Lipopeptides; Male; Middle Aged; Prostheses and Implants; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole | 2012 |
The surgical management of rhinocerebral mucormycosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Cause of Death; Combined Modality Therapy; Diagnosis, Differential; Fatal Outcome; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Maxillary Sinusitis; Middle Aged; Mucormycosis; Nose Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2013 |
Relapsing cerebral aspergilloma associated with pregnancy.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Central Nervous System Fungal Infections; Female; Humans; Infant, Newborn; Magnetic Resonance Imaging; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Seizures; Triazoles; Voriconazole | 2013 |
Pilot investigation on long-term subcutaneous microdialysis: proof of principle in humans.
Topics: Adult; Humans; Male; Microdialysis; Middle Aged; Pilot Projects; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2013 |
Penicillium marneffei chylous ascites in acquired immune deficiency syndrome: a case report.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Amphotericin B; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Chylous Ascites; Cyclopropanes; Diagnosis, Differential; Humans; Male; Middle Aged; Mycoses; Penicillium; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2012 |
Pustules and sinus tracts involving the right arm of an elderly patient--quiz case. Diagnosis: eumycetoma.
Topics: Aged, 80 and over; Antifungal Agents; Humans; Male; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2012 |
Simultaneous cutaneous infection due to Paecilomyces lilacinus and Alternaria in a heart transplant patient.
Topics: Alternaria; Alternariosis; Antifungal Agents; Dermatomycoses; Heart Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Paecilomyces; Pyrimidines; Triazoles; Voriconazole | 2012 |
Successful treatment of a severe case of fusariomycosis in a beluga whale (Delphinapterus leucas leucas).
Topics: Animals; Animals, Zoo; Antifungal Agents; Drug Administration Schedule; Extremities; Fusarium; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole; Whales | 2012 |
Pharmacokinetic effect of voriconazole on cyclosporine in the treatment of aspergillosis after renal transplantation.
Topics: Adult; Antiviral Agents; Aspergillosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Pyrimidines; Triazoles; Voriconazole | 2012 |
Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Czech Republic; Databases, Factual; Echinocandins; Female; Galactose; Humans; Leukemia; Lung Diseases, Fungal; Male; Mannans; Middle Aged; Neutrophils; Pyrimidines; Retrospective Studies; Slovakia; Triazoles; Voriconazole; Young Adult | 2013 |
Validation of a fast and reliable liquid chromatography-tandem mass spectrometry (LC-MS/MS) with atmospheric pressure chemical ionization method for simultaneous quantitation of voriconazole, itraconazole and its active metabolite hydroxyitraconazole in h
Topics: Antifungal Agents; Antineoplastic Agents; Chromatography, Liquid; Drug Monitoring; Humans; Itraconazole; Liquid-Liquid Extraction; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2013 |
Subtherapeutic itraconazole and voriconazole levels in children with cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Child; Cystic Fibrosis; Humans; Itraconazole; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro antifungal drug susceptibilities of Penicillium marneffei from China.
Topics: Animals; Antifungal Agents; China; Humans; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Penicillium; Pyrimidines; Rats; Terbinafine; Triazoles; Voriconazole | 2013 |
Highly variable plasma concentrations of voriconazole in pediatric hematopoietic stem cell transplantation patients.
Topics: Adolescent; Analysis of Variance; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis.
Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Echinocandins; Female; Fungal Proteins; Humans; Mice; Mutation; Neutrophils; Promoter Regions, Genetic; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Voriconazole for Candida endophthalmitis.
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Male; Pyrimidines; Tomography, Optical Coherence; Treatment Outcome; Triazoles; Urine; Voriconazole | 2012 |
Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.
Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Mice; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Successful monitoring and treatment of intraocular dissemination of acanthamoeba.
Topics: 14-alpha Demethylase Inhibitors; Acanthamoeba; Acanthamoeba Keratitis; Animals; Antigens, Protozoan; Diagnosis, Differential; DNA, Protozoan; Follow-Up Studies; Humans; Intravitreal Injections; Male; Middle Aged; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole | 2012 |
Ochroconis gallopavum infection in a lung transplant recipient: report of a case.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Biopsy; Bronchiolitis Obliterans; Disease Progression; Drug Administration Schedule; Enterobacter cloacae; Enterococcus; Fatal Outcome; Humans; Imipenem; Lung Transplantation; Male; Opportunistic Infections; Phaeohyphomycosis; Pyrimidines; Respiratory Tract Infections; Skin; Sputum; Tobramycin; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Treatment of iatrogenic fungal infections: a black mold defines a new gray zone in medicine.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Arthritis; Centers for Disease Control and Prevention, U.S.; Drug Contamination; Fungi; Humans; Iatrogenic Disease; Injections, Spinal; Meningitis, Fungal; Methylprednisolone; Methylprednisolone Acetate; Pyrimidines; Referral and Consultation; Spinal Diseases; Spinal Puncture; Triazoles; United States; Voriconazole | 2013 |
A simple high-performance liquid chromatography method for simultaneous determination of three triazole antifungals in human plasma.
Topics: Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Itraconazole; Limit of Detection; Naproxen; Observer Variation; Pyrimidines; Reference Standards; Reproducibility of Results; Triazoles; Voriconazole | 2013 |
Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; DNA, Fungal; Female; Hospitals, Teaching; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Naphthalenes; Pyrimidines; Sequence Analysis, DNA; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Case report of exposure to voriconazole in the second and third trimesters of pregnancy.
Topics: Adult; Aspergillosis; Aspergillus flavus; Female; Humans; Pregnancy; Pregnancy Trimester, Third; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Colistin; Cystic Fibrosis; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Exophiala; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Aspergillosis; Drug Evaluation; Female; gamma-Glutamyltransferase; Humans; Liver; Male; Middle Aged; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Meningitis outbreak challenges hospital pharmacies.
Topics: Amphotericin B; Antifungal Agents; Drug Contamination; Drug Monitoring; Drug Therapy, Combination; Humans; Meningitis, Fungal; Pharmacy Service, Hospital; Pyrimidines; Triazoles; Voriconazole; Workforce | 2012 |
In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.
Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Microbial Sensitivity Tests; Point Mutation; Promoter Regions, Genetic; Pyrimidines; Tandem Repeat Sequences; Triazoles; Voriconazole | 2013 |
Early clinical observations in prospectively followed patients with fungal meningitis related to contaminated epidural steroid injections.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Disease Outbreaks; Drug Contamination; Follow-Up Studies; Humans; Iatrogenic Disease; Injections, Epidural; Leukocyte Count; Meningitis, Fungal; Methylprednisolone; Methylprednisolone Acetate; Prospective Studies; Pyrimidines; Spinal Puncture; Statistics, Nonparametric; Triazoles; Virginia; Voriconazole | 2013 |
[The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
Topics: Antifungal Agents; beta-Glucans; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; Cystic Fibrosis; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lymphoma, Large B-Cell, Diffuse; Male; Mannans; Pyrimidines; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii.
Topics: Antifungal Agents; Caspofungin; Ciprofloxacin; Coccidioides; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Histoplasma; Lipopeptides; Microbial Sensitivity Tests; Mycelium; Pyrimidines; Triazoles; Voriconazole | 2013 |
Invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure.
Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Invasive Pulmonary Aspergillosis; Liver Failure, Acute; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Successful treatment of Trichosporon asahii infection with voriconazole after bone marrow transplant.
Topics: Antifungal Agents; beta-Thalassemia; Bone Marrow Transplantation; Child; Humans; Male; Prognosis; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2013 |
Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection.
Topics: Animal Structures; Animals; Antiprotozoal Agents; Chagas Disease; Disease Models, Animal; Female; Histocytochemistry; Mice; Mice, Inbred BALB C; Parasitemia; Pyrimidines; Survival Analysis; Triazoles; Trypanosoma cruzi; Voriconazole | 2013 |
Pharmacogenetics and beyond: variability of voriconazole plasma levels in a patient with primary immunodeficiency.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cytochrome P-450 CYP2C19; Genetic Association Studies; Granulomatous Disease, Chronic; Humans; Male; Pharmacogenetics; Pyrimidines; Triazoles; Voriconazole | 2012 |
Corneal stromal abscessation in two horses treated with intracorneal and subconjunctival injection of 1% voriconazole solution.
Topics: Abscess; Animals; Antifungal Agents; Eye Diseases; Horse Diseases; Horses; Injections, Intraocular; Male; Pyrimidines; Triazoles; Voriconazole | 2013 |
STB5 is a negative regulator of azole resistance in Candida glabrata.
Topics: Amino Acid Sequence; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida glabrata; DNA-Binding Proteins; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Deletion; Gene Expression Regulation, Fungal; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Oxidative Stress; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Alignment; Transcription Factors; Triazoles; Voriconazole | 2013 |
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole | 2013 |
Combination antifungal therapy for invasive pulmonary aspergillosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Photo quiz: basic mycology].
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Pyrimidines; Triazoles; Voriconazole | 2012 |
Concurrent pulmonary Aspergillus fumigatus and mucor infection in a cardiac transplant recipient: a case report.
Topics: Air Microbiology; Antifungal Agents; Cardiomyopathy, Dilated; Cyclonic Storms; Environmental Exposure; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Pyrimidines; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Coordinated roles of pregnane X receptor and constitutive androstane receptor in autoinduction of voriconazole metabolism in mice.
Topics: Animals; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Constitutive Androstane Receptor; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Gene Expression Regulation; Hepatocytes; Host Specificity; Humans; Ketoconazole; Liver; Membrane Proteins; Mice; Mice, Transgenic; Oxidoreductases, N-Demethylating; Pregnane X Receptor; Primary Cell Culture; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; RNA, Messenger; Species Specificity; Triazoles; Voriconazole | 2013 |
Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens.
Topics: Antifungal Agents; Candida albicans; Clotrimazole; Escherichia coli; Fluconazole; Fungal Proteins; Humans; Itraconazole; Ketoconazole; Kinetics; Lanosterol; NADP; Protein Binding; Pyrimidines; Recombinant Proteins; Species Specificity; Sterol 14-Demethylase; Triazoles; Voriconazole | 2013 |
Prothioconazole and prothioconazole-desthio activities against Candida albicans sterol 14-α-demethylase.
Topics: Antifungal Agents; Candida albicans; Enzyme Inhibitors; Protein Binding; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2013 |
Prevalence of yeast other than Candida albicans in denture wearers.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Dentures; DNA Fingerprinting; Female; Fluconazole; Humans; Male; Microbial Interactions; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Oral Hygiene; Polymerase Chain Reaction; Prospective Studies; Pyrimidines; RNA, Fungal; RNA, Ribosomal; RNA, Transfer; Triazoles; Voriconazole | 2013 |
Voriconazole-induced bradycardia without QT interval prolongation: a possible non-concentration-dependent adverse effect.
Topics: Antifungal Agents; Bradycardia; Electrocardiography; Female; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2013 |
Evaluation of the in vitro activity of voriconazole as predictive of in vivo outcome in a murine Aspergillus fumigatus infection model.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Drug Resistance, Fungal; Galactose; Immunocompromised Host; Kidney; Male; Mannans; Mice; Microbial Sensitivity Tests; Predictive Value of Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
MIC values of voriconazole are predictive of treatment results in murine infections by Aspergillus terreus species complex.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Galactose; Male; Mannans; Mice; Microbial Sensitivity Tests; Prognosis; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2013 |
Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange.
Topics: Antifungal Agents; Antiphospholipid Syndrome; Critical Illness; Humans; Male; Middle Aged; Plasma Exchange; Plasmapheresis; Pyrimidines; Triazoles; Voriconazole | 2013 |
Quantification of voriconazole in human bronchoalveolar lavage fluid using high-performance liquid chromatography with fluorescence detection.
Topics: Bronchoalveolar Lavage Fluid; Chromatography, High Pressure Liquid; Drug Stability; Humans; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Triazoles; Voriconazole | 2013 |
Mohs micrographic surgery for the treatment of localized cutaneous alternariosis.
Topics: Alternariosis; Antifungal Agents; Humans; Male; Middle Aged; Mohs Surgery; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2013 |
Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Serum; Triazoles; Voriconazole | 2013 |
Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case report.
Topics: Aged, 80 and over; Amputation, Surgical; Antifungal Agents; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow; Decitabine; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Humans; Leg Ulcer; Leukemia, Myeloid, Acute; Mycoses; Pancytopenia; Pyrimidines; Scedosporium; Soft Tissue Infections; Triazoles; Voriconazole | 2013 |
Evaluation of intravenous voriconazole in patients with compromised renal function.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Mycoses; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole; Young Adult | 2013 |
Genetic variation in plant CYP51s confers resistance against voriconazole, a novel inhibitor of brassinosteroid-dependent sterol biosynthesis.
Topics: Arabidopsis; Arabidopsis Proteins; Biosynthetic Pathways; Brassinosteroids; Drug Resistance; Fragaria; Genetic Variation; Metabolome; Phenotype; Pyrimidines; Sterol 14-Demethylase; Sterols; Triazoles; Voriconazole | 2013 |
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Invasive sino-orbital mycosis in an aplastic anemia patient caused by Neosartorya laciniosa.
Topics: Aged; Anemia, Aplastic; Antifungal Agents; Debridement; DNA, Fungal; Echinocandins; Eye Enucleation; Fungal Proteins; Humans; Lipopeptides; Male; Micafungin; Molecular Sequence Data; Mycoses; Neosartorya; Orbital Diseases; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Sequence Homology; Sinusitis; Triazoles; Voriconazole | 2013 |
Differential pulse polarographic investigation of the antifungal drugs itraconazole, ketoconazole, fluconazole and voriconazole using a dropping mercury electrode.
Topics: Antifungal Agents; Electrochemistry; Electrodes; Fluconazole; Hydrogen-Ion Concentration; Indicators and Reagents; Itraconazole; Ketoconazole; Mercury; Polarography; Pyrimidines; Reference Standards; Reproducibility of Results; Triazoles; Voriconazole | 2012 |
[Combination antifungal therapy in hematopoietic stem cell transplantation patients].
Topics: Amphotericin B; Antifungal Agents; Child; Dermatomycoses; Drug Therapy, Combination; Fusariosis; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lung Diseases, Fungal; Male; Nasopharyngeal Diseases; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Effects of a defective endoplasmic reticulum-associated degradation pathway on the stress response, virulence, and antifungal drug susceptibility of the mold pathogen Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytosol; Drug Resistance, Fungal; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endoplasmic Reticulum-Associated Degradation; Fungal Proteins; Gene Deletion; Gene Expression Regulation, Fungal; Mice; Proteasome Endopeptidase Complex; Protein Folding; Pyrimidines; Survival Analysis; Triazoles; Ubiquitin-Protein Ligases; Virulence; Voriconazole | 2013 |
Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin.
Topics: Aged; Antifungal Agents; DNA, Fungal; Echinocandins; Emericella; Exudates and Transudates; Galactose; Glucocorticoids; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Microscopy; Molecular Sequence Data; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis.
Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Middle Aged; Molecular Typing; Mycological Typing Techniques; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
[Endophthalmitis in course of candidosis--a case report].
Topics: Adult; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Male; Pyrimidines; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole | 2012 |
[Favorable outcome in a case of complicated fungal keratitis].
Topics: Abscess; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Diabetes Complications; Eye Injuries; Female; Fusariosis; Fusarium; Humans; Keratitis; Lens Implantation, Intraocular; Middle Aged; Phacoemulsification; Pyrimidines; Triazoles; Voriconazole; Wound Infection | 2013 |
In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Software for dosage individualization of voriconazole for immunocompromised patients.
Topics: Adult; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Models, Theoretical; Pyrimidines; Software; Triazoles; Voriconazole | 2013 |
A 56-year-old man with undifferentiated fever in the ICU and endobronchial plaques.
Topics: Antifungal Agents; Aspergillus fumigatus; Bronchitis; Bronchoscopy; Colectomy; Fever; Humans; Intensive Care Units; Intestinal Diseases; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Reflections on the approach to treatment of a mycologic disaster.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Cladosporium; Humans; Mucormycosis; Mycoses; Pyrimidines; Rhizopus; Rhodotorula; Triazoles; Voriconazole | 2013 |
Schizophyllum commune: a new organism in eye infection.
Topics: Administration, Topical; Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Keratitis; Male; Molecular Sequence Data; Mycoses; Polymerase Chain Reaction; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Voriconazole suppresses the growth of Leishmania species in vitro.
Topics: Animals; Antiprotozoal Agents; Fluconazole; Inhibitory Concentration 50; Ketoconazole; Leishmania; Parasitic Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2013 |
Selection of the antifungal agent decides prognosis of invasive aspergillosis: case report of a successful outcome with voriconazole.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Humans; Male; Orbital Diseases; Prognosis; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype.
Topics: Adolescent; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Body Weight; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Administration Schedule; Genotype; Humans; Injections, Intravenous; Male; Obesity; Pyrimidines; Triazoles; Voriconazole | 2013 |
Successful management of voriconazole-associated hyponatremia with therapeutic drug monitoring.
Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Drug Monitoring; Humans; Hyponatremia; Invasive Pulmonary Aspergillosis; Male; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Post-operative endophthalmitis due to Fusarium dimerum.
Topics: Administration, Ophthalmic; Administration, Oral; Administration, Topical; Antifungal Agents; Cataract Extraction; Drug Therapy, Combination; Endophthalmitis; Female; Fusarium; Humans; Lens Implantation, Intraocular; Middle Aged; Postoperative Complications; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2012 |
EUCAST technical note on voriconazole and Aspergillus spp.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Dose-Response Relationship, Drug; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Triazoles; Voriconazole | 2013 |
Experimental models of disseminated scedosporiosis with cerebral involvement.
Topics: Animals; Antifungal Agents; Blood-Brain Barrier; Brain; Central Nervous System Fungal Infections; Disease Models, Animal; Dose-Response Relationship, Drug; Immunocompromised Host; Magnetic Resonance Imaging; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Scedosporium; Survival Analysis; Triazoles; Voriconazole | 2013 |
Native aortic valve fungal endocarditis.
Topics: Administration, Oral; Adult; Antifungal Agents; Aortic Valve; Candida albicans; Candidiasis; Diagnosis, Differential; Echocardiography, Transesophageal; Endocarditis; Follow-Up Studies; Heart Valve Diseases; Humans; Male; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Voriconazole is cytotoxic at locally delivered concentrations: a pilot study.
Topics: Animals; Antifungal Agents; Cell Line; Cell Proliferation; Cell Survival; Fibroblasts; Mice; Mycoses; Osteoblasts; Pilot Projects; Pyrimidines; Triazoles; Voriconazole | 2013 |
Cerebral Scedosporium apiospermum infection presenting with intestinal manifestations.
Topics: Amphotericin B; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Colitis, Ulcerative; Histocytochemistry; Humans; Male; Microscopy; Middle Aged; Psychosurgery; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events.
Topics: Adult; Antifungal Agents; Brain Diseases, Metabolic; Candidiasis; Drug Administration Schedule; Drug Monitoring; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Aspergillus petrous apicitis associated with cerebral and peritubular abscesses in an immunocompetent man.
Topics: 14-alpha Demethylase Inhibitors; Abscess; Aged; Antifungal Agents; Aspergillus; Cranial Nerve Diseases; Delayed Diagnosis; Humans; Immunocompetence; Magnetic Resonance Imaging; Male; Neuroaspergillosis; Petrositis; Pyrimidines; Radiography; Skull Base; Triazoles; Voriconazole | 2013 |
Aspergillus galactomannan antigen for diagnosis and treatment monitoring in cerebral aspergillosis.
Topics: Antifungal Agents; Antigens, Fungal; Drug Monitoring; Early Diagnosis; Heart Transplantation; Humans; Immunoenzyme Techniques; Male; Membrane Glycoproteins; Meningitis, Fungal; Middle Aged; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Female; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Recurrence; Remission Induction; Retrospective Studies; Rhizopus; Triazoles; Voriconazole | 2013 |
Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series.
Topics: Adolescent; Antifungal Agents; Caspofungin; Child; Child, Preschool; Coccidioidomycosis; Echinocandins; Female; Humans; Infant; Lipopeptides; Male; Pyrimidines; Retrospective Studies; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Elements of style in managing coccidioidomycosis.
Topics: Antifungal Agents; Caspofungin; Coccidioidomycosis; Echinocandins; Female; Humans; Lipopeptides; Male; Pyrimidines; Triazoles; Voriconazole | 2013 |
Disseminated paracoccidioidomycosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Humans; Male; Paracoccidioidomycosis; Pyrimidines; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole | 2013 |
Voriconazole induced bradycardia.
Topics: Antifungal Agents; Aspergillosis; Bradycardia; Child; Child, Preschool; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2013 |
Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Consolidation Chemotherapy; Economics, Pharmaceutical; Female; Fluconazole; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Heart Transplantation; Humans; Incidence; Lung Transplantation; Male; Middle Aged; Proportional Hazards Models; Pyrimidines; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole; Young Adult | 2013 |
Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Genes, Fungal; Humans; Kuwait; Microbial Sensitivity Tests; Phylogeny; Pyrimidines; Statistics, Nonparametric; Triazoles; Voriconazole | 2013 |
Localized Histoplasma capsulatum osteomyelitis of the fibula in an immunocompetent teenage boy: a case report.
Topics: Antifungal Agents; Child; Fibula; Histoplasma; Histoplasmosis; Humans; Immunocompetence; Male; Osteomyelitis; Pyrimidines; Radiography; Triazoles; Voriconazole | 2013 |
Dermatic Scedosporium apiospermum infection after autologous bone marrow transplantation.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Dermatomycoses; Drugs, Chinese Herbal; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Opportunistic Infections; Postoperative Complications; Pyrimidines; Scedosporium; Skin Ulcer; Transplantation Conditioning; Transplantation, Autologous; Triazoles; Voriconazole; Young Adult | 2013 |
Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.
Topics: Amphotericin B; Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Multiple bilateral pulmonary "fungus balls" in an immunocompetent patient unsuitable for surgical treatment: efficacy of azoles treatment.
Topics: Aged; Antifungal Agents; Humans; Lung; Male; Mycetoma; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Preemptive treatment with voriconazole in lung transplant recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillus fumigatus; Cohort Studies; Female; Humans; Incidence; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Microbial Sensitivity Tests; Nitriles; Phenotype; Phylogeny; Polymerase Chain Reaction; Pyridines; Pyrimidines; Sequence Analysis, DNA; Tertiary Care Centers; Triazoles; Voriconazole; Young Adult | 2013 |
A case-report of unpredictable and massive voriconazole intoxication in a patient with extensive CYP2C19 and CYP2C9 polymorphisms.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Drug Monitoring; Half-Life; Humans; Male; Neurotoxicity Syndromes; Pyrimidines; Triazoles; Voriconazole | 2013 |
Intracranial blastomycosis presenting as an enhancing cerebellopontine mass.
Topics: Adult; Antifungal Agents; Blastomyces; Blastomycosis; Cerebellar Diseases; Cerebellar Neoplasms; Cerebellopontine Angle; Craniotomy; Humans; Immunoenzyme Techniques; Magnetic Resonance Imaging; Male; Necrosis; Positron-Emission Tomography; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.
Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Candida; Candidiasis; Fluconazole; Lepidoptera; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Pyrimidines; Triazoles; Voriconazole | 2013 |
Candida krusei arthritis in an adolescent with acute myelogenous leukemia.
Topics: Adolescent; Antifungal Agents; Arthritis, Infectious; Candida; Candidiasis; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Pyrimidines; Triazoles; Voriconazole | 2013 |
Outcomes of persons with blastomycosis involving the central nervous system.
Topics: Amphotericin B; Azoles; Biopsy; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Humans; Magnetic Resonance Imaging; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate.
Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Aspergillosis; Cheilitis; Child; Child, Preschool; Dermatitis, Photoallergic; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Male; Methotrexate; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Excavated pneumonia: an unusual suspect.
Topics: Adult; Amphotericin B; Antifungal Agents; Azoles; Communicable Diseases, Emerging; Fatal Outcome; Febrile Neutropenia; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Species distribution and drug susceptibilities of Candida isolates in TSARY 2010.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candida; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole | 2013 |
Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Echinocandins; Luminescent Measurements; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
Correlation of CYP2C19 phenotype with voriconazole plasma concentration in children.
Topics: Adolescent; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C19; Female; Humans; Infant; Male; Phenotype; Polymorphism, Single Nucleotide; Pyrimidines; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2013 |
Rapid high performance liquid chromatographic assay for determination of voriconazole concentration in human plasma.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Pyrimidines; Triazoles; Voriconazole | 2013 |
Disseminated Ochroconis gallopava infection in a heart transplant patient.
Topics: Antifungal Agents; Ascomycota; Brain; Fatal Outcome; Heart Transplantation; Humans; Lung; Male; Middle Aged; Mycoses; Peritoneum; Pyrimidines; Triazoles; Voriconazole | 2013 |
Antifungal Azoles: Structural Insights into Undesired Tight Binding to Cholesterol-Metabolizing CYP46A1.
Topics: Antifungal Agents; Azoles; Binding Sites; Cholesterol; Cholesterol 24-Hydroxylase; Clotrimazole; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Humans; Protein Binding; Pyrimidines; Steroid Hydroxylases; Sterol 14-Demethylase; Triazoles; Voriconazole | 2013 |
Compassionate use of voriconazole in newborn infants diagnosed with severe invasive fungal sepsis.
Topics: Antifungal Agents; Compassionate Use Trials; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2013 |
A 76-year-old man with a right lung adenocarcinoma and invasive Aspergillosis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antifungal Agents; Aspergillus fumigatus; Histocytochemistry; Humans; Invasive Pulmonary Aspergillosis; Lung; Lung Neoplasms; Male; Microscopy; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Positron-Emission Tomography; Pyrimidines; Triazoles; Voriconazole | 2013 |
Nonmelanoma skin cancer in childhood after hematopoietic stem cell transplant: a report of 4 cases.
Topics: Adolescent; Adult; Antifungal Agents; Boston; Carcinoma, Squamous Cell; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Male; Neoplasm Staging; Prognosis; Pyrimidines; Risk Factors; Skin Neoplasms; Survival Rate; Survivors; Triazoles; Voriconazole; Whole-Body Irradiation; Young Adult | 2014 |
[Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient].
Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Caspofungin; Echinocandins; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lung; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
Topics: Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azoles; Base Sequence; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Polyenes; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Analysis, DNA; Triazoles; Tunisia; Voriconazole | 2013 |
Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Cohort Studies; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Resolution of Coccidioides immitis endophthalmitis with an aggressive surgical and medical therapeutic approach.
Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Vitrectomy; Voriconazole | 2013 |
Determination of voriconazole serum concentration by bioassay, a valid method for therapeutic drug monitoring for clinical laboratories.
Topics: Antifungal Agents; Candida; Drug Monitoring; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
Exacerbation of myasthenia gravis with voriconazole.
Topics: Antifungal Agents; Aspergillosis; Blepharoptosis; Computer Simulation; Disease Progression; Female; Humans; Middle Aged; Myasthenia Gravis; Ophthalmoplegia; Pyrimidines; Triazoles; Voriconazole | 2013 |
Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
Topics: Aged; Air Microbiology; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Drug Resistance, Fungal; Female; Genes, Fungal; Genotype; Hospitals; Humans; Male; Middle Aged; Molecular Typing; Mycological Typing Techniques; Netherlands; Pyrimidines; Residence Characteristics; Selection, Genetic; Sequence Analysis, DNA; Surveys and Questionnaires; Treatment Failure; Triazoles; Voriconazole; Young Adult | 2013 |
Voriconazole resistance in Aspergillus fumigatus: should we be concerned?
Topics: Air Microbiology; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Female; Humans; Male; Molecular Typing; Pyrimidines; Residence Characteristics; Triazoles; Voriconazole | 2013 |
In vitro fluconazole and voriconazole susceptibilities of Candida bloodstream isolates in Korea: use of the CLSI and EUCAST epidemiological cutoff values.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Triazoles; Voriconazole | 2013 |
cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
Topics: Alleles; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Germany; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Prevalence; Pyrimidines; Triazoles; Voriconazole | 2013 |
Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
Topics: Antifungal Agents; Consensus; Drug Monitoring; Humans; Japan; Pyrimidines; Triazoles; Voriconazole | 2013 |
Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
Topics: Acanthamoeba castellanii; Amebicides; Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Aza Compounds; Chlorhexidine; Colorimetry; Drug Combinations; Fluoroquinolones; HeLa Cells; Humans; Macrophages; Mice; Moxifloxacin; Ophthalmic Solutions; Parasitic Sensitivity Tests; Pyrimidines; Quinolines; Triazoles; Voriconazole | 2013 |
Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Geography; Humans; Microbial Sensitivity Tests; Mutation; Nitriles; Pyridines; Pyrimidines; Reference Values; Triazoles; Voriconazole | 2013 |
Relapse of fungal meningitis associated with contaminated methylprednisolone.
Topics: Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Drug Contamination; Humans; Injections, Epidural; Male; Meningitis, Fungal; Methylprednisolone; Methylprednisolone Acetate; Pyrimidines; Recurrence; Saccharomycetales; Triazoles; Voriconazole | 2013 |
Management of a case of Candida endogenous endophthalmitis in a neonate.
Topics: Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia; Candida tropicalis; Candidemia; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Infant, Newborn; Intravitreal Injections; Pyrimidines; Triazoles; Vancomycin; Voriconazole | 2014 |
Association between drug tolerability and medical resource use in prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplant.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Child; Female; Health Services; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2013 |
Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity.
Topics: Adolescent; Aged; Aged, 80 and over; Antifungal Agents; Child; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Liver; Liver Function Tests; Logistic Models; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adhesiveness; Animals; Antifungal Agents; Aspergillus fumigatus; beta-Cyclodextrins; Candida albicans; Cornea; Drug Delivery Systems; Drug Stability; Eye; Gels; Goats; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Microbial Sensitivity Tests; Permeability; Pyrimidines; Rheology; Temperature; Triazoles; Viscosity; Voriconazole | 2013 |
Rhizopus keratitis following corneal trauma.
Topics: Administration, Ophthalmic; Administration, Oral; Antifungal Agents; Bacteriological Techniques; Corneal Injuries; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Eye Infections, Fungal; Eye Injuries, Penetrating; Humans; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizopus; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Steady-state pharmacokinetics and metabolism of voriconazole in patients.
Topics: Administration, Oral; Adult; Antifungal Agents; Biotransformation; Humans; Plasma; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2013 |
Atypical presentation of invasive pulmonary aspergillosis in a liver transplant recipient.
Topics: Adolescent; Antifungal Agents; Hepatoblastoma; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Liver Neoplasms; Liver Transplantation; Male; Opportunistic Infections; Pyrimidines; Solitary Pulmonary Nodule; Time Factors; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Candida urinary tract infection and Candida species susceptibilities to antifungal agents.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Flucytosine; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Urinary Tract Infections; Voriconazole | 2013 |
Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients.
Topics: Adult; Antifungal Agents; Bronchoalveolar Lavage Fluid; Female; Humans; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Pilot Projects; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2013 |
Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Echinocandins; Fungal Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Serum; Triazoles; Voriconazole | 2013 |
In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
Topics: Antifungal Agents; Drug Synergism; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole | 2013 |
Voriconazole: skeletal fluorosis.
Topics: Antifungal Agents; Bone Diseases; Fluoride Poisoning; Humans; Pyrimidines; Triazoles; Voriconazole | 2013 |
Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Topics: Antifungal Agents; Candida; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
[Severe corneal infection by Colletotrichum gloeosporioides in a farmer].
Topics: Aged; Agricultural Workers' Diseases; Antifungal Agents; Colletotrichum; Corneal Transplantation; Corneal Ulcer; Diagnosis, Differential; Eye Infections, Fungal; Humans; Keratitis, Herpetic; Male; Pyrimidines; Triazoles; Voriconazole | 2014 |
Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2013 |
Modest efficacy of voriconazole against murine infections by Sporothrix schenckii and lack of efficacy against Sporothrix brasiliensis.
Topics: Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Liver; Male; Mice; Pyrimidines; Spleen; Sporothrix; Sporotrichosis; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Photo quiz. Generalized pain in a 20-year-old man with chronic granulomatous disease.
Topics: Antifungal Agents; Bone and Bones; Chemoprevention; Fluoride Poisoning; France; Granulomatous Disease, Chronic; Hand; Humans; Male; Pain; Periostitis; Pyrimidines; Radiography; Triazoles; Voriconazole; Young Adult | 2013 |
Differential expression of ATP-binding cassette and/or major facilitator superfamily class efflux pumps contributes to voriconazole resistance in Aspergillus flavus.
Topics: Antifungal Agents; Aspergillus flavus; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Drug Resistance, Fungal; Fungal Proteins; Gene Expression Regulation, Fungal; Microbial Sensitivity Tests; Oligomycins; Protein Isoforms; Pyrimidines; RNA, Fungal; RNA, Messenger; Triazoles; Voriconazole | 2013 |
Successful treatment of acute thyroiditis due to Aspergillus spp. in the context of disseminated invasive aspergillosis in a kidney transplant patient.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Female; Humans; Kidney Transplantation; Middle Aged; Postoperative Complications; Pyrimidines; Remission Induction; Thyroiditis; Triazoles; Voriconazole | 2013 |
Aspergillosis sinusitis with cranio-orbital spread in an apparently immunocompetent patient.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Blindness; Brain; Combined Modality Therapy; Debridement; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Ophthalmoplegia; Orbit; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2013 |
Microcalorimetry assay for rapid detection of voriconazole resistance in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillus fumigatus; Calorimetry; Drug Resistance, Fungal; Microbial Sensitivity Tests; Pyrimidines; Thermodynamics; Time Factors; Triazoles; Voriconazole | 2013 |
Subacute exogenous Rhizoctonia solani endophthalmitis following cataract extraction with intraocular lens implantation.
Topics: Acute Disease; Antifungal Agents; Cataract Extraction; Combined Modality Therapy; Device Removal; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Rhizoctonia; Triazoles; Vitrectomy; Voriconazole | 2013 |
Acute chiasmal abscess resulting from perineural extension of invasive sino-orbital aspergillosis in an immunocompetent patient.
Topics: Abscess; Antifungal Agents; Aspergillosis; Cranial Sinuses; Debridement; Humans; Immunocompetence; Immunohistochemistry; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Optic Chiasm; Optic Nerve; Orbital Diseases; Pyrimidines; Triazoles; Visual Fields; Voriconazole | 2014 |
Scleral and intraocular amoebic dissemination in Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Adult; Antifungal Agents; Cryotherapy; Female; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Pyrimidines; Retrospective Studies; Scleritis; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Spray-dried voriconazole-cyclodextrin complexes: solubility, dissolution rate and chemical stability.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Carbohydrate Conformation; Drug Stability; Molecular Docking Simulation; Pyrimidines; Solubility; Temperature; Triazoles; Voriconazole | 2013 |
Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.
Topics: Acremonium; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2014 |
Intermolecular interaction of voriconazole analogues with model membrane by DSC and NMR, and their antifungal activity using NMR based metabolic profiling.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antifungal Agents; Calorimetry, Differential Scanning; Candida albicans; Carboxylic Acids; Esters; Hydroxybenzoate Ethers; Lipid Bilayers; Magnetic Resonance Spectroscopy; Metabolome; Microbial Sensitivity Tests; Pyrimidines; Transition Temperature; Triazoles; Voriconazole | 2013 |
Extensive proteomic remodeling is induced by eukaryotic translation elongation factor 1Bγ deletion in Aspergillus fumigatus.
Topics: Actin Cytoskeleton; Antifungal Agents; Aspergillus fumigatus; Fungal Proteins; Gene Expression Regulation, Fungal; Gene Targeting; Genetic Complementation Test; Glutathione Transferase; Glycerolphosphate Dehydrogenase; Homeodomain Proteins; HSP70 Heat-Shock Proteins; Humans; Oxidation-Reduction; Oxidative Stress; Peptide Elongation Factor 1; Phenotype; Protein Biosynthesis; Proteomics; Pyrimidines; Triazoles; Voriconazole | 2013 |
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida albicans; Candidiasis; Caspofungin; Cefoperazone; Drug Interactions; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyrimidines; Sulbactam; Triazoles; Voriconazole | 2014 |
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult | 2014 |
In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French nationwide study.
Topics: Adult; Aged; Cohort Studies; Dermatitis, Phototoxic; Female; France; Humans; Male; Middle Aged; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole; Young Adult | 2013 |
Treatment of a brain abscess caused by Scedosporium apiospermum and Phaeoacremonium parasiticum in a renal transplant recipient.
Topics: Antifungal Agents; Brain Abscess; Cerebral Phaeohyphomycosis; Coinfection; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Antiprotozoal Agents; Benzamidines; Biguanides; Chlorhexidine; Disinfectants; Humans; Parasitic Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.
Topics: Acremonium; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Echinocandins; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
An enantioselective synthesis of voriconazole.
Topics: Molecular Structure; Pyrimidines; Stereoisomerism; Triazoles; Voriconazole | 2013 |
Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus niger; Belgium; Female; Humans; Incidence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Mycological Typing Techniques; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2014 |
Disseminated fusariosis with immune reconstitution syndrome and cracking mycotic aortic aneurysm in a 55-year-old patient with acute myeloid leukaemia.
Topics: Amphotericin B; Aneurysm, Infected; Antifungal Agents; Female; Fusariosis; Humans; Immune Reconstitution Inflammatory Syndrome; Immunocompromised Host; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2013 |
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia.
Topics: Allografts; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Substitution; Fatal Outcome; Female; Fluconazole; Fungemia; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Scedosporium; Triazoles; Voriconazole; Young Adult | 2013 |
Skin infection caused by Scedosporium apiospermum in immunocompromised patients. Report of two cases.
Topics: Abscess; Aged; Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Male; Naphthalenes; Pyrimidines; Scedosporium; Terbinafine; Triazoles; Voriconazole | 2013 |
Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study.
Topics: Adult; Antifungal Agents; Cross Infection; End Stage Liver Disease; Female; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Survival Rate; Triazoles; Voriconazole | 2013 |
Ulcerative tracheobronchitis due to Aspergillus.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Asthma; Biopsy; Bronchitis; Bronchoscopy; Critical Care; Humans; Incidental Findings; Male; Pyrimidines; Respiration, Artificial; Respiratory Mucosa; Tracheitis; Tracheostomy; Treatment Failure; Treatment Outcome; Triazoles; Ulcer; Voriconazole | 2013 |
Fungal peritonitis associated with Curvularia geniculata and Pithomyces species in a patient with vulvar cancer who was successfully treated with oral voriconazole.
Topics: Antifungal Agents; Antineoplastic Agents; Ascomycota; Diabetic Nephropathies; Female; Humans; Immunocompromised Host; Medroxyprogesterone; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole; Vulvar Neoplasms | 2014 |
Aspergillus tubingenesis endophthalmitis after cataract surgery with implantation of preloaded intraocular lens.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Device Removal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Lipopeptides; Male; Micafungin; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Visual Acuity; Vitrectomy; Voriconazole | 2014 |
Successful treatment of Fusarium keratitis after photo refractive keratectomy.
Topics: Adult; Antifungal Agents; Cornea; Diagnosis, Differential; Eye Infections, Fungal; Female; Follow-Up Studies; Fusariosis; Fusarium; Humans; Keratitis; Myopia; Ophthalmic Solutions; Photorefractive Keratectomy; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole | 2013 |
A reference laboratory experience of clinically achievable voriconazole, posaconazole, and itraconazole concentrations within the bloodstream and cerebral spinal fluid.
Topics: Antifungal Agents; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2014 |
Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Leukemia; Male; Mycoses; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2014 |
[Fungal keratitis caused by Scedosporium apiospermum: first report from Turkey].
Topics: Antifungal Agents; Conjunctiva; Cornea; Disease Progression; Drug Resistance, Fungal; Drug Therapy, Combination; Eye Foreign Bodies; Eye Infections, Fungal; Eye Injuries; Female; Humans; Keratitis; Keratoplasty, Penetrating; Middle Aged; Natamycin; Pyrimidines; Scedosporium; Treatment Refusal; Triazoles; Turkey; Voriconazole | 2013 |
[Three cases of fungemia caused by Blastoschizomyces capitatus].
Topics: Adult; Amphotericin B; Antifungal Agents; Caspofungin; Child; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Saccharomycetales; Triazoles; Voriconazole; Young Adult | 2013 |
In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies.
Topics: Acremonium; Amphotericin B; Anidulafungin; Antifungal Agents; Drug Combinations; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2014 |
Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis.
Topics: Antifungal Agents; beta-Glucans; Biomarkers; Bronchoalveolar Lavage; Child; Cystic Fibrosis; Early Diagnosis; Fatal Outcome; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole | 2013 |
Acute meningitis caused by Cladosporium sphaerospermum.
Topics: Aged; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cladosporium; Drug Therapy, Combination; Humans; Male; Meningitis, Fungal; Pyrimidines; Taiwan; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Voriconazole-induced periostitis causing arthralgias mimicking a flare of granulomatosis with polyangiitis.
Topics: Aged; Alkaline Phosphatase; Antifungal Agents; Arthralgia; Diagnosis, Differential; Disease Progression; Female; Granulomatosis with Polyangiitis; Hip Joint; Humans; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru.
Topics: Acanthamoeba; Amebiasis; Amebicides; Chlorhexidine; Humans; Parasitic Sensitivity Tests; Peru; Pyrimidines; Triazoles; Voriconazole | 2014 |
Perplexity of a fungus in the sinus.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Ascomycota; Benzenesulfonates; Brain Abscess; Central Nervous System Fungal Infections; Chronic Disease; Coloring Agents; Debridement; Epidural Abscess; Frontal Lobe; Frontal Sinus; Humans; Lactic Acid; Male; Phenols; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Remission Induction; Retrospective Studies; Secondary Prevention; Tertiary Care Centers; Triazoles; Voriconazole | 2014 |
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey.
Topics: Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Economics, Pharmaceutical; Humans; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Turkey; Voriconazole | 2013 |
[Photo quiz: Deep-seated mycosis].
Topics: Adolescent; Antifungal Agents; Disease Susceptibility; Emericella; Granulomatous Disease, Chronic; Humans; Lung; Lung Diseases, Fungal; Male; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Disseminated pulmonary penicilliosis in a rheumatoid arthritis patient.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Echinocandins; Humans; Hydrocortisone; Lipopeptides; Lung; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species.
Topics: Animals; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Caspofungin; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Galactose; Humans; Lipopeptides; Male; Mannans; Microbial Sensitivity Tests; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort.
Topics: Adult; Aged; Antifungal Agents; Aspergillus; Brain; Cohort Studies; Critical Illness; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Risk Factors; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2014 |
Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fungemia; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 2014 |
Outbreak of fungal endophthalmitis due to Fusarium oxysporum following cataract surgery.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Cataract Extraction; Disease Outbreaks; Endophthalmitis; Eye Infections, Fungal; Female; Fusariosis; Fusarium; Humans; Male; Middle Aged; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2014 |
Atypical lentigines in a man with mixed African American and white race/ethnicity receiving long-term voriconazole therapy.
Topics: Adrenal Cortex Hormones; Adult; Antifungal Agents; Black or African American; Dermatomycoses; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Lentigo; Male; Pyrimidines; Risk Assessment; Sarcoidosis, Pulmonary; Triazoles; Voriconazole; White People | 2014 |
Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotype.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Dose-Response Relationship, Drug; Female; Hallucinations; Homozygote; Humans; Liver; Male; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2014 |
Bullous phototoxicity from voriconazole.
Topics: Adult; Antifungal Agents; Dermatitis, Phototoxic; Drug Eruptions; Female; Foot Dermatoses; Humans; Pyrimidines; Skin Diseases, Vesiculobullous; Sunbathing; Triazoles; Voriconazole | 2014 |
Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Drug Costs; Echinocandins; Female; Humans; Infant; Leukemia, Myeloid, Acute; Lipopeptides; Male; Micafungin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2014 |
Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.
Topics: Antifungal Agents; Candida; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2014 |
Voriconazole-induced periostitis in two post-transplant patients.
Topics: Antifungal Agents; Female; Heart Transplantation; Humans; Male; Middle Aged; Opportunistic Infections; Periostitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Radionuclide Imaging; Radiopharmaceuticals; Stem Cell Transplantation; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Factors affecting voriconazole plasma concentrations in patients with invasive fungal infections.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Mycoses; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole | 2014 |
Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Caspofungin; Child; Drug Approval; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Off-Label Use; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole; Young Adult | 2014 |
Antibiotics sensitivity of Candida clinical and food-borne isolates.
Topics: Candida; Caspofungin; Drug Resistance, Bacterial; Echinocandins; Fluconazole; Food Microbiology; Foodborne Diseases; Humans; Lipopeptides; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina.
Topics: Animals; Cholesterol; Cholesterol 24-Hydroxylase; Cytokines; Electroretinography; Enzyme Inhibitors; Homeostasis; Hydroxycholesterols; Male; Microglia; Nerve Tissue Proteins; Neuroglia; Pyrimidines; Rats; Rats, Wistar; Retina; Steroid Hydroxylases; Triazoles; Up-Regulation; Voriconazole | 2014 |
Utilizing hardware culture in a case of atypical keratitis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Contact Lenses, Hydrophilic; Corneal Ulcer; Drug Therapy, Combination; Equipment Contamination; Eye Infections, Fungal; Humans; Male; Mycological Typing Techniques; Natamycin; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2014 |
Chronic granulomatous invasive fungal sinusitis: an evolving approach to management.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Granuloma; Humans; Male; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2014 |
A computational exploration of imprinted polymer affinity based on voriconazole metabolites.
Topics: Adsorption; Binding Sites; Computer Simulation; Cross-Linking Reagents; Methacrylates; Models, Molecular; Molecular Conformation; Molecular Imprinting; Particle Size; Polymerization; Polymers; Pyrimidines; Spectrophotometry, Ultraviolet; Surface Properties; Thermodynamics; Triazoles; Voriconazole | 2014 |
Recurrent erythematous plaques on sun-exposed sites in an African American boy with chronic granulomatous disease.
Topics: Biopsy, Needle; Child; Granulomatous Disease, Chronic; Humans; Immunocompromised Host; Immunohistochemistry; Lung Diseases, Fungal; Lupus Erythematosus, Discoid; Male; Photosensitivity Disorders; Prognosis; Pyrimidines; Recurrence; Severity of Illness Index; Sunlight; Triazoles; Voriconazole | 2014 |
Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia.
Topics: Aged; Antifungal Agents; Aspergillus; Echinocandins; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Risk Factors; Triazoles; Voriconazole | 2014 |
Aspergillus spondylodiscitis in an immunocompetent patient following spinal anesthesia.
Topics: Adult; Anesthesia, Spinal; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cesarean Section; Debridement; Discitis; Female; Humans; Immunocompetence; Pregnancy; Puerperal Infection; Pyrimidines; Triazoles; Voriconazole | 2014 |
Phototoxic dermatoses in pediatric BMT patients receiving voriconazole.
Topics: Allografts; Antifungal Agents; Bone Marrow Transplantation; Child; Female; Humans; Male; Photosensitivity Disorders; Pyrimidines; Retrospective Studies; Skin Neoplasms; Sunlight; Sunscreening Agents; Triazoles; Voriconazole | 2014 |
Immunomodulatory effects of voriconazole and caspofungin on human peripheral blood mononuclear cells stimulated by Candida albicans and Candida krusei.
Topics: Adult; Antifungal Agents; Candida albicans; Caspofungin; Cell Proliferation; Cells, Cultured; Echinocandins; Humans; Immunologic Factors; Leukocytes, Mononuclear; Lipopeptides; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
A high-definition view of endogenous fungal endophthalmitis.
Topics: Antifungal Agents; Caspofungin; Echinocandins; Endophthalmitis; Fundus Oculi; Humans; Lipopeptides; Male; Middle Aged; Ophthalmoscopy; Photography; Pyrimidines; Tomography, Optical Coherence; Triazoles; Voriconazole | 2014 |
Coccidioidomycosis in a Pacific walrus (Odobenus rosmarus divergens).
Topics: Animals; Antifungal Agents; Coccidioidomycosis; Female; Pyrimidines; Triazoles; Voriconazole; Walruses | 2014 |
The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cyclosporine; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2014 |
Aspergilloma and massive haemoptysis.
Topics: Adult; Aneurysm, False; Angiography; Antifungal Agents; Embolization, Therapeutic; Female; Hemoptysis; Humans; Ill-Housed Persons; Mycetoma; Pulmonary Artery; Pulmonary Aspergillosis; Pyrimidines; Severity of Illness Index; Substance Abuse, Intravenous; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2014 |
Efficacy and safety of antifungal additives in Optisol-GS corneal storage medium.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cell Count; Chondroitin Sulfates; Colony Count, Microbial; Complex Mixtures; Cornea; Culture Media, Serum-Free; Dextrans; Drug Combinations; Drug Contamination; Endothelium, Corneal; Gentamicins; Humans; Microbial Sensitivity Tests; Organ Preservation; Organ Preservation Solutions; Pyrimidines; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Tumorlike cardiac fungal mycetoma caused by Scedosporium apiospermum presenting as symptomatic ventricular tachycardia.
Topics: Adult; Antifungal Agents; Heart; Hemodynamics; Humans; Male; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Tachycardia, Ventricular; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Does fungicide application in vineyards induce resistance to medical azoles in Aspergillus species?
Topics: Adaptation, Physiological; Agriculture; Antifungal Agents; Aspergillus; Azoles; Environmental Monitoring; Fungicides, Industrial; Humans; Itraconazole; Microbial Sensitivity Tests; Portugal; Pyrimidines; Triazoles; Voriconazole; Wine | 2014 |
Alopecia and nail changes associated with voriconazole therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antifungal Agents; Cross-Sectional Studies; Disease Outbreaks; Female; Humans; Male; Methylprednisolone; Michigan; Middle Aged; Mycoses; Nails; Prevalence; Triazoles; Voriconazole | 2014 |
Multiple Aspergillus brain abscesses after liver transplantation.
Topics: Antifungal Agents; Brain Abscess; Female; Humans; Liver Transplantation; Magnetic Resonance Imaging; Middle Aged; Neuroaspergillosis; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Algorithms; Antifungal Agents; Azoles; Drug Dosage Calculations; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Sirolimus; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2015 |
Posaconazole responsive cerebral aspergillosis in an immunocompetent adult.
Topics: Aged; Antifungal Agents; Aspergillosis; Brain; Encephalitis; Humans; Magnetic Resonance Imaging; Male; Suction; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Experimental treatment of Curvularia infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Immunocompromised Host; Male; Mice; Mycoses; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Canada; Female; Fusariosis; Fusarium; Humans; Male; Middle Aged; Prospective Studies; Registries; Survival Analysis; Treatment Outcome; Triazoles; United States; Voriconazole; Young Adult | 2014 |
Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Biological Assay; Candida albicans; Candidemia; Drug Resistance, Fungal; Gene Expression Profiling; Genetic Variation; Humans; Lepidoptera; Pyrimidines; Survival Analysis; Triazoles; Virulence; Voriconazole | 2014 |
Cysticidal activity of antifungals against different genotypes of Acanthamoeba.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amebiasis; Antifungal Agents; Cysts; Humans; Parasitic Sensitivity Tests; Triazoles; Voriconazole | 2014 |
Experimental therapy with azoles against Candida guilliermondii.
Topics: Antifungal Agents; Azoles; Candida; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2014 |
[Cladophilaphora bantiana brain abscess treated with voriconazole in an immunocompetent patient].
Topics: Adult; Antifungal Agents; Ascomycota; Brain Abscess; Central Nervous System Fungal Infections; Cerebral Phaeohyphomycosis; Frontal Lobe; Humans; Immunocompetence; Magnetic Resonance Imaging; Male; Parietal Lobe; Pyrimidines; Triazoles; Voriconazole | 2014 |
Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Brazil; Calmodulin; Cluster Analysis; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Prevalence; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole | 2014 |
Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Molecular Sequence Data; Mutation, Missense; Sequence Analysis, DNA; Triazoles; Voriconazole | 2014 |
[Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
Topics: Antifungal Agents; Drugs, Generic; Humans; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Fungemia; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Romania; Saccharomyces cerevisiae; Triazoles; Voriconazole; Yeasts; Young Adult | 2015 |
Last generation triazoles for imported eumycetoma in eleven consecutive adults.
Topics: Adolescent; Adult; Antifungal Agents; beta-Glucans; Child; Exophiala; Fluorodeoxyglucose F18; Fusarium; Humans; Madurella; Magnetic Resonance Imaging; Male; Mycetoma; Positron-Emission Tomography; Proteoglycans; Retrospective Studies; Skin; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
Keratitis caused by Absidia corymbifera in an immunocompetent male with no corneal injuries.
Topics: Absidia; Administration, Ophthalmic; Adrenal Cortex Hormones; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Humans; Immunocompetence; Male; Middle Aged; Mucormycosis; Ophthalmic Solutions; Staining and Labeling; Triazoles; Voriconazole | 2015 |
Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole | 2015 |
Successful long-term management of invasive cerebral fungal infection following liver transplantation.
Topics: Antifungal Agents; Aspergillus; Aspergillus flavus; Brain Diseases; Central Nervous System Fungal Infections; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Middle Aged; Neuroaspergillosis; Radiography; Scedosporium; Triazoles; Voriconazole | 2015 |
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Candida; China; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mutation; Rhodotorula; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole | 2015 |
Use of posaconazole delayed-release tablets for treatment of invasive aspergillosis.
Topics: Aged; Antifungal Agents; Brain; Brain Abscess; Delayed-Action Preparations; Humans; Male; Neuroaspergillosis; Tablets; Treatment Outcome; Triazoles; Voriconazole | 2015 |
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole | 2015 |
Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole.
Topics: Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Mycoses; Transplant Recipients; Transplants; Triazoles; Voriconazole | 2015 |
Multi-triazole-resistant Aspergillus fumigatus infections in Australia.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Australia; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Retrospective Studies; Triazoles; Voriconazole | 2015 |
Breakthrough invasive fungal infection under the use of posaconazole and voriconazole.
Topics: Antifungal Agents; Colletotrichum; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Opportunistic Infections; Triazoles; Voriconazole | 2016 |
Genetic Analysis Using an Isogenic Mating Pair of Aspergillus fumigatus Identifies Azole Resistance Genes and Lack of MAT Locus's Role in Virulence.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Crosses, Genetic; Drug Resistance, Multiple, Fungal; Fungal Proteins; Genes, Mating Type, Fungal; Genetic Loci; Hydroxymethylglutaryl CoA Reductases; Itraconazole; Larva; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mixed Function Oxygenases; Moths; Mutation; Sterol 14-Demethylase; Survival Analysis; Triazoles; Virulence; Voriconazole | 2015 |
Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51).
Topics: 14-alpha Demethylase Inhibitors; Acanthamoeba castellanii; Amebiasis; Amebicides; Antifungal Agents; Azoles; Cell Proliferation; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Sterol 14-Demethylase; Triazoles; Voriconazole | 2015 |
First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Promoter Regions, Genetic; Triazoles; Turkey; Voriconazole; Young Adult | 2015 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
In vivo efficacy of voriconazole and posaconazole therapy in a novel invertebrate model of Aspergillus fumigatus infection.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Larva; Lepidoptera; Microbial Sensitivity Tests; Survival Analysis; Triazoles; Voriconazole | 2015 |
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Contribution of a Simple Bioassay in Effective Therapeutic Drug Monitoring of Posaconazole and Voriconazole.
Topics: Antifungal Agents; Biological Assay; Blood Proteins; Calibration; Drug Monitoring; Humans; Protein Binding; Triazoles; Voriconazole | 2015 |
Azole resistance in canine and feline isolates of Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cat Diseases; Cats; Cytochrome P-450 Enzyme System; Dog Diseases; Dogs; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2015 |
Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
Topics: Agar; Animals; Antifungal Agents; Culture Media; Disease Models, Animal; Drosophila melanogaster; Female; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Survival Analysis; Triazoles; Virulence; Voriconazole | 2015 |
Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.
Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Nitriles; Pyridines; Species Specificity; Triazoles; Voriconazole | 2015 |
Voriconazole and posaconazole therapy for experimental Candida lusitaniae infection.
Topics: Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Kidney; Male; Mice; Proteoglycans; Treatment Outcome; Triazoles; Voriconazole | 2016 |
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Topics: Alleles; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candida glabrata; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Nitriles; Protein Isoforms; Pyridines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole | 2016 |
Aspergillus Mediastinitis after Orthotopic Heart Transplantation: A Case Report.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Combined Modality Therapy; Debridement; Drainage; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Mediastinitis; Middle Aged; Reoperation; Surgical Flaps; Surgical Wound Infection; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2015 |
Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Iran; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Mycological Typing Techniques; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Voriconazole | 2016 |
In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Coordination Complexes; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Peptides, Cyclic; Triazoles; Voriconazole | 2016 |
Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture Collection.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bacterial Typing Techniques; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Epidemiological Monitoring; Fungal Proteins; Gene Expression; Genotype; Humans; Italy; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Mutation; Promoter Regions, Genetic; Triazoles; Voriconazole | 2016 |
Molecular Characterization of a Voriconazole-Resistant, Posaconazole-Susceptible Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Cytomegalovirus Infections; Drug Resistance, Fungal; Fungal Proteins; Humans; Lung Transplantation; Male; Microbial Sensitivity Tests; Transplant Recipients; Triazoles; United States; Voriconazole | 2016 |
A combination approach to treating fungal infections.
Topics: Antifungal Agents; Candida albicans; Cell Line, Tumor; Cell Survival; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Epithelial Cells; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Tobramycin; Triazoles; Voriconazole | 2015 |
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Quantification of the Triazole Antifungal Compounds Voriconazole and Posaconazole in Human Serum or Plasma Using Liquid Chromatography Electrospray Tandem Mass Spectrometry (HPLC-ESI-MS/MS).
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2016 |
Isavuconazole: a role for the newest broad-spectrum triazole.
Topics: Antifungal Agents; Female; Humans; Male; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2016 |
Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species.
Topics: Amphotericin B; Animals; Antifungal Agents; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Fungal; Humans; Immunocompromised Host; Male; Mice; Mycoses; Neutropenia; Scopulariopsis; Species Specificity; Survival Analysis; Triazoles; Virulence; Voriconazole | 2016 |
Cross-resistance to fluconazole induced by exposure to the agricultural azole tetraconazole: an environmental resistance school?
Topics: Animals; Anti-Allergic Agents; Antifungal Agents; ATP-Binding Cassette Transporters; Candida; Chlorobenzenes; Drug Resistance, Microbial; Ergosterol; Fluconazole; Fungicides, Industrial; Gene Expression Regulation, Fungal; Humans; Itraconazole; Malathion; Microbial Sensitivity Tests; Promethazine; Rhodamines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2016 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Environmental Microbiology; Humans; Iran; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Opportunistic Infections; Triazoles; Voriconazole | 2016 |
In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Benzoxazoles; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Fungal Proteins; Gene Expression; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; TOR Serine-Threonine Kinases; Triazoles; Voriconazole | 2016 |
[NEW ANTIFUNGAL DRUGS FOR PREVENTION AND TREATMENT OF VISCERAL MYCOSES].
Topics: Antifungal Agents; Caspofungin; Drug Therapy; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2015 |
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole | 2016 |
Drug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized Patients.
Topics: Antifungal Agents; Drug Interactions; Hospitalization; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Posaconazole Substitution for Voriconazole-Associated Phototoxic Effects.
Topics: Aged; Antifungal Agents; Chronic Disease; Dermatitis, Phototoxic; Exophiala; Female; Follow-Up Studies; Humans; Meningitis, Fungal; Phaeohyphomycosis; Retreatment; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2016 |
[Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Triazoles; Turkey; Voriconazole | 2016 |
Voriconazole Dosing in Obese Patients.
Topics: Antifungal Agents; Humans; Obesity; Pyrimidines; Triazoles; Voriconazole | 2016 |
Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Phenotype; Sequence Analysis, DNA; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2016 |
Fungal infection of cystic fibrosis patients - single center experience.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Cystic Fibrosis; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Scedosporium; Triazoles; Voriconazole; Yeasts | 2016 |
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole | 2016 |
Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal Activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; HEK293 Cells; Hemolysis; Heterocyclic Compounds, 2-Ring; Humans; Itraconazole; Mice; Microbial Sensitivity Tests; Reactive Oxygen Species; Structure-Activity Relationship; Thiazoles; Triazoles; Voriconazole | 2016 |
Recurrent trichosporonosis with central nervous system involvement in an allogeneic hematopoietic stem cell transplant recipient.
Topics: Anemia, Aplastic; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Central Nervous System; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrocephalus; Immunocompromised Host; Immunosuppression Therapy; Laminectomy; Lipopeptides; Magnetic Resonance Imaging; Opportunistic Infections; Recurrence; Transplantation, Autologous; Treatment Outcome; Triazoles; Trichosporon; Trichosporonosis; Ventriculoperitoneal Shunt; Voriconazole | 2016 |
Comment on: Utility of voriconazole therapeutic drug monitoring: a meta-analysis.
Topics: Antifungal Agents; Drug Monitoring; Humans; Pyrimidines; Triazoles; Voriconazole | 2016 |
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.
Topics: Adult; Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Itraconazole; Spain; Triazoles; Voriconazole | 2017 |
Aspergillus fumigatus carrying TR34/L98H resistance allele causing complicated suppurative otitis media in Tanzania: Call for improved diagnosis of fungi in sub-Saharan Africa.
Topics: Adolescent; Adult; Alleles; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Female; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Otitis Media, Suppurative; Tanzania; Triazoles; Voriconazole; Young Adult | 2016 |
Antimold Prophylaxis May Reduce the Risk of Invasive Fusariosis in Hematologic Patients with Superficial Skin Lesions with Positive Culture for Fusarium.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antifungal Agents; Female; Fusariosis; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Intertrigo; Leukemia; Male; Middle Aged; Onychomycosis; Prospective Studies; Skin; Triazoles; Voriconazole; Young Adult | 2016 |
Genotyping of Aspergillus fumigatus Reveals Compartmentalization of Genotypes in Disseminated Disease after Invasive Pulmonary Aspergillosis.
Topics: Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillus fumigatus; Female; Genotype; Graft vs Host Disease; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Microbial Sensitivity Tests; Microsatellite Repeats; Molecular Typing; Mycological Typing Techniques; Triazoles; Voriconazole | 2017 |
Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.
Topics: Amphotericin B; Antifungal Agents; Fungal Proteins; Fusarium; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
A rapid UPLC-MS/MS assay for the simultaneous measurement of fluconazole, voriconazole, posaconazole, itraconazole, and hydroxyitraconazole concentrations in serum.
Topics: Antifungal Agents; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Fluconazole; Humans; Itraconazole; Limit of Detection; Reproducibility of Results; Tandem Mass Spectrometry; Time Factors; Triazoles; Voriconazole | 2017 |
Tintelnotia, a new genus in Phaeosphaeriaceae harbouring agents of cornea and nail infections in humans.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Cornea; Echinocandins; Eye Infections, Fungal; Female; Humans; Itraconazole; Keratitis; Lipopeptides; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Phylogeny; Terbinafine; Triazoles; Voriconazole | 2017 |
Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzylisoquinolines; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Female; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients.
Topics: Antifungal Agents; Biomarkers; Cytochrome P-450 CYP3A; Drug Interactions; Female; Follow-Up Studies; Genotype; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Male; Middle Aged; Organ Transplantation; Polymorphism, Single Nucleotide; Postoperative Complications; Prognosis; Retrospective Studies; Risk Factors; Tacrolimus; Triazoles; Voriconazole | 2017 |
Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.
Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Disease Models, Animal; Immunosuppression Therapy; Lung Diseases, Fungal; Mice; Mucormycosis; Nitriles; Pyridines; Rhizopus; Triazoles; Voriconazole | 2017 |
Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient Variability.
Topics: Antifungal Agents; Azoles; Drug Monitoring; Female; Humans; Itraconazole; Lung Transplantation; Male; Middle Aged; Plasma; Retrospective Studies; Tablets; Transplant Recipients; Triazoles; Voriconazole | 2017 |
Cutaneous phaeohyphomycosis in a hematopoietic stem cell transplant patient caused by Alternaria rosae: First case report.
Topics: Acute Kidney Injury; Acyclovir; Aged; Alternaria; Alternariosis; Antibiotic Prophylaxis; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Graft vs Host Disease; Hand; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Levofloxacin; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Paranasal Sinuses; Phaeohyphomycosis; Pneumonia; Prednisone; Primary Myelofibrosis; Respiratory Insufficiency; Spores, Fungal; Transplantation, Homologous; Triazoles; Voriconazole | 2017 |
Triazole Resistance in
Topics: Antifungal Agents; Aspergillus fumigatus; China; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Promoter Regions, Genetic; Tandem Repeat Sequences; Triazoles; Voriconazole | 2017 |
Topics: Aged; Antifungal Agents; Aspergillosis; Brain; Female; Humans; Immunocompromised Host; Lung Diseases, Fungal; Triazoles; Voriconazole | 2017 |
Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
Topics: Antifungal Agents; Ascomycota; Caspofungin; Dihydroorotate Dehydrogenase; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Oxidoreductases Acting on CH-CH Group Donors; Scedosporium; Triazoles; Voriconazole | 2017 |
New pharmacological opportunities for the treatment of invasive mould diseases.
Topics: Amphotericin B; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles; Voriconazole | 2017 |
Changing epidemiology of candidaemia in Australia.
Topics: Anidulafungin; Antifungal Agents; Australia; Azoles; Candida; Candida glabrata; Candida tropicalis; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole | 2017 |
Clinical effectiveness of early posaconazole suspension pre-emptive therapy in lung transplant recipients: The Alfred's experience.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cohort Studies; Drug Monitoring; Female; Humans; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Suspensions; Transplant Recipients; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Female; Fungal Proteins; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Polymorphism, Genetic; Prospective Studies; Tertiary Healthcare; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2017 |
Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Sterol 14-Demethylase; Triazoles; Voriconazole | 2017 |
A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Infant; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Peru; Prospective Studies; Triazoles; Voriconazole; Young Adult | 2017 |
Use of isavuconazole in a patient with voriconazole-induced QTc prolongation.
Topics: Antifungal Agents; Cystic Fibrosis; Female; Humans; Long QT Syndrome; Lung Transplantation; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult | 2017 |
In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
Topics: Acetamides; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Nitriles; Piperazines; Point Mutation; Pyridines; Pyrimidines; Pyrroles; Triazoles; Voriconazole | 2017 |
Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Hospitals, University; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Survival Analysis; Texas; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2017 |
Evidence of unique genetic diversity in Aspergillus fumigatus isolates from Cameroon.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cameroon; Genetic Variation; Genotype; Geography; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Phylogeny; Soil Microbiology; Triazoles; Voriconazole | 2017 |
Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum.
Topics: Acetonitriles; Adult; Antifungal Agents; Calibration; Chromatography, Liquid; Drug Monitoring; Female; Fluconazole; Humans; Indicators and Reagents; Isotope Labeling; Itraconazole; Nitriles; Plasma; Pyridines; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2017 |
Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a
Topics: Aged; Alleles; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Male; Microbial Sensitivity Tests; Mutation; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Assessment of carvacrol for control of avian aspergillosis in intratracheally challenged chickens in comparison to voriconazole with a reference on economic impact.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chickens; Cymenes; Eugenol; Microbial Sensitivity Tests; Monoterpenes; Poultry Diseases; Real-Time Polymerase Chain Reaction; Spores, Fungal; Thymol; Triazoles; Voriconazole | 2017 |
Effects of Photodynamic Therapy on the Growth and Antifungal Susceptibility of Scedosporium and Lomentospora spp.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Humans; Immunocompromised Host; Itraconazole; Methylene Blue; Microbial Sensitivity Tests; Photochemotherapy; Photosensitizing Agents; Scedosporium; Triazoles; Voriconazole | 2017 |
Topics: Antifungal Agents; Candida; Caspofungin; Drug Interactions; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study.
Topics: Administration, Intravenous; Administration, Oral; Adult; Antifungal Agents; Colorado; Drug Compounding; Drug Monitoring; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Synergistic Effects of Tacrolimus and Azoles against Exophiala dermatitidis.
Topics: Antifungal Agents; Biofilms; Calcineurin Inhibitors; Candida parapsilosis; Drug Synergism; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Phaeohyphomycosis; Tacrolimus; Triazoles; Voriconazole | 2017 |
Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.
Topics: Acetamides; Animals; Antifungal Agents; Aspergillus flavus; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Invasive Pulmonary Aspergillosis; Mice; Piperazines; Pyrimidines; Pyrroles; Triazoles; Voriconazole | 2018 |
Diversity of clinical isolates of Aspergillus terreus in antifungal susceptibilities, genotypes and virulence in Galleria mellonella model: Comparison between respiratory and ear isolates.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear; Genotype; Hospitals, University; Humans; Itraconazole; Lepidoptera; Microsatellite Repeats; Respiratory System; Triazoles; Voriconazole | 2017 |
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
Topics: Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillus; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Male; Neutropenia; Nitriles; Pyridines; Transaminases; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2018 |
Persistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels.
Topics: Antifungal Agents; Brain Diseases; Humans; Male; Middle Aged; Serum; Tablets; Triazoles; Voriconazole | 2018 |
Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Hospitals, University; Humans; Immunocompromised Host; Iran; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
Relation of the polymorphism of cyp51A sequence and the susceptibility of Aspergillus fumigatus isolates to triazoles determined by commercial gradient test (Etest) and by reference methods.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Polymorphism, Genetic; Triazoles; Voriconazole | 2017 |
The challenges of treating aspergillus abdominal aneurysm after hematopoietic cell transplant: Rapid voriconazole metabolizer.
Topics: Aneurysm, Infected; Antifungal Agents; Aspergillosis; Cytochrome P-450 CYP2C19; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Triazoles; Voriconazole | 2019 |
Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients.
Topics: Adolescent; Antifungal Agents; Candida; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; Fluconazole; Humans; Kluyveromyces; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Nitriles; Opportunistic Infections; Pichia; Pyridines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole | 2018 |
Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Reproducibility of Results; Triazoles; Voriconazole | 2018 |
Topics: Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Endophthalmitis; Eye; Female; Fusarium; Humans; Hyphae; Immunocompromised Host; Leukemia, Myeloid, Acute; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole | 2018 |
Posaconazole-Induced Pseudohyperaldosteronism.
Topics: Aged; Antifungal Agents; Heart Failure; Histoplasmosis; Humans; Hydroxysteroid Dehydrogenases; Hyperaldosteronism; Hypertension; Hypokalemia; Mineralocorticoid Excess Syndrome, Apparent; Triazoles; Voriconazole | 2018 |
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2018 |
Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.
Topics: Acetaminophen; Analgesics; Antifungal Agents; Aspirin; Candida; Candida albicans; Candida glabrata; Candidiasis; Dipyrone; Drug Resistance, Fungal; Fluconazole; Humans; Ibuprofen; Itraconazole; Meloxicam; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms.
Topics: Amino Acid Substitution; Animals; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Moths; Point Mutation; Polymorphism, Single Nucleotide; Triazoles; Voriconazole | 2018 |
Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; China; Cost-Benefit Analysis; Female; Fluconazole; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2018 |
Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials.
Topics: Antifungal Agents; Clinical Trials as Topic; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Simultaneous quantification of systemic azoles and their major metabolites in human serum by HPLC/PDA: role of azole metabolic rate.
Topics: Antifungal Agents; Azoles; Chromatography, High Pressure Liquid; Humans; Itraconazole; Serum; Triazoles; Voriconazole | 2018 |
Disseminated Exophiala dermatitidis causing septic arthritis and osteomyelitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Exophiala; Female; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Osteomyelitis; Phaeohyphomycosis; Triazoles; Voriconazole | 2018 |
A vexing case of bone pain in a renal transplant recipient: Voriconazole-induced periostitis.
Topics: Antifungal Agents; Drug Substitution; Graft Rejection; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Kidney Transplantation; Male; Middle Aged; Periostitis; Transplant Recipients; Triazoles; Voriconazole | 2018 |
Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.
Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2018 |
Quantification of Serum Voriconazole, Isavuconazole, and Posaconazole by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
Topics: Antifungal Agents; Chromatography, Liquid; Humans; Nitriles; Pyridines; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2018 |
Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candida glabrata; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Itraconazole; Lanosterol; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Sterol 14-Demethylase; Triazoles; Voriconazole | 2018 |
Treatment of Suspected Invasive Fungal Infection in War Wounds.
Topics: Administration, Topical; Afghan Campaign 2001-; Amphotericin B; Antifungal Agents; beta-Cyclodextrins; Debridement; Excipients; Humans; Mycoses; Recurrence; Risk Factors; Tobramycin; Treatment Outcome; Triazoles; Vancomycin; Voriconazole; Wounds and Injuries | 2018 |
Diagnosis and Treatment of Invasive Aspergillus fumigatus Wound Infection Following Subtotal Colectomy for Perforated Toxic Megacolon in an Immunosuppressed Patient.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colectomy; Debridement; Female; Humans; Immunocompromised Host; Megacolon, Toxic; Postoperative Complications; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Posaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Triazoles; Voriconazole | 2019 |
Inhibitory effect of isavuconazole, ketoconazole, and voriconazole on the pharmacokinetics of methadone in vivo and in vitro.
Topics: Analgesics, Opioid; Animals; Antifungal Agents; Ketoconazole; Male; Methadone; Nitriles; Pyridines; Rats, Sprague-Dawley; Triazoles; Voriconazole | 2019 |
Impact of Antifungal Compounds on Viability and Anti-
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Cell Survival; Deoxycholic Acid; Doxorubicin; Drug Combinations; Fluconazole; Humans; Killer Cells, Natural; Microbial Sensitivity Tests; Polyethylene Glycols; Triazoles; Voriconazole | 2019 |
Isavuconazole: Case Report and Pharmacokinetic Considerations.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bronchoalveolar Lavage Fluid; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Half-Life; Humans; Immunocompromised Host; Nitriles; Pyridines; Tandem Mass Spectrometry; Triazoles; Voriconazole; Young Adult | 2018 |
Yeast-like filamentous fungi: Molecular identification and in vitro susceptibility study.
Topics: Antifungal Agents; DNA, Fungal; Fluconazole; Fungi; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole | 2019 |
Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Retrospective Studies; Triazoles; United Kingdom; Voriconazole | 2019 |
The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchopulmonary Sequestration; Extracorporeal Membrane Oxygenation; Humans; Influenza, Human; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Predicting the Effects of Different Triazole Antifungal Agents on the Pharmacokinetics of Tamoxifen.
Topics: Antifungal Agents; Bone Density Conservation Agents; Drug Interactions; Female; Fluconazole; Forecasting; Humans; Itraconazole; Middle Aged; Models, Biological; Tamoxifen; Triazoles; Voriconazole | 2019 |
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Case-Control Studies; Cost-Benefit Analysis; Decision Trees; Female; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Quality-Adjusted Life Years; Sweden; Triazoles; Voriconazole | 2019 |
The Evolution of Azole Resistance in
Topics: Amino Acid Sequence; Antifungal Agents; Azoles; Candida albicans; Fluconazole; Fungal Proteins; Itraconazole; Mutation; Protein Binding; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |
First fungemia case due to environmental yeast Wickerhamomyces myanmarensis: detection by multiplex qPCR and antifungal susceptibility.
Topics: Antifungal Agents; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Male; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Saccharomycetales; Triazoles; Voriconazole | 2019 |
Why do lung transplant patients discontinue triazole prophylaxis?
Topics: Adult; Aged; Antifungal Agents; Drug Interactions; Female; Humans; Invasive Fungal Infections; Itraconazole; Lung Transplantation; Male; Medication Adherence; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Voriconazole | 2019 |
Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center.
Topics: Academic Medical Centers; Adult; Aged; Antifungal Agents; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2019 |
Antifungal Drugs Influence Neutrophil Effector Functions.
Topics: Amphotericin B; Antifungal Agents; Interleukin-8; Neutrophils; Nitriles; Phagocytosis; Pyridines; Triazoles; Voriconazole | 2019 |
Comparison of the inhibitory effect of ketoconazole, voriconazole, fluconazole, and itraconazole on the pharmacokinetics of bosentan and its corresponding active metabolite hydroxy bosentan in rats.
Topics: Animals; Antifungal Agents; Antihypertensive Agents; Bosentan; Drug Interactions; Fluconazole; Itraconazole; Ketoconazole; Male; Rats; Rats, Sprague-Dawley; Triazoles; Voriconazole | 2020 |
When medicine transforms art.
Topics: Adult; Antifungal Agents; Art; Coccidioidomycosis; Color; Female; Humans; Lung; Tomography, X-Ray Computed; Triazoles; Vision Disorders; Voriconazole | 2019 |
The cost-effectiveness of isavuconazole compared to the standard of care in the treatment of patients with invasive fungal infection prior to differential pathogen diagnosis in the United Kingdom.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Trees; Diagnosis, Differential; Health Expenditures; Health Resources; Health Services; Hospitalization; Humans; Invasive Fungal Infections; Models, Economic; Nitriles; Prescription Fees; Pyridines; Quality-Adjusted Life Years; State Medicine; Survival Analysis; Triazoles; Uncertainty; United Kingdom; Voriconazole | 2020 |
Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.
Topics: Administration, Topical; Antifungal Agents; Aspergillus fumigatus; Benzamides; Cell Line; Drug Synergism; Humans; Pulmonary Alveoli; Pulmonary Aspergillosis; Triazoles; Voriconazole | 2019 |
Isavuconazole and voriconazole inhibition of sterol 14α-demethylases (CYP51) from Aspergillus fumigatus and Homo sapiens.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Aspergillus fumigatus; Cytochrome P450 Family 51; Humans; Inhibitory Concentration 50; Nitriles; Protein Binding; Pyridines; Recombinant Proteins; Sterols; Triazoles; Voriconazole | 2019 |
Impact of Triazole Therapeutic Drug Monitoring Availability and Timing.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2019 |
Aerosolization of Second-generation Triazoles: In Vitro Evaluation and Application in Therapy of Invasive Airway Aspergillosis.
Topics: Administration, Inhalation; Adult; Aerosols; Antifungal Agents; Aspergillosis; Bronchoscopy; Feasibility Studies; Female; Humans; Invasive Fungal Infections; Lung Transplantation; Respiratory Tract Infections; Triazoles; Voriconazole | 2019 |
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole | 2019 |
Use of triazoles for the treatment of invasive aspergillosis: A three-year cohort analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Cohort Studies; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2020 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |
Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2020 |
Simultaneous quantitation of five triazole anti-fungal agents by paper spray-mass spectrometry.
Topics: Antifungal Agents; Dried Blood Spot Testing; Drug Monitoring; Fluconazole; Humans; Isotope Labeling; Laboratories; Limit of Detection; Paper; Reference Standards; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2020 |
[Cryptic Aspergillus species - a case report of chronic cavitary pulmonary Aspergillus lentulus infection in a heart transplant recipient].
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Heart Transplantation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Transplant Recipients; Triazoles; Voriconazole | 2019 |
Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
Topics: Adolescent; Adult; Allografts; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2018 |
Synergistic effects of vorinostat (SAHA) and azoles against Aspergillus species and their biofilms.
Topics: Aspergillus; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; Azoles; Biofilms; Drug Synergism; Gene Expression Regulation; HSP90 Heat-Shock Proteins; Itraconazole; Microbial Sensitivity Tests; Plankton; Triazoles; Voriconazole; Vorinostat | 2020 |
Novel Application of Pentabromobenzyl Column for Simultaneous Determination of Eight Antifungal Drugs Using High-performance Liquid Chromatography.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Clotrimazole; Humans; Hydrocarbons, Brominated; Imidazoles; Ketoconazole; Liquid-Liquid Extraction; Molecular Structure; Thiophenes; Triazoles; Voriconazole | 2020 |
In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017-2018.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Nitriles; Public Health Surveillance; Pyridines; Triazoles; Voriconazole | 2020 |
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Tinea Pedis; Triazoles; Trichophyton; Voriconazole | 2020 |
COVID-19 associated pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; Female; Galactose; Germany; Hemorrhage; Hospitals, Teaching; Humans; Intensive Care Units; Lung Diseases; Male; Mannans; Metapneumovirus; Middle Aged; Nitriles; Pandemics; Paramyxoviridae Infections; Pneumonia, Viral; Pulmonary Aspergillosis; Pyridines; Respiratory Distress Syndrome; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2020 |
Successful treatment of Aspergillus fumigatus sternal osteomyelitis with isavuconazole in a heart transplant recipient.
Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Heart Transplantation; Humans; Male; Nitriles; Osteomyelitis; Pyridines; Triazoles; Voriconazole | 2020 |
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
Topics: Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Incidence; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Skin Neoplasms; Triazoles; United States; Voriconazole | 2020 |
Isavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients.
Topics: Antifungal Agents; Humans; Lung; Nitriles; Pyridines; Retrospective Studies; Transplant Recipients; Triazoles; Voriconazole | 2021 |
Central nervous system blastomycosis clinical characteristics and outcomes.
Topics: Adult; Antifungal Agents; Azoles; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Cohort Studies; Female; Humans; Male; Middle Aged; Tennessee; Treatment Outcome; Triazoles; Voriconazole | 2021 |
Revision of EUCAST breakpoints: consequences for susceptibility of contemporary Danish mould isolates to isavuconazole and comparators.
Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; Denmark; Drug Resistance, Fungal; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2020 |
Topics: Antifungal Agents; Ascomycota; Fungi; Microbial Sensitivity Tests; Nitriles; Pyridines; Thiazoles; Triazoles; Voriconazole | 2020 |
Successful challenge of voriconazole in a patient with posaconazole-associated minor drug eruption: A case report.
Topics: Adult; Antifungal Agents; Diagnosis, Differential; Drug Eruptions; Female; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Triazoles; Voriconazole | 2020 |
The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain.
Topics: Antifungal Agents; Aspergillosis; Clinical Laboratory Techniques; Cost-Benefit Analysis; Diagnosis, Differential; Fungi; Hospitalists; Humans; Mucormycosis; Nitriles; Pyridines; Spain; Standard of Care; Triazoles; Voriconazole | 2021 |
Antifungal susceptibility profile and molecular identification of Cyp51C mutations in clinical and environmental isolates of Aspergillus flavus from Argentina.
Topics: Amphotericin B; Antifungal Agents; Argentina; Aspergillosis; Aspergillus flavus; Cytochrome P450 Family 51; Drug Resistance, Fungal; Environmental Microbiology; Environmental Monitoring; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2021 |
Dementia-Like Symptoms Associated With Posaconazole.
Topics: Antifungal Agents; Dementia; Humans; Triazoles; Voriconazole | 2022 |
Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dasatinib; Drug Interactions; Drug Monitoring; Humans; Itraconazole; Ketoconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Models, Animal; Protein Kinase Inhibitors; Rats; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2020 |
Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Caspofungin; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Rhodotorula; Species Specificity; Triazoles; Voriconazole | 2020 |
Isavuconazole as Salvage Therapy for Refractory Pediatric Coccidioidal Meningitis.
Topics: Amphotericin B; Antifungal Agents; Child; Coccidioides; Coccidioidomycosis; Deoxycholic Acid; Drug Combinations; Humans; Meningitis, Fungal; Nitriles; Pyridines; Salvage Therapy; Triazoles; Voriconazole | 2021 |
Rapid and Simple Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) Method for Simultaneous Quantifications of Triazole Antifungals in Human Serum.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Itraconazole; Reproducibility of Results; Triazoles; Voriconazole | 2021 |
Isavuconazole nonwildtype Aspergillus fumigatus isolates from a global surveillance study display alterations in multiple genes involved in the ergosterol biosynthesis pathway not previously associated with resistance to other azoles.
Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Ergosterol; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole; Whole Genome Sequencing | 2021 |
Identification and in vitro antifungal susceptibility of causative agents of onychomycosis due to Aspergillus species in Mashhad, Iran.
Topics: Antifungal Agents; Aspergillus; Calmodulin; Fungal Proteins; Humans; Iran; Microbial Sensitivity Tests; Nitriles; Onychomycosis; Pyridines; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Tubulin; Voriconazole | 2021 |
Voriconazole-induced periostitis.
Topics: Adult; Antifungal Agents; Female; Humans; Periostitis; Radiography; Triazoles; Voriconazole | 2021 |
Disposition of posaconazole after single oral administration in large falcons (Falco spp): Effect of meal and dosage and a non-compartmental model to predict effective dosage.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Bird Diseases; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Falconiformes; Female; Male; Triazoles; Voriconazole | 2021 |
Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Mycoses; Sinusitis; Triazoles; Voriconazole | 2021 |
Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.
Topics: Animals; Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Nitriles; Pyridines; Retrospective Studies; Transplant Recipients; Triazoles; Voriconazole | 2021 |
Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for
Topics: Antifungal Agents; Disk Diffusion Antimicrobial Tests; Itraconazole; Madurella; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2021 |
Antifungal drugs work together to treat germs causing fungal infections.
Topics: Anidulafungin; Antifungal Agents; Candida auris; Candidiasis, Invasive; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Nitriles; Pyridines; Triazoles; Voriconazole | 2021 |
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Europe; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; North America; Opportunistic Infections; Triazoles; Voriconazole | 2021 |
The effect of biosynthesized selenium nanoparticles on the expression of CYP51A and HSP90 antifungal resistance genes in Aspergillus fumigatus and Aspergillus flavus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Itraconazole; Microbial Sensitivity Tests; Nanoparticles; Selenium; Triazoles; Voriconazole | 2022 |
Broad-spectrum azoles and flucloxacillin: a dangerous match.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Interactions; Drug Therapy, Combination; Female; Floxacillin; Humans; Male; Middle Aged; Nitriles; Pyridines; Staphylococcal Infections; Staphylococcus aureus; Triazoles; Voriconazole | 2022 |
Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada.
Topics: Antifungal Agents; Aspergillosis; Canada; Cost-Benefit Analysis; Humans; Invasive Pulmonary Aspergillosis; Nitriles; Pyridines; Triazoles; Voriconazole | 2022 |
Antifungal activity and mechanism of action of 2-chloro-N -phenylacetamide: a new molecule with activity against strains of Aspergillus flavus.
Topics: Antifungal Agents; Aspergillus flavus; Microbial Sensitivity Tests; Molecular Docking Simulation; Triazoles; Voriconazole | 2021 |
Interaction between flucloxacillin and azoles: Is isavuconazole next?
Topics: Antifungal Agents; Azoles; Drug Interactions; Floxacillin; Humans; Nitriles; Pyridines; Triazoles; Voriconazole | 2021 |
Azole resistance in Aspergillus fumigatus isolates from respiratory specimens in Lyon University Hospitals, France: prevalence and mechanisms involved.
Topics: Antifungal Agents; Aspergillus fumigatus; Cross-Sectional Studies; Cytochrome P-450 Enzyme System; France; Fungal Proteins; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Pyridines; Respiratory Tract Infections; Retrospective Studies; Triazoles; Tubulin; Voriconazole | 2021 |
Evaluation of Voriconazole and Posaconazole Dosing in Patients With Thermal Burn Injuries.
Topics: Adult; Antifungal Agents; Azoles; Burns; Humans; Retrospective Studies; Triazoles; Voriconazole | 2022 |
Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance.
Topics: Animals; Antifungal Agents; Aspergillosis; Clinical Decision Rules; Invasive Fungal Infections; Triazoles; Voriconazole | 2021 |
Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib.
Topics: Antifungal Agents; Carcinoma, Non-Small-Cell Lung; Crizotinib; Fluconazole; Humans; Itraconazole; Lung Neoplasms; Triazoles; Voriconazole | 2022 |
A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Atrial Fibrillation; Bronchoscopy; COVID-19; Dexamethasone; Diabetes Mellitus, Type 2; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mucormycosis; Nitriles; Obesity; Oxygen Inhalation Therapy; Pulmonary Aspergillosis; Pyridines; Respiration, Artificial; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2022 |
Topics: Antifungal Agents; Aspergillus; Azoles; Candida; Candida albicans; Drug Resistance, Fungal; Exophiala; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Morpholines; Sirolimus; TOR Serine-Threonine Kinases; Triazoles; Voriconazole | 2022 |
Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia.
Topics: Adult; Fluconazole; Humans; Leukemia, Promyelocytic, Acute; Male; Papilledema; Pseudotumor Cerebri; Tretinoin; Triazoles; Voriconazole; Young Adult | 2022 |
Successful treatment of angioinvasive aspergillosis causing diaphragmatic rupture with bowel perforation and cerebral aspergillosis in a patient with FLT3-mutated acute myeloid leukemia: A case report.
Topics: Adult; Antifungal Agents; fms-Like Tyrosine Kinase 3; Humans; Intestinal Perforation; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Micafungin; Pyrimidines; Thoracic Injuries; Triazoles; Voriconazole | 2022 |
Itraconazole and Voriconazole: The Complexity of Dose Adjustments.
Topics: Antifungal Agents; Humans; Itraconazole; Triazoles; Voriconazole | 2022 |
Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies.
Topics: Adult; Antifungal Agents; Azoles; Chemical and Drug Induced Liver Injury; Echinocandins; Fungi; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Retrospective Studies; Triazoles; Voriconazole | 2022 |
Real-World Comparison of Isavuconazole and Voriconazole in Terms of the Need for Dosage Adjustments Guided by Clinical Pharmacological Advice During Primary Prophylaxis of Invasive Fungal Infections in Pediatric Patients with Hemato-Oncological Malignanci
Topics: Antifungal Agents; Azoles; Child; Humans; Invasive Fungal Infections; Neoplasms; Nitriles; Pyridines; Retrospective Studies; Triazoles; Voriconazole | 2022 |
Triazole-resistant
Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; China; Drug Resistance, Fungal; Fermentation; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2022 |
Voriconazole in Hematopoietic Stem Cell Transplantation and Cellular Therapies: Real-World Usage and Therapeutic Level Attainment at a Major Transplantation Center.
Topics: Adult; Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Receptors, Chimeric Antigen; Triazoles; Voriconazole | 2022 |
Horizontal Gene Transfer of Triazole Resistance in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Fungal; Fungal Proteins; Fungi; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2022 |
External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy.
Topics: Adult; Antifungal Agents; Bayes Theorem; China; Hematologic Neoplasms; Humans; Models, Biological; Triazoles; Voriconazole | 2022 |
In vitro synergistic antifungal activities of caspofungin in combination with fluconazole or voriconazole against Candida species determined by the Etest method.
Topics: Antifungal Agents; Candida; Candida glabrata; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2022 |
Antifungal prophylactic effectiveness and intrapulmonary concentrations of voriconazole versus posaconazole in lung transplant recipients.
Topics: Animals; Antifungal Agents; Humans; Invasive Fungal Infections; Lung; Retrospective Studies; Transplant Recipients; Triazoles; Voriconazole | 2022 |
Voriconazole-induced severe skin allergy and neurological adverse event in a liver failure patient: A case report.
Topics: Adult; Antifungal Agents; Humans; Hypersensitivity; Liver Failure; Male; Triazoles; Voriconazole | 2022 |
Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains.
Topics: Antifungal Agents; Aspergillus; Azoles; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2023 |
In vitro activity of isavuconazole against clinically relevant Trichosporon species: a comparative evaluation of EUCAST broth microdilution and MIC Test Strip methods.
Topics: Antifungal Agents; Fluconazole; Microbial Sensitivity Tests; Triazoles; Trichosporon; Voriconazole | 2023 |
In vitro antifungal and antibiofilm activities of auranofin against itraconazole-resistant Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Auranofin; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2023 |
Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies.
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Nitriles; Prospective Studies; Triazoles; Voriconazole | 2023 |
A case of drug-induced myopathy in alcoholic cirrhosis caused by voriconazole.
Topics: Aged; Antifungal Agents; Humans; Liver Cirrhosis, Alcoholic; Micafungin; Triazoles; Voriconazole | 2023 |
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis-a two-centre observational study.
Topics: Animals; Antifungal Agents; COVID-19; Pulmonary Aspergillosis; Retrospective Studies; Triazoles; Voriconazole | 2023 |
Antifungal susceptibility patterns for Aspergillus, Scedosporium, and Exophiala isolates recovered from cystic fibrosis patients against amphotericin B, and three triazoles and their impact after long-term therapies.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Azoles; Cystic Fibrosis; Exophiala; Itraconazole; Scedosporium; Triazoles; Voriconazole | 2023 |
HPLC-MS/MS Method Validation for Antifungal Agents in Human Serum in Clinical Application.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Itraconazole; Tandem Mass Spectrometry; Triazoles; United States; Voriconazole | 2023 |
Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia.
Topics: Antifungal Agents; Child; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Retrospective Studies; Triazoles; Voriconazole | 2023 |
Triazole Antifungal Quantification for Therapeutic Drug Monitoring in Serum by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): Posaconazole, Voriconazole, Itraconazole, and Hydroxyitraconazole.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Monitoring; Itraconazole; Methanol; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2024 |